# EDGAR Filing Document

**Accession Number:** 0000849395
**File Stem:** 0001628280-26-021560
**Filing Date:** 2026-3
**Character Count:** 581216
**Document Hash:** 5a4bfc1aaf27554c73c9c3a2c8296f53
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-021560.hdr.sgml**: 20260327

**ACCESSION NUMBER**: 0001628280-26-021560

**CONFORMED SUBMISSION TYPE**: DEF 14A

**PUBLIC DOCUMENT COUNT**: 113

**CONFORMED PERIOD OF REPORT**: 20260327

**FILED AS OF DATE**: 20260327

**DATE AS OF CHANGE**: 20260327

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CRH PUBLIC LTD CO
- **CENTRAL INDEX KEY:** 0000849395
- **STANDARD INDUSTRIAL CLASSIFICATION:** CEMENT, HYDRAULIC [3241]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEF 14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-32846
- **FILM NUMBER:** 26800765

**BUSINESS ADDRESS:**
- **STREET 1:** STONEMASON'S WAY, RATHFARNHAM
- **CITY:** DUBLIN 16
- **STATE:** L2
- **ZIP:** D16 KH51
- **BUSINESS PHONE:** 353 1 404 1000

**MAIL ADDRESS:**
- **STREET 1:** STONEMASON'S WAY, RATHFARNHAM
- **CITY:** DUBLIN 16
- **STATE:** L2
- **ZIP:** D16 KH51

?xml version='1.0' encoding='ASCII'? crh-20260326

1<br>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

SCHEDULE 14A

PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES

EXCHANGE ACT OF 1934 (AMENDMENT NO.)

Filed by the Registrant ☑

Filed by a party other than the Registrant ☐

Check the appropriate box:

---

| | |
|:---|:---|
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☑ | Definitive Proxy Statement |
| ☐ | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a-12 |

---

![CRH-Logo-FullColour-RGB.jpg](crh-20260326_g1.jpg)<br>

CRH public limited company

(Name of Registrant as Specified In Its Charter)

---

| | |
|:---|:---|
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) | (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
| Payment of Filing Fee (Check all boxes that apply): | Payment of Filing Fee (Check all boxes that apply): |
| ☑ | No fee required |
| ☐ | Fee paid previously with preliminary materials |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |

---

![CRH3080_MASTER_Assets_FEB_FC.jpg](crh-20260326_g2.jpg)

![CRH-Logo-FullColour-RGB.jpg](crh-20260326_g1.jpg)<br>

Built for Growth,

Notice of Meeting and Proxy Statement 2026

This Notice of Meeting and Proxy Statement (this 'Proxy Statement') is important and requires your immediate attention. If you are in any doubt as to any aspect of the

Proposals referred to in this Proxy Statement or as to the action you should take, you should consult your broker, financial advisor, legal advisor or accountant or other

independent professional advisor. The Proxy Statement should be read as a whole. Your attention is drawn to the Letter from the Chair, which is set out on pages 3 to 4

of this Proxy Statement. We recommend that you review the information on the process for, and deadlines applicable to, attending the 2026 Annual General Meeting

(the '2026 AGM') and appointing a proxy in the General Information section on pages 84 to 88 of this Proxy Statement.

**Important Notice Regarding the Availability of Proxy Materials for the 2026 AGM to be held on May 7, 2026**

We have elected to take advantage of the U.S. Securities and Exchange Commission (the 'SEC') rules that allow us to provide shareholders access to our proxy

materials electronically. Our Annual Report for the fiscal year ended December 31, 2025 (the '2025 Annual Report') and this Proxy Statement are available at

www.envisionreports.com/CRH. On behalf of our Board of Directors, we are making these materials available to you beginning on or about March 27, 2026 in

connection with CRH's solicitation of proxies for the 2026 AGM. Beginning on March 27, 2026, we mailed to our shareholders a Notice of Internet Availability of Proxy

Materials (the 'Notice of Internet Availability') containing instructions regarding how to access the 2025 Annual Report and the Proxy Statement online. The Notice of

Internet Availability contains instructions regarding how you can elect to receive these proxy materials in printed form by mail or electronically by e-mail. This election to

receive proxy materials by mail or e-mail will remain in effect until you terminate it.

![CRH3080_MASTER_Assets_FEB_FC2.jpg](crh-20260326_g3.jpg)

1<br>

CRH PROXY STATEMENT 2026

The Leading Provider

of Building Materials

**As the leading provider of** 

**building materials, CRH is** 

**critical to the modernization** 

**of infrastructure.** 

With a network of 83,000 people across

4,000 locations in 28 countries, we connect

deep local relationships with our global

expertise and unmatched scale.

Our connected portfolio positions us as the

partner of choice across transportation,

water and reindustrialization projects and

enables us to play a vital role in economic

growth, building and maintaining the critical

infrastructure networks that our economies

rely on.

With leading positions in high-growth

markets and strong exposure to growing

infrastructure megatrends that create

significant opportunities for growth, CRH is

uniquely positioned to reimagine the built

environment to shape our communities for a

better tomorrow.

---

| | |
|:---|:---|
| **Inside this Document** |  |
| [Letter from the Chair](#if1c879db7a4c45ea95381876b038728a_16) | [3](#if1c879db7a4c45ea95381876b038728a_16) |
| [Performance Highlights 2025](#if1c879db7a4c45ea95381876b038728a_19) | [5](#if1c879db7a4c45ea95381876b038728a_19) |
| [Share Price Performance](#if1c879db7a4c45ea95381876b038728a_22) | [6](#if1c879db7a4c45ea95381876b038728a_22) |
| [Our Growth Algorithm](#if1c879db7a4c45ea95381876b038728a_25) | [7](#if1c879db7a4c45ea95381876b038728a_25) |
| [Our Leading Performance](#if1c879db7a4c45ea95381876b038728a_28) | [8](#if1c879db7a4c45ea95381876b038728a_28) |
| [Investing for Future Growth](#if1c879db7a4c45ea95381876b038728a_31) | [9](#if1c879db7a4c45ea95381876b038728a_31) |
| [**Table of Contents**](#if1c879db7a4c45ea95381876b038728a_34) | [10](#if1c879db7a4c45ea95381876b038728a_34) |

---

![CRH3080_MASTER_Assets_FEB_FC3.jpg](crh-20260326_g4.jpg)

2<br>

CRH PROXY STATEMENT 2026

3<br>

CRH PROXY STATEMENT 2026

**Letter from the Chair**

CRH's Winning Way delivered record

financial results for 2025 with excellent

strategic progress

Dear Shareholder,

I am pleased to invite you to attend the 2026 AGM of CRH to be held on Thursday, May 7,

2026 at 11:00 a.m. (Dublin) at the Royal Marine Hotel, Marine Road, Dun Laoghaire, Co. Dublin,

Ireland. Details in relation to attending and voting on the Proposals on the agenda for the 2026

AGM are set out on pages 12 to 39 of this Proxy Statement.

![CRH3030_Letterhead_Shots_0001_Layer 2.jpg](crh-20260326_g5.jpg)

**Performance & Strategy**

In 2025, CRH's superior strategy, leading

performance, value-creating capital allocation

and proven growth capabilities delivered

another record performance. This was

underpinned by our unmatched scale,

connected portfolio, and unique,

entrepreneurial culture across our leading

market positions in North America, Europe

and Australia. Total revenues increased 5% to

$37.4 billion (2024: $35.6 billion), net income

was 8% ahead of 2024 at $3.8 billion (2024:

$3.5 billion) and Adjusted EBITDA\* rose 11%

to $7.7 billion (2024: $6.9 billion). CRH's

Diluted Earnings per Share ('Diluted EPS')

improved significantly, increasing by 10% to

$5.51 (2024: $5.02).

CRH continues to judiciously deploy capital,

investing for the future by way of acquisitions

and growth investments as well as returning

cash to shareholders through dividends and

share buybacks. In 2025, CRH invested $4.1

billion in 38 value-accretive acquisitions,

including the $2.1 billion acquisition of Eco

Material Technologies ('Eco Material'),

significantly strengthening our cementitious

materials platform in the United States.

We also invested $1.7 billion in growth capital

expenditure projects, leveraging our size and

scale to fully capitalize on investment

opportunities which expand our capabilities,

support margin growth and enhance long-term

shareholder value. These investments continue

to strengthen our connected growth platforms

of Aggregates, Cementitious, Roads and

Water to deliver for customers across our

end-markets.

We remain committed to our policy of

consistent long-term dividend growth. The

total dividend for 2025 was $1.48 per share,

representing an increase of approximately 6%

versus prior year (2024: $1.40). We also

returned $1.2 billion (2024: $1.3 billion) to

shareholders through our share buyback

program, repurchasing approximately 11.7

million Ordinary Shares in 2025 (2024: 15.9

million). On November 5, 2025, CRH

commenced a further share buyback tranche

of $0.3 billion, which was completed on

February 17, 2026 and the Company's Board

of Directors (the 'Board') has extended the

program with an additional $0.3 billion tranche

to be completed no later than April 28, 2026.

We will continue to assess our share buyback

program throughout 2026, providing further

Note:

\*Represents a non-GAAP financial measure. See the

discussion within 'Reconciliation of Non-GAAP

Figures' in Annex A for a definition and reconciliation

to the most directly comparable GAAP measure.

updates throughout the year.

Supported by CRH's excellent strategic

progress and record financial results, our

share price performed strongly in 2025,

delivering a Total Shareholder Return ('TSR')

of 36.8% for the 12 months ended December

31, 2025. The price per share increased from

$92.52 on December 31, 2024 to $124.80 on

December 31, 2025.

**S&P 500**

Following CRH's inclusion in the MSCI US and

Russell 1000, our inclusion in the S&P 500

from December 2025 is another important

milestone on our journey since the

establishment of our primary listing on the

New York Stock Exchange ('NYSE') in

September 2023.

**Safety and Well-Being**

The safety and well-being (including physical

and mental health) of our employees,

contractors, and other stakeholders is

embedded in CRH's values. Our ambition is to

have a culture of safety and wellness working

towards zero harm, with a goal of having zero

fatalities in any year. Regrettably, despite

these efforts, CRH recorded three fatalities

during the year. Our thoughts are with their

families and we will continue to make every

effort to reach our target of zero harm and

zero fatalities. The Safety, Environment &

Social Responsibility Committee, a Board

committee, receives regular reports in relation

to safety related policies, initiatives, measures,

metrics and incidents.

**London Stock Exchange Listings &**

**Preference Share Capital Structure**

Following a review of CRH's London Stock

Exchange ('LSE') Ordinary Share listing and

our Preference Share capital structure, we

announced on March 13, 2026 our intention to

delist from the LSE the Company's Ordinary

Shares and 7% Preference Shares (the 'LSE

Delisting') and, subject to shareholder

approval, to cancel the Company's 5% and

7% Preference Shares (the 'Preference Share

Cancellations'). As part of the review, CRH

carefully considered, among other factors, the

level of activity for its Ordinary Shares on the

4<br>

CRH PROXY STATEMENT 2026

LSE as well as the additional cost, regulatory

and administrative obligations arising from

retaining the LSE listings and maintaining the

5% and 7% Preference Shares. Following the

review, the Board is satisfied that it is in the

best interests of CRH, and its shareholders, to

proceed with the LSE Delisting and, subject to

shareholder approval, the Preference Share

Cancellations.

Once the LSE Delisting takes effect, CRH's

Ordinary Shares will be solely listed on the

NYSE.

**Management Succession** 

Jim Mintern succeeded Albert Manifold as

Chief Executive Officer effective January 1,

2025. CRH has already benefitted from, and

will continue to benefit from Jim's leadership.

On his appointment, the Board agreed a range

of personal and CRH objectives with Jim for

2025. These were all achieved.

A robust and comprehensive process,

supported by independent advisors, which

considered both internal and external

candidates, resulted in the appointment of

Nancy Buese as Jim's successor as Chief

Financial Officer, effective May 12, 2025.

Nancy has a very strong record of financial

leadership and operational insight which will

be deployed for CRH. Nancy's biographical

details are set out on page 41.

**Board Composition** 

**and Board Evaluation**

Our Board consists of 12 highly experienced

Directors with a balance of tenures and a

diversity of backgrounds and experience.

The biographies of the current Board members,

each of whom has been nominated to stand

for re-election at the 2026 AGM, are set out

on pages 19 to 22.

We have a robust process for appraising the

performance of Directors. Accordingly, having

reviewed the performance of each Board

member and the independence of the

non-management Directors, the Board is

recommending the re-election of each Director

by shareholders.

In line with our Corporate Governance

Guidelines, periodically our Board evaluation

processes are facilitated by a third-party

advisor. An externally facilitated process in

relation to the performance of the Board and

its Committees during 2025 is currently

ongoing.

Any resulting recommendations will be

reviewed by the Nomination & Corporate

Governance Committee with appropriate

action plans being developed for consideration

by the Board.

**Executive Compensation** 

The report from the Compensation Committee

on page 49 and the detailed disclosures in the

"Compensation Discussion & Analysis" (CD&A)

section on pages 50 to 80 outline how our

executive compensation policies were applied

during 2025.

**2026 AGM** 

There are 12 Proposals on the agenda of the

2026 AGM for consideration by shareholders.

These include resolutions regarding the

re-election of Directors, executive

compensation for 2025, the appointment and

compensation of the external auditors and the

renewal of shareholder authorities required

under Irish law. Resolutions in relation to the

following items of special business are also

included:

**Proposed Preference Share Cancellations**

As noted above, the Board proposes, subject

to shareholder approval, to retire the

Company's two classes of legacy Preference

Shares by cancelling them in exchange for a

cash payment to the holders. A detailed

description of the proposed process to cancel

the Preference Shares, including the

shareholder approvals required, is set out on

pages 31 to 34. Your Board believes that the

Preference Share Cancellations, if

implemented, would result in a number of

benefits for CRH and its shareholders,

including reducing certain administrative

obligations and streamlining applicable

regulatory requirements, while providing an

opportunity for the Preference Shareholders to

monetize their holdings. The Preference

Shares are separate and independent from the

Ordinary Shares, and the Ordinary Shares will

not be impacted by the proposed

cancellations.

**Proposed Amendment to Articles** 

**of Association**

The Board is proposing to amend the

Company's Articles to delete a qualification

shareholding requirement for Directors to

better align with U.S. market practice. The

Company's share ownership guidelines, which

were revised in 2025, now also apply to non-

management Directors and require

significantly higher holdings than those

required under the Articles.

A detailed description of the proposed

amendment is set out on page 39.

**Shareholder Engagement**

CRH devotes considerable time and resources

each year to shareholder engagement. We

recognize the importance of effective dialogue as

an integral element of good corporate

governance. The Investor Relations team,

together with the Chief Executive Officer, Chief

Financial Officer and other senior executives,

regularly meet with institutional shareholders. I

also engage with shareholders regularly on behalf

of the Board to discuss the Board's priorities and

relevant governance matters. In addition, CRH

held an Investor Day on September 30, 2025 at

which we showcased how our strategy positions

us to deliver further growth and value for our

shareholders.

**Conclusion**

The Board of CRH is very appreciative of the

ongoing commitment of CRH's employees to

delivering for our customers and our

shareholders. The quality, caliber, and

commitment of CRH's people was responsible

for CRH's excellent performance in 2025 and

underpins the Board's confidence in CRH's

future.

**Richie Boucher**

Chair

March 27, 2026

---

| | |
|:---|:---|
| **Board Priority Areas** | **Board Priority Areas** |
| **Priority Area** | **Commentary** |
| Operational Performance | Oversight of the ongoing enhancement of operational performance in CRH's existing and acquired businesses |
| Strategy | Overseeing strategy development and execution for CRH's businesses, including with respect to CRH's connected <br>portfolio and support for sustainable construction<br>|
| Capital Allocation | Overseeing the allocation of CRH's capital in terms of portfolio management through capital expenditure, acquisitions <br>and divestitures, as well as providing shareholder distributions through both dividends and share buybacks<br>|
| Human Capital <br>Management<br>| Oversight of policies and practices relating to workforce safety, engagement and development and ensuring the <br>continued ability for CRH's employees to contribute to CRH's success<br>|
| Succession Planning | Supporting succession transition and overseeing future succession planning |
| Governance | Ongoing Board performance evaluation and refreshment |
| Shareholder Engagement | Oversight of shareholder engagement, including efforts to increase investors' understanding of CRH and broadening <br>CRH's investor base, as well as understanding and responding to shareholders' insights and perspectives<br>|

---

5<br>

CRH PROXY STATEMENT 2026

**Performance Highlights 2025**

A Leading Compounder of Capital

We have a proven track record of delivering consistent growth and superior

value to our shareholders. In 2025, our connected portfolio and unmatched

scale delivered another year of double-digit Adjusted EBITDA\* growth and a

12<sup>th</sup> consecutive year of Adjusted EBITDA margin\* expansion<sup>1</sup>. This exceptional

consistency reflects the strength of our unique growth algorithm and reinforces

our position as the leading compounder of capital in our industry.

**Revenues** 

($B)

$37.4B

+5% ▲

![547](crh-20260326_g6.gif)

![548](crh-20260326_g7.gif)

![549](crh-20260326_g8.gif)

**Net Income** 

($B)

$3.8B

+8% ▲

![581](crh-20260326_g9.gif)

![582](crh-20260326_g10.gif)

![583](crh-20260326_g11.gif)

**Adjusted** 

**EBITDA\*** ($B)

$7.7B

+11% ▲

![622](crh-20260326_g12.gif)

![623](crh-20260326_g13.gif)

![624](crh-20260326_g14.gif)

![](crh-20260326_g15.gif)

![](crh-20260326_g15.gif)

![](crh-20260326_g15.gif)

**Net Income** 

**Margin** (%)

10.1%

+20bps ▲

![669](crh-20260326_g16.gif)

![670](crh-20260326_g17.gif)

![671](crh-20260326_g18.gif)

![](crh-20260326_g15.gif)

![](crh-20260326_g15.gif)

**Adjusted EBITDA**

**Margin\*** (%)

20.5%

+100bps ▲

![720](crh-20260326_g19.gif)

![721](crh-20260326_g20.gif)

![722](crh-20260326_g21.gif)

**Diluted** 

**EPS** ($)

$5.51

+10% ▲

![756](crh-20260326_g22.gif)

![757](crh-20260326_g23.gif)

![758](crh-20260326_g24.gif)

![](crh-20260326_g15.gif)

Notes:

\*Represents a non-GAAP financial measure. See the discussion within 'Reconciliation of Non-GAAP Figures' in Annex A for a definition and reconciliation to the most directly comparable GAAP

measure.

1. Based on IFRS financial reporting through 2022 and U.S. GAAP for 2023 through 2025.

6<br>

CRH PROXY STATEMENT 2026

**Share Price Performance**

Another Strong Share

Price Performance

CRH's share price posted strong gains in 2025 significantly outperforming

both the S&P 500 Index and the S&P 500 Materials Index over the period.

Combined with our policy of consistent long-term dividend growth, the Total

Shareholder Return was 36.8% representing another impressive performance

and delivery for our shareholders.

![](crh-20260326_g25.gif)

![230](crh-20260326_g26.gif)

**+35%**

CRH

**CRH Share Price Performance**

The CRH share price performed strongly in

2025, significantly outperforming both the S&P

500 Index and S&P 500 Materials Index over

the 12 months ended December 31, 2025.

The shares returned 35% (before dividends) in

the period and reached a new record high of

$128.94 per share in December.

For comparability, price

performance rebased = 100

+16%

S&P 500

+8%

S&P 500

Materials

Dec 24

Dec 25

![](crh-20260326_g27.gif)

![](crh-20260326_g25.gif)

**Five-Year Comparative Total Return**![148](crh-20260326_g28.gif)

**to Shareholders 2020 - 2025**<sup>2</sup>

For comparability, price

performance rebased = 100

**+27%**

CRH

In the five years since 2020, CRH's cumulative

TSR has outperformed both the S&P 500 Index

and the S&P 500 Materials Index. On an

annualized basis, the CRH TSR was 27% over

the period. Since 1970 the Company has

delivered an industry-leading compound

+14%

S&P 500

annualized long-term TSR of 16.3%. This track

record makes us the leading compounder of

capital in our industry.

+7%

S&P 500

Materials

CRH has produced an industry-leading

compound annualized long-term TSR of

16.3% since 1970

2020

2025

![](crh-20260326_g29.gif)

Note:

2. Long-term TSR represents the total accumulated value delivered to shareholders (via gross dividends reinvested and share appreciation) if €100 was invested in CRH shares in 1970. The

graph showing the Five-Year Comparative Total Return to Shareholders 2020-2025 assumes that the initial investment in our Ordinary Shares and each index was €100, with reinvestment

of dividends. Performance data for the Company is provided as of the last trading day of each relevant fiscal year.

![CRH3080_MASTER_Assets_FEB_.jpg](crh-20260326_g30.jpg)

7<br>

CRH PROXY STATEMENT 2026

**Our Growth Algorithm**

Strong foundation for continued

growth across the portfolio

Growing infrastructure megatrends present a strong foundation for continued growth

across our connected portfolio. Coupled with our Winning Way, this has delivered

consistent value for shareholders, positioning CRH as the leading compounder of

capital in our industry.

**Growing** 

**Megatrends**

**Capitalizing on Growing Megatrends**

Our connected portfolio is strategically aligned with growing

infrastructure megatrends across the transportation, water, and

reindustrialization construction markets. In this way we are

addressing population growth, an expanding economy, climate

resiliency, and aging infrastructure – all powerful catalysts of

growth for our business. The urgent need for more resilient,

modernized infrastructure increasingly plays to the strength of

our Aggregates, Cementitious, Roads and Water growth

platforms.

Infrastructure

Transportation

Water

![](crh-20260326_g31.gif)

Reindustrialization

![](crh-20260326_g31.gif)

**CRH**

**Winning Way**

**Our Winning Way**

Driven by a unique entrepreneurial culture developed over

the last five decades, our Winning Way is built upon four

key levers which drive the continued execution of our

superior strategy, leading performance across our 4,000

locations, a relentless focus on allocating capital to

maximize shareholder value, and underpins our proven

growth capabilities. These levers are supported by our

connected portfolio, leading positions of scale, a

customer centric focus, and our empowered local teams.

**Leading** 

**Compounder**

**of Capital**

**A Leading Compounder of Capital**

Our strong track record of consistent long-term delivery,

positions CRH as the leading compounder of capital in

our industry. This is evidenced by our ten-year Diluted

EPS compound annual growth rate (CAGR) and

annualized total shareholder return (TSR) both of which

increased by 19%<sup>3</sup>over the period.

Proven long-term delivery

Double-digit earnings growth<sup>3</sup>

![](crh-20260326_g32.gif)

Note:

3. 'Double-digit earnings growth' refers to CRH's compound annualized growth rate of Adjusted EBITDA, a non-GAAP financial measure, for the period from December 31, 2015 to December

31, 2025. Metrics from the financial year ended December 31, 2015 are based on IFRS. 2015 EBITDA has been modified to exclude contributions from subsequently divested businesses.

The adjustments required to reflect these metrics under U.S. GAAP have not been quantified. No material differences have been identified that would impact trends calculated in

accordance with U.S. GAAP in comparison to IFRS. For source data of these 2015 metrics, please see the discussion within 'Reconciliation of Non-GAAP Figures' in Annex A.

![CRH3080_MASTER_Assets_FEB.jpg](crh-20260326_g33.jpg)

8<br>

CRH PROXY STATEMENT 2026

**Our Leading Performance**

Our Leading Performance

Our culture of leading performance is a proven driver of excellence.

Our operating businesses are locally-led, but benefit from a globally-enabled

performance model that we replicate at scale to unlock new levels of

performance. Our ability to replicate and scale our innovation and technical

expertise across multiple geographies is one such example of our

ability to unlock tremendous opportunity for further growth.

**Our Leading Performance** 

**in Action**

CRH is committed to driving profitable

growth by providing our customers with

innovative solutions that make

construction simpler, safer, and more

sustainable. Sustainability is embedded

in our strategy and an important enabler

of our leading performance model.

Our sustainability framework identifies

three areas: water, circularity and

decarbonization, where CRH's connected

portfolio positions us to capture further

value and accelerate growth across each

of our four growth platforms.

**Tonnes of wastes and** 

**by-products recycled (mt)**

**Revenues from products** 

**with enhanced sustainability** 

**attributes ($B)**<sup>4</sup>

**Delivering Value through Innovation** 

Innovation at CRH is a catalyst for driving

value creation at scale. We combine deep

technical expertise with an open innovation

model which harnesses the strength of our

own internal research and development

with that of our strategic external

partnerships.

**Investing in Next-Generation** 

**Materials**

CRH's $2.1 billion acquisition of Eco

Material during the year is a clear

demonstration of our commitment to

innovation and marked a strategic

milestone in our Cementitious strategy.

By integrating Eco Material, a leader in

Supplementary Cementitious Materials

(SCMs) such as fly ash and pozzolans,

CRH is positioning itself at the forefront

of next-generation cement and concrete.

![27](crh-20260326_g34.gif)

![81](crh-20260326_g35.gif)

![96](crh-20260326_g36.gif)

**Reducing Water Loss** 

**Through Artificial Intelligence (AI)**

During the year CRH expanded our smart

infrastructure capabilities through the

investment in VODA.ai - a predictive

analytics platform that uses AI to assess

water pipe conditions and risks, enabling

smarter asset management for utilities.

The partnership enhances our customer-

facing CivilSense™ platform, operated

by Oldcastle Infrastructure, by combining

cutting-edge AI-driven predictive analytics

with real-time leak detection, enabling

utilities to proactively identify and address

potential pipe failures before they escalate.

This reduces water loss and addresses

some of the urgent challenges posed

by aging infrastructure and the need for

innovative, climate-resilient solutions.

![](crh-20260326_g15.gif)

![66](crh-20260326_g37.gif)

![111](crh-20260326_g38.gif)

![126](crh-20260326_g39.gif)

![](crh-20260326_g15.gif)

Notes:

4. Revenues from products with enhanced sustainability attributes is defined as revenues derived from those products that incorporate any, or a combination of: recycled materials; are

produced using alternative energy and fuel sources; have a lower carbon footprint as compared to those products using traditional manufacturing processes; and/or are designed to

specifically benefit the environment.

![CRH25_MASTER_Assets_3.jpg](crh-20260326_g40.jpg)

9<br>

CRH PROXY STATEMENT 2026

**Investing for Future Growth**

Investing for Growth and

Further Value Creation

In 2025, CRH continued to strengthen our leadership positions

with strategic acquisitions in high-growth markets across

North America, Europe and Australia.

In 2025, CRH completed 37 bolt-on deals for

$2 billion, in addition to the $2.1 billion

strategic acquisition of Eco Material, the

leading supplier of SCMs in North America.

In many instances these acquisitions are

originated by our local teams with long-term

relationships generating significant competitive

advantage when it comes to investment

opportunities. This underpins our future

acquisition pipeline and reinforces our position

as the acquirer of choice for small and

medium-sized businesses in our industry.

These bolt-on investments, combined with

larger strategic acquisitions, have further

strengthened and sharpened our connected

Aggregates, Cementitious, Roads and Water

growth platforms to deliver for our customers.

**Strong Balance Sheet** 

**Provides Further Optionality**

Backed by our compelling growth profile,

consistent cash generation and the strength of

our balance sheet, we expect to have $40

billion in financial capacity to deploy for growth

investments and shareholder returns over the

five-year period from 2026-2030. Of this,

approximately 70% is expected to be allocated

to our strong M&A pipeline and strategic

growth investments that maintain and grow our

market leading positions, through high-

returning, low-risk growth capital expenditure

projects. We will also continue our track record

of value-accretive returns to shareholders

through our policy of consistent long-term

dividend growth and share buybacks.

**Financial Capacity**<sup>5</sup>

~$40B

2026—2030

![1512](crh-20260326_g41.gif)

---

| | |
|:---|:---|
| Growth Investments | **70%** |
| Shareholder Returns | **30%** |

---

$4.1B

M&A spend on 38 value-

enhancing acquisitions

$1.2B

Spend on repurchase of

Ordinary Shares in 2025

$1.0B

Returned to shareholders

through dividend payments

in 2025

Note:

5. Financial capacity is defined as the anticipated cash and debt financing available (after maintenance capital expenditure) for growth investments and cash returns to shareholders. The

information shown above is indicative only and any capital deployment will be dependent on the value creation opportunities arising over the period. CRH's ability to deliver on its financial

capacity ambitions is dependent on it achieving its planning assumptions, which may be negatively impacted by (but not limited to) adverse changes in economic conditions in the countries

where CRH operates, a slowdown in the growth of the overall construction and building materials sector or changes in availability of public funding for infrastructure, and other factors

discussed under the heading "Risk Factors" in CRH's 2025 Annual Report filed with the SEC on February 18, 2026.

![CRH3080_MASTER_Assets_FEB.jpg](crh-20260326_g42.jpg)

10<br>

![CRH3080_MASTER_Assets_FEB.jpg](crh-20260326_g43.jpg)

Table of

Contents

---

| | |
|:---|:---|
| [Notice of 2026 AGM](#if1c879db7a4c45ea95381876b038728a_37) | [12](#if1c879db7a4c45ea95381876b038728a_37) |
| [Proposals to be Voted on at the 2026 AGM](#if1c879db7a4c45ea95381876b038728a_40) | [13](#if1c879db7a4c45ea95381876b038728a_40) |
| [Proposal 1 - Re-election of Directors](#if1c879db7a4c45ea95381876b038728a_49) | [16](#if1c879db7a4c45ea95381876b038728a_49) |
| [Proposal 2 - Advisory Vote to Approve Named Executive Officer Compensation ('Say-on-Pay')](#if1c879db7a4c45ea95381876b038728a_52) | [24](#if1c879db7a4c45ea95381876b038728a_52) |
| [Proposal 3 -](#if1c879db7a4c45ea95381876b038728a_55) Ratification of the Appointment of Deloitte & Touche LLP as Auditor and Authority to Set the <br>Compensation of the Auditor<br>| [25](#if1c879db7a4c45ea95381876b038728a_55) |
| [Proposal 4 - Renewal of the Annual Authority of the Board of Directors to Issue Shares](#if1c879db7a4c45ea95381876b038728a_58) | [27](#if1c879db7a4c45ea95381876b038728a_58) |
| [Proposal 5 - R](#if1c879db7a4c45ea95381876b038728a_61)enewal of the Annual Authority of the Board of Directors to Issue Shares for Cash without first Offering <br>Shares to Existing Shareholders<br>| [28](#if1c879db7a4c45ea95381876b038728a_61) |
| [Proposal 6 - Renewal of the Annual Authority of the Board of Directors to Make Market Repurchases and Overseas](#if1c879db7a4c45ea95381876b038728a_64)<br>[Market Repurchases of t](#if1c879db7a4c45ea95381876b038728a_64)he Company's Issued Ordinary Shares<br>| [29](#if1c879db7a4c45ea95381876b038728a_64) |
| [Proposal 7](#if1c879db7a4c45ea95381876b038728a_67)-[To Renew the Annual Authority to Re-Issue Treasury Shares and Determine the Price Range at which](#if1c879db7a4c45ea95381876b038728a_67)<br>[the Company can Re-Issue Such Shares that it Holds as Treasury Shares](#if1c879db7a4c45ea95381876b038728a_67)<br>| [30](#if1c879db7a4c45ea95381876b038728a_67) |
| [Overview of Proposals 8 through 11 Relating to Proposed Cancellation of the Preference Shares](#if1c879db7a4c45ea95381876b038728a_70) | [31](#if1c879db7a4c45ea95381876b038728a_70) |
| [Proposal 8 - Approval of the Schemes of Arrangement to Cancel the Preference Shares and the Granting of Authority](#if1c879db7a4c45ea95381876b038728a_73)<br>[to the Directors to Give Effect to the Schemes of Arrangement](#if1c879db7a4c45ea95381876b038728a_73)<br>| [35](#if1c879db7a4c45ea95381876b038728a_73) |
| [Proposal 9 - Approval of the Proposed Cancellation of the Preference Shares](#if1c879db7a4c45ea95381876b038728a_76) | [36](#if1c879db7a4c45ea95381876b038728a_76) |
| Proposal 10 - Approval of the Variation to the Company's Authorized Share Capital by the Removal of the Cancelled <br>Preference Shares<br>| [37](#if1c879db7a4c45ea95381876b038728a_79) |
| [Proposal 11 - Approval of Certain Amendments to the Company's Articles](#if1c879db7a4c45ea95381876b038728a_79)to Remove References therein to any <br>Class(es) of Preference Shares Cancelled in Connection with the Proposed Preference Shares Cancellations <br>| [38](#if1c879db7a4c45ea95381876b038728a_82) |
| [Proposal 12 - Approval of an Amendment to the Company's Articles to Delete a Provision Regarding Qualification](#if1c879db7a4c45ea95381876b038728a_85)<br>[Shareholding Requirement for Directors Set Forth Therein](#if1c879db7a4c45ea95381876b038728a_85)<br>| [39](#if1c879db7a4c45ea95381876b038728a_85) |
| [Corporate Governance](#if1c879db7a4c45ea95381876b038728a_88) | [40](#if1c879db7a4c45ea95381876b038728a_88) |
| [Compensation Discussion](#if1c879db7a4c45ea95381876b038728a_91) & Analysis ('CD&A') | [49](#if1c879db7a4c45ea95381876b038728a_91) |
| Share [Ownership Information](#if1c879db7a4c45ea95381876b038728a_133) | [81](#if1c879db7a4c45ea95381876b038728a_133) |
| [Securities Authorized for Issuance Under Equity Compensation Plans](#if1c879db7a4c45ea95381876b038728a_139) | [82](#if1c879db7a4c45ea95381876b038728a_139) |
| R[elated Party Transactions](#if1c879db7a4c45ea95381876b038728a_142) | [82](#if1c879db7a4c45ea95381876b038728a_142) |
| [Insider Trading Arrangements and Policies](#if1c879db7a4c45ea95381876b038728a_148) | [83](#if1c879db7a4c45ea95381876b038728a_148) |
| [General Information](#if1c879db7a4c45ea95381876b038728a_151) | [84](#if1c879db7a4c45ea95381876b038728a_151) |
| [Annex A - Reconciliation of Non-GAAP Financial Measures](#if1c879db7a4c45ea95381876b038728a_154) | [89](#if1c879db7a4c45ea95381876b038728a_154) |
| [Annex B - Part I - 5% Preference Share Scheme of Arrangement](#if1c879db7a4c45ea95381876b038728a_160) | [91](#if1c879db7a4c45ea95381876b038728a_160) |
| [Annex B - Part II - 5% Preference Share Scheme of Arrangement Explanatory Statement](#if1c879db7a4c45ea95381876b038728a_163) | [97](#if1c879db7a4c45ea95381876b038728a_163) |
| [Annex C - Part I - 7% Preference Share Scheme of Arrangement](#if1c879db7a4c45ea95381876b038728a_166) | [104](#if1c879db7a4c45ea95381876b038728a_166) |
| [Annex C - Part II - 7% Preference Share Scheme of Arrangement Explanatory Statement](#if1c879db7a4c45ea95381876b038728a_169) | [110](#if1c879db7a4c45ea95381876b038728a_169) |
| Annex D - Proposal 11 - Proposed Amendments to Articles of Association | [117](#if1c879db7a4c45ea95381876b038728a_172) |
| [Annex E - FAQs Regarding the Preference Share Cancellations and Delistings](#if1c879db7a4c45ea95381876b038728a_175) | [125](#if1c879db7a4c45ea95381876b038728a_175) |
| [Annex F - Proposal 12 - Proposed Amendments to Articles of Association](#if1c879db7a4c45ea95381876b038728a_178) | [130](#if1c879db7a4c45ea95381876b038728a_178) |

---

![CRH3080_MASTER_Assets_FEB.jpg](crh-20260326_g42.jpg)

11<br>

CRH PROXY STATEMENT 2026

**Forward-Looking Statements** 

Safe Harbor Provisions

Under The Private Securities

Litigation Reform Act of 1995

In reliance upon the "Safe Harbor" provisions of the United States

Private Securities Litigation Reform Act of 1995, CRH is providing

the following cautionary statement.

This Proxy Statement, and the documents

incorporated by reference herein, contain

statements that are, or may be deemed to be,

forward-looking statements with respect to the

financial condition, results of operations,

business, viability, and future performance of

CRH and certain of the plans and objectives of

CRH. These forward-looking statements may

generally, but not always, be identified by the

use of words such as "will", "anticipates",

"should", "could", "would", "targets", "aims",

"may", "continues", "expects", "is expected

to", "estimates", "believes", "intends" or similar

expressions. These forward-looking statements

include all matters that are not historical facts

or matters of fact at the date of this document.

These forward-looking statements include all

matters that are not matters of fact at the date

of this Proxy Statement and include statements

about plans and expectations regarding CRH's

products and related impacts in the future;

M&A activity and growth capital expenditure

projects, including impacts on CRH's

valuation; corporate governance; executive

compensation, including ability to recruit, retain

and incentivize highly talented executives and

non-management Directors; the appointment

and terms of Directors and officers; CRH's

share buyback program and dividends;

anticipated financial capacity and capital

allocation; shareholder engagement; prospects

and drivers for CRH's growth and value,

including the connected portfolio and CRH's

Winning Way; existing and emerging

technologies, including CRH's ability to

leverage and drive efficiency and growth;

CRH's ability to replicate and scale its model;

decarbonization targets and sustainability-

related initiatives, including the commercial

opportunity presented for CRH; and expected

benefits of the proposed cancellation of the

Preference Shares.

By their nature, forward-looking statements

involve risk and uncertainty because they relate

to events and depend on circumstances that

may or may not occur in the future and reflect

the Company's current expectations and

assumptions as to such future events and

circumstances that may not prove to be

accurate. You are cautioned not to place

undue reliance on any forward-looking

statements.

These forward-looking statements are made as

of the date of this document. The Company

expressly disclaims any obligation or

undertaking to publicly update or revise these

forward-looking statements other than as

required by applicable law. For a discussion

of some of the risks and important factors that

could cause actual outcomes and results to

differ materially from those expressed herein,

see "Risk Factors" in the 2025 Annual Report

on Form 10-K filed with the SEC on February

18, 2026 (the '2025 Annual Report').

![CRH3080_MASTER_Assets_FEB_14.jpg](crh-20260326_g44.jpg)

12<br>

CRH PROXY STATEMENT 2026

Notice of 2026 AGM

---

| | |
|:---|:---|
| Meeting Information<br>Notice is hereby given that the 2026 AGM of CRH plc <br>will take place at the Royal Marine Hotel, Dun Laoghaire, <br>Co. Dublin, Ireland at 11:00 a.m. (Dublin) on Thursday, <br>May 7, 2026. | Meeting Information<br>Notice is hereby given that the 2026 AGM of CRH plc <br>will take place at the Royal Marine Hotel, Dun Laoghaire, <br>Co. Dublin, Ireland at 11:00 a.m. (Dublin) on Thursday, <br>May 7, 2026. |
| **Date & Time** <br>11:00 a.m. (Dublin) on <br>Thursday, May 7, 2026. | **Date & Time** <br>11:00 a.m. (Dublin) on <br>Thursday, May 7, 2026. |
| **Availability** <br>This Notice of Meeting and Proxy Statement, our 2025 <br>Annual Report and our Irish Statutory Accounts, which will be <br>laid before the 2026 AGM, are available at www.crh.com. <br>Copies of the Notice of Meeting and Proxy Statement and the <br>2025 Annual Report are also available at <br>www.envisionreports.com/CRH. | **Availability** <br>This Notice of Meeting and Proxy Statement, our 2025 <br>Annual Report and our Irish Statutory Accounts, which will be <br>laid before the 2026 AGM, are available at www.crh.com. <br>Copies of the Notice of Meeting and Proxy Statement and the <br>2025 Annual Report are also available at <br>www.envisionreports.com/CRH. |
|  | For more information and <br>resources visit www.crh.com |
| + | For more information and <br>resources visit www.crh.com |
|  | For more information and <br>resources visit www.crh.com |
| **Record Date\***<br>7:00 p.m. (Dublin)/3:00 p.m. (New York) on <br>Wednesday, March 11, 2026 for Ordinary <br>Shareholders. | **Record Date\***<br>7:00 p.m. (Dublin)/3:00 p.m. (New York) on <br>Wednesday, March 11, 2026 for Ordinary <br>Shareholders. |
| **When and Where to Vote**<br>Only Ordinary Shareholders as of 7:00 p.m. (Dublin)/3:00 p.m. (New York) <br>on Wednesday, March 11, 2026 and 7% Preference Shareholders as of 7:00 <br>p.m. (Dublin)/2:00 p.m. (New York) on Sunday, May 3, 2026 (each such date, <br>the 'Record Date' as the context so requires) will be entitled to receive notice <br>of, and to vote at, the 2026 AGM. <br>The process for appointing a proxy and/or voting in connection with <br>the Proposals to be voted on at the 2026 AGM depends on the <br>manner in which you hold your shares. We recommend that you <br>review the information on the process for, and deadlines applicable <br>to, voting, attending the 2026 AGM and appointing a proxy in the <br>General Information section on pages 84 to 88 of this Proxy <br>Statement. <br>Please check the Company's website in advance of the 2026 AGM in <br>case there are any changes made to the arrangements for the 2026 <br>AGM. | **When and Where to Vote**<br>Only Ordinary Shareholders as of 7:00 p.m. (Dublin)/3:00 p.m. (New York) <br>on Wednesday, March 11, 2026 and 7% Preference Shareholders as of 7:00 <br>p.m. (Dublin)/2:00 p.m. (New York) on Sunday, May 3, 2026 (each such date, <br>the 'Record Date' as the context so requires) will be entitled to receive notice <br>of, and to vote at, the 2026 AGM. <br>The process for appointing a proxy and/or voting in connection with <br>the Proposals to be voted on at the 2026 AGM depends on the <br>manner in which you hold your shares. We recommend that you <br>review the information on the process for, and deadlines applicable <br>to, voting, attending the 2026 AGM and appointing a proxy in the <br>General Information section on pages 84 to 88 of this Proxy <br>Statement. <br>Please check the Company's website in advance of the 2026 AGM in <br>case there are any changes made to the arrangements for the 2026 <br>AGM. |

---

---

| |
|:---|
| How to vote<br>It is important that your <br>shares be represented and <br>voted at the 2026 AGM. <br>You can vote by using any <br>of the following methods:  |
| **Internet** <br>Cast your vote online <br>by logging on to <br>*www.envisionreports.com/*<br>*CRH*<br>|
| **Mail** <br>By following the <br>instructions on your <br>printed proxy card or <br>form of instruction and <br>returning the completed <br>proxy form in the <br>postage-paid envelope <br>provided<br>|
| **In Person**<br>By attending the 2026 <br>AGM and voting in <br>person<br>|

---

Note:

\* 7.00 p.m. (Dublin)/2:00 p.m. (New York) on Sunday, May 3, 2026 for 7% Preference Shareholders in respect of Proposal 9 only.

13<br>

CRH PROXY STATEMENT 2026

Proposals to be Voted

on at the 2026 AGM\*

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Proposal** | **Proposal** | **Board Voting** <br>**Recommendation**<br>| **Explanation of Proposal and Reason(s) for Board Recommendations** | **Page** |
| 1 | By separate resolutions, to re-elect each of the <br>12 Director nominees as described in this Proxy <br>Statement.<br>| FOR <br>each Director <br>nominee<br>| In nominating them for re-election, the Board determined that each <br>Director continues to be effective and demonstrate commitment to the <br>role. The Board has further determined that the Directors standing for re-<br>election possess a range of diverse backgrounds, skills, knowledge, and <br>experience that are integral to an effective and well-functioning Board.<br>| 16 |
| 2 | To approve, on an advisory basis, the <br>compensation of the Company's Named <br>Executive Officers ('NEOs') for 2025 as <br>disclosed in this Proxy Statement <br>('Say-on-Pay').<br>| FOR | Provides shareholders with the opportunity to express their non-binding <br>view on the compensation of our NEOs for 2025. CRH's executive <br>compensation programs are designed to align the compensation of our <br>NEOs with CRH's performance and the interests of our executives with our <br>shareholders.<br>| 24 |
| 3 | By separate resolutions: (a) to ratify, in a non-<br>binding vote, the appointment of Deloitte & <br>Touche LLP ('Deloitte U.S.') as the Company's <br>independent registered public accounting firm for <br>fiscal year 2026; and (b) to authorize, in a binding <br>vote, the Audit Committee to fix the compensation <br>of Deloitte U.S., Deloitte Ireland LLP ('Deloitte <br>Ireland'), the member firms of Deloitte Touche <br>Tohmatsu Limited and their respective affiliates <br>(together, 'Deloitte').<br>| FOR <br>(a) and (b) <br>| The Audit Committee has appointed Deloitte U.S. as the Company's <br>independent registered public accounting firm for the year ending <br>December 31, 2026, and related interim periods. Deloitte Ireland will <br>continue to serve as the Company's statutory auditor under Irish law.<br>The Company requests shareholders' non-binding ratification of the <br>appointment of Deloitte U.S. as its independent registered public <br>accounting firm for the year ending December 31, 2026. The Company <br>also requests authorization for the Audit Committee to fix the <br>compensation of Deloitte.<br>| 25 |
| 4 | To renew the annual authority of the Board of <br>Directors of the Company to issue shares.<br>| FOR | Under Irish law, the Board must have authority from the shareholders to <br>issue any shares. Approval of this authority, which is for an amount which <br>represents 20% of the issued Ordinary Shares as of March 11, 2026, is <br>consistent with NYSE rules and listing standards and with U.S. capital <br>markets practice and governance standards for Irish-incorporated <br>companies.<br>| 27 |
| 5 | To renew the annual authority of the Board of <br>Directors of the Company to issue shares for <br>cash without first offering shares to existing <br>shareholders. <br>| FOR | Under Irish law, unless otherwise authorized, when the Company issues <br>shares for cash, it is required first to offer those shares on the same or <br>more favorable terms to existing shareholders of the Company on a pro-<br>rata basis. Approval of this authority, which is to disapply pre-emption <br>rights up to a maximum of 20% of the Company's issued Ordinary Shares <br>on an unrestricted basis, is consistent with NYSE rules and listing <br>standards and with U.S. capital markets practice and governance <br>standards for Irish-incorporated companies.<br>| 28 |
| 6 | To renew the annual authority of the Board of <br>Directors of the Company to make market <br>repurchases and overseas market repurchases <br>of Ordinary Shares of the Company.<br>| FOR | Under Irish law, unless the Company is using the redemption mechanism <br>pursuant to Article 4A of the Articles, the Company (and/or its subsidiaries) <br>cannot repurchase any of the Company's Ordinary Shares without <br>shareholder approval. Reflecting the Company's commitment to return <br>cash to shareholders and in order to have flexibility as to how share <br>repurchases are made, the authority is being sought to make repurchases <br>of up to 10% of the issued Ordinary Shares.<br>| 29 |
| 7 | To renew the annual authority to re-issue <br>treasury shares and determine the price range <br>at which the Company can re-issue such <br>shares that it holds as treasury shares.<br>| FOR | Under Irish law, shareholders must authorize the price range at which the <br>Company may re-issue any shares held in treasury. The authority being <br>sought from shareholders provides for the minimum and maximum prices <br>at which any Ordinary Shares held in treasury may be re-issued. <br>| 30 |
| 8 | To approve the Schemes of Arrangement to <br>cancel the Preference Shares and the <br>granting of authority to the Board to take all <br>such actions as it considers necessary or <br>appropriate to give effect to the Schemes of <br>Arrangement. <br>| FOR | In connection with the Preference Shares Cancellations, the Board is seeking <br>approval to cancel the Preference Shares in exchange for cash consideration <br>pursuant to separate Schemes of Arrangement.<br>| 35 |

---

14<br>

CRH PROXY STATEMENT 2026

---

| | | | | |
|:---|:---|:---|:---|:---|
| 9 | To approve the proposed cancellation of the <br>Preference Shares by way of reduction of <br>capital. <br>| FOR | In connection with the Preference Shares Cancellations, the Board is seeking <br>approval to reduce CRH's issued share capital by €1,170,940, being the <br>aggregate nominal value of the Preference Shares, with €63,500 of this amount <br>relating to the 5% Preference Shares, and €1,107,440 of this amount relating to <br>the 7% Preference Shares (the 'Capital Reduction'). The Capital Reduction is <br>required to implement the Preference Share Cancellations and will require the <br>approval of both Ordinary Shareholders and the holders of the 7% Preference <br>Shares.<br>| 36 |
| 10 | To approve the variation to the Company's <br>authorized share capital by the removal of <br>any cancelled Preference Shares in <br>connection with the proposed Preference <br>Share Cancellations.<br>| FOR | In connection with the Preference Shares Cancellations, the Board is seeking <br>approval to vary the Company's authorized share capital by removing the <br>class(es) of Preference Shares cancelled pursuant to the Schemes of <br>Arrangement. <br>| 37 |
| 11 | Approval of certain amendments to the <br>Company's Articles in connection with the <br>proposed Preference Share Cancellations.<br>| FOR | In connection with the Preference Shares Cancellations, the Board is seeking <br>approval to amend the Articles of the Company to remove any references to <br>the class(es) of Preference Shares cancelled pursuant to the Schemes of <br>Arrangement and to insert a new Article 16 relating to the implementation of the <br>Preference Shares Cancellations.<br>| 38 |
| 12 | Approval of an Amendment to the Company's <br>Articles to Delete the Qualification <br>Shareholding Requirement for Directors Set <br>Forth Therein.<br>| FOR | The Board is proposing to amend the Company's Articles to delete a <br>qualification shareholding requirement for Directors to better align with U.S. <br>market practice and to remove duplication with the Company's share <br>ownership guidelines, which were revised in 2025 and which now also apply to <br>non-management Directors.<br>| 39 |

---

Notes:

\* Capitalized terms used but not defined in this section shall have the meaning ascribed to such terms in the following sections of this Proxy Statement.

By order of the Board of Directors

Neil Colgan

Company Secretary

March 27, 2026

![CRH3080_MASTER_Assets_FEB_.jpg](crh-20260326_g45.jpg)

15<br>

CRH PROXY STATEMENT 2026

Proxy Statement

for the 2026 AGM

This Proxy Statement relates to the solicitation

of votes or proxies by CRH, on behalf of its Board

of Directors (the 'Board'), for use at the Company's

2026 AGM and at any adjournment or postponement

of such meeting.

Unless otherwise specified or the context

otherwise requires, the terms 'Company',

'CRH', 'we', 'us', and 'our' and other similar

terms used in this Proxy Statement refer to

CRH plc and its consolidated subsidiaries.

Except as otherwise specified or the context

otherwise requires, references to years indicate

our fiscal year ended or ending December 31

of the respective year. For example, references

to 'fiscal year 2025' or similar references refer

to the fiscal year ended December 31, 2025.

References to 'Ordinary Shares' refer to our

ordinary shares of €0.32 each.

The terms 'shareholder' or 'holder' or 'Ordinary

Shareholder' in relation to an Ordinary Share of

the Company means the registered

shareholder of that Ordinary Share.

References to 'Articles' refer to CRH's Articles

of Association, as amended from time to time.

The Company's website address is

*www.crh.com*. We include textual references

to website addresses throughout this Proxy

Statement for reference only. The information

contained in, or available through, these

websites is not part of, or incorporated by

reference into, this Proxy Statement.

Addresses, including electronic addresses

provided in this Proxy Statement, are provided

solely for the purposes so specified. You may

not use any electronic address provided in this

Proxy Statement or other proxy materials to

communicate with the Company for any

purpose other than those expressly stated

herein or therein.

This Proxy Statement and the accompanying

proxy card or voting instruction form, or the

Notice of Internet Availability of Proxy Materials

('Notice of Internet Availability'), are first being

mailed or otherwise furnished on or about

March 27, 2026, to shareholders of record as

of 7:00 p.m. (Dublin)/3:00 p.m. (New York) on

Wednesday, March 11, 2026.

16<br>

CRH PROXY STATEMENT 2026

Proposals Requiring Your Vote

Proposal 1 – Re-election of Directors

**The Board of Directors recommends that shareholders vote FOR the re-election of all nominees** 

**to the Board of Directors.**

In accordance with the Company's Articles, all members of the Board retire at the AGM, with those eligible standing for re-election each year.

Following a review by the Nomination & Corporate Governance Committee, the Board has determined that each Director is eligible for re-election,

continues to be effective and that each Director demonstrates commitment to the role. The Board further determines that each Director has sufficient

time to meet his or her commitment to the Company and has individual skills and experience which are relevant and beneficial to support the Board in

fulfilling its duties. Each Director nominee has agreed to stand for re-election and has agreed to serve if re-elected. We currently have no reason to

believe that any of the nominees would be unable or unwilling to serve if re-elected. However, if before the AGM any director nominee becomes

unable to serve, or chooses not to serve, the Board may nominate another individual as a substitute.

You are being asked to vote on the re-election of each of the following 12 Director nominees to serve as a Director until the 2027 AGM (or their earlier

resignation, removal or death):

**Director Nominees**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name** | **Position** | **Independent** | **Age** | **Director** <br>**Since**<br>| **Audit** <br>**Committee**<br>| **Compensation** <br>**Committee**<br>| **Nomination** <br>**& Corporate** <br>**Governance** <br>**Committee**<br>| **Acquisitions,** <br>**Divestments &** <br>**Finance** <br>**Committee**<br>| **Safety,** <br>**Environmental** <br>**& Social** <br>**Responsibility** <br>**Committee**<br>|
| Richie Boucher | Independent Chair  | ✓ | 67 | 2018 |  | ✓ | Chair | Chair |  |
| Caroline Dowling | Non-management Director | ✓ | 59 | 2021 | ✓ |  |  |  | ✓ |
| Richard Fearon | Non-management Director | ✓ | 70 | 2020 | ✓ | ✓ |  | ✓ |  |
| Johan Karlström | Non-management Director | ✓ | 69 | 2019 |  |  |  | ✓ | ✓ |
| Shaun Kelly | Non-management Director | ✓ | 66 | 2019 | Chair | ✓ |  | ✓ |  |
| Badar Khan | Non-management Director | ✓ | 55 | 2021 | ✓ |  | ✓ |  |  |
| Lamar McKay | Non-management Director | ✓ | 67 | 2020 |  | Chair | ✓ |  | ✓ |
| Jim Mintern | Chief Executive Officer |  | 59 | 2021 |  |  |  | ✓ | ✓ |
| Gillian L. Platt | Non-management Director | ✓ | 72 | 2017 |  |  | ✓ |  | ✓ |
| Mary K. Rhinehart | Non-management Director | ✓ | 67 | 2018 |  | ✓ | ✓ |  | Chair |
| Siobhán Talbot | Non-management Director | ✓ | 62 | 2018 | ✓ | ✓ | ✓ |  |  |
| Christina Verchere | Non-management Director | ✓ | 54 | 2023 | ✓ |  |  | ✓ |  |

---

**Membership of the CRH Board (as of March 27, 2026)**

CRH is overseen by Directors with a diverse set of backgrounds, experiences and competencies which the Board feels are important to the long-term success

of the Company and to drive further value creation for the Company's shareholders.

CRH's Directors contribute significant experience and skills in the areas most relevant to overseeing the Company's business and strategy, including

experience in building materials or similar capital intensive industries; global markets; strategy; capital allocation/M&A; safety and sustainability; and IT &

Cybersecurity. Details of the competencies of each Director are included in the respective biographies for such Director on pages 19 to 22 and are

summarized in the table below. The competencies noted are intended to depict notable areas of focus for each Director, and not having a listed competency

does not mean that a particular Director does not possess that qualification or skill. Nominees have developed competencies in these skills through education,

direct experience and oversight responsibilities.

**Summary of Director Competencies**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Accounting,** <br>**Internal Control** <br>**& Financial** <br>**Expertise**<br>| **Capital** <br>**Allocation/**<br>**M&A**<br>| **Governance** | **Building** <br>**Materials or** <br>**Capital Intensive** <br>**Industry** <br>**Experience**<br>| **IT & Cyber-**<br>**security**<br>| **Talent** <br>**Management**<br>| **Compensation** | **Safety &** <br>**Sustainability**<br>| **Strategy** | **Capital** <br>**Markets**<br>|
| R. Boucher |  | ▲ | ▲ |  |  | ▲ | ▲ |  | ▲ | ▲ |
| C. Dowling |  | ▲ |  |  | ▲ | ▲ | ▲ | ▲ | ▲ |  |
| R. Fearon | ▲ | ▲ | ▲ | ▲ | ▲ |  | ▲ | ▲ | ▲ | ▲ |
| J. Karlström |  | ▲ | ▲ | ▲ |  | ▲ | ▲ | ▲ | ▲ |  |
| S. Kelly | ▲ | ▲ | ▲ |  | ▲ | ▲ | ▲ |  | ▲ |  |
| B. Khan |  | ▲ | ▲ |  | ▲ | ▲ |  | ▲ | ▲ |  |
| L. McKay |  | ▲ | ▲ | ▲ | ▲ |  | ▲ | ▲ | ▲ |  |
| J. Mintern | ▲ | ▲ |  | ▲ | ▲ | ▲ |  | ▲ | ▲ | ▲ |
| G.L. Platt |  |  | ▲ |  |  | ▲ | ▲ | ▲ | ▲ |  |
| M.K. Rhinehart | ▲ | ▲ | ▲ | ▲ |  | ▲ | ▲ | ▲ | ▲ |  |
| S. Talbot | ▲ | ▲ | ▲ |  |  | ▲ | ▲ | ▲ | ▲ |  |
| C. Verchere | ▲ | ▲ | | ▲ | | ▲ | | ▲ | ▲ | |

---

17<br>

CRH PROXY STATEMENT 2026

**Independence**

![2539](crh-20260326_g46.gif)

---

| | |
|:---|:---|
| Independent  | **92%** |
| Non-Independent | **8%** |

---

**Geography**

![2554](crh-20260326_g47.gif)

---

| | |
|:---|:---|
| North America | **58%** |
| International | **42%** |

---

**Tenure of Non-management Director**

![2593](crh-20260326_g48.gif)

---

| | |
|:---|:---|
| 3–6 years | **45%** |
| 6–9 years | **55%** |

---

**Meeting attendance** 

Each of our current Directors attended at least

75% of the meetings of our Board and the

Committees on which they served as a regular

member during 2025. There were a total of 13

Board meetings held during 2025. Overall

attendance at Board and Committee meetings

during 2025 was over 95% for our Directors as

a group.

Directors are also expected to attend the AGM.

With the exception of one Director, who was

unable to attend due to a conflict, all Directors

attended the 2025 AGM held on May 8, 2025.

**Vote Required**

Re-election of each Director nominee, which is

an ordinary resolution under Irish company law,

requires that more than 50% of the votes cast

on this resolution must be cast 'FOR' the

nominee. Abstentions and broker non-votes

are not considered votes cast and will not

impact the outcome of the vote on Proposal 1.

The text of the resolution in respect of

Proposal 1 is as follows:

"That, by separate resolutions, the following 12

Directors be re-elected:

(a) Mr. R. Boucher;

(b) Ms. C. Dowling;

(c) Mr. R. Fearon; 

(d) Mr. J. Karlström; 

(e) Mr. S. Kelly; 

(f) Mr. B. Khan; 

(g) Mr. L. McKay; 

(h) Mr. J. Mintern; 

(i) Ms. G.L. Platt; 

(j) Ms. M.K. Rhinehart; 

(k) Ms. S. Talbot; and 

(l) Ms. C. Verchere."

18<br>

CRH PROXY STATEMENT 2026

![CRH3080_MASTER_Assets_FEB_27.jpg](crh-20260326_g49.jpg)

Our Board

of Directors

Our Director nominees

possess a broad range of

backgrounds, skills,

knowledge, and experience

that we believe are integral

to an effective and

well-functioning Board.

For more information about our Director

nominees, please see our Director

biographies that follow:

19<br>

CRH PROXY STATEMENT 2026

![Richie Boucher.jpg](crh-20260326_g50.jpg)

**Richie Boucher (67)**

Independent Chair &

Non-management Director

Chair since:

January 2020

Non-management Director since:

March 2018

Board Committees:

• Acquisitions, Divestments & Finance (Chair)

• Compensation

• Nomination & Corporate Governance (Chair)

Key Skills and Experience:

Leadership: Richie brings extensive leadership

experience across the financial services sector,

with a distinguished career spanning executive

and board-level roles in major global institutions.

He served as Chief Executive of Bank of

Ireland from February 2009 to October 2017,

where he led the bank through a period of

significant transformation and strategic growth.

Financial Services: Prior to his tenure as Chief

Executive of Bank of Ireland, Richie held key

senior management positions at various banks

in various geographies, including Bank of

Ireland, Royal Bank of Scotland and Ulster

Bank where he developed deep expertise in

corporate strategy, risk management, and

operational leadership. He has also served as

President of the Institute of Banking in Ireland

and the Irish Banking Federation, contributing

to the advancement of industry standards and

leadership in financial services.

M&A: Comprehensive knowledge and

involvement in M&A activities and strategic

initiatives across U.S. and European markets.

Additional Skills: Governance, Capital

Allocation, Capital Markets, Talent

Management, Compensation, Strategy.

Career Highlights: Bank of Ireland, Chief

Executive Officer; Royal Bank of Scotland;

Ulster Bank; and President of the Institute of

Banking and the Irish Banking Federation.

Other Public Company Boards: Kennedy-

Wilson Holdings, Inc. [NYSE]; Eurobank

Ergasias S.A. [ATH] (former in last 5 years).

Education: Bachelor of Arts in Economics,

Trinity College Dublin.

![CRH25_Creative_Proxy_Board_JM_NEW.jpg](crh-20260326_g51.jpg)

**Jim Mintern (59)**

Chief Executive Officer

& Executive Director

Executive Director since:

June 2021

Board Committees:

• Acquisitions, Divestments & Finance

• Safety, Environment & Social Responsibility

Key Skills and Experience:

Leadership: As the Chief Executive Officer and

with more than two decades at CRH and over

30 years in the construction and materials

industry, Jim has a wealth of experience and a

proven record of leading diverse teams across

global, national and local levels to drive

growth, innovation and operational excellence.

Prior to becoming Chief Executive Officer, Jim

served as Chief Financial Officer of CRH,

overseeing the Company's global financial

operations and the strategic transition of

CRH's primary listing to the U.S. and the NYSE

in 2023. Before that, he held several other

senior leadership roles at operational, country,

regional and divisional levels for CRH across

the group.

M&A: Wide-ranging M&A and capital allocation

experience with comprehensive knowledge of

U.S. and international markets.

Accounting and Financial Expertise:

Extensive accounting, internal control, financial

management and operational experience.

Fellow of Chartered Accountants Ireland.

Additional Skills: Building Materials or Capital

Intensive Industry Experience, IT & Cyber

Security, Capital Markets, Safety &

Sustainability, Strategy.

Career Highlights: CRH, Chief Executive

Officer and Chief Financial Officer.

Other Public Company Boards: None.

Education: Bachelor of Commerce/Business

and Master's in Accounting, University College

Dublin.

![Lamar McKay.jpg](crh-20260326_g52.jpg)

**Lamar McKay (67)**

Senior Independent Director &

Non-management Director

Non-management Director since:

December 2020

Board Committees:

• Compensation (Chair)

• Nomination & Corporate Governance

• Safety, Environment & Social Responsibility

Key Skills and Experience:

Leadership: Lamar is a distinguished

executive with an impressive legacy spanning

over 40 years in the global energy sector. His

career includes a succession of senior

executive roles at BP, particularly following its

strategic merger with Amoco. From April 2016

to February 2020, he served as the Deputy

Group Chief Executive Officer. Throughout his

tenure, Lamar spearheaded BP's worldwide

Upstream Division and was the Chairman and

CEO of BP Americas.

Government Relations and Regulatory

Oversight: Lamar was responsible for BP's

interests in the TNK-BP joint venture. His

leadership was critical during his time as CEO

of BP Americas, where he also served as

President of the Gulf Coast Restoration

Organization, guiding essential response and

restoration initiatives in the aftermath of the

Deepwater Horizon incident.

Technical Expertise in Geological Science,

Engineering and Chemical Processes:

Lamar is Non-executive Chair of APA

Corporation, an independent energy company

that explores for, develops and produces,

natural gas, crude oil and natural gas liquids.

Capital Allocation: Deep understanding of the

oil and gas sector, a sector that has many

similarities to the building materials sector

given its capital-intensive nature, along with

extensive M&A experience.

Additional Skills: Governance, Building

Materials or Capital Intensive Industry

Experience, IT & Cyber Security,

Compensation, Safety & Sustainability,

Strategy.

Career Highlights: BP (and Amoco prior to

acquisition), Deputy Chief Executive Officer,

Chief Transformation Officer, and Chief

Executive, Worldwide Upstream Business.

Other Public Company Boards: APA

Corporation [NYSE].

Education: Bachelor of Science, Mississippi

State University.

20<br>

CRH PROXY STATEMENT 2026

![Caroline Dowling.jpg](crh-20260326_g53.jpg)

**Caroline Dowling (59)**

Non-management Director

Non-management Director since:

March 2021

Board Committees:

• Audit

• Safety, Environment & Social Responsibility

Key Skills and Experience:

Leadership: Caroline is the former Business

Group President of Flex, a $26 billion industry-

leading, Fortune Global 500 electronics

manufacturing services provider with more

than 200,000 employees and operations in 30

countries. In this role she led the

Telecommunications, Enterprise Compute,

Networking and Cloud Data Center and the

Global Services Division.

Supply Chain Optimization: Caroline brings

insights to the Board that are reflective of CRH's

experience with complex supply chains. Her

leadership was instrumental in propelling growth,

fostering innovation, and achieving operational

excellence throughout Flex.

Global Technology Sector Expertise in

Marketing, Retail, Sales and Service:

Caroline held a wide range of senior executive

roles at Flex over the course of 16 years,

including President of NOVO & Technical

Services and SVP of Global Business

Development. She garnered extensive

leadership experience in a diverse range of

areas in the IT industry across all strategy,

marketing and sales functions.

Experienced Board Member: Current

member of a number of public and private

boards providing strategic guidance.

Additional Skills: Capital Allocation, IT &

Cyber Security, Talent Management,

Compensation, Safety & Sustainability,

Strategy.

Career Highlights: Flex, Business Group

President; The Dii Group, Vice President of

Europe and Director of European Business.

Other Public Company Boards: DCC [LSE];

Fabrinet [NYSE]; IMI [LSE] (former in last 5

years).

Education: Diploma in Environmental, Social

and Governance, Corporate Governance

Institute.

![Richard Fearon.jpg](crh-20260326_g54.jpg)

**Richard Fearon (70)**

Non-management Director

Non-management Director since:

December 2020

Board Committees:

• Acquisitions, Divestments & Finance

• Audit\*

• Compensation

Key Skills and Experience:

Chief Financial and Planning Officer: Richard

brings financial leadership and risk

management experience to the Board. Until

March 2021, he served as Vice Chairman and

Chief Financial and Planning Officer of Eaton

Corporation, a pre-eminent global power

management entity, where he had an impactful

tenure from 2009 and 2002, respectively.

Operational Expertise: Richard brings a

wealth of risk management expertise

underpinned by his oversight of multiple critical

operational and strategic functions. These

include areas such as accounting, control,

corporate development, M&A, capital

allocation, information systems, internal audit,

investor relations, strategic planning, tax and

treasury functions.

Diverse Leadership Experience: A wide

range of industry-leading corporations and

consultancies.

Additional Skills: Accounting, Governance,

Building Materials or Capital Intensive Industry

Experience, Compensation, IT & Cyber

Security, Safety & Sustainability, Strategy.

Career Highlights: Eaton Corporation plc,

Vice Chairman, Chief Financial Officer and

Planning Officer; Transamerica Corporation;

NatSteel Ltd.; The Walt Disney Company; Booz

Allen & Hamilton; The Boston Consulting

Group.

Other Public Company Boards: Avient

Corporation [NYSE]; Crown Holdings, Inc.

[NYSE]; Waters Corporation [NYSE]; Eaton

Corporation plc [NYSE] (former in last 5 years);

Hennessy Capital Investment Corp. VI [NYSE]

(former in last 5 years).

Education: Bachelor of Arts in Economics,

Stanford University; Master of Business

Administration, Harvard Business School; and

Juris Doctor, Harvard Law School.

![Johan Karlstrom.jpg](crh-20260326_g55.jpg)

**Johan Karlström (69)**

Non-management Director

Non-management Director since:

September 2019

Board Committees:

• Acquisitions, Divestments & Finance

• Safety, Environment & Social Responsibility

Key Skills and Experience:

Global Construction Experience: As the

former President and Chief Executive Officer of

Skanska AB, a pre-eminent multi-national

construction and project development firm,

Johan has a deep understanding of global

markets that he brings to the Board. His career

encompasses a diverse array of global

leadership roles across the United States and

Europe, culminating in his tenure as President

and Chief Executive from 2008 to his

retirement. Prior to this, he was President and

Chief Executive Officer of BPA (now Bravida), a

publicly listed mechanical and installation group,

from 1996 to 2000.

Sustainability Leader: Johan led Skanska's

Green Construction Initiative, with the aim of

developing environmentally friendly solutions

for their customers. This sustainability ethos

continues to drive Johan's leadership in the

dynamic field of construction.

Additional Skills: Governance, Capital

Allocation, Building Materials or Capital

Intensive Industry Experience, Talent

Management, Compensation, Safety &

Sustainability, Strategy.

Career Highlights: Skanska AB, President and

Chief Executive Officer; and BPA (now

Bravida), President and Chief Executive Officer.

Other Public Company Boards: Sandvik AB

[NASDAQ Stockholm] (former in last 5 years).

Education: Master of Science, Engineering,

KTH Royal Institute of Technology.

Note:

\*Audit Committee Financial Expert as determined by the Board.

21<br>

CRH PROXY STATEMENT 2026

![Shaun Kelly.jpg](crh-20260326_g56.jpg)

**Shaun Kelly (66)**

Non-management Director

Non-management Director since:

December 2019

Board Committees:

• Acquisitions, Divestments & Finance

• Audit (Chair)\*

• Compensation

Key Skills and Experience:

Global Strategist: As the Global Chief

Operating Officer of KPMG International until

September 2019, Shaun possesses a wealth of

experience in crafting and executing robust

business strategies within the competitive

landscape of global markets. His leadership

role encompassed both the implementation of

the firm's over-arching global strategy, and the

successful orchestration of a myriad of global

initiatives that drove KPMG's mission forward.

Financial Management Expert: Shaun has

distinguished himself in the fields of accounting,

internal control, financial management and

financial reporting. His deep understanding of

both U.S. and international markets, along with

the intricacies of operating conditions, sets him

apart as a leader in his field.

Additional Skills: Governance, M&A, Talent

Management, IT & Cyber Security,

Compensation, Strategy.

Career Highlights: KPMG Global, Chief

Operating Officer, Partner in Charge, U.S.

Transaction Services, Vice Chair and Head of

U.S. Tax, Vice Chair Operations and Chief

Operating Officer - Americas.

Other Public Company Boards: None.

Education: Bachelor of Commerce and

Diploma in Professional Accounting, University

College Dublin; and Honorary Doctorate from

Queen's University Belfast.

![Badar Kahn.jpg](crh-20260326_g57.jpg)

**Badar Khan (55)**

Non-management Director

Non-management Director since:

October 2021

Board Committees:

• Audit

• Nomination & Corporate Governance

Key Skills and Experience:

Large Scale Infrastructure: As Chief

Executive Officer and Director of EVgo, Inc.,

one of the largest public electric vehicle fast

charging networks in the U.S., Badar brings a

depth of expertise in large-scale infrastructure.

Additionally, until June 2022, he was the

President of National Grid U.S., a segment of

the leading energy transmission and

distribution company, National Grid.

Innovator: Badar's extensive leadership

experience within the energy sector has been

characterized by a pursuit of transformative

solutions, harnessing cutting-edge technology

to fundamentally reshape how individuals and

businesses engage with and utilize energy. He

brings that commitment to innovation at CRH.

Diverse Regulatory Experience: Badar's

regulatory acumen enriches the Board,

equipping CRH with the knowledge necessary

to adeptly navigate complex legal and

environmental challenges, coupled with his

experience in international energy services.

Additional Skills: Governance, Capital

Allocation, Talent Management, IT & Cyber

Security, Safety & Sustainability, Strategy.

Career Highlights: EVgo, Inc. Chief Executive

Officer; National Grid, President; National Grid

U.S., President; National Grid Ventures,

President; Centrica, Chief Executive Officer,

Direct Energy, President, Direct Energy

Upstream & Trading, Managing Director, British

Gas Business and SVP, Direct Energy U.S

Northeast.

Other Public Company Boards: EVgo, Inc.

[NASDAQ].

Education: Bachelor of Engineering, Brunel

University; Master of Business Administration,

The Wharton School of the University of

Pennsylvania.

![Gillian Platt.jpg](crh-20260326_g58.jpg)

**Gillian L. Platt (72)**

Non-management Director

Non-management Director since:

January 2017

Board Committees:

• Nomination & Corporate Governance

• Safety, Environment & Social Responsibility

Key Skills and Experience:

Human Resources & People Development:

Gillian's background in human resources and

talent management brings an invaluable people

perspective to the Board. During her executive

career, Gillian has held several senior

leadership positions across multiple industries

and geographies. Gillian also held the position

of Executive Vice President and Chief Human

Resources Officer at Finning International, Inc.

(the world's largest Caterpillar equipment

dealer) with global responsibility for human

resources, talent development and

communications.

Strategy & Communications: Gillian has held

considerable responsibility in strategy

development and communications, and prior to

her tenure at Finning International, held senior

executive roles at Aviva, the multinational

insurance company as Executive Vice

President Human Resources and Executive

Vice President Strategy and Corporate

Development.

Additional Skills: Governance, Compensation,

Safety & Sustainability, Talent Management.

Career Highlights: Finning International, Inc.,

Executive Vice President & Chief Human

Resources Officer; Aviva, Executive Vice

President, Human Resources & Corporate

Affairs and Executive Vice President, Strategy

& Corporate Development.

Other Public Company Boards: Interfor

Corporation [TSX].

Education: Bachelor of Arts, University of

Western Ontario; Master of Education,

University of Toronto.

Note:

\*Audit Committee Financial Expert as determined by the Board.

22<br>

CRH PROXY STATEMENT 2026

![Mary Rhineheart.jpg](crh-20260326_g59.jpg)

**Mary K. Rhinehart (67)**

Non-management Director

Non-management Director since:

October 2018

Board Committees:

• Compensation Committee

• Nomination & Corporate Governance

• Safety, Environment & Social Responsibility

(Chair)

Key Skills and Experience:

Building Materials Sector: Mary brings a

wealth of leadership and experience from

within the building materials industry, having

served more than 40 years with the Berkshire

Hathaway group of companies. This included

her role as CEO and Chair of Johns Manville

Corporation, a leading global manufacturer of

premium-quality building products and

engineered specialty materials, and now as

Non-Executive Chair of Johns Manville and

Non-Executive Chair of Lubrizol Corporation,

also owned by Berkshire Hathaway. Mary was

formerly a Director of Graphic Packaging

Holding Company, a Non-Executive Director of

Ply Gem Holdings Inc., and Lead Director of

CoBiz Financial.

Strategic Management Expert: Prior to

becoming CEO, Mary was EVP Finance and

CFO at Johns Manville. She held key strategic

roles as a P&L leader of several business units

and key leadership roles in finance, global

treasury, global supply chain, human resources

and business development.

Additional Skills: Capital Allocation,

Accounting, Internal Control & Financial

Expertise, Governance, Talent Management,

Compensation, Safety & Sustainability,

Strategy.

Career Highlights: Johns Manville, Chief

Executive Officer and Chair, SVP and CFO, VP

Finance, and VP Controller & Treasurer.

Other Public Company Boards: Graphic

Packaging Holding Company [NYSE] (former in

the last 5 years).

Education: Bachelor of Finance, University of

Colorado; Master of Business Administration,

University of Denver.

![Siobhan Talbot.jpg](crh-20260326_g60.jpg)

**Siobhán Talbot (62)**

Non-management Director

Non-management Director since:

December 2018

Board Committees:

• Audit\*

• Compensation

• Nomination & Corporate Governance

Key Skills and Experience:

Business Leader: Siobhán is a distinguished

business leader and was Group Managing

Director of Glanbia, where she led significant

transformation, creating a leading global

nutrition organization operating across 32

countries with significant U.S. operations.

Siobhán held this position for ten years until

her retirement in December 2023.

Accounting & Financial Expertise: Siobhán is

a trained accountant and prior to her

appointment as Group Managing Director of

Glanbia in 2013, she held a variety of finance

roles across the Group, most notably as

Finance Director, a role which encompassed

responsibility for Glanbia's strategic planning.

Prior to joining Glanbia, Siobhán worked as an

accountant with PwC in Ireland and Australia.

Siobhán is a Fellow of Chartered Accountants

Ireland.

Additional Skills: Governance, M&A, Capital

Allocation, Talent Management, Safety &

Sustainability, Strategy.

Career Highlights: Glanbia plc, Group

Managing Director, Group Finance Director,

Deputy Group Finance Director, and Group

Secretary.

Other Public Company Boards: Glanbia plc

[LSE] [ISEQ] (former in the last 5 years).

Education: Bachelor of Commerce, University

College Dublin; Diploma in Professional

Accounting, University College Dublin;

Honorary Doctorate, University College Cork;

and Honorary Doctorate, University College

Dublin.

![Christine Vercher.jpg](crh-20260326_g61.jpg)

**Christina Verchere (54)**

Non-management Director

Non-management Director since:

March 2023

Board Committees:

• Acquisitions, Divestments & Finance

• Audit

Key Skills and Experience:

Oil & Gas Sector Expertise: Christina brings

over 25 years of experience from the capital-

intensive oil and gas sector. She currently

serves as Chief Executive Officer of OMV

Petrom S.A. (OMVP) since 2018. OMVP is the

largest integrated energy producer in

Southeastern Europe and is active across the

energy value chain from oil and gas production

to power generation and supply.

International Leadership: Prior to joining

OMVP, Christina spent over 20 years working

with BP where she held a variety of senior

leadership positions across multiple regions,

including the UK, the U.S., Canada and

Indonesia and was responsible for the

restructuring of BP's Upstream business into a

functional model.

Additional Skills: M&A, Accounting, Internal

Control and Financial Expertise, Talent

Management, Safety & Sustainability, Strategy.

Career Highlights: OMV Petrom, Chief

Executive Officer; BP Regional President, Asia

Pacific, President and CEO, BP Canada, and

VP Upstream Program Management Office.

Other Public Company Boards: OMV Petrom

S.A. [BVB].

Education: Master of Economics Science,

University of Aberdeen.

Note:

\*Audit Committee Financial Expert as determined by the Board.

23<br>

CRH PROXY STATEMENT 2026

**Director Compensation** 

Non-management Directors receive their fees in a mix of cash and equity. The fee structure for 2025 was as follows:

---

| | |
|:---|:---|
| **Non-management Director Fee Structure for 2025** | **$'000** |
| Board Retainer |  |
| Cash Retainer | 140 |
| Equity Retainer | 180 |
| Board Leadership Premiums (i) |  |
| Chair - Cash  | 300 |
| Chair - Equity | 120 |
| Senior Independent Director - Cash | 40 |
| Committee Pay (i) |  |
| Acquisitions, Divestments & Finance Committee Chair | 18 |
| Audit Committee Chair | 28 |
| Compensation Committee Chair | 25 |
| Nomination & Corporate Governance Committee Chair | 20 |
| Safety, Environment & Social Responsibility Committee Chair | 20 |
| Other Non-management Director Pay Policies |  |
| Share Ownership Guidelines | 5x Cash Retainer in 5 years, with 75% net share holdings until the Guidelines are met |

---

Notes:

(i)These cash fees are in addition to the Board Retainer.

The following table summarizes the compensation awarded or paid to the non-management Directors for the year ended December 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Non-management Director Compensation for the year ended December 31, 2025** | **Non-management Director Compensation for the year ended December 31, 2025** | **Non-management Director Compensation for the year ended December 31, 2025** | **Non-management Director Compensation for the year ended December 31, 2025** | **Non-management Director Compensation for the year ended December 31, 2025** |
|  | **Fees earned or paid in cash** <br>**$'000**<br>| **Share Awards (i)** <br>**$'000**<br>| **All Other Compensation (ii)**<br>**$'000**<br>| **Total**<br>**$'000**<br>|
| R. Boucher | 478 | 300 | 28 | 806 |
| P. Decker (iii) | 35 | 105 | – | 140 |
| C. Dowling  | 140 | 180 | 28 | 348 |
| R. Fearon  | 140 | 180 | 5 | 325 |
| J. Karlström | 140 | 180 | 2 | 322 |
| S. Kelly  | 168 | 180 | – | 348 |
| B. Khan | 140 | 180 | 2 | 322 |
| L. McKay  | 205 | 180 | – | 385 |
| G.L. Platt | 140 | 180 | 2 | 322 |
| M.K. Rhinehart | 160 | 180 | 6 | 346 |
| S. Talbot | 140 | 180 | 22 | 342 |
| C. Verchere | 140 | 180 | – | 320 |
|  | 2026 | 2205 | 95 | 4326 |

---

Notes:

(i)Represents the grant date fair value of Restricted Share Units ('RSUs'), calculated in accordance with FASB ASC Topic 718, issued to the non-management Directors

under the CRH plc 2025 Equity Incentive Plan (the '2025 Equity Incentive Plan') on May 13, 2025. RSUs vest on the earlier of the first anniversary of the date of grant or

the date of CRH's next AGM following the date of grant of the RSU. RSUs accrue dividend equivalents at the time and at the same rate as dividends are paid on CRH's

Ordinary Shares, with such dividend equivalents being released to the recipient in the form of additional RSUs (equal to the credited amount of dividends paid divided

by the fair market value on the date of the dividend payment) if and to the extent that the RSUs vest.

(ii)For Mr. Boucher, Ms. Dowling and Ms. Talbot, includes solely the reimbursement of taxes payable in connection with hotel accommodations in respect of meetings held

in Ireland, in compliance with Irish law. For Mr. Fearon, Mr. Khan, Mr. Karlström, Ms. Platt and Ms. Rhinehart, includes solely professional advice related to Irish tax filing

fees.

(iii)Mr. Decker served as a member of the Board from October 1, 2025 through December 1, 2025, at which point he resigned from the Board due to unforeseen

circumstances. Mr. Decker's decision to resign was not the result of any disagreement relating to the Company's operations, policies or practices. Mr. Decker's RSU

award lapsed following his resignation from the Board.

Details of the shareholdings of the non-management Directors are outlined on page 81.

**How we set Non-management Director Compensation**

The fees and awards for the non-management Directors are set within the limits of the 2025 Equity Incentive Plan previously approved by

shareholders. In determining non-management Director compensation, the Board receives advice from the Compensation Committee's independent

compensation advisor. The Executive Director receives no additional compensation for his Board service.

The non-management Directors are not entitled to receive any compensation upon the termination of their appointment and no fees will be payable in

respect of any unserved portion of the term of their appointment. Other than discussed above, the non-management Directors are not entitled to

participate in the Company's annual incentive award program or other benefit plans. Each non-management Director is entitled to reimbursement

from the Company for reasonable expenses incurred in the performance of their duties. The non-management Directors may be entitled, in certain

circumstances and at the Company's expense, to obtain independent professional advice in the furtherance of their duties as Directors.

24<br>

CRH PROXY STATEMENT 2026

Proposal 2 – Advisory Vote

to Approve Named Executive

Officer Compensation

('Say-on-Pay')

**The Board of Directors recommends** 

**that shareholders vote FOR the** 

**approval, on an advisory and non-**

**binding basis, of the compensation** 

**of our NEOs.**

The resolution gives shareholders the

opportunity to express their non-binding views

on the 2025 compensation of our NEOs as

disclosed in this Proxy Statement.

As described in the "Compensation Discussion

& Analysis" ('CD&A') section of this Proxy

Statement on pages 49 to 80, our executive

compensation program is designed to:

• ensure alignment of executive and

shareholder interests through share-based

long-term incentive awards and share

ownership guidelines;

• maintain policies and programs that will

attract, retain and motivate executives, and

fairly reward our executives for the

contribution they make to the business;

• provide total compensation which is market

competitive, with regard to the size and

complexity of the Company's operations

and the markets in which we compete for

talent (using peer company and

compensation survey data comparisons);

• maintain compensation packages that

include salary, short- and long-term

incentives, benefits and retirement

provisions, and perquisites; and

• appropriately align executive pay and

performance by delivering a significant

amount of total compensation through

variable incentive compensation.

We ask shareholders to review the CD&A

section of this Proxy Statement, including the

compensation tables and the related narrative

discussion included therein for more

information.

As an advisory vote, the outcome of the vote

on this Proposal 2 will not be binding on CRH.

However, the Compensation Committee values

the opinions and views of shareholders and will

consider the outcome of the vote when making

future compensation decisions regarding our

executive compensation programs.

**Vote Required**

Approval of Proposal 2, on an advisory and

non-binding basis, requires that more than

50% of the votes cast on this resolution must

be cast "FOR" the resolution. Abstentions and

broker non-votes are not considered votes

cast and will not impact the outcome of the

vote on this Proposal 2.

The text of the resolution in respect of

Proposal 2 is as follows:

"That, on an advisory and non-binding basis,

the compensation of the Company's Named

Executive Officers as disclosed in the Notice of

Meeting and Proxy Statement for the 2026

AGM on pages 49 to 80 under the heading

"Compensation Discussion & Analysis" is

approved."

25<br>

CRH PROXY STATEMENT 2026

Proposal 3 – Ratification of

the Appointment of Deloitte

& Touche LLP as Auditor

and Authority to set the

Compensation of the Auditor

**The Board of Directors recommends** 

**that shareholders vote FOR the** 

**proposal to ratify the appointment of** 

**Deloitte & Touche LLP ('Deloitte U.S.')** 

**as independent auditor of the** 

**Company and FOR the proposal to** 

**authorize the Audit Committee to fix** 

**the auditors' compensation.**

The Audit Committee has selected Deloitte

U.S. as its independent registered public

accounting firm for the fiscal year ending

December 31, 2026, and related interim

periods, and Deloitte Ireland LLP ('Deloitte

Ireland') as the Company's statutory auditor

under Irish law.

The Company requests shareholders' non-

binding ratification of the appointment of

Deloitte U.S. as its independent registered

public accounting firm. The Company also

requests authorization for the Audit Committee

to fix the compensation of Deloitte U.S.,

Deloitte Ireland, the member firms of Deloitte

Touche Tohmatsu Limited and their respective

affiliates (together, 'Deloitte').

Representatives of Deloitte U.S. and Deloitte

Ireland will be present at the 2026 AGM, will

have the opportunity to make a statement if

they desire to do so, and will be available to

respond to questions.

**Report of the Audit Committee**

While management has the primary

responsibility for the financial statements and

the financial reporting process, including the

system of internal controls, the Audit

Committee reviews the Company's audited

financial statements and financial reporting

process on behalf of the Board. The

Company's auditor, Deloitte U.S., is

responsible for performing an independent

audit of the Company's Consolidated Financial

Statements in accordance with the standards

of the U.S. Public Company Accounting

Oversight Board (the 'PCAOB') and to issue a

report thereon. The Audit Committee monitors

those processes. In this context, the Audit

Committee has met and held discussions with

management and Deloitte U.S. regarding the

fair and complete presentation of the

Company's results. The Audit Committee has

also discussed the significant accounting

policies applied by the Company in its financial

statements. Management has represented to

the Audit Committee that the Company's

Consolidated Financial Statements were

prepared in accordance with U.S. generally

accepted accounting principles ('GAAP'), and

the Audit Committee has reviewed and

discussed the Consolidated Financial

Statements with management and the auditor.

The Audit Committee has also discussed with

Deloitte U.S. the matters required to be

discussed by Auditing Standard No. 1301,

"Communications with Audit Committees"

issued by the PCAOB.

In addition, the Audit Committee has received

and reviewed the written disclosures and the

letter from Deloitte U.S. required by the

PCAOB regarding Deloitte's communications

with the Audit Committee concerning

independence and discussed with Deloitte U.S.

the auditor's independence from the Company

and its management in connection with the

matters stated therein. The Audit Committee

also considered whether the auditor's provision

of non-audit services to the Company and its

tenure is compatible with the auditor's

independence. The Audit Committee has

concluded that the auditor is independent from

the Company and its management.

The Audit Committee discussed with the

Company's internal and external auditors the

overall scope and plans for their respective

audits. The Audit Committee meets separately

with the internal and external auditors, with and

without management present, to discuss the

results of their examinations, the evaluations of

the Company's internal controls and the overall

quality of the Company's financial reporting.

In reliance on the reviews and discussions

referred to above, the Audit Committee

recommended to the Board, and the Board

approved, that the audited Consolidated

Financial Statements be included in the

Company's 2025 Annual Report on Form 10-K

filed with the SEC on February 18, 2026.

The Audit Committee and the Board believe

that the appointment of Deloitte U.S. as the

independent registered public accounting firm

is in the best interests of the Company and its

shareholders and has recommended that

shareholders ratify the appointment of Deloitte

U.S. as our independent auditor for the fiscal

year ending December 31, 2026.

**Submitted by the Audit Committee** 

**of the Board.** 

Shaun Kelly (Chair)

Caroline Dowling

Richard Fearon

Badar Khan

Siobhán Talbot

Christina Verchere

26<br>

CRH PROXY STATEMENT 2026

**Fees of the Auditors**

The Audit Committee is responsible for assessing the compensation of the independent registered public accounting firm in light of, among other

things, the firm's qualifications and performance.

Deloitte U.S. has been the Company's independent registered public accounting firm since February 28, 2025. Deloitte Ireland preceded Deloitte U.S. and was

the Company's independent registered public accounting firm from April 23, 2020 until February 28, 2025. The following table sets forth the aggregate fees for

professional services rendered by Deloitte for the periods indicated in respect of the following categories. The Company did not pay any other fees to its auditors

during the periods indicated below.

---

| | | |
|:---|:---|:---|
|  | **Deloitte** | **Deloitte** |
|  | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***in $ millions*** | **2025** | **2024** |
| Audit fees (i)  | 29 | 31 |
| Audit-related fees (ii) | 2 | 1 |
| Tax fees  | 1 | - |
| All other fees | - | - |
| Total | 32 | 32 |

---

Notes:

(i)Represents the aggregate fees for professional services performed by Deloitte for the audit of our annual financial statements, internal control attestation procedures,

statutory audits of our parent company and subsidiary financial statements and other services that are normally provided in connection with statutory and regulatory

filings or engagements.

(ii)Represents fees for assurance and related services performed by Deloitte that are reasonably related to the performance of the audit or review of our financial

statements. This includes employee benefit plan audits, agreed-upon procedures reports, and services in connection with the Company's potential divestitures.

**Pre-Approval Policies and Procedures**

In order to ensure auditor independence and objectivity, the Audit Committee has adopted a policy which sets out the types of permitted and non-

permitted non-audit services and those which require explicit prior approval. The policy of our Audit Committee is to pre-approve all audit and non-

audit services provided by Deloitte. On an annual basis the Audit Committee will review and pre-approve the services which may be provided by the

independent auditor. All of the audit and non-audit services carried out in the years ended December 31, 2025 and 2024 were pre-approved by the

Audit Committee.

The fees paid to Deloitte for non-audit services in 2025 amounted to $2.9 million and represented approximately 10% of the total audit fees for the year.

**Vote Required**

The resolutions in respect of Proposal 3(a) (the ratification of the appointment of Deloitte U.S., in a non-binding vote) and Proposal 3(b) (the

authorization of the Audit Committee to fix Deloitte's compensation, in a binding vote, which is an ordinary resolution under Irish company law),

require that more than 50% of the votes cast on this resolution must be cast "FOR" the resolutions. Abstentions and broker non-votes are not

considered votes cast and will not impact the outcome of the vote on this Proposal 3.

As an advisory vote, the outcome of the vote on the appointment of Deloitte U.S. (Proposal 3(a)) will not be binding on CRH. However, the Board

values the opinions and views of shareholders and will consider the outcome of the vote when making future decisions regarding the appointment of

the auditor.

The text of the resolution in respect of Proposal 3 is as follows:

"That, by separate resolutions:

(a)in a non-binding vote, the appointment of Deloitte & Touche LLP as independent auditor of CRH is ratified; and

(b)in a binding vote, the Audit Committee is authorized to fix the compensation of Deloitte & Touche LLP, Deloitte Ireland LLP, the member firms of

Deloitte Touche Tohmatsu Limited and their respective affiliates."

27<br>

CRH PROXY STATEMENT 2026

Proposal 4 – Renewal of the

Annual Authority of the Board

of Directors to Issue Shares

**The Board of Directors recommends** 

**that shareholders vote FOR the** 

**proposal to renew the annual** 

**authority of the Board of Directors to** 

**issue shares.** 

Under Irish law, directors of an Irish public

limited company must have authority from its

shareholders to issue any shares, including

shares which are part of the Company's

authorized but unissued share capital. The

authority in Proposal 4 is for an amount which

represents approximately 20% of the issued

Ordinary Shares as of March 11, 2026. Any

allotment exceeding 20% of the issued

Ordinary Shares will only be made with the

prior approval of the shareholders of the

Company at a General Meeting.

Granting the Board this authority is a routine

matter for Irish public limited companies and is

consistent with NYSE rules and listing

standards and with U.S. capital markets

practice and governance standards for Irish-

incorporated companies. This authority is

fundamental to our business because it

enables us to issue shares, including, if

applicable, to fund acquisitions and raise

capital and in connection with our equity

compensation plans (where required). We are

not asking you to approve an increase in our

authorized share capital or to approve a

specific issuance of shares. Instead, approval

of this Proposal 4 will only grant the Board the

authority to issue shares that are already

authorized under our Articles upon the terms

below.

The Directors have no present intention of

issuing any shares, other than in connection

with CRH's equity compensation plans.

**Vote Required**

Approval of Proposal 4, which is an ordinary

resolution under Irish company law, requires

that more than 50% of the votes cast on this

resolution must be cast "FOR" the resolution.

Abstentions and broker non-votes are not

considered votes cast and will not impact the

outcome of the vote on this Proposal 4.

The text of the resolution in respect of

Proposal 4 is as follows:

"That, in accordance with the powers,

provisions and limitations of Article 11(d) of the

Articles of Association of the Company, the

Directors be and they are hereby authorized to

allot relevant securities (within the meaning of

Section 1021 of the Companies Act 2014) up

to an aggregate of 141,008,744 Ordinary

Shares.

This authority shall expire at the close of

business on the earlier of the date of the

Annual General Meeting in 2027 or November

6, 2027."

28<br>

CRH PROXY STATEMENT 2026

Proposal 5 – Renewal of the

Annual Authority of the Board

of Directors to Issue Shares

for Cash without first Offering

Shares to Existing

Shareholders

**The Board of Directors recommends** 

**that shareholders vote FOR the** 

**proposal to renew the annual** 

**authority of the Board of Directors** 

**to issue shares for cash without** 

**first offering shares to existing** 

**shareholders.**

Under Irish law, unless otherwise authorized,

when an Irish public limited company issues

shares for cash it is required first to offer those

shares on the same or more favorable terms to

existing shareholders of the Company on a pro

rata basis (commonly referred to as the

statutory pre-emption right). In this Proposal 5,

the Board seeks a renewal of the shareholder

authority approved at the 2025 AGM for the

disapplication of pre-emption rights up to a

maximum of 20% of the Company's issued

Ordinary Shares on an unrestricted basis.

Granting the Board this authority is a routine

matter for Irish public limited companies and is

consistent with NYSE rules and listing

standards and with U.S. capital markets

practice and governance standards for Irish-

incorporated companies. Similar to the

authorization sought under Proposal 4, this

authority is fundamental to our business

because it enables us to issue shares under

our equity compensation plans (where

required) and, if applicable, will facilitate our

ability to fund acquisitions and otherwise raise

capital. We are not asking you to approve an

increase in our authorized share capital.

Approval of Proposal 5 will only grant the

Board the authority to issue shares in the

manner already permitted under our Articles

upon the terms below. Without this

authorization, in each case where we issue

shares for cash, we would first have to offer

those shares on the same or more favorable

terms to all of our existing shareholders. This

requirement could cause delays in the

completion of acquisitions and capital raising

for our business and undermine the operation

of our equity compensation plans.

**Vote Required**

Approval of Proposal 5, which is a special

resolution under Irish company law, requires

that at least 75% of the votes cast on this

resolution must be cast "FOR" the resolution.

Abstentions and broker non-votes are not

considered votes cast and will not impact the

outcome of the vote on this Proposal 5.

The text of the resolution in respect of

Proposal 5 is as follows:

"As a special resolution, that the Directors be

and they are hereby empowered to allot equity

securities (within the meaning of Section 1023

of the Companies Act 2014) for cash to the

extent permitted by Proposal 4, provided that

this authority may only be used for:

(a)the allotment of equity securities up to an

aggregate of 141,008,744 Ordinary Shares;

and/or

(b)the allotment of equity securities by way of

a rights issue or other pre-emptive issue to

the holders of Ordinary Shares in

accordance with Article 11(e) of the Articles

of Association of the Company on the basis

that the reference to a rights issue in Article

11(e) shall include rights issues and other

pre-emptive issues.

This authority shall expire at the close of

business on the earlier of the date of the

Annual General Meeting in 2027 or November

6, 2027, save that the Company may before

such expiry make an offer or agreement which

would or might require equity securities to be

allotted after such expiry date and the

Directors may allot equity securities in

pursuance of such offer or agreement as if

such power had not expired."

29<br>

CRH PROXY STATEMENT 2026

Proposal 6 – Renewal of the

Annual Authority of the Board

of Directors to Make Market

Repurchases and Overseas

Market Repurchases of the

Company's Issued Ordinary

Shares

**The Board of Directors recommends** 

**that shareholders vote FOR the** 

**proposal to renew the annual** 

**authority of the Board of Directors** 

**to make market repurchases and** 

**overseas market repurchases of up** 

**to 10% of the Company's issued** 

**Ordinary Shares.**

The Company has an ongoing commitment to

returning cash to shareholders and managing

the share capital of the Company. The Board

believes that the Company should retain the

ability to repurchase its own shares in support

of this ongoing commitment.

Under Irish law, neither the Company nor any

subsidiary of the Company may make market

repurchases of the Company's Ordinary

Shares without shareholder approval.

Accordingly, shareholders are being asked to

authorize the Company, or any of its

subsidiaries, to make market repurchases and

overseas market repurchases of up to 10% of

the Company's issued Ordinary Shares as of

the date of the passing of Proposal 6.

The Company currently also has the flexibility

to make repurchases of Ordinary Shares by

way of redemption pursuant to Article 4A of

our Articles and all of the repurchases over the

last year have used this mechanism. It is the

Company's intention to continue to seek

shareholder authority to provide for additional

flexibility and to give subsidiaries of the

Company flexibility to make market

repurchases and overseas market repurchases

of the Company's shares.

The general authority, if approved by our

shareholders, will become effective from the

date of passing of the resolution.

**Vote Required**

Approval of Proposal 6, which is an ordinary

resolution under Irish company law, requires

that more than 50% of the votes cast on this

resolution must be cast "FOR" the resolution.

Abstentions and broker non-votes are not

considered votes cast and will not impact the

outcome of the vote on this Proposal 6.

The text of the resolution in respect of

Proposal 6 is as follows:

"As an ordinary resolution, that, the Company

and/or any of its subsidiaries be and are

hereby authorized to make market repurchases

and/or overseas market repurchases (as

defined in Section 1072 of the Companies Act

2014) of Ordinary Shares on such terms and

conditions and in such manner as the Directors

may from time to time determine but subject,

however, to the provisions of the Companies

Act 2014 and to the following restrictions and

provisions:

(a)the maximum aggregate number of

Ordinary Shares authorized to be acquired

pursuant to the terms of this resolution shall

not exceed, in the aggregate, 10% of the

Ordinary Shares in issue at the date of the

passing of this resolution;

(b)the minimum price (exclusive of taxes and

expenses), which may be paid for any

Ordinary Share, shall be the nominal value

of the Ordinary Shares; and

(c)the maximum price (exclusive of taxes and

expenses), which may be paid for any

Ordinary Shares, shall be an amount equal

to 110% of the closing price for the

Ordinary Shares on the market on which the

purchase is to be effected on the trading

day preceding the date of purchase.

This authority shall expire at the close of

business on the earlier of the date of the

Annual General Meeting in 2027 or November

6, 2027. The Company or any subsidiary may,

before such expiration, make an offer or

agreement which would or might be wholly

executed after such expiration and may

complete any such contract as if the authority

conferred hereby had not expired."

30<br>

CRH PROXY STATEMENT 2026

Proposal 7 – Renewal of the

Annual Authority to Re-Issue

Treasury Shares and to

Determine the Price Range at

which the Company can Re-

issue such Shares that it Holds

as Treasury Shares

**The Board of Directors recommends** 

**that shareholders vote FOR the** 

**proposal to determine the price range** 

**at which the Company can re-issue** 

**shares that it holds as treasury** 

**shares.**

Our market repurchases, overseas market

repurchases, redemptions and other share

repurchase activities may result in Ordinary

Shares being acquired and held by the

Company as treasury shares. We may re-issue

treasury shares that we acquire for certain

reasons, including in connection with our

equity compensation plans.

Under Irish law, our shareholders must

authorize the price range at which we may re-

issue any shares held in treasury. In Proposal

7, that price range is expressed as a minimum

and maximum percentage of the prevailing

market price (as defined below).

The authority being sought from shareholders

provides that the minimum and maximum

prices at which an Ordinary Share held in

treasury may be re-issued are 95% and 120%,

respectively, of the closing market price of the

Ordinary Shares on NYSE for the five trading

days prior to the date of re-issue, except as

described below with respect to obligations

under equity compensation plans. Any re-issue

of treasury shares will be at price levels that

the Board considers in the best interests of the

Company.

**Vote Required**

Approval of Proposal 7, which is a special

resolution under Irish company law, requires

that at least 75% of the votes cast on this

resolution must be cast "FOR" the resolution.

Abstentions and broker non-votes are not

considered votes cast and will not impact the

outcome of the vote on this Proposal 7.

The text of the resolution in respect of

Proposal 7 is as follows:

"As a special resolution, the Company be and

is hereby authorized to re-issue treasury

shares (as defined in Section 1078 of the

Companies Act 2014) in accordance with

Article 8B of the Articles of Association and

subject to the following restrictions and

provisions:

a.the maximum price at which such treasury

share may be re-issued shall be an amount

equal to 120% of the "market price";

b.the minimum price at which a treasury

share may be re-issued shall be the nominal

value of the share where such a share is

required to satisfy an obligation under any

compensation program (including any share

scheme or option schemes) operated by the

Company or any of its subsidiaries (as

defined by Section 7 of the Companies Act

2014) or, in all other cases, an amount

equal to 95% of the "market price";

c.for the purposes of this resolution, the

"market price" shall mean the average

closing price per Ordinary Share of the

Company on NYSE for the five trading days

prior to the date of re-issue.

This authority shall expire at the close of

business on the earlier of the date of the

Annual General Meeting in 2027 or November

6, 2027 unless previously varied or renewed in

accordance with the provisions of Section 109

and/or 1078 (as applicable) of the Companies

Act 2014 (and/or any corresponding provision

of any amended or replacement legislation)

and is without prejudice or limitation to any

other authority of the Company to re-issue

treasury shares on-market."

31<br>

CRH PROXY STATEMENT 2026

Overview of Proposals

8 through 11 Relating to

Proposed Cancellation of the

Preference Shares

**Overview**

On March 13, 2026, following a review of its

LSE Ordinary Share listing as well as its

Preference Share capital structure, CRH

announced its intention to delist the Ordinary

Shares and the 7% Preference Shares from the

LSE and, subject to approval by Ordinary

Shareholders and Preference Shareholders, to

cancel the 7% Preference Shares and the 5%

Preference Shares. As part of the review, the

Board carefully considered, among other

factors, the regulatory and administrative

obligations arising from retaining the 5%

Preference Shares and 7% Preference Shares

(together, the 'Preference Shares'). Following

completion of the review, the Board concluded

that it is in the best interests of CRH and its

Ordinary Shareholders and Preference

Shareholders as a whole to seek to simplify the

Company's share capital structure and reduce

certain regulatory and administrative

obligations applicable to it, by retiring both the

7% Preference Shares and the 5% Preference

Shares (and delisting the 5% Preference

Shares from Euronext Growth Dublin), subject

to approval of the Ordinary Shareholders and

Preference Shareholders. The total par value of

the issued and outstanding legacy Preference

Shares is €1,170,940.

CRH proposes to cancel its (i) 50,000 5%

Cumulative Preference Shares of €1.27 each

(ISIN: IE0001827264) issued in 1950 (the '5%

Preference Shares') and (ii) its 872,000 7%"A"

Cumulative Preference Shares of €1.27 each

(ISIN: IE0001827603) issued in 1973 (the '7%

Preference Shares') (the 'Preference Share

Cancellations'), pursuant to two separate

schemes of arrangement under Chapter 1 of

Part 9 of the Irish Companies Act 2014 (the

'Schemes' or the 'Schemes of Arrangement').

A scheme of arrangement is a court-approved

arrangement between a company and its

shareholders carried out in accordance with

the Companies Act 2014. The Preference

Share Cancellations will also involve the

associated Capital Reduction under the

Companies Act 2014 to cancel the Preference

Shares. Each of the Schemes of Arrangement

and the Capital Reduction require the approval

of the High Court of Ireland (the 'Irish High

Court').

The 5% Preference Shares are currently

admitted to trading on Euronext Growth

Dublin. The 7% Preference Shares are

currently admitted to trading on the LSE but

will be delisted with effect from 8:00 a.m.

(London) on April 20, 2026. The last day of

trading of the 7% Preference Shares on the

LSE will be April 17, 2026.

The Board is seeking the approval of Ordinary

Shareholders (and the holders of the 7%

Preference Shares (the '7% Preference

Shareholders'), voting with the Ordinary

Shareholders as a single class, for the

purposes of Proposal 9 only) of Proposals 8

through 11 in connection with the Preference

Share Cancellations. Further details on the

approvals required to implement the

Preference Share Cancellations are described

below in the section titled "Approvals Required

to Implement the Proposed Cancellation of

Preference Shares" on page 32.

The Preference Share Cancellations are

subject to certain conditions set forth in the

Schemes of Arrangement (the 'Conditions')

and will become effective only after all

Conditions have been satisfied or, if allowed by

law, waived. Each Preference Share

Cancellation will require, among other things, (i)

approval at the 2026 AGM of each of

Proposals 8, 9, 10 and 11, (ii) approval by the

applicable class of Preference Shareholders of

the applicable Scheme at the scheme

meetings convened pursuant to the authority of

the Board (the 'Scheme Meetings'), and (iii) the

sanction of the applicable Scheme, and the

confirmation of the applicable Capital

Reduction, by the Irish High Court. Subject to

the satisfaction or if allowed by law, waiver of

the Conditions at the time the Schemes

become effective (the 'Effective Time'), all

Preference Shares will be cancelled pursuant

to Sections 84 to 86 of the Companies Act

2014 in accordance with the terms of each

Scheme. Further details on the conditions to

the Preference Share Cancellations are

described in the section entitled "Conditions to

Implement the Preference Share Cancellations"

on pages 32 and 33.

The Preference Shares are separate and

independent from the Ordinary Shares, and the

Ordinary Shares will not be impacted by

Proposals 8 through 11.

*Cancellation Consideration*

Under the terms of the proposed Schemes

both classes will receive cancellation

consideration of an amount equal to 40 times

the annual dividend per Preference Share. This

reflects a value determined by reference to the

annual dividend per Preference Share

capitalized at a rate of 2.5156% or

approximately 100bps below the 30-year Bund

rate as of March 12, 2026. The holders of the

5% Preference Shares (the '5% Preference

Shareholders') will receive €2.54 for each 5%

Preference Share cancelled (the '5%

Cancellation Consideration'), representing

200% of the nominal value per share. The 7%

Preference Shareholders will receive €3.556 for

each 7% Preference Share cancelled (the '7%

Cancellation Consideration', and together with

the 5% Cancellation Consideration, the

'Cancellation Consideration'), representing

280% of the nominal value per share. The

premium above nominal value will be paid from

the Company's profits available for distribution,

and the nominal value will be paid by way of

repayment of capital. The Cancellation

Consideration comprises the entire amount

payable in respect of the cancellation of the

Preference Shares and there is no separate

entitlement or payment in respect of any

dividend entitlement unpaid or otherwise

accrued up to and including the Effective Time.

32<br>

CRH PROXY STATEMENT 2026

The total aggregate payment in consideration

for the cancellation of the Preference Shares

will be €3.23 million (approximately $3.75

million). Given historic low levels of trading for

the Preference Shares on their respective

exchanges (including predecessor exchanges),

it is not possible to identify the market value of

the Preference Shares and the extent to which

the Cancellation Consideration amounts to a

premium to the market value of the Preference

Shares. However, the Board believes that the

Cancellation Consideration represents a

significant premium to the value of the

Preference Shares.

*Cancellation of Listings* 

As noted above, the Company has applied to

the UK Financial Conduct Authority (the 'FCA')

and the LSE respectively for the listing of the

7% Preference Shares on the official list of the

FCA to be cancelled and for the admission to

trading of the 7% Preference Shares on the

Main Market of the LSE to be cancelled, with

such delisting to become effective from 8:00

a.m. (London) on April 20, 2026. The Company

has also applied to Euronext Growth Dublin for

the cancellation of the listing and admission to

trading of the 5% Preference Shares on

Euronext Growth Dublin, and such delisting is

subject to receipt of the requisite approvals for

the cancellation of the 5% Preference Shares

at the AGM and the 5% Preference Shares

Scheme Meeting (as defined below). If the

Scheme in respect of the 5% Preference

Shares becomes effective, the delisting from

Euronext Growth Dublin is expected to take

effect on or around the Effective Time.

**Recommendation of the Board** 

**and its Reasons for the Proposed** 

**Preference Share Cancellations**

The Board recommends that Ordinary

Shareholders (and 7% Preference

Shareholders, voting with Ordinary

Shareholders as a single class, for the

purposes of Proposal 9 only) approve

Proposals 8 through 11 with respect to the

proposed Preference Share Cancellations for

the following reasons:

Simplify capital and listing structure and

associated compliance requirements:

CRH is required to comply with administrative

and regulatory requirements related to the

Preference Shares. CRH believes that these

compliance and other administrative burdens

are disproportionate to the value of the

Preference Shares and the small percentage of

the Company's total issued share capital that

they represent. The Board believes that the

Preference Share Cancellations, if

implemented, would yield a number of

efficiencies for CRH and its Ordinary

Shareholders, through simplifying the

Company's capital structure and streamlining

applicable regulatory requirements.

Opportunity for Preference Shareholders to

monetize their holding:

There has been very little reported trading in

the 7% or 5% Preference Shares over the past

decade, leaving the Preference Shareholders

with limited opportunity to sell their shares. The

proposed Preference Share Cancellations will

provide the holders with the opportunity to

convert their illiquid assets into cash at a

significant premium.

**Approvals Required to Implement** 

**the Proposed Cancellation of** 

**Preference Shares** 

As noted above, the Preference Share

Cancellations require the approval of Ordinary

Shareholders (and the 7% Preference

Shareholders with respect to Proposal 9 only)

of each of Proposals 8, 9, 10 and 11 at the

2026 AGM. Under the Articles, 7% Preference

Shareholders are entitled to vote in respect of

a capital reduction of the Company and will

therefore be entitled to vote on Proposal 9 at

the 2026 AGM with the Ordinary Shareholders,

voting as a single class. The 7% Preference

Shareholders are not entitled to vote on any

other Proposals at the 2026 AGM.

In addition to seeking the approval of

Proposals 8 through 11 at the 2026 AGM,

each class of Preference Shareholders will be

asked to approve the applicable Scheme at a

separate Scheme Meeting for each class. On

or around the date of this Proxy Statement, the

Company issued a separate notice of Scheme

Meeting, the terms of the applicable Scheme

and related documentation, in respect of each

Scheme Meeting to the Preference

Shareholders in order to allow them to

consider, and if thought fit, approve the

cancellation of each class of Preference

Shares. The Scheme Meetings to obtain such

approvals are scheduled to be held on May 21,

2026 at (i) 10:00 a.m. (Dublin) in respect of the

7% Preference Shares, and (ii) 10:30 a.m.

(Dublin) in respect of the 5% Preference

Shares, or such later time as the immediately

preceding Scheme Meeting for the 7%

Preference Shares concludes. The full text of

each Scheme is set out in Part I of Annex B

and Annex C of this Proxy Statement.

In summary, the Preference Share

Cancellations require approval by:

(a)the Ordinary Shareholders of the Schemes

and the granting of authority to the

Directors of CRH to give effect to the

Scheme(s), as described in Proposal 8

(acting by a majority of greater than 50% of

votes cast);

(b)the Ordinary Shareholders (and 7%

Preference Shareholders voting with the

Ordinary Shareholders as a single class) of

the Capital Reduction relating to the

cancellation of any class(es) of Preference

Shares cancelled pursuant to the Schemes,

as described in Proposal 9 (acting by a

majority of at least 75% of votes cast);

(c)the Ordinary Shareholders of the variation to

the authorized share capital to remove any

class(es) of Preference Shares, cancelled

pursuant to the Schemes, as described in

Proposal 10 (acting by a majority of greater

than 50% of votes cast);

(d)the Ordinary Shareholders of the amended

Articles to remove references to any

class(es) of Preference Shares cancelled

pursuant to the Schemes and to add a new

Article 16 to facilitate the implementation of

the Schemes, as described in Proposal 11

(acting by a majority of at least 75% of

votes cast);

(e)the 5% Preference Shareholders (who

represent at least 75% in value of the

members present and voting either in

person or by proxy) of the Scheme of

Arrangement to cancel the 5% Preference

Shares (including the related delisting from

Euronext Growth Dublin) (the '5%

Preference Share Scheme') at the Scheme

Meeting to approve the 5% Preference

Share Scheme (the '5% Preference Share

Scheme Meeting') (acting by a majority of at

least 75% of votes cast); and

(f)the 7% Preference Shareholders (who

represent at least 75% in value of the

members present and voting either in

person or by proxy) of the Scheme of

Arrangement to cancel the 7% Preference

Shares (the '7% Preference Share Scheme')

at the Scheme Meeting to approve the 7%

Preference Share Scheme (the '7%

Preference Share Scheme Meeting') (acting

by a majority of at least 75% of votes cast).

**Conditions to Implement the** 

**Preference Share Cancellations** 

The implementation of each Preference Share

Cancellation is conditional upon the applicable

Scheme becoming effective. The effectiveness

of each Scheme is subject to the satisfaction

(or if allowed by law, waiver) of the following

conditions:

(a)each of Proposals 8, 9, 10 and 11 being

duly passed by the requisite majorities at

the 2026 AGM (or any adjournment to such

meeting);

(b)approval of the applicable Scheme by the

applicable class of Preference Shareholders

(who represent at least 75% in value of the

members present and voting either in

person or by proxy at the applicable

Scheme Meeting, and with the quorum of at

least two persons holding or representing in

person or by proxy at least one third in

nominal value of the applicable class of

Preference Shares in issue being satisfied at

such Scheme Meeting);

(c)the sanction by the Irish High Court of the

applicable Scheme (with or without any

modification(s), addition(s) or condition(s)

approved or imposed by the Irish High

Court) pursuant to Section 453 of the

Companies Act 2014, and the confirmation

of the Capital Reduction involved therein by

the Irish High Court;

(d)the delivery of a copy of the order or orders

of the Irish High Court sanctioning any of

33<br>

CRH PROXY STATEMENT 2026

the Schemes and confirming the Capital

Reduction (the 'Scheme Order'), together

with a copy of the minute required by

Section 86 of the Companies Act 2014, to

the Irish Registrar of Companies (the 'Irish

Registrar') for registration in accordance

with Section 454 of the Companies Act

2014, and registration of the applicable

Scheme Order and minute by the Irish

Registrar; and

(e)the Board not having resolved to abandon,

discontinue and/or withdraw the applicable

Schemes prior to the Irish High Court

hearings to sanction the applicable

Schemes (the 'Court Hearings').

The effectiveness of each Scheme is not inter-

conditional. If the relevant approvals and

conditions are satisfied in respect of a Scheme

relating to only one class of Preference Share,

the cancellation in respect of that class of

Preference Share shall proceed.

Even if Proposals 8 through 11 are approved

by the requisite majorities at the 2026 AGM,

the Board reserves the right to abandon,

discontinue and/or withdraw the Schemes

prior to the Court Hearings without further

action from Ordinary Shareholders or

Preference Shareholders if it determines that

the Preference Share Cancellations would no

longer be in the best interests of the Company

and its Ordinary Shareholders and Preference

Shareholders as a whole.

**Effective Time**

Subject to obtaining the requisite approvals at

the 2026 AGM and Scheme Meeting(s), an

application will be made to the Irish High Court

to set a date for the hearing to sanction the

Scheme(s) under Section 453(2)(c) of the

Companies Act 2014 and to confirm the

Capital Reduction. Assuming the Conditions

are satisfied, each Scheme is expected to take

effect in accordance with its terms as soon as

a copy of the relevant Scheme Order and a

copy of the minute required by Section 86(1) of

the Companies Act 2014 have been delivered

to the Irish Registrar for registration and

registered by the Irish Registrar. In each case,

the effectiveness of the Schemes will be

notified to Ordinary Shareholders and

Preference Shareholders by (i) an

announcement through a Regulatory

Information Service (as defined in the Irish

Takeover Rules), with such announcement

being made available on the Company's

website, and/or (ii) in such other manner as the

Irish High Court might direct. The Scheme

Meetings are expected to be held at the offices

of Arthur Cox LLP, Ten Earlsfort Terrace,

Dublin 2, D02 T380, Ireland on May 21, 2026

at 10:00 a.m. (Dublin) in respect of the 7%

Preference Shares, and at 10:30 a.m. (Dublin),

or such later time as the immediately preceding

Scheme Meeting for the 7% Preference Shares

concludes and, subject to the satisfaction (or,

if permitted by law, waiver) of the Conditions,

the Scheme(s) are expected to become

effective before the end of July 2026. The

timing of the Schemes becoming effective

depends on a number of factors including the

availability of the Irish High Court to hear the

application(s) to sanction the Scheme(s), and, if

sanctioned, the date the Scheme Order(s) are

delivered to and registered by the Irish

Registrar. If the Scheme(s) become effective, at

the Effective Time, the applicable class of

Preference Shares will be cancelled pursuant

to Section 84 to 86 of the Companies Act

2014 in accordance with the terms of the

applicable Scheme.

Once effective, each Scheme will be binding

on all of the Preference Shareholders to which

the Scheme relates, irrespective of whether or

not they attended or voted on the relevant

resolutions at the applicable Scheme Meeting

and/or AGM.

The above summary of the terms and

conditions of the Schemes of Arrangement

does not purport to be complete, may not

contain all of the information about the

proposed Preference Share Cancellations that

is important to you, and is qualified in its

entirety by reference to the full text of each

Scheme of Arrangement which is set out in

Part I of each of Annex B and Annex C to this

Proxy Statement. The required notices in

respect of the Scheme Meetings have been

sent separately to the Preference

Shareholders. This document is not intended

to, and does not, constitute the legal notice in

respect of the Scheme Meetings.

**If the Proposed Preference Share** 

**Cancellations are not Approved**

If the proposed Preference Share Cancellations

are not approved at the 2026 AGM or any

adjournment or postponement thereof, or by

the applicable class of Preference

Shareholders at the Scheme Meetings, the

Company will be unable to implement the

proposed Preference Share Cancellations in

the manner contemplated in this Proxy

Statement.

**Impact of the Preference Share** 

**Cancellations on the Company's** 

**Share Capital** 

The following table contains approximate

information, based on share information as of

March 11, 2026, relating to the effect of the

proposed Preference Share Cancellations on

CRH's issued and outstanding and authorized

but unissued Ordinary Shares and Preference

Shares in the event that the Preference Share

Cancellations occur:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Description** | **Number of Ordinary** <br>**Shares Authorized**<br>| **Number of Ordinary** <br>**Shares Issued** <br>**(including Treasury** <br>**Shares)**<br>| **Number of 5%** <br>**Preference Shares** <br>**Authorized**<br>| **Number of 5%** <br>**Preference Shares** <br>**Issued** <br>| **Number of 7%** <br>**Preference Shares** <br>**Authorized**<br>| **Number of 7%** <br>**Preference Shares** <br>**Issued** <br>|
| Pre-Preference Share <br>Cancellations <br>| 1250000000 | 705043723 | 150000 | 50000 | 872000 | 872000 |
| Post-Preference <br>Share Cancellations <br>| 1250000000 | 705043723 | 0 | 0 | 0 | 0 |

---

Notes:

(i)Number of Ordinary Shares Issued shown as of March 11, 2026 and does not reflect any repurchases/redemptions under CRH's share buyback program subsequent thereto.

If the Preference Share Cancellations are

implemented, the Company's current

authorized share capital will be varied from

€401,297,940 divided into 150,000 5%

Preference Shares, 872,000 7% Preference

Shares and 1,250,000,000 Ordinary Shares of

€0.32 each, to €400,000,000 divided into

1,250,000,000 Ordinary Shares of €0.32 each,

by removing the cancelled classes of

Preference Shares from the Company's

authorized share capital. If only one class of

Preference Shares is cancelled, the authorized

share capital will be reduced by the removal of

that cancelled class of Preference Shares only.

The proposed Preference Share Cancellations

will have no impact on the number of

authorized or issued Ordinary Shares.

**Accounting Matters**

The Company's Consolidated Balance Sheets

will be impacted by the proposed Preference

Share Cancellations, if implemented, as

follows: (i) the stated capital attributable to the

Preference Shares (which is calculated as

nominal value multiplied by the number of

Preference Shares issued and outstanding) will

be reduced from €1,170,940 to €nil, (ii) the

amount attributable to Retained Earnings will

be reduced by an amount equal to the

Cancellation Consideration payable in respect

of any cancelled class of Preference Shares

less the aggregate nominal value of the

cancelled Preference Shares.

If only one class of Preference Share is

cancelled, (i) the stated capital attributable to

the Preference Shares will be reduced by an

34<br>

CRH PROXY STATEMENT 2026

amount equal to the aggregate nominal value

of all issued and outstanding shares in such

class, and, (ii) the amount attributable to

Retained Earnings will be reduced by an

amount equal to the Cancellation

Consideration payable in respect of such

cancelled class of Preference Shares less the

aggregate nominal value of such cancelled

class of such Preference Shares.

We do not anticipate that any other relevant

accounting considerations would arise as a

result of any implementation of the Preference

Share Cancellations.

**Interests of Directors and Executive** 

**Officers** 

No director or executive officer of the

Company holds any interests in the Preference

Shares or has any substantial interests, directly

or indirectly, in the matters relating to the

Preference Share Cancellations.

**Summary of Irish Tax Consequences** 

**of the Proposed Preference Share** 

**Cancellations**

The following is a high-level summary of the

material Irish tax considerations relating to the

proposed Preference Share Cancellations

applicable to the persons who are the absolute

beneficial owners of the Preference Shares for

Irish tax purposes. For the purposes of this

summary, 'Non-Irish Holders' means

Preference Shareholders who: (i) are the

absolute beneficial owners of their Preference

Shares; (ii) are neither resident (nor, in the case

of individuals, ordinarily resident) in Ireland for

Irish tax purposes, and where such Preference

Shares have not at any time been (1) used in or

for the purposes of a trade carried on by that

Preference Shareholder through an Irish

branch or agency; nor (2) used, held or

acquired for use by or for the purposes of such

branch or agency. Anti-avoidance provisions

that apply to persons that are temporarily non-

Irish resident are not considered.

This summary is general in nature and does

not represent a detailed description of the Irish

tax considerations to a Preference Shareholder

in light of their particular circumstances.

The summary is based on existing Irish tax law

and published practice of the Irish Revenue

Commissioners as of the date of this Proxy

Statement. Changes in law and/or

administrative practice may result in changes

to the Irish tax considerations described,

possibly with retrospective effect.

Preference Shareholders who are in any

doubt about their tax position and/or may

be subject to taxation in any jurisdiction

other than Ireland are strongly

recommended to consult an appropriately

qualified independent professional advisor

immediately for tax advice in connection

with the proposed Preference Share

Cancellations.

**Ordinary Shareholders**

There will be no Irish tax implications in

connection with the Preference Share

Cancellations for Ordinary Shareholders who

are not also Preference Shareholders.

**Preference Shareholders** 

Non-Irish Holders should not generally be

subject to Irish capital gains tax ('Irish CGT') or

corporation tax on chargeable gains on the

disposal of their Preference Shares pursuant to

the Preference Share Cancellations. Irish

resident Preference Shareholders (or those

who are ordinarily resident in Ireland or have

used their Preference Shares in connection

with a trade carried on in Ireland through a

branch or agency) will generally be subject to

Irish CGT at a rate of 33% on any chargeable

gain on the disposal of their Preference Shares

pursuant to the Preference Share

Cancellations, subject to available exemptions

and reliefs.

Payments made by the Company to

Preference Shareholders under the Schemes

for the redemption, repayment or purchase of

its Preference Shares will not be subject to

Irish dividend withholding tax in Ireland where

the arrangement does not form part of a

scheme the main purpose of which is to enable

the owner of the shares to participate in the

profits of the company without receiving a

dividend. Unless exempted, any dividends or

other relevant distributions paid by the

Company to Preference Shareholders under

the Scheme will be subject to withholding at

the standard rate of income tax (currently

25%).

Preference Shareholders will not be chargeable

to Irish stamp duty on the disposal of their

Preference Shares in connection with the

Schemes. Further information regarding the

Irish tax consequences of the proposed

Preference Share Cancellations is set out in

Part 2 of each of Annex B and C to this Proxy

Statement.

Further information regarding the Preference

Share Cancellations is set out in the "FAQs

Regarding the Preference Share Cancellations

and Delistings" at Annex E of this Proxy

Statement, which are available on the

Company's website, *www.crh.com*, under the

heading "Shareholder Center".

**The Board of Directors recommends** 

**that Ordinary Shareholders (and 7%** 

**Preference Shareholders, voting with** 

**the Ordinary Shareholders in respect** 

**of Proposal 9 only) vote FOR the** 

**resolutions set out in Proposals 8** 

**through 11 in connection with the** 

**proposed Preference Share** 

**Cancellations.**

35<br>

CRH PROXY STATEMENT 2026

Proposal 8 – Approval of the

Schemes of Arrangement to

Cancel the Preference Shares

and the Granting of Authority

to the Directors to give effect

to the Schemes of

Arrangement

**The Board of Directors recommends** 

**that Ordinary Shareholders vote FOR** 

**the proposal to approve the Schemes** 

**of Arrangement to Cancel the** 

**Preference Shares and grant** 

**authority to the Directors to give** 

**effect to the Schemes of** 

**Arrangement.**

As further described in the section titled

"Overview of Proposals 8 through 11 Relating

to the Proposed Cancellation of the Preference

Shares", the Company is seeking to cancel its

two classes of Preference Shares pursuant to

two separate Schemes of Arrangement. The

Preference Share Cancellations require, among

other things, approval of the Schemes by the

Company's Ordinary Shareholders. A summary

of the terms and conditions of the Schemes

are set forth on pages 31 to 34 of this Proxy

Statement, with the full text of each Scheme of

Arrangement set out in Part I of Annex B and

Annex C to this Proxy Statement.

**Vote Required**

Approval of Proposal 8, which is an ordinary

resolution under Irish company law, requires

that more than 50% of the votes cast at the

2026 AGM must be cast "FOR" the resolution.

Abstentions and broker non-votes are not

considered votes cast at the meeting and

therefore will not impact the outcome of the

vote on this Proposal.

The text of the resolution in respect of

Proposal 8 is as follows:

"As an ordinary resolution that, subject to the

approval of the applicable Scheme of

Arrangement by the requisite majorities at the

applicable Scheme Meeting, each Scheme of

Arrangement (copies of which have been

produced to this meeting and for the purposes

of identification signed by the Chair thereof) in

its original form or with or subject to any

modification(s), addition(s) or condition(s)

approved or imposed by the High Court of

Ireland, be and are hereby approved and the

directors of CRH plc be and are hereby

authorized to take all such action as they

consider necessary or appropriate for carrying

each and any of the Schemes of Arrangement

into effect."

36<br>

CRH PROXY STATEMENT 2026

Proposal 9 – Approval of the

Proposed Cancellation of the

Preference Shares

**The Board of Directors recommends** 

**that Ordinary Shareholders and the** 

**7% Preference Shareholders vote** 

**FOR the proposal to approve the** 

**Cancellation of the Preference** 

**Shares.**

Under the Articles, the 7% Preference

Shareholders are entitled to vote in respect

of a capital reduction of the Company and

will therefore be entitled to vote on

Proposal 9 with the Ordinary Shareholders,

voting as a single class (but not on the

other resolutions).

As of March 11, 2026, being the latest

practicable date prior to publication of this

Proxy Statement, the amount standing to the

portion of the Company's share capital

account associated with the Preference Shares

is €1,170,940, being the aggregate nominal

value of all of the Preference Shares, with

€63,500 of this amount relating to the 5%

Preference Shares (the '5% Balance'), and

€1,107,440 of this amount relating to the 7%

Preference Shares (the '7% Balance'), (the

'Preference Share Capital').

In Proposal 9, the Ordinary Shareholders and

the 7% Preference Shareholders, voting as a

single class, are being asked to approve, by

special resolution, the cancellation of the

Preference Shares by way of a reduction of the

Preference Share Capital by:

(a)an amount equal to the 5% Balance if the

5% Preference Share Scheme becomes

effective; and

(b)an amount equal to the 7% Balance if the

7% Preference Share Scheme becomes

effective.

The entire balance of each class of Preference

Share will be cancelled if the corresponding

Scheme is passed by the respective class. If

approved by the requisite majorities, and

subject to confirmation by the Irish High Court,

the cancellation of the Preference Shares will

become effective simultaneous to the

applicable Schemes becoming effective.

Proposal 9 is conditional upon any of the

Schemes becoming effective.

**Vote Required**

Approval of Proposal 9, which is a special

resolution under Irish company law, requires

that at least 75% of the votes cast must be

cast "FOR" the resolution. Abstentions and

broker non-votes are not considered votes

cast and will not impact the outcome of the

vote on this Proposal.

The text of the resolution in respect of

Proposal 9 is as follows:

"As a special resolution, that subject to and

with the confirmation of the High Court of

Ireland ("Irish High Court") in accordance with

Sections 84 and 85 of the Companies Act

2014:

(i)the share capital of the Company be

reduced by cancelling, extinguishing and

repaying all of the 50,000 5% Cumulative

Preference Shares of €1.27 each in the

capital of CRH (the "5% Preference

Shares"), in exchange for the payment of an

amount equal to €2.54 for each 5%

Preference Share, with a corresponding

reduction of: (A) an amount equal to the

nominal value of such 5% Preference

Shares to the Company's share capital

account, and (B) an amount equal to the

premium over such nominal value to the

Company's profits available for distribution;

and

(ii)the share capital of the Company be

reduced by cancelling, extinguishing and

repaying all of the 872,000 7% "A"

Cumulative Preference Shares of €1.27

each in the capital of CRH (the "7%

Preference Shares"), in exchange for the

payment of an amount equal to €3.556 for

each 7% Preference Share, with a

corresponding reduction of (A) an amount

equal to the nominal value of such 7%

Preference Shares to the Company's share

capital account, and (B) an amount equal to

the premium over nominal value to the

Company's profits available for distribution,

provided that each of the capital reduction

resolutions referred to in (i) and (ii) is

independently and severally approved and

provided further that in the event that the

confirmation of the Irish High Court is sought

and obtained in respect of only one of the

capital reduction resolutions referred to in (i) or

(ii), the validity of this resolution in respect of

the capital reduction so sought shall not be

limited or forfeited by virtue of the confirmation

of the Irish High Court in respect of the other

capital reduction referred to in (i) or (ii) not

being sought or obtained, or being sought and/

or obtained at a different time."

37<br>

CRH PROXY STATEMENT 2026

Proposal 10 – Approval of the

Variation to the Company's

Authorized Share Capital by

the Removal of the Cancelled

Preference Shares

**The Board of Directors recommends** 

**that Ordinary Shareholders vote FOR** 

**the proposal to vary the Company's** 

**authorized share capital by the** 

**removal of any class(es) of** 

**Preference Shares that are cancelled** 

**pursuant to the Schemes.**

The authorized share capital of CRH is

currently €401,297,940 divided into 150,000

5% Preference Shares, 872,000 7%

Preference Shares and 1,250,000,000

Ordinary Shares of €0.32 each. The Company

is seeking Ordinary Shareholder approval to

vary and remove from the Company's

authorized share capital an amount equal to

the nominal value of any class(es) of

Preference Shares cancelled pursuant to the

Schemes, being (i) €190,500 in respect of the

5% Preference Shares, and (ii) €1,107,440 in

respect of the 7% Preference Shares.

Proposal 10 is conditional upon any of the

Schemes becoming effective. If one or both of

the Schemes is implemented, the variation to

CRH's authorized share capital will become

effective immediately following any of the

Schemes becoming effective.

**Vote Required**

Approval of Proposal 10, which is an ordinary

resolution under Irish company law, requires

that more than 50% of the votes cast must be

cast "FOR" the resolution. Abstentions and

broker non-votes are not considered votes

cast and will not impact the outcome of the

vote on this Proposal.

The text of the resolutions in respect of

Proposal 10 is as follows:

As an ordinary resolution, that:

(i) subject to the scheme of arrangement in

respect of the cancellation of the 5%

Cumulative Preference Shares of €1.27

each in the capital of the Company (the

"5% Preference Shares") becoming

effective, the authorized share capital of

the Company be and is hereby varied and

diminished by €190,500 by the removal of

the 5% Preference Shares from the

authorized share capital of the Company;

and

(ii) subject to the scheme of arrangement in

respect of the cancellation of the 7% "A"

Cumulative Preference Shares of €1.27

each in the capital of the Company (the

"7% Preference Shares") becoming

effective, the authorized share capital of

the Company be and is hereby varied and

diminished by €1,107,440 by the removal

of the 7% Preference Shares from the

authorized share capital of the Company,

provided that each of the variations and

diminutions referred to in (i) and (ii) is

independently and severally approved, and

provided further that in the event of the

completion of only one of the schemes of

arrangement referred to in (i) or (ii), the validity

of this resolution in respect of the variation and

diminution regarding such scheme of

arrangement shall not be limited or forfeited by

virtue of the other scheme of arrangement

referred to in (i) or (ii) not completing, or

completing at a different time."

38<br>

CRH PROXY STATEMENT 2026

Proposal 11 – Approval of

Certain Amendments to the

Company's Articles to Remove

References therein to any

Class(es) of Preference Shares

Cancelled in connection with

the proposed Preference

Share Cancellations

**The Board of Directors recommends** 

**that Ordinary Shareholders vote FOR** 

**the amendments to the Articles** 

**to delete references therein to any** 

**class(es) of Preference Shares** 

**cancelled in connection with the** 

**proposed Preference Share** 

**Cancellations.**

The Company is seeking Ordinary Shareholder

approval to amend the Articles to (i) remove

references to any classes of Preference Shares

cancelled pursuant to any of the Schemes, (ii)

delete redundant provisions that relate to the

Preference Shares, and (iii) consequential

renumbering of and updates to cross

references in the Articles to reflect such

amendments. The proposed amendments also

include a new Article 16 to facilitate

implementation of the Schemes by providing

that (i) any Preference Shares issued or

transferred after the Voting Record Time (as

defined in the applicable Scheme) (if any) will

be bound by the terms of the applicable

Schemes, and (ii) the Directors of CRH are

granted authority to appoint an attorney to take

actions to implement the applicable Schemes.

The foregoing description of the proposed

amendments to the Articles is intended only as

a summary and is qualified in its entirety by

reference to the complete text of the proposed

amendments, which is attached to this Proxy

Statement as Annex D. We encourage you to

read the proposed amendments set out in

Annex D in their entirety before casting your

vote. Certain explanatory footnotes are

included in the proposed amendments to the

Articles described in Annex D to denote the

amendments which will apply in circumstances

where (i) both Schemes, and/or (ii) only one of

the Schemes, are implemented.

Proposal 11 is conditional upon one or both of

the Schemes becoming effective. If one or

both of the Schemes is implemented, the

applicable form of Articles will become

effective at the Effective Time.

**Vote Required**

Approval of Proposal 11, which is a special

resolution under Irish company law, requires

that at least 75% of the votes cast must be

cast "FOR" the resolution. Abstentions and

broker non-votes are not considered votes

cast and will not impact the outcome of the

vote on this Proposal.

The text of the resolutions in respect of

Proposal 11 is as follows:

"As a special resolution, that:

(i) subject to the scheme of arrangement in

respect of the cancellation of the 5%

Cumulative Preference Shares of €1.27

each in the capital of the Company (the

"5% Preference Shares) becoming

effective, the Articles of Association of the

Company be and are hereby amended by

the deletion of the Articles regarding the

5% Preference Shares, and other related

changes, in the manner indicated in Annex

D of the Notice of Meeting and Proxy

Statement for the 2026 AGM; and

(ii) subject to the scheme of arrangement in

respect of the cancellation of the 7% "A"

Cumulative Preference Shares of €1.27

each in the capital of the Company (the

"7% Preference Shares") becoming

effective, the Articles of Association of the

Company be amended by the deletion of

the Articles regarding the 7% Preference

Shares, and other related changes, in the

manner indicated in Annex D of the Notice

of Meeting and Proxy Statement for the

2026 AGM,

provided that each of the amendments referred

to in (i) and (ii) is independently and severally

approved and provided further that in the event

of the completion of only one of the schemes

of arrangement referred to in (i) or (ii), the

validity of the resolution in respect of the

amendment regarding such scheme of

arrangement shall not be limited or forfeited by

virtue of the other scheme of arrangement

referred to in (i) or (ii) not completing, or

completing at a different time."

39<br>

CRH PROXY STATEMENT 2026

Proposal 12 – Approval of

an Amendment to the Articles

to Delete a Provision

Regarding Qualification

Shareholding Requirement for

Directors Set Forth Therein

**The Board of Directors recommends** 

**that shareholders vote FOR the** 

**proposal to amend the Articles to** 

**delete the qualification shareholding** 

**requirement for Directors set forth** 

**therein.**

As previously disclosed, effective January 1,

2025, the Company adopted share ownership

guidelines for its NEOs and non-management

Directors to reinforce the alignment between

CRH executives and shareholders and foster a

long-term, ownership mindset. Pursuant to

these guidelines, non-management Directors

are expected to hold shares having a minimum

value equal to five times their cash retainer. In

addition, non-management Directors receive

an annual equity retainer, which for the fiscal

year 2025 was in the amount of $180,000. The

initial equity retainer for newly appointed non-

management Directors is pro-rated for service

for the year of appointment.

Article 87 of the Articles ('Article 87') currently

contains a separate requirement that a Director

hold alone, and not jointly with any other

person, 1,000 Ordinary Shares within two

months after his or her appointment or election

(which time period may be extended if trading

in the Company's shares is prohibited at the

relevant time). The full text of Article 87 is set

out in Annex F to this Proxy Statement.

The Board believes that the share ownership

guidelines, in conjunction with the equity

retainer for non-management Directors,

provide for an appropriate alignment of

interests between Directors and the

Company's shareholders, in a manner which is

consistent with U.S. market practice. The level

of shareholdings required of Directors pursuant

to Article 87 is significantly lower than the

Company's share ownership guidelines.

Accordingly, Article 87 no longer serves a

distinct purpose. For these reasons, the Board

believes it is in the best interests of CRH and

its shareholders to adopt this proposed

amendment to the Articles.

The foregoing description of the proposed

amendment to the Articles is intended only as

a summary and is qualified in its entirety by

reference to the proposed amendment, which

is attached to this Proxy Statement as Annex

F. We encourage you to read the proposed

amendment set out in Annex F in its entirety

before casting your vote.

Proposal 12 is not conditional upon approval of

any of the other proposed amendments to the

Articles that are being voted upon at the AGM.

If Proposal 12 is approved by our shareholders

at the AGM, it will become effective

immediately.

**Vote Required**

Approval of Proposal 12, which is a special

resolution under Irish company law, requires

that at least 75% of the votes cast on this

resolution must be cast "FOR" the resolution.

Abstentions and broker non-votes are not

considered votes cast and will not impact the

outcome of the vote on this Proposal.

The text of the resolution in respect of

Proposal 12 is as follows:

"As a special resolution, that the Articles of

Association be and are hereby amended in the

manner provided at Annex F to the Notice of

Meeting and Proxy Statement for the 2026

AGM."

40<br>

CRH PROXY STATEMENT 2026

![CRH3080_MASTER_Assets_FEB_PR10.jpg](crh-20260326_g62.jpg)

Corporate Governance

CRH is committed to a high standard of corporate governance and

regularly reviews its governance structures and arrangements.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Governance Framework** | **Governance Framework** | **Governance Framework** |  |
|  | **Board of Directors**  | **Board of Directors**  | **Board of Directors**  |  |
| Collectively responsible for promoting the long-term sustainable success of CRH and generating value for shareholders. Its role <br>is to provide leadership; to establish and monitor CRH's purpose, values and strategy; to set CRH's risk appetite and ensure <br>that there is a robust framework of prudent and effective controls to enable risks and opportunities to be assessed and <br>managed; and to ensure that there is effective dialogue with shareholders on all relevant matters. | Collectively responsible for promoting the long-term sustainable success of CRH and generating value for shareholders. Its role <br>is to provide leadership; to establish and monitor CRH's purpose, values and strategy; to set CRH's risk appetite and ensure <br>that there is a robust framework of prudent and effective controls to enable risks and opportunities to be assessed and <br>managed; and to ensure that there is effective dialogue with shareholders on all relevant matters. | Collectively responsible for promoting the long-term sustainable success of CRH and generating value for shareholders. Its role <br>is to provide leadership; to establish and monitor CRH's purpose, values and strategy; to set CRH's risk appetite and ensure <br>that there is a robust framework of prudent and effective controls to enable risks and opportunities to be assessed and <br>managed; and to ensure that there is effective dialogue with shareholders on all relevant matters. | Collectively responsible for promoting the long-term sustainable success of CRH and generating value for shareholders. Its role <br>is to provide leadership; to establish and monitor CRH's purpose, values and strategy; to set CRH's risk appetite and ensure <br>that there is a robust framework of prudent and effective controls to enable risks and opportunities to be assessed and <br>managed; and to ensure that there is effective dialogue with shareholders on all relevant matters. | Collectively responsible for promoting the long-term sustainable success of CRH and generating value for shareholders. Its role <br>is to provide leadership; to establish and monitor CRH's purpose, values and strategy; to set CRH's risk appetite and ensure <br>that there is a robust framework of prudent and effective controls to enable risks and opportunities to be assessed and <br>managed; and to ensure that there is effective dialogue with shareholders on all relevant matters. |
| **The Board has established five Committees to assist in the execution of its responsibilities.** <br>**The charters of each Committee are available on the CRH website, www.crh.com.** | **The Board has established five Committees to assist in the execution of its responsibilities.** <br>**The charters of each Committee are available on the CRH website, www.crh.com.** | **The Board has established five Committees to assist in the execution of its responsibilities.** <br>**The charters of each Committee are available on the CRH website, www.crh.com.** | **The Board has established five Committees to assist in the execution of its responsibilities.** <br>**The charters of each Committee are available on the CRH website, www.crh.com.** | **The Board has established five Committees to assist in the execution of its responsibilities.** <br>**The charters of each Committee are available on the CRH website, www.crh.com.** |
| **The Board has established five Committees to assist in the execution of its responsibilities.** <br>**The charters of each Committee are available on the CRH website, www.crh.com.** | **The Board has established five Committees to assist in the execution of its responsibilities.** <br>**The charters of each Committee are available on the CRH website, www.crh.com.** | **The Board has established five Committees to assist in the execution of its responsibilities.** <br>**The charters of each Committee are available on the CRH website, www.crh.com.** | **The Board has established five Committees to assist in the execution of its responsibilities.** <br>**The charters of each Committee are available on the CRH website, www.crh.com.** | **The Board has established five Committees to assist in the execution of its responsibilities.** <br>**The charters of each Committee are available on the CRH website, www.crh.com.** |
| **Acquisitions,** <br>**Divestments &** <br>**Finance Committee** <br>Reviews the strategic <br>rationale and impact of <br>proposed acquisitions, <br>divestitures, large <br>capital expenditure <br>projects and advising <br>the Board on the <br>financial requirements <br>of CRH and on <br>appropriate funding <br>arrangements.<br>| **Audit Committee**<br>Provides governance <br>and oversight of CRH's <br>financial reporting and <br>monitoring and <br>assessing CRH's risk <br>management and <br>internal control <br>systems.<br>| **Compensation** <br>**Committee**<br>Sets and ensures that <br>CRH's compensation <br>policies are fair and <br>responsible and that <br>they incentivize and <br>retain talent. The <br>Committee also <br>approves the <br>compensation <br>packages for the <br>Chair, Chief Executive <br>Officer and Executive <br>Officers.<br>| **Nomination &** <br>**Corporate** <br>**Governance** <br>**Committee**<br>Monitors the Board's <br>structure, size, <br>composition and <br>balance of skills to <br>ensure that the Board <br>can meet its strategic <br>objectives and <br>regulatory <br>responsibilities. It <br>monitors corporate <br>governance <br>developments, human <br>capital management <br>and employee <br>engagement.<br>| **Safety,** <br>**Environment &** <br>**Social** <br>**Responsibility** <br>**Committee**<br>Monitors and assesses <br>performance in the <br>areas of safety, climate <br>change and <br>sustainability and <br>employee engagement <br>and inclusion <br>programs.<br>|
| **The Board has delegated responsibility for the management of CRH,** <br>**through the Chief Executive Officer, to executive management.** | **The Board has delegated responsibility for the management of CRH,** <br>**through the Chief Executive Officer, to executive management.** | **The Board has delegated responsibility for the management of CRH,** <br>**through the Chief Executive Officer, to executive management.** | **The Board has delegated responsibility for the management of CRH,** <br>**through the Chief Executive Officer, to executive management.** | **The Board has delegated responsibility for the management of CRH,** <br>**through the Chief Executive Officer, to executive management.** |
|  | **Chief Executive Officer**  | **Chief Executive Officer**  | **Chief Executive Officer**  |  |
| The Chief Executive Officer has responsibility for full day-to-day operational and profit performance of CRH and <br>accountability to the Board for all authority delegated to executive management. He is also responsible for executing <br>strategy agreed with the Board and reporting regularly on the progress and performance of CRH. | The Chief Executive Officer has responsibility for full day-to-day operational and profit performance of CRH and <br>accountability to the Board for all authority delegated to executive management. He is also responsible for executing <br>strategy agreed with the Board and reporting regularly on the progress and performance of CRH. | The Chief Executive Officer has responsibility for full day-to-day operational and profit performance of CRH and <br>accountability to the Board for all authority delegated to executive management. He is also responsible for executing <br>strategy agreed with the Board and reporting regularly on the progress and performance of CRH. | The Chief Executive Officer has responsibility for full day-to-day operational and profit performance of CRH and <br>accountability to the Board for all authority delegated to executive management. He is also responsible for executing <br>strategy agreed with the Board and reporting regularly on the progress and performance of CRH. | The Chief Executive Officer has responsibility for full day-to-day operational and profit performance of CRH and <br>accountability to the Board for all authority delegated to executive management. He is also responsible for executing <br>strategy agreed with the Board and reporting regularly on the progress and performance of CRH. |
| **The Global Leadership Team supports the Chief Executive Officer in executing his responsibilities.** | **The Global Leadership Team supports the Chief Executive Officer in executing his responsibilities.** | **The Global Leadership Team supports the Chief Executive Officer in executing his responsibilities.** | **The Global Leadership Team supports the Chief Executive Officer in executing his responsibilities.** | **The Global Leadership Team supports the Chief Executive Officer in executing his responsibilities.** |
|  | **Global Leadership Team** | **Global Leadership Team** | **Global Leadership Team** |  |
| The Global Leadership Team is responsible for pursuing performance delivery and progressing <br>CRH's business strategy and climate-related agenda. | The Global Leadership Team is responsible for pursuing performance delivery and progressing <br>CRH's business strategy and climate-related agenda. | The Global Leadership Team is responsible for pursuing performance delivery and progressing <br>CRH's business strategy and climate-related agenda. | The Global Leadership Team is responsible for pursuing performance delivery and progressing <br>CRH's business strategy and climate-related agenda. | The Global Leadership Team is responsible for pursuing performance delivery and progressing <br>CRH's business strategy and climate-related agenda. |

---

41<br>

CRH PROXY STATEMENT 2026

---

| | | |
|:---|:---|:---|
| ![CRH25_Creative_GLT_JM_SMPIC.jpg](crh-20260326_g63.jpg) | ![CRH25_Creative_GLT_JM_SMPIC.jpg](crh-20260326_g63.jpg) | ![CRH25_Creative_GLT_JM_SMPIC.jpg](crh-20260326_g63.jpg) |
| **Jim Mintern** | **Jim Mintern** | **Jim Mintern** |
| Chief Executive Officer  | Chief Executive Officer  | Chief Executive Officer  |
|  | + | See biography on page 19. |

---

---

| |
|:---|
| ![CRH GLT photos and frame_0003_Layer 7.jpg](crh-20260326_g64.jpg) |
| **Pádraig Ó Ríordáin** |
| Chief Legal and Corporate <br>Affairs Officer<br>Age: 60<br>Skills and experience: Pádraig <br>joined CRH in 2025. He has <br>over 30 years' experience in <br>advising multinational and <br>domestic corporations across <br>the United States and Europe. <br>He was previously Chief Legal <br>Officer at Flutter Entertainment, <br>and prior to that, a partner at <br>Arthur Cox LLP for 20 years, <br>including eight years as <br>Managing Partner. He has also <br>served as Chairman of both the <br>Dublin Airport Authority and <br>The National Lottery in Ireland. <br>A Harvard Law School <br>graduate, Pádraig is a qualified <br>lawyer in both Ireland and New <br>York.<br>Education: BCL (Law), LL.M <br>(Law)<br>|

---

---

| |
|:---|
| ![CRH GLT photos and frame_0008_Layer 2.jpg](crh-20260326_g65.jpg) |
| **Nancy Buese** |
| Chief Financial Officer<br>Age: 56<br>Skills and experience: Nancy <br>was appointed Chief Financial <br>Officer in May 2025. Prior to <br>joining CRH, Nancy served as <br>Executive Vice President and <br>Chief Financial Officer for the <br>Baker Hughes Company from <br>2022 until 2025. She also held <br>the role of Executive Vice <br>President and Chief Financial <br>Officer for the Newmont <br>Corporation from 2016 to <br>2022. Nancy is a certified <br>public accountant and a former <br>partner at Ernst & Young. She <br>has served on the Board of <br>Chubb Limited (NYSE: CB) <br>since 2023.<br>Education: BS/BA (Accounting <br>and Business Administration)<br>|

---

---

| |
|:---|
| ![CRH GLT photos and frame_0002_Layer 8.jpg](crh-20260326_g66.jpg) |
| **Kristin Lane** |
| Chief Human Resources Officer<br>Age: 56<br>Skills and experience: Kristin <br>joined CRH in 2016. She has <br>held a number of senior <br>positions across our <br>operations, most recently as <br>Chief Human Resources Officer <br>of our Americas Division, <br>before being appointed to her <br>current role in July 2024. <br>Before joining CRH, Kristin held <br>various global HR roles in the <br>building products, retail, <br>distribution and management <br>consulting industries. <br>Education: BS<br>|

---

---

| |
|:---|
| ![CRH GLT photos and frame_0007_Layer 3.jpg](crh-20260326_g67.jpg) |
| **Randy Lake** |
| Chief Operating Officer<br>Age: 60<br>Skills and experience: Randy <br>joined CRH in the Americas in <br>1996 and has held several senior <br>operating and leadership <br>positions across multiple areas of <br>the business, including CRH's <br>architectural products and its <br>Materials business. Prior to his <br>current appointment, Randy <br>served as President of Americas <br>Materials from 2012 to 2020 and <br>Group Executive, Strategic <br>Operations from 2020 to 2021. <br>Randy is actively involved in the <br>Materials industry in North <br>America and served as Chairman <br>of the U.S. National Stone, Sand <br>& Gravel Association in 2018.<br>Education: BS (Business <br>Administration), MBA<br>|

---

---

| |
|:---|
| ![CRH GLT photos and frame_0001_Layer 9.jpg](crh-20260326_g68.jpg) |
| **Juan Pablo San Agustín** |
| Chief Strategy Officer<br>Age: 57<br>Skills and experience: Juan <br>Pablo joined CRH in 2020. He <br>has over 25 years' experience <br>working in the building <br>materials industry across the <br>Americas and Europe. His <br>areas of expertise cover <br>strategic planning, M&A, <br>venture capital, digital <br>innovation and marketing. <br>Immediately prior to CRH, he <br>served as EVP of Strategic <br>Planning and New Business <br>Development at CEMEX.<br>Education: BS, MBA<br>|

---

---

| |
|:---|
| ![CRH GLT photos and frame_0006_Layer 4.jpg](crh-20260326_g69.jpg) |
| **Peter Buckley** |
| President, International Division<br>Age: 60<br>Skills and experience: Peter <br>joined CRH in 2009 as Country <br>Manager, China. Since then, he <br>has held a variety of Senior <br>Vice President roles across <br>Asia-Pacific and Europe as well <br>as playing a senior leadership <br>role across our Ash Grove <br>Cement business, and in the <br>UK and Ireland. He was <br>President of CRH's Europe <br>West region prior to taking up <br>his current role in 2024. Before <br>joining CRH, Peter held various <br>management positions globally <br>in the paper and packaging <br>industry.<br>Education: BComm<br>|

---

---

| |
|:---|
| ![CRH GLT photos and frame_0000_Layer 10.jpg](crh-20260326_g70.jpg) |
| **Philip Wheatley** |
| Chief Development Officer<br>Age: 51<br>Skills and experience: Philip is <br>CRH's Chief Development <br>Officer, with global responsibility <br>for CRH's M&A activities. Philip <br>has over 18 years' experience <br>with CRH, driving the company's <br>growth through M&A and <br>strategic planning, and his roles <br>have included Chief Growth <br>Officer, Group Head of M&A, <br>Group Strategy and <br>Development Director and <br>Development Director for the <br>Company's Materials business in <br>CRH's International Division. <br>Before joining CRH, Philip held <br>various M&A and operating roles <br>in the financial services and <br>building materials industries.<br>Education: BA, ACA<br>|

---

---

| |
|:---|
| ![CRH GLT photos and frame_0005_Layer 5.jpg](crh-20260326_g71.jpg) |
| **Nathan Creech** |
| President, Americas Division<br>Age: 50<br>Skills and experience: Nathan <br>joined CRH in the Americas in <br>2011 and has since served in a <br>number of business development <br>and executive leadership roles <br>including Vice President U.S. <br>Strategy & Development and <br>Senior Vice President, Central <br>Division of Americas Materials. <br>Prior to his current appointment, <br>Nathan served as President of <br>CRH's Americas Building <br>Products platform from 2021 to <br>2023. Prior to joining CRH, he <br>held various operating and <br>strategy roles in the building <br>materials industry. <br>Education: BS (Business), MBA<br>|

---

Members of our Global Leadership Team are appointed to their roles and serve at the discretion of the Company, rather than for a specific term of office.

42<br>

CRH PROXY STATEMENT 2026

**Corporate Governance Guidelines**

The Board has adopted Corporate Governance

Guidelines (the 'Governance Guidelines') as a

general framework to assist the Board in

carrying out its responsibility for the business

and affairs of CRH. The Governance

Guidelines, which are available on

*www.crh.com*, cover the role of the Board and

management, the qualifications and criteria

that the Nomination & Corporate Governance

Committee considers when considering

Director nominees, the composition of the

Board, and the structure, operations, duties

and responsibilities of the Board. The

Nomination & Corporate Governance

Committee reviews the Governance Guidelines

annually and recommends any changes for

approval by the Board.

**Board Leadership and Structure**

The roles of Chair and Chief Executive Officer

are not currently combined. The Chair is Richie

Boucher, who is an independent non-

management Director. Mr. Boucher was

appointed to this role in January 2020, having

joined the Board in March 2018. The Chief

Executive Officer is Jim Mintern, who was

appointed effective January 1, 2025.

There is a clear division of responsibilities

between the roles of the Chair and the Chief

Executive Officer, which is set out in the

Governance Guidelines.

The Board has also appointed a Senior

Independent Director, who chairs Board

meetings in the absence of the Chair and who

is available to shareholders who have concerns

that cannot be addressed through the Chair,

the Chief Executive Officer or the Chief

Financial Officer.

The Board regularly reviews the Board

structure to ensure that it remains appropriate

for CRH.

**Director Independence**

Pursuant to NYSE rules and listing standards,

in order for a Director to qualify as

"independent", the Board must affirmatively

determine that the Director has no material

relationship with CRH that would impair the

Director's independence. Our Board's

guidelines for Director independence conform

to the independence requirements in the NYSE

rules and listing standards.

In addition, the Board considers all relevant

facts and circumstances when making an

independence determination, including all

relevant transactions, relationships and

arrangements among Board members, their

family members and the Company.

Each of our 12 Directors who will stand for

re-election at the 2026 AGM were determined

to be independent under the foregoing

requirements, except for Jim Mintern who was

not independent pursuant to NYSE rules and

listing standards because he is CRH's Chief

Executive Officer. Patrick Decker, who served

as a Director from October 1, 2025 through

December 1, 2025, was also determined to be

independent under the foregoing requirements.

All members of the Audit, Compensation and

Nomination & Corporate Governance

Committees are independent and, in addition,

meet all additional applicable independence

tests of the NYSE rules and listing standards

and any additional standards imposed under

U.S. securities laws and the rules and

regulations of the SEC.

The Nomination & Corporate Governance

Committee reviews the independence of each

Director annually and makes recommendations

to the Board regarding independence.

**Tenure of Directors**

All Directors serve a one-year term, except that

the initial term for each Director runs from the

date of appointment until the next AGM, and

are subject to re-election by shareholders at

each AGM.

The Board does not believe that it should limit

the number of terms for which a person may

serve as a Director as they develop significant

insights into the Company and its operations

over time. Nonetheless, the Board keeps the

tenure of Directors under regular and rigorous

review to ensure there is an appropriate focus

on Board refreshment and mix of skills and

expertise relevant to the needs of the Board

and CRH.

**Process for Board Refreshment and** 

**Selection of Non-management** 

**Directors**

It is the policy of the Board that there is regular

refreshment of the Board and its Committees,

which ensures to the extent possible that the

collective experience, skills and diversity of the

Directors is reflected in its composition and the

composition of the Committees and Chair

roles, taking into account other requirements

such as Board succession planning and the

need for financial experts to be members of the

Audit Committee.

The Board plans for its own succession with

the assistance of the Nomination & Corporate

Governance Committee. The process to

identify, evaluate and appoint a non-

management Director with the suitable

experience, skills and time commitment takes

into account both the needs of the Company

and the diversity of background and

experience, tenure and skills of existing Board

members. The Board is committed to ensuring

that the Board and each Board Committee is

appropriately diverse in background and

experience, which is reflected in the

Governance Guidelines. The Board values

diversity of talents, skills, abilities and

experiences and believes that Board diversity

of all types enhances the performance of the

Board and provides significant benefits to the

Company. Accordingly, diversity in all its forms

is a core component that the Nomination &

Corporate Governance Committee takes into

account when selecting new Director

candidates.

The Nomination & Corporate Governance

Committee welcomes candidates for non-

management Directors recommended by

shareholders and will consider these

candidates in the same manner as other

candidates. Shareholder recommendations for

candidates for Director must include the same

information as required by CRH's Articles for

shareholder Director nominees and be sent to

the Nomination & Corporate Governance

Committee, c/o Company Secretary, 42

Fitzwilliam Square, Dublin 2, D02 R279,

Ireland.

For additional information, see "How do I

submit director nominees or a shareholder

proposal at the 2027 AGM?" on page 87.

43<br>

CRH PROXY STATEMENT 2026

**Non-management Director** 

**Appointment Process**

• Non-management Director recruitment

processes are supported by an external

search firm;

• A skills matrix is maintained to identify

particular skills that would enhance the

Board or which might need to be replaced

following any Board transitions. The

composition and skills of the Board are also

reviewed as part of the annual Board

evaluation process;

• Potential candidate lists are collated based

on the skills and experience required by the

Board following input from the Nomination

& Corporate Governance Committee;

• The Nomination & Corporate Governance

Committee reviews candidate lists and

selects individuals for interview; and

• Once a preferred candidate is identified

other members of the Board are invited to

meet with them prior to formal

consideration of their appointment to the

Board.

All members of the Board retire annually at the

AGM, with those being eligible standing for re-

election each year. The Nomination &

Corporate Governance Committee and the

Board annually reviews the performance of

each non-management Director, including his

or her commitment to the role, whether he or

she has sufficient time to meet his or her

commitment to the Company and whether his

or her skills remain relevant and beneficial to

support the Board in fulfilling its duties, and

makes a recommendation to shareholders in

relation to their re-election.

**Board Evaluation**

The Nomination & Corporate Governance

Committee is responsible for conducting an

annual review of Board effectiveness, the

composition of the Board, the operation and

performance of the Chair, the Board and its

Committees, and the effectiveness of Board

communications. The Senior Independent

Director, who is a member of the Nomination &

Corporate Governance Committee, is generally

delegated responsibility by the Nomination &

Corporate Governance Committee to lead the

evaluation process on its behalf. Periodically,

the evaluation is supported by an external

service provider, as was the case for the

evaluation being completed in respect of 2025.

**Director Orientation and** 

**Continuing Education**

The Chair arranges a tailored and comprehensive

orientation program with each new non-

management Director. New non-management

Directors are provided with extensive briefing

materials on the Company and its operations, the

procedures relating to the Board and its

Committees and their duties and responsibilities

as Directors under legislation and regulations that

apply to the Company.

Non-management Directors regularly receive

copies of research and analyses conducted on

the Company and the building materials sector,

and receive relevant industry, economic and

geopolitical updates. Directors are provided

with regular training on compliance and ethics

matters, while updates in relation to other

relevant matters, for example, changes in

applicable corporate law, are provided from

time to time.

In addition, Board site visits are leveraged to

gain a detailed understanding of CRH's

business model and strategy.

**Shareholder Engagement** 

Engagement with our investors helps us better

understand their views regarding our financial

performance and oversight of strategy and risk.

CRH's independent Chair reached out to

shareholders representing approximately 40%

of CRH's Ordinary Shares outstanding leading

to engagement with shareholders representing

approximately 25.6% of CRH's Ordinary

Shares outstanding, with the independent

Chair participating in many of these

engagements, during which he outlined the

Board's priorities and perspectives, and shared

updates on a wide range of topics, including:

• The safety and well-being of our people;

• Capital allocation policies and priorities;

• The Board's processes for overseeing

succession planning; and

• Board composition, and focus areas for

refreshment.

The feedback from these meetings was

provided to the Board and relevant

Committees.

In addition, CRH held an Investor Day on

September 30, 2025 at which we showcased

how our strategy positions us to deliver growth

for our shareholders.

**Employee Engagement and** 

**Organization Culture**

The results from organizational health surveys

are reported to the Board and the Safety,

Environmental & Social Responsibility (SESR)

Committee, while reports on the operation of

CRH's Hotline are reported to the Audit

Committee and the SESR Committee.

**Executive Succession Planning**

Long-term executive succession planning is an

ongoing focus for the Board. The senior executive

team and the full Board routinely consider

potential candidates for senior leadership

positions under a range of timelines and

readiness scenarios. For internal executives, this

includes the skills and expertise of the individuals

and their development programs to support them

in their career progression.

On January 1, 2025, Jim Mintern was appointed

Chief Executive Officer, and Alan Connolly

assumed the role of Interim Chief Financial

Officer. Nancy Buese was appointed to the role of

Chief Financial Officer on May 12, 2025.

For the Chief Financial Officer succession

process, the Board engaged Egon Zehnder, an

external search agency, to advise on and support

the implementation of a rigorous program,

involving consideration of both internal and

external candidates.

**Executive Sessions** 

The independent non-management Directors

meet periodically in executive sessions at

scheduled Board meetings. They may also

have other special meetings throughout the

year. These executive sessions are designed to

promote candor and discussion of matters in a

setting that is independent of executive

Directors. The Chair leads each of these

executive sessions.

44<br>

CRH PROXY STATEMENT 2026

**Committees of the Board**

The Board has established five Committees to

assist in the execution of its responsibilities:

• Acquisitions, Divestments & Finance;

• Audit;

• Compensation;

• Nomination & Corporate Governance; and

• Safety, Environment & Social Responsibility.

Ad hoc committees and sub-committees are

formed from time to time by the Board to deal

with specific matters.

The responsibilities of each of the Board's

Committees, which are summarized below, are

set out in detail in their respective Charters,

current copies of which are available on the CRH

website, www.crh.com.

**Acquisitions, Divestments & Finance Committee**

---

| | | |
|:---|:---|:---|
| **Chair** | **Members** | **Primary Responsibilities** |
| Richie Boucher | Richard Fearon <br>Johan Karlström<br>Shaun Kelly<br>Jim Mintern<br>Christina Verchere<br>| •Considering and approving acquisitions and divestitures and large capital expenditure projects up to agreed limits;<br>•Keeping the Board advised on the financial (including taxation) implications of Board decisions in relation to acquisitions;<br>•Approving guarantees related to bank financing provided by CRH up to certain limits; and<br>•Assisting management, at their request, in considering financial or taxation aspects of CRH's affairs.<br>|
|  |  | **Number of Meetings in 2025** |
|  |  | The Committee met 4 times during 2025. |

---

**Audit Committee**

---

| | | |
|:---|:---|:---|
| **Chair** | **Members** | **Primary Responsibilities** |
| Shaun Kelly\* | Caroline Dowling<br>Richard Fearon\*<br>Badar Khan<br>Siobhán Talbot\*<br>Christina Verchere<br>ALL INDEPENDENT<br>\*The Board has <br>determined that these <br>individuals are "Audit <br>Committee Financial <br>Experts" under <br>relevant SEC rules <br>| •Monitoring the integrity of CRH's financial statements, its periodic filings under the U.S. Securities Exchange Act of 1934, as <br>amended (the 'Exchange Act'), its annual report and financial statements prepared in accordance with Irish company law, <br>earnings releases, and any other formal announcements relating to its financial performance, reviewing, and reporting to the <br>Board on, significant financial reporting issues and judgments which they contain, having regard to the matters <br>communicated to it by the auditor; <br>•Monitoring the audit of the financial statements;<br>•Reviewing and discussing CRH's annual audited financial statements, quarterly financial statements and SEC filings that <br>contain such financial statements with management and the independent auditor, including reviewing CRH's specific <br>disclosures under "Management's Discussion and Analysis of Financial Condition and Results of Operations" in its annual <br>and quarterly periodic filings with the SEC;<br>•Reviewing and discussing with management, internal audit and the independent auditor the adequacy and effectiveness of <br>the Company's internal control over financial reporting and disclosure controls and procedures;<br>•Overseeing the processes by which management assesses and manages the Company's exposure to risk, and reviewing <br>and discussing the Company's significant enterprise risk exposures, including cyber and information security, and the steps <br>management has taken to monitor, address and mitigate such exposures;<br>•Establishing and overseeing procedures for the handling of complaints or concerns received by the Company regarding <br>accounting, internal accounting controls, auditing or reporting matters and other ethics and compliance matters including alleged <br>violations of the Company's Code of Business Conduct and the confidential, anonymous submission by employees of the <br>Company of concerns regarding questionable accounting, auditing or reporting matters<br>•Keeping under review the adequacy of the Company's compliance function;<br>•Monitoring and reviewing the effectiveness of the internal audit function in the context of the Company's overall risk <br>management system;<br>•Reviewing the effectiveness of the audit process and the independence and objectivity of the external auditors; <br>•Developing and monitoring the policy on non-audit services to be provided by the external auditor; and<br>•Approving the compensation and terms of engagement of the external auditor.<br>|
|  |  | **Number of Meetings in 2025** |
|  |  | The Committee met 8 times during 2025. |

---

45<br>

CRH PROXY STATEMENT 2026

**Compensation Committee**

---

| | | |
|:---|:---|:---|
| **Chair** | **Members** | **Primary Responsibilities** |
| Lamar McKay | Richie Boucher<br>Richard Fearon<br>Shaun Kelly<br>Mary K. Rhinehart<br>Siobhán Talbot<br>ALL INDEPENDENT<br>| •Reviewing the Company's overall executive compensation approach and philosophy and overseeing the development of <br>the Company's compensation policies and programs, taking into account all factors which it deems necessary to meet <br>the current and future needs of the Company;<br>•Reviewing and making recommendations to the Board with respect to incentive compensation and equity-based plans, <br>including whether to adopt, amend or terminate any such plans;<br>•Approving the design of, and determining the financial and non-financial targets for, any short-term performance-related <br>compensation programs operated by the Company and approving the total annual payments made under such <br>programs. The Committee shall additionally review the design of all long-term equity compensation plans for approval by <br>the Board and shareholders, as applicable;<br>•Reviewing and approving corporate goals and objectives relevant to compensation of the Chief Executive Officer, <br>evaluating his performance in light of those goals and objectives, and determining and approving the Chief Executive <br>Officer's compensation level;<br>•Reviewing and approving the annual compensation of the Company's executive officers;<br>•Periodically reviewing the form and amounts of the compensation of the non-management Directors and recommending <br>any changes to the Board;<br>•Reviewing and approving any share ownership guidelines for non-management Directors and the Company's executive <br>officers;<br>•Establishing the selection criteria, selecting, appointing and setting the terms of reference for any compensation <br>consultants who advise the Committee, and for obtaining reliable, up-to-date information about compensation in other <br>comparable companies, subject to consideration by the Committee of all factors relevant to that person's independence <br>from management to the extent required under the NYSE rules and listing standards;<br>•Preparing such reports and other disclosure as may be required by applicable law and regulation to be prepared by the <br>Committee, including disclosure required under Item 407(e)(5) of Regulation S-K and disclosure required to be prepared <br>by the Committee for inclusion in the Company's annual proxy statement, and, where relevant, shall make <br>recommendations to the Board with respect to any compensation-related proposals to be considered at the AGM, <br>including say-on-pay and any compensation-related shareholder proposals; and<br>•Reviewing any compensation recovery or recoupment policy applicable to the Chief Executive Officer and other executive <br>officers.<br>|
|  |  | **Number of Meetings in 2025** |
|  |  | The Committee met 6 times during 2025. |

---

**Nomination & Corporate Governance Committee**

---

| | | |
|:---|:---|:---|
| **Chair** | **Members** | **Primary Responsibilities** |
| Richie Boucher | Badar Khan<br>Lamar McKay<br>Gillian L. Platt<br>Mary K. Rhinehart<br>Siobhán Talbot<br>ALL INDEPENDENT<br>| •Identifying and recommending for the approval of the Board: (i) candidates to fill Board vacancies as and when they arise; <br>and (ii) Board nominees to stand for re-election as Directors at the annual general or, as applicable, special meeting of <br>shareholders;<br>•Reviewing the independence of each Director and making recommendations to the Board regarding independence;<br>•Considering succession planning for Directors and senior executives;<br>•Keeping under review the leadership needs of CRH, both management and non-management, with a view to ensuring the <br>continued ability of the Company to compete effectively in the marketplace;<br>•Approving the terms of reference for any external person or agency engaged to facilitate the evaluation of Board <br>performance and overseeing the annual performance evaluation process of Company management and of the Board, <br>including its Committees;<br>•Developing, and recommending to the Board, corporate governance guidelines applicable or appropriate to CRH and <br>keeping under review corporate governance developments (including ethics-related matters);<br>•Through the Chair of the Board or through the Chair of the Committee, ensuring that the Company maintains contact as <br>appropriate with its principal shareholders about corporate governance matters;<br>•Reviewing the disclosures and statements made in any reports to shareholders on corporate governance contained in <br>CRH's regulatory disclosures; and<br>•Reviewing and determining whether to approve any proposed transaction or ratify any transaction involving CRH and a <br>related person which would be required to be disclosed under the rules of the SEC.<br>|
|  |  | **Number of Meetings in 2025** |
|  |  | The Committee met 5 times during 2025. |

---

46<br>

CRH PROXY STATEMENT 2026

**Safety, Environment & Social Responsibility Committee**

---

| | | |
|:---|:---|:---|
| **Chair** | **Members** | **Primary Responsibilities** |
| Mary K. <br>Rhinehart<br>| Caroline Dowling<br>Johan Karlström<br>Lamar McKay<br>Jim Mintern<br>Gillian L. Platt<br>| •Overseeing and monitoring compliance with policies and procedures relating to employee health and safety, the environment and <br>social responsibility;<br>•Monitoring performance against key safety performance indicators and considering the findings resulting from audits of safety <br>performance across the Company;<br>•Considering the outcome of investigations from significant safety incidents and monitoring the implementation of any <br>recommendations or corrective actions resulting from key findings;<br>•Reviewing and approving environmental and climate-related goals aligned with the Company's strategy and objectives, as well as <br>applicable legal or regulatory requirements;<br>•Monitoring progress in relation to the Company's sustainability initiatives;<br>•Monitoring the progress of initiatives in the area of engagement and inclusion programs; and<br>•Reviewing and approving any reports on Safety, Environment and Social Responsibility in public documents such as the <br>Sustainability Performance Report.<br>|
|  |  | **Number of Meetings in 2025** |
|  |  | The Committee met 4 times during 2025. |

---

47<br>

CRH PROXY STATEMENT 2026

![CRH3080_MASTER_Assets_FEB_.jpg](crh-20260326_g72.jpg)

**Risk Oversight**

Our Enterprise Risk Management ('ERM')

framework and processes enable the

consistent identification, assessment and

management of our main threats and

opportunities. Our ERM framework is

embedded across our business and helps

inform our people to assist them to take the

right risks for the right rewards in line with

CRH's appetite for risk.

The Board has delegated responsibility for

monitoring the effectiveness of the Company's

risk management and internal control systems to

the Audit Committee.

Our leaders promote a risk-aware culture and

the adoption of recognized leading practices to

ensure robust risk management across CRH.

They are supported by a global community of

risk champions spanning all CRH functions and

operating companies, focused on promoting

more informed, more agile decision-making.

CRH's ERM team conducts a thorough bi-

annual risk assessment process, covering all

CRH functions and operating companies, with

senior leaders and their management teams.

To help ensure the quality and consistency of

our risk information, the CRH risk team has

undertaken an extensive program of

workshops, facilitating more than 60 sessions

during 2025.

---

| | | | |
|:---|:---|:---|:---|
| **Risk Governance Framework** | **Risk Governance Framework** | **Risk Governance Framework** | **Risk Governance Framework** |
| **Board of Directors**  | **Board of Directors**  | **Board of Directors**  | **Board of Directors**  |
| Ultimately responsible for strategy, risk and governance across CRH. Sets the risk appetite and <br>ensures risks are being managed within appetite. Delegates responsibility to the Audit Committee. | Ultimately responsible for strategy, risk and governance across CRH. Sets the risk appetite and <br>ensures risks are being managed within appetite. Delegates responsibility to the Audit Committee. | Ultimately responsible for strategy, risk and governance across CRH. Sets the risk appetite and <br>ensures risks are being managed within appetite. Delegates responsibility to the Audit Committee. | Ultimately responsible for strategy, risk and governance across CRH. Sets the risk appetite and <br>ensures risks are being managed within appetite. Delegates responsibility to the Audit Committee. |
| **SESR Committee**<br>Responsible for monitoring <br>developments related to sustainability <br>risks including safety, health, <br>environment, climate and social <br>performance, and providing strategic <br>direction, oversight and risk assurance. | **Audit Committee**<br>Responsible for monitoring and <br>assessing the Company's risk <br>management and internal control <br>systems. Receives regular updates on <br>risk management strategies, mitigation <br>and action plans. A key area of <br>responsibility and focus of the <br>Committee each year is to monitor <br>the financial reporting process. | **Audit Committee**<br>Responsible for monitoring and <br>assessing the Company's risk <br>management and internal control <br>systems. Receives regular updates on <br>risk management strategies, mitigation <br>and action plans. A key area of <br>responsibility and focus of the <br>Committee each year is to monitor <br>the financial reporting process. | **Other CRH Committees**<br>Committees include: Acquisitions, <br>Divestments & Finance; Compensation; <br>and Nomination & Corporate <br>Governance. |
| **Global Leadership Team** <br>Responsible for setting strategy, pursuing performance delivery and progressing our ambitious sustainability agenda. Delegates <br>responsibility for risk strategy, oversight and governance to the Risk Committee. | **Global Leadership Team** <br>Responsible for setting strategy, pursuing performance delivery and progressing our ambitious sustainability agenda. Delegates <br>responsibility for risk strategy, oversight and governance to the Risk Committee. | **Global Leadership Team** <br>Responsible for setting strategy, pursuing performance delivery and progressing our ambitious sustainability agenda. Delegates <br>responsibility for risk strategy, oversight and governance to the Risk Committee. | **Global Leadership Team** <br>Responsible for setting strategy, pursuing performance delivery and progressing our ambitious sustainability agenda. Delegates <br>responsibility for risk strategy, oversight and governance to the Risk Committee. |
| **Risk Committee**<br>Responsible for setting risk strategy and overseeing our <br>governance model and how we identify, assess and manage the <br>principal and emerging global risks the Company encounters in <br>the pursuit of our strategic objectives. | **Risk Committee**<br>Responsible for setting risk strategy and overseeing our <br>governance model and how we identify, assess and manage the <br>principal and emerging global risks the Company encounters in <br>the pursuit of our strategic objectives. | **Other Leadership Councils**<br>Responsible for overseeing aspects of strategy, policy, targets <br>and objectives related to a particular priority area for the <br>Company, such as health and safety, climate and information <br>security | **Other Leadership Councils**<br>Responsible for overseeing aspects of strategy, policy, targets <br>and objectives related to a particular priority area for the <br>Company, such as health and safety, climate and information <br>security |
| **Regional Leadership**<br>Responsible for identifying and managing divisional risks, <br>ensuring risk management frameworks are operating effectively <br>and capturing upside of risk, where possible. | **Regional Leadership**<br>Responsible for identifying and managing divisional risks, <br>ensuring risk management frameworks are operating effectively <br>and capturing upside of risk, where possible. | **Risk Champion Network**<br>Embedded across businesses, functions and divisions. <br>Responsible for integration of risk management frameworks, <br>regular reporting of risks and sharing best practice mitigation. | **Risk Champion Network**<br>Embedded across businesses, functions and divisions. <br>Responsible for integration of risk management frameworks, <br>regular reporting of risks and sharing best practice mitigation. |
| **First Line of Defense**<br>Operating company/business leaders <br>are responsible for risk identification, <br>management and ensuring that the <br>control environment is robust. | **Second Line of Defense**<br>CRH has various oversight functions <br>which are responsible for providing <br>subject matter expertise, defining <br>standards and ensuring adherence. | **Second Line of Defense**<br>CRH has various oversight functions <br>which are responsible for providing <br>subject matter expertise, defining <br>standards and ensuring adherence. | **Third Line of Defense**<br>CRH Internal Audit provides <br>independent assurance over the control <br>environment on a continuous basis. |

---

48<br>

CRH PROXY STATEMENT 2026

**Sustainability Oversight**

**Board Oversight** 

Sustainability, including addressing the impact

of climate change, is embedded in CRH's

strategy and an important enabler of our

leading performance model. The Board

recognizes the importance of addressing the

challenges of climate change and believes that

the Company is well placed to provide value-

driven solutions in the areas of water,

circularity and decarbonization, where CRH's

connected portfolio of essential materials,

infrastructure products and value-added

services positions us to capture further value

and accelerate growth. Climate change and

sustainability are frequent discussion topics at

Board and Committee meetings, with the

Board and its Committees discussing various

aspects of CRH's climate strategy, including

the linkage between CRH's compensation

policies and practices and CRH's sustainability

(and climate-related) objectives, stakeholder

expectations, the regulatory environment and

CRH's carbon emissions reduction targets

throughout the year. Mitigating and managing

the impact of climate change presents

opportunities and challenges for both CRH and

our customers. These opportunities and

challenges form an integral part of discussions

on CRH's strategy and business model, capital

allocation, risk management and sustainability

performance.

The SESR Committee, to which the Board has

delegated primary responsibility for monitoring

developments related to sustainability,

including climate, and providing strategic

direction, oversight and support to the Board

on these important topics, meets every

quarter. The Board monitors and oversees

progress against climate-related targets and

goals through detailed reports of discussions

and recommendations which are presented to

it by the SESR Committee following the

conclusion of each Committee meeting.

**Management Responsibility** 

The Chief Executive Officer is responsible for

the operational and profit performance of the

Company and is accountable to the Board for

all authority delegated to executive

management. The Chief Executive Officer

executes strategy agreed with the Board and

regularly reports to the Board on the progress

and performance of CRH, including in relation

to climate-related matters. The Chief Executive

Officer is supported by the Global Leadership

Team, which is responsible for implementing

strategy, pursuing performance delivery and

progressing the Company's sustainability and

climate-related agenda. Responsibility for

formulating and executing our climate strategy

sits with the Chief Operating Officer. The

Global Leadership Team receives support from

various executive-level committees and other

working groups and functions on sustainability

and climate-related issues. For more

information on CRH's organizational structure,

including how responsibilities feed through

each level, please see our Risk Governance

Framework on page 47.

**Code of Business Conduct** 

The foundation of the CRH Compliance

Program is the Code of Business Conduct

(CoBC) and supporting policies, which set out

our standards of legal, honest and ethical

behavior. The CoBC also promotes compliance

with all applicable bribery & corruption laws

and all relevant SEC rules and regulations,

including disclosure requirements. The CoBC

is applicable to all employees of the Company,

including the Chief Executive Officer, our

Global Leadership Team and senior financial

officers. An electronic copy of the CoBC is

available on our website, www.crh.com.

**CRH Hotline** 

CRH is committed to creating an atmosphere

where employees feel empowered and

comfortable to speak up when they have good

faith concerns. CRH has a Speak Up Policy,

which is available on our website in the relevant

languages of our operating companies. Our

Speak Up Policy outlines CRH's commitment to

providing various ways to speak up, handling

those reports appropriately and confidentially and

treating all reporters with fairness and respect.

The Speak Up Policy also affirms our zero-

tolerance approach to retaliation or any form of

penalization for reporting good faith concerns.

CRH engages an external service provider to

administer an independent 24/7 multi-lingual

confidential "Hotline" facility that allows reporters

to make an anonymous report. CRH is committed

to supporting all persons, including current,

former and potential employees, customers,

independent contractors, suppliers and/or other

external stakeholders to raise good faith concerns

that may be relevant to the CoBC, inappropriate

or illegal behavior or violations of any CRH

policies or local laws. All concerns are handled

and investigated appropriately with suitable

actions taken based on investigation findings.

Both the Audit Committee and the SESR

Committee receive regular updates from Legal

and Compliance on the key insights gained from

the assessment of issues being raised via the

Hotline as well as the responses to, and actions

taken as a consequence of, issues being

reported.

**Shareholder Communications** 

**with the Board**

Shareholders or interested parties desiring to

communicate directly with the Board as a

whole or with any individual Director (including

the Chair) may do so in writing addressed to

the intended recipient or recipients, c/o

Company Secretary, 42 Fitzwilliam Square,

Dublin 2, D02 R279, Ireland. The Office of the

Company Secretary reviews all such

communications and refers relevant

correspondence directly to a Director or the

Board following discussion with the Chair, as

appropriate.

49<br>

CRH PROXY STATEMENT 2026

![CRH3080_MASTER_Assets_FEB_28.jpg](crh-20260326_g73.jpg)

Compensation Discussion

& Analysis (CD&A)

**Compensation Committee Report**

The Compensation Committee has reviewed

and discussed this CD&A with management.

Based on its review and discussion with

management, the Compensation Committee

recommended to the Board that the CD&A

section be included in this Proxy Statement

and incorporated by reference into the 2025

Annual Report.

**Submitted by the Compensation** 

**Committee of the Board.**

Lamar McKay (Chair)

Richie Boucher

Richard Fearon

Shaun Kelly

Mary K. Rhinehart

Siobhán Talbot

50<br>

CRH PROXY STATEMENT 2026

![CRH3030_Wrapper plus10K_PRIN__v1.jpg](crh-20260326_g74.jpg)

Compensation

Discussion & Analysis

**Table of Contents**

---

| | |
|:---|:---|
| [Introduction](#if1c879db7a4c45ea95381876b038728a_97) | [51](#if1c879db7a4c45ea95381876b038728a_97) |
| [A Message from the Compensation Committee](#i0f41d26a152d44b4b2b9f2a27db90490_3616) | [52](#if1c879db7a4c45ea95381876b038728a_100) |
| [Executive Summary](#if1c879db7a4c45ea95381876b038728a_103) | [53](#if1c879db7a4c45ea95381876b038728a_103) |
| [Executive Compensation Philosophy and Objectives](#ia90b1fbab2214708ad1cbc2cb386b03b_436) | [55](#if1c879db7a4c45ea95381876b038728a_106) |
| [- Compensation Principles](#ia90b1fbab2214708ad1cbc2cb386b03b_437) | [55](#ia90b1fbab2214708ad1cbc2cb386b03b_437) |
| [Strong Compensation Governance (What We Do/What We Don't Do)](#i4d59ed054668415dbaa2bc29594f6fcb_330) | [56](#if1c879db7a4c45ea95381876b038728a_109) |
| [- Compensation Governance](#iefbe4a99bc2545ed8889e4a3f046d471_0-0-1-2-1309790) | [56](#iefbe4a99bc2545ed8889e4a3f046d471_0-0-1-2-1309790) |
| [2025 Overview of Pay Elements and Alignment to Strategy](#ib827916b00654bf0948bbb4823f6992a_751) | [57](#if1c879db7a4c45ea95381876b038728a_112) |
| [The Role of Individual Performance](#i4f4d9446e35d4fcaaa01e79c9f18dc03_329) | [58](#if1c879db7a4c45ea95381876b038728a_115) |
| [How Compensation Was Determined for 2025](#if1c879db7a4c45ea95381876b038728a_118) | [59](#if1c879db7a4c45ea95381876b038728a_118) |
| [2025 Compensation Decision Process](#if1c879db7a4c45ea95381876b038728a_121) | [63](#if1c879db7a4c45ea95381876b038728a_121) |
| - Compensation Committee | [63](#i964c77e2a3c241369e5994538d1fc68a_5584) |
| - Compensation Consultants | [63](#i964c77e2a3c241369e5994538d1fc68a_5586) |
| - Management | [63](#i964c77e2a3c241369e5994538d1fc68a_5579) |
| - [Assessment of Competitive Pay and Peer Group](#i964c77e2a3c241369e5994538d1fc68a_5581) | [63](#i964c77e2a3c241369e5994538d1fc68a_5581) |
| [Governance Features of our Executive Compensation Programs](#ia54bc1a954db4729ac05ccd3a37e1c04_42895) | [65](#if1c879db7a4c45ea95381876b038728a_124) |
| - [Share Ownership Guidelines](#ia54bc1a954db4729ac05ccd3a37e1c04_42883) | [65](#ia54bc1a954db4729ac05ccd3a37e1c04_42883) |
| - Compensation Policies and Practices as They Relate to Risk Management | [65](#ia54bc1a954db4729ac05ccd3a37e1c04_42916) |
| - Anti-Hedging and Pledging Policy | [65](#ia54bc1a954db4729ac05ccd3a37e1c04_42907) |
| - [Tax Deductibility](#ia54bc1a954db4729ac05ccd3a37e1c04_42874) | [65](#ia54bc1a954db4729ac05ccd3a37e1c04_42874) |
| - [Timing of Equity Grants](#ia54bc1a954db4729ac05ccd3a37e1c04_42866) | [65](#ia54bc1a954db4729ac05ccd3a37e1c04_42866) |
| - Clawback Policy | [65](#ia54bc1a954db4729ac05ccd3a37e1c04_42892) |
| - [Other Employee Share Schemes](#ia54bc1a954db4729ac05ccd3a37e1c04_42870) | [65](#ia54bc1a954db4729ac05ccd3a37e1c04_42870) |
| - [Benefits and Perquisites](#ia54bc1a954db4729ac05ccd3a37e1c04_42887) | [65](#ia54bc1a954db4729ac05ccd3a37e1c04_42887) |
| - [Retirement Benefits](#ia54bc1a954db4729ac05ccd3a37e1c04_42881) | [66](#ia54bc1a954db4729ac05ccd3a37e1c04_42881) |
| Employment Agreements  | [66](#ia54bc1a954db4729ac05ccd3a37e1c04_42900) |
| [Executive Compensation](#ia54bc1a954db4729ac05ccd3a37e1c04_42898) | [67](#ia54bc1a954db4729ac05ccd3a37e1c04_42898) |
| [Summary Compensation](#ia54bc1a954db4729ac05ccd3a37e1c04_42914) | [67](#ia54bc1a954db4729ac05ccd3a37e1c04_42914) |
| [Grants of Plan-Based Awards](#ia54bc1a954db4729ac05ccd3a37e1c04_42912) | [69](#ia54bc1a954db4729ac05ccd3a37e1c04_42912) |
| [Outstanding Equity Awards at 2025 Fiscal Year-End](#ia54bc1a954db4729ac05ccd3a37e1c04_42906) | [70](#ia54bc1a954db4729ac05ccd3a37e1c04_42906) |
| [Option Exercises and Stock Vested](#ia54bc1a954db4729ac05ccd3a37e1c04_42869) | [71](#ia54bc1a954db4729ac05ccd3a37e1c04_42869) |
| [Payments Upon Termination or in Connection with a Change in Control](#ia54bc1a954db4729ac05ccd3a37e1c04_42890) | [74](#ia54bc1a954db4729ac05ccd3a37e1c04_42890) |
| [Non-management Director Compensation](#ia54bc1a954db4729ac05ccd3a37e1c04_42873) | [76](#ia54bc1a954db4729ac05ccd3a37e1c04_42873) |
| [Compensation Committee Interlocks and Insider Participation](#ia54bc1a954db4729ac05ccd3a37e1c04_42882) | [76](#ia54bc1a954db4729ac05ccd3a37e1c04_42882) |
| [CEO Pay Ratio](#if1c879db7a4c45ea95381876b038728a_127) | [77](#if1c879db7a4c45ea95381876b038728a_127) |
| [Pay Versus Performance](#if1c879db7a4c45ea95381876b038728a_130) | [78](#if1c879db7a4c45ea95381876b038728a_130) |

---

51<br>

CRH PROXY STATEMENT 2026

Introduction

The CD&A describes:

• the Company's executive compensation

philosophy and programs;

• how our compensation programs support

our long-term strategy and the long-term

interests of our shareholders;

• the Compensation Committee's decision-

making processes; and

• information about the material elements of

compensation that are paid, awarded to, or

earned by our "Named Executive

Officers" ('NEOs').

Our NEOs consist of our Chief Executive

Officer, our Chief Financial Officer, our former

interim Chief Financial Officer, and the three

other most highly compensated executive

officers. Our NEOs for 2025 were:

As announced in September 2024, Jim Mintern

succeeded Albert Manifold as Chief Executive

Officer effective January 1, 2025. Alan Connolly

was appointed Interim Chief Financial Officer

following Mr. Mintern's appointment as Chief

Executive Officer and served as Interim Chief

Financial Officer from January 1, 2025 to May 11,

2025, following which Mr. Connolly returned to his

previous role as Director of Strategic Finance. Ms.

Buese was subsequently appointed Chief

Financial Officer effective as of May 12, 2025.

---

| |
|:---|
| ![CRH25_Creative_GLT_JM_.jpg](crh-20260326_g75.jpg) |
| **Jim Mintern** |
| Chief Executive Officer <br>& Executive Director<br>|

---

---

| |
|:---|
| ![CRH3080 Annual Report 2025_CDA_0003_Layer 2.jpg](crh-20260326_g76.jpg) |
| **Nancy Buese** |
| Chief Financial Officer  |

---

---

| |
|:---|
| ![CRH3080 Annual Report 2025_CDA_0002_Layer 3.jpg](crh-20260326_g77.jpg) |
| **Randy Lake** |
| Chief Operating Officer |

---

---

| |
|:---|
| ![CRH3080 Annual Report 2025_CDA_0001_Layer 4.jpg](crh-20260326_g78.jpg) |
| **Peter Buckley** |
| President, International Division |

---

---

| |
|:---|
| ![CRH3080 Annual Report 2025_CDA_0000_Layer 5.jpg](crh-20260326_g79.jpg) |
| **Nathan Creech** |
| President, Americas Division |

---

52<br>

CRH PROXY STATEMENT 2026

**A Message from the Compensation Committee** 

Company performance and incentive

outcomes are strongly aligned

Dear Shareholder,

2025 represented another record year for CRH, with our superior strategy,

connected portfolio and leading performance continuing to deliver

higher revenues, profits and margins. This was also reflected in our share price.

![CRH3030_Letterhead_Shots_0000_Layer 3.jpg](crh-20260326_g80.jpg)

As members of the Compensation Committee

(the 'Compensation Committee' or, for the

purposes of the CD&A, the 'Committee') we

believe maintaining a compensation program

that aligns execution of CRH's strategic goals

with shareholder value creation and

emphasizing a pay-for-performance

philosophy is a core component of CRH's

continued success. Attracting, retaining and

motivating highly talented executives also

continues to be a key focus.

To support the Company in achieving these

aims, the Committee implemented an updated

compensation framework during 2025, which

is summarized on page 57 (the '2025

Compensation Framework').

The Committee took a thoughtful approach to

designing and implementing this new program

considering relevant factors, including,

maintaining our emphasis on setting rigorous

goals and rewarding strong performance;

addressing the competitive pay differential

between CRH and the U.S. market and our

primary performance peers; supporting

executive transitions; retention in a competitive

talent market; and investor perspectives.

**Recognizing Strong Performance** 

**Outcomes for 2025**

Incentive outcomes for 2025 under the 2025

Annual Incentive Plan based on the 2025

Compensation Framework and 2023

Performance Share Plan awards reflect a

strong performance against the rigorous

performance targets set by the Committee

and CRH's continuing delivery of higher

revenues, profits and margins, driven by our

superior strategy and connected portfolio.

**Executing Key Leadership** 

**Transitions** 

Jim Mintern was appointed Chief Executive

Officer effective January 1, 2025. Mr.

Mintern's compensation as Chief Executive

Officer appropriately incentivizes him to lead

CRH through its next chapter.

Nancy Buese succeeded Jim Mintern as Chief

Financial Officer effective May 12, 2025. Her

compensation package is summarized on

Prior to Nancy's appointment, Alan Connolly

acted as Interim Chief Financial Officer. The

Board very much appreciates Alan's work

during this period.

**Engaging with our Shareholders** 

CRH's Board, including the members of this

Committee, maintains a proactive approach to

shareholder engagement, enabling us to better

understand investor perspectives and ensure

their feedback is appropriately considered in

CRH's compensation program and other

practices.

We value engagement with our shareholders

on topics such as CRH's evolving pay

practices, the alignment with U.S. market and

peer standards, anticipated changes to the

compensation and relative performance peer

groups, and the Committee's approach to

target-setting and metric selection in our

annual and long-term incentive plans. We very

much appreciate the support of shareholders,

reflected in the very strong votes in favor of

the 2025 Equity Incentive Plan and our 'Say-

on-Pay' vote at the 2025 AGM.

**Conclusion**

2025 was another year of strong performance

and value creation for shareholders, driven by

the efforts of all of our employees and the

exceptional leadership of Jim Mintern, our

Chief Executive Officer, and his senior

executive team. The compensation outcomes

for the executives reflect significant

performance against the rigorous targets

during the year. Thank you for your continued

support and engagement.

Lamar McKay (Chair)

Richie Boucher

Richard Fearon

Shaun Kelly

Mary K. Rhinehart

Siobhán Talbot

March 27, 2026

53<br>

CRH PROXY STATEMENT 2026

Executive Summary

**2025 Performance Highlights**

**Revenues**

$37.4B

+5%

*(2024: $35.6B)*

*(2023: $34.9B)*

**Net Income**

$3.8B

+8%

*(2024: $3.5B)*

*(2023: $3.1B)*

**Adjusted EBITDA\***

$7.7B

+11%

*(2024: $6.9B)*

*(2023: $6.2B)*

**Dividend per share**

$1.48

+6%

*(2024: $1.40)*

*(2023: $1.33)*

**Diluted EPS**

$5.51

+10%

*(2024: $5.02)*

*(2023: $4.33)*

CRH delivered another strong year of

performance in 2025, with Net income 8%

ahead of 2024 at $3.8 billion (2024: $3.5

billion) and Adjusted EBITDA\* of $7.7 billion

(2024: $6.9 billion) 11% ahead. CRH's Diluted

EPS was 10% higher than 2024 at $5.51

(2024: $5.02). In addition, CRH's share price

grew 35% from $92.52 per share on December

31, 2024 to $124.80 per share on December

31, 2025. CRH's superior strategy, connected

portfolio and leading performance supported

this record outcome, while CRH's strong cash

generation and disciplined approach to capital

allocation provides further opportunities to

create value for all of its shareholders.

The total dividend per share for 2025 was

increased by approximately 6%. As part of our

ongoing share buyback program, we

repurchased approximately 11.7 million

Ordinary Shares in 2025 (2024: 15.9 million) for

a total consideration of $1.2 billion (2024: $1.3

billion). On November 5, 2025, the Company

commenced a further tranche of $0.3 billion

which completed on February 17, 2026 and

the Board has extended the program with an

additional $0.3 billion tranche to be completed

no later than April 28, 2026. We will continue

to assess our share buyback program

throughout 2026, with further updates

throughout the year. The increase in our

dividend and continuation of our share

buyback program in 2025 demonstrates our

confidence in the outlook for our business and

our continued strong cash generation.

**Summary of 2025** 

**Compensation Outcomes** 

The Committee's approach to compensation

and the metrics used in the compensation

program to incentivize management reflect

CRH's focus on continuous business

improvement, strong cash generation, efficient

and disciplined capital allocation, and support

the long-term performance of the Company, as

further summarized on page 57. A summary of

2025 compensation for our NEOs is set out on

pages 67 to 68.

**Base Salary** 

Mr. Mintern's base salary was increased by

75% to reflect his new role as Chief Executive

Officer, Ms. Buese did not receive any base

salary increase because she joined CRH in

2025, Mr. Buckley's base salary increased by

23% to reflect the appointment to his current

role, and each of Messrs. Lake and Creech

received a salary increase of 4% in recognition

of their continued strong performance,

contribution and leadership of CRH.

**2025 Annual Incentive Plan** 

Reflecting CRH's strong performance in 2025

underpinned by our customer-centric strategy,

the financial metrics for the Annual Incentive

Plan (Diluted EPS, Cash Flow and Return on

Net Assets ('RONA')), were achieved at a level

of 135% of target. The Committee also

assessed that the performance of the NEOs

against their individual performance objectives,

accounting for 20% of their potential

opportunity under the Annual Incentive Plan,

was at a level which warranted a payout of

150% of target (see pages 59 to 60 for more

details). The combined outcome for the 2025

Annual Incentive Plan was a payout level of

138% of target.

**2023 Performance Share Plan Award** 

The Performance Share Plan ('PSP') awards

made in 2023 were subject to performance

over the three-year period to December 31,

2025 (the 2023 award for Mr. Mintern is

assessed using the same performance period,

but does not vest until February 2028) and

have been assessed against the Cash Flow,

RONA, Relative Total Shareholder Return

('TSR') and Sustainability Scorecard measures

set by the Committee in 2023.

The Committee is satisfied that the 98.75%

vesting of the award is appropriate and that

the value of these awards attributed to the

increase in share price over the period is due

to the Company's underlying performance.

Note:

\*Represents a non-GAAP financial measure.

See the discussion within 'Reconciliation of

Non-GAAP Figures' in Annex A for a definition

and reconciliation to the most directly

comparable GAAP measure.

54<br>

CRH PROXY STATEMENT 2026

**Overall Incentive Outcome** 

The Committee is satisfied that there is a very strong alignment between the incentive outcomes outlined above for 2025, which were based on

significant performance against the rigorous performance targets set by the Committee, and the performance of CRH. The Committee also took into

account a number of factors, including feedback from other committees in relation to matters such as safety performance and culture, whether any

extraneous factors outside the control of management had unduly influenced the outcome, and progress in relation to strategic objectives not

captured by the financial measures used for compensation purposes. Based on this review, the Committee determined that no adjustment to

incentive outcomes in respect of any of these matters was necessary.

---

| | | | |
|:---|:---|:---|:---|
| **2025 Compensation Snapshot** | **2025 Compensation Snapshot** | **2025 Compensation Snapshot** | **2025 Compensation Snapshot** |
|  | **Fixed** | **Performance-related Variable Compensation** | **Performance-related Variable Compensation** |
| **NEO** | **Salary ($) (i)** | **Annual Incentive Plan (% of Target) (ii)** | **2023 PSP Award (% of Max) (iii)** |
| Jim Mintern, Chief Executive Officer | 1750000 | 138.00% | 98.75% |
| Nancy Buese, Chief Financial Officer (iv) | 1000000 | 138.00% |  |
| Randy Lake, Chief Operating Officer | 1578000 | 138.00% | 98.75% |
| Peter Buckley, President, International Division | 1042455 | 138.00% | 98.75% |
| Nathan Creech, President, Americas Division (v) | 1213000 | 138.00% | 98.75% |
| Alan Connolly, Former Interim Chief Financial Officer (vi) | 597720 | 138.00% | 98.75% |

---

Notes:

(i)The salaries for Mr. Buckley and Mr. Connolly for 2025 were set and paid in euro and have been converted to U.S. Dollars using the average Bloomberg composite rate

for 2025.

(ii)The Annual Incentive Plan outcome for 2025 reflects target performance outcomes as measured under the 2025 Compensation Framework.

(iii)The 2023 PSP Award outcome for 2025 reflects maximum rather than target performance outcomes determined in accordance with the compensation policy approved

by shareholders at the 2022 AGM and which expired at the end of 2024 (the '2022 Policy').

(iv)Ms. Buese joined CRH and was appointed Chief Financial Officer effective May 12, 2025. In connection with her appointment, Ms. Buese received a one-time cash

bonus of $1,000,000 and a one-time RSU grant with a grant date fair value equal to $2,000,000, vesting 50% in 2026 and 50% in 2027, subject to continued

employment.

(v)In connection with his support of the leadership transition and his continued efforts to drive performance and growth in the Americas, Mr. Creech received a one-time

RSU grant with a grant date fair value equal to $3,000,000, which will vest 100% in 2028, subject to continued employment.

(vi)Mr. Connolly served as Interim Chief Financial Officer from January 1, 2025 through May 11, 2025. In June 2025, for his service as Interim Chief Financial Officer, Mr.

Connolly received a one-time cash bonus of $200,000, to reflect market pay for the period of time Mr. Connolly held the Interim Chief Financial Officer role, and a one-

time RSU grant with a grant date fair value equal to $300,000, vesting 50% in 2026 and 50% in 2027 to recognize the support for transition of the role to Ms. Buese

and is subject to continued employment.

**Shareholder Engagement**

We believe that it is important to maintain an open dialogue, and engage regularly, with shareholders on all aspects of our compensation program.

This includes engagement both before and, where relevant, after votes on compensation at AGMs to understand shareholders' perspectives on our

policies and practices.

This dialogue helps inform our decision-making considerations, which has been helpful as we align our program to U.S. market practices.

**"Say-on-Pay" Results**

CRH's practice, which was approved by our shareholders at the 2025 AGM, is to conduct the advisory vote on "Say-on-Pay" annually. The table

below summarizes the advisory vote on the "Say-on-Pay" resolution at the 2025 AGM in relation to the compensation paid to the NEOs of CRH. The

Say-on-Pay resolution is non-binding, but the Board and the Committee carefully considers the outcome of the advisory vote when making future

compensation decisions.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Compensation-related Votes** | | | | |
|  | **Year of AGM** | **% in Favor** | **% Against** | **% of Issued Ordinary Shares Voted** |
| Compensation of NEOs | 2025 | 94.57% | 5.43% | 74.06% |

---

55<br>

CRH PROXY STATEMENT 2026

**Executive Compensation Philosophy and Objectives**

We strive to create an executive compensation program that is fair, responsible and competitive, while attracting and retaining executives of the

caliber necessary for CRH to compete in all of its markets.

**Compensation Principles**

Our executive compensation programs are designed to align the interests of our NEOs with our shareholders, underpinned by the following core

principles:

---

| | |
|:---|:---|
| **Core Principles of our Compensation Arrangements** | **Core Principles of our Compensation Arrangements** |
| **Alignment with Business Strategy** | •Reward and motivate executives to perform in the long-term interests of shareholders;<br>•Foster entrepreneurship within the Company by rewarding the creation of shareholder value through organic and <br>acquisitive growth;<br>•Provide a blend of fixed and variable compensation and short- and long-term incentives linked to the delivery of key <br>business goals over the short- and long-term which are critical for the execution of the Company's strategy; and<br>•Reflect the risk policies and appetite of the Company.<br>|
| **Consistency and Oversight** | •Ensure that compensation structure remains consistent across the Company, given CRH's international footprint, with <br>the Committee overseeing compensation policy across CRH; and<br>•Manage any conflicts of interest by having the Committee approve the compensation of the Chief Executive Officer and <br>the executive officers and set the compensation for the non-management Directors within the limits approved by <br>shareholders.<br>|
| **Pay for Performance** | •Drive performance and link reward to the responsibilities and individual contribution of executives;<br>•Ensure that there is appropriate alignment between pay and performance by delivering a significant amount of total <br>compensation through variable short- and long-term incentives linked to the delivery of key business objectives; and<br>•Ensure that total compensation is more variable (and, in particular, weighted towards long-term performance) for roles <br>with greater levels of responsibility.<br>|
| **Shareholder Alignment** | •Ensure the alignment of executive and shareholders' interests through share-based incentive awards linked to the <br>delivery of key strategic objectives and the creation of shareholder value. Our NEOs are also subject to share ownership <br>guidelines. <br>|
| **Market Pay Competitiveness** | •Ensure that compensation is market competitive, with regard to the size and complexity of CRH and the markets in <br>which we operate, enabling the Company to recruit and retain talented executives, including establishing a new <br>executive compensation peer group, which was developed in line with U.S. market best practice and was used to <br>benchmark executive pay levels. The peer group, which was updated for 2025, is detailed on pages 63 to 64.<br>|

---

56<br>

CRH PROXY STATEMENT 2026

**Strong Compensation Governance (What We Do/What We Don't Do)**

Our compensation programs incorporate best practices that we believe drive performance, while mitigating risk and aligning the interests of our

executives with those of our shareholders. The table below highlights the key features of our compensation practices.

---

| | |
|:---|:---|
| **Compensation Governance** | **Compensation Governance** |
| **What We Do** | **What We Do** |
| ✔ | Tie pay to performance by ensuring that a significant portion of NEO compensation is variable and performance-based |
| ✔ | Set challenging financial targets for incentive awards taking into consideration our business strategy, operating goals and the macro-environment |
| ✔ | Apply a market-based approach for determining target compensation |
| ✔ | Utilize performance-based awards as a primary element of our long-term incentives |
| ✔ | Require substantial share ownership under our share ownership guidelines for NEOs and non-management Directors |
| ✔ | Engage in risk mitigation by including balanced performance metrics in our compensation programs, clawback provisions and oversight to identify risk |
| ✔ | Prohibit transactions by our Directors and executive officers intended to hedge or offset the market value of CRH shares owned by them or pledging shares |
| ✔ | Maintain a robust clawback policy providing for the right to cancel or recoup incentive compensation in the event of financial restatements |
| ✔ | Engage in ongoing dialogue with shareholders related to executive compensation matters and consider the feedback received |
| **What We Don't Do** | **What We Don't Do** |
| ![x.jpg](crh-20260326_g81.jpg) | No excessive benefits or perquisites |
| ![x.jpg](crh-20260326_g81.jpg) | No repricing of stock options or awards without shareholder approval |
| ![x.jpg](crh-20260326_g81.jpg) | No excessive change of control benefits. Our NEOs' compensatory arrangements do not provide for:<br>•automatic "single-trigger" vesting on long-term incentive awards;<br>•enhanced cash severance or similar change of control benefits, other than reasonable enhancements for our Chief Executive Officer and our new Chief <br>Financial Officer; or<br>•tax gross-ups (other than for certain Consolidated Omnibus Budget Reconciliation Act (COBRA) costs)<br>|
| ![x.jpg](crh-20260326_g81.jpg) | No resetting of financial targets established at the beginning of a performance period, other than adjustments to preserve the value of the incentive |
| ![x.jpg](crh-20260326_g81.jpg) | No guaranteed bonuses or uncapped incentive award opportunities for NEOs |
| ![x.jpg](crh-20260326_g81.jpg) | No payment of dividends or dividend equivalents on equity awards unless and until underlying awards vest |

---

57<br>

CRH PROXY STATEMENT 2026

**2025 Overview of Pay Elements and Alignment to Strategy**

The following table summarizes the key compensation elements of our NEOs in 2025. A significant portion of the NEOs' compensation is linked to the delivery of key

business goals over the short- and long-term which are critical to the execution of the Company's strategy and the creation of shareholder value. In particular, in light of

the criticality of Cash Flow and RONA to our Company's strategy, we measure and incentivize the achievement of these metrics both annually and on a long-term basis

through our annual bonus and equity incentive plans.

Each element of the NEOs' packages is described in detail in the section titled "How Compensation Was Determined for 2025" on page 59.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Pay Element** | **Delivery** | **Purpose** | **2025 Performance** <br>**Measures**<br>| **Further Details/Alignment with Strategy** |  |  |
| **Fixed** | **Fixed** | **Fixed** | **Fixed** | **Fixed** |  |  |
| Base Salary | Cash, fixed amount paid <br>on a monthly basis | Market competitive salary <br>helps to attract and retain <br>key talent | _ | Reviewed annually in light of individual performance, level of <br>responsibility, knowledge and experience, competitive market <br>compensation practice, and pay levels elsewhere in the Company |  |  |
| Base Salary | Cash, fixed amount paid <br>on a monthly basis | Market competitive salary <br>helps to attract and retain <br>key talent | _ | Reviewed annually in light of individual performance, level of <br>responsibility, knowledge and experience, competitive market <br>compensation practice, and pay levels elsewhere in the Company | **Variable (At Risk)** | **Variable (At Risk)** |
| Annual <br>Incentive Plan | Cash-based awards <br>based on achievement <br>of selected performance <br>metrics | Reward the creation of <br>shareholder value through <br>operational excellence and <br>organic and acquisitive <br>growth. The Annual <br>Incentive Plan incentivizes <br>NEOs to deliver Company <br>and individual goals <br>that support long-term <br>value creation | Operating Cash Flow <br>(30%)<br>| Operating Cash Flow is a measure of CRH's ability to generate <br>cash to fund organic and acquisitive growth and provide returns to <br>our shareholders via dividends and share buybacks<br>|  |  |
| Annual <br>Incentive Plan | Cash-based awards <br>based on achievement <br>of selected performance <br>metrics | Reward the creation of <br>shareholder value through <br>operational excellence and <br>organic and acquisitive <br>growth. The Annual <br>Incentive Plan incentivizes <br>NEOs to deliver Company <br>and individual goals <br>that support long-term <br>value creation | EPS (30%) | EPS is a measure of underlying profitability |  |  |
| Annual <br>Incentive Plan | Cash-based awards <br>based on achievement <br>of selected performance <br>metrics | Reward the creation of <br>shareholder value through <br>operational excellence and <br>organic and acquisitive <br>growth. The Annual <br>Incentive Plan incentivizes <br>NEOs to deliver Company <br>and individual goals <br>that support long-term <br>value creation | RONA (20%) | RONA is a measure of CRH's ability to create value through <br>excellence in operational performance<br>|  |  |
| Annual <br>Incentive Plan | Cash-based awards <br>based on achievement <br>of selected performance <br>metrics | Reward the creation of <br>shareholder value through <br>operational excellence and <br>organic and acquisitive <br>growth. The Annual <br>Incentive Plan incentivizes <br>NEOs to deliver Company <br>and individual goals <br>that support long-term <br>value creation | Sustainability/Strategic <br>Measures (20%)<br>| Sustainability/strategic measures enable a focus on specific factors <br>aligned with CRH's short- and medium-term strategic objectives <br>that promote long-term success<br>|  |  |
| 2025 Equity <br>Incentive Plan <br>- RSUs<br>| Equity-based awards <br>(totaling 40% of annual <br>award under the 2025 <br>Equity Incentive Plan) <br>with three-year ratable <br>vesting<br>| Market competitive award <br>helps to encourage <br>retention<br>| _ | Reviewed annually in light of individual performance, level of <br>responsibility, knowledge and experience, competitive market <br>compensation practice, and pay levels elsewhere in the Company<br>|  |  |
| 2025 Equity <br>Incentive Plan <br>- PSUs | Equity-based awards <br>(totaling 60% of annual <br>award under the 2025 <br>Equity Incentive Plan) <br>with three-year cliff <br>vesting based on <br>achievement of selected <br>performance metrics | Align the interests of key <br>management across <br>different businesses and <br>regions with those of <br>shareholders through an <br>interest in CRH shares <br>and by incentivizing <br>the achievement of long-<br>term performance goals | Cash Flow (50%) | Cash flow is a measure of CRH's ability to generate cash to fund <br>organic and acquisitive growth and provide returns to our <br>shareholders via dividends and share buybacks<br>|  |  |
| 2025 Equity <br>Incentive Plan <br>- PSUs | Equity-based awards <br>(totaling 60% of annual <br>award under the 2025 <br>Equity Incentive Plan) <br>with three-year cliff <br>vesting based on <br>achievement of selected <br>performance metrics | Align the interests of key <br>management across <br>different businesses and <br>regions with those of <br>shareholders through an <br>interest in CRH shares <br>and by incentivizing <br>the achievement of long-<br>term performance goals | RONA (25%) | RONA is a measure of CRH's ability to create value through <br>excellence in operational performance |  |  |
| 2025 Equity <br>Incentive Plan <br>- PSUs | Equity-based awards <br>(totaling 60% of annual <br>award under the 2025 <br>Equity Incentive Plan) <br>with three-year cliff <br>vesting based on <br>achievement of selected <br>performance metrics | Align the interests of key <br>management across <br>different businesses and <br>regions with those of <br>shareholders through an <br>interest in CRH shares <br>and by incentivizing <br>the achievement of long-<br>term performance goals | RONA (25%) | RONA is a measure of CRH's ability to create value through <br>excellence in operational performance | Relative TSR (25%) | TSR is a measure of shareholder return on investment in CRH and <br>is measured relative to our peers<br>|
| 2025 Equity <br>Incentive Plan <br>- PSUs | Equity-based awards <br>(totaling 60% of annual <br>award under the 2025 <br>Equity Incentive Plan) <br>with three-year cliff <br>vesting based on <br>achievement of selected <br>performance metrics | Align the interests of key <br>management across <br>different businesses and <br>regions with those of <br>shareholders through an <br>interest in CRH shares <br>and by incentivizing <br>the achievement of long-<br>term performance goals |  |  |  |  |

---

58<br>

CRH PROXY STATEMENT 2026

**The Role of Individual Performance**

Individual performance informs the decision-making in relation to NEO base salaries, as well as the outcome of that element of the annual bonus

linked to the achievement of strategic objectives. The Committee considered the following achievements and accomplishments of the NEOs in 2025:

---

| | | |
|:---|:---|:---|
| **Individual Performance** | **Individual Performance** | |
| **Name** | **Position** | **Achievements/Accomplishments in 2025** |
| Jim Mintern | Chief Executive Officer and <br>Executive Director<br>| •Led the evolution of CRH's strategy while delivering strong results, including ensuring that CRH met all <br>necessary criteria for S&P 500 inclusion;<br>•Strong delivery of connected portfolio across all businesses creating incremental value including <br>investment and acceleration of innovation and technology;<br>•Supported continuous performance improvement by embedding a culture of operational excellence, <br>accelerating innovation and technology initiatives and delivered sustainable growth; and<br>•Strengthened organizational capacity through deep talent pipelines, effective succession planning, and <br>key leadership transitions, supported by a culture of safety, engagement, and growth.<br>|
| Nancy Buese | Chief Financial Officer | •Supported and enabled the development of a growth mindset and driving performance to achieve <br>sustainable growth and increased value for shareholders; and<br>•Worked closely with colleagues to support the processes for succession and development while <br>supporting a culture of safety, engagement and growth.<br>|
| Randy Lake<br>Peter Buckley<br>Nathan Creech<br>| Chief Operating Officer<br>President, International Division<br>President, Americas Division<br>| •Strong delivery of connected portfolio across all businesses creating incremental value including <br>aligning cross-functional teams while improving customer experience;<br>•Championed CRH's continuous performance improvement, accelerating innovation and technology <br>initiatives that contributed to sustainable growth and enhanced shareholder value; and<br>•Strengthened organizational capacity through deep talent pipelines, effective succession planning, and <br>smooth leadership transitions, supported by a culture of safety, engagement, and growth — achieving <br>higher retention and leadership readiness across CRH.<br>|

---

59<br>

CRH PROXY STATEMENT 2026

**How Compensation Was Determined for 2025**

**Base Salary**

Base salaries of the NEOs are set taking into account:

• the scope of the NEO's role and responsibilities;

• the individual's skills, experience and performance;

• salary levels at the 2025 Compensation Peer Group; and

• pay and conditions elsewhere in the Company.

Base salary is normally reviewed annually with changes generally effective on January 1, although the Board or the Committee may make an out-of-

cycle increase if considered to be appropriate.

Mr. Mintern's base salary was increased 75% to reflect his new role as Chief Executive Officer, Ms. Buese did not receive any base salary increase as

she joined CRH in 2025, Mr. Buckley's base salary was increased by 23% to reflect his appointment as President, International Division, and each of

Messrs. Lake and Creech received a base salary increase of 4% in recognition of their continued strong performance, contribution and leadership of

CRH. Details of Mr. Connolly's compensation, who served as Interim Chief Financial Officer from January 1, 2025 to May 11, 2025 are set out on

The following table outlines the annual base salary of the NEOs in 2025 and 2024, as well as the year-over-year percentage increase in base salary.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Year-over-year change in base salary** | **Year-over-year change in base salary** | **Year-over-year change in base salary** | **Year-over-year change in base salary** | |
| **Name** | **Position** | **2025 Salary ($)** | **2024 Salary ($)** | **Percentage Increase**  |
| Jim Mintern | Chief Executive Officer  | 1750000 | 1,000,219 (i) | 75% |
| Nancy Buese | Chief Financial Officer | 1000000 |  |  |
| Randy Lake | Chief Operating Officer | 1578000 | 1521520 | 4% |
| Peter Buckley | President, International Division | 1,042,455 (i) | 876,244 (i) | 23% |
| Nathan Creech | President, Americas Division | 1213000 | 1170000 | 4% |

---

Note:

(i)The salary for Mr. Mintern was similarly set and paid in euro in 2024 and has been converted to U.S. Dollars using the average Bloomberg composite rate for 2024. The

salary for Mr. Buckley was set and paid in euro and has been converted to U.S. Dollars using the average Bloomberg composite rate for the applicable year.

**Annual Incentive Plan**

CRH's Annual Incentive Plan is designed to reward the creation of shareholder value through operational excellence and organic and acquisitive

growth. The plan incentivizes the NEOs to deliver Company and individual goals that support long-term value creation.

At the beginning of each year, the Committee determines the threshold, target and maximum bonus payable for each NEO, together with the

applicable performance metrics.

CRH's Annual Incentive Plan for 2025 was based on a combination of financial targets and sustainability/strategic measures. The metrics for target

payout, which is up to a maximum of 100% of the total annual bonus opportunity, are based on targets extracted from the 2025 budget set by the

Board in respect of each metric. The threshold level for bonus payouts in 2025 was for the achievement of 50% of target, whereas maximum payout

is achieved for stretch performance of 200% of target. The relative weighting of the components of 2025 is set out on page 60.

When setting the targets for the Annual Incentive Plan, the Committee makes certain assumptions with respect to the year ahead and also compares

the proposed targets to the outcomes for the previous year to ensure that the targets are sufficiently rigorous. The metrics in the plan are influenced

by the economic cycle and other factors, such as ongoing portfolio management, government infrastructure spending programs and items outside of

management's control which may not continue into the next financial year.

When reviewing performance against the Annual Incentive Plan, the Committee ensures that appropriate adjustments are applied to the financial

targets to reflect significant development activity and actual exchange rates.

The financial targets for the 2025 Annual Incentive Plan, which represent 80% of the potential bonus opportunity, were set in early 2025.

Reflecting the strong performance in 2025 underpinned by CRH's customer-centric strategy, the financial metrics for the Annual Incentive Plan, which

accounted for 80% of the overall opportunity, were achieved at a level of 135% of target. The Committee assessed that the performance of the NEOs

against their individual non-financial objectives, accounting for 20% of their potential opportunity under the Annual Incentive Plan, was at a level which

warranted a payout of 150% of target. The combined payout level was, therefore, 138% of target.

In determining this outcome, the Committee also took into account a number of factors, including, feedback from other Committees in relation to

matters such as safety performance and culture, whether any extraneous factors outside the control of management had unduly influenced the

outcome, progress in relation to strategic objectives not captured by the financial measures used for compensation purposes, and the experience of

key stakeholder groups (including employees). Based on this review, the Committee determined that no adjustment to incentive outcomes in respect

of any of these matters was necessary.

60<br>

CRH PROXY STATEMENT 2026

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **2025 Annual Incentive Plan – Targets & Achievement** | **2025 Annual Incentive Plan – Targets & Achievement** | **2025 Annual Incentive Plan – Targets & Achievement** | **2025 Annual Incentive Plan – Targets & Achievement** | **2025 Annual Incentive Plan – Targets & Achievement** | **2025 Annual Incentive Plan – Targets & Achievement** | |
|  |  | **2025 Targets – Performance needed for payout at (i) (ii)** | **2025 Targets – Performance needed for payout at (i) (ii)** | **2025 Targets – Performance needed for payout at (i) (ii)** |  |  |
| **Measure** | **Weighting** <br>**(% of total bonus)**<br>| **Threshold** | **Target** | **Maximum** | **2025 Performance** <br>**Achieved (iii)**<br>| **Percentage of Target** <br>**Awarded** <br>|
| Operating Cash Flow (iii) | 30% | $3.62B | $4.26B | $4.77B | $4.67B | 181% |
| Diluted EPS (iii) | 30% | $4.63 | $5.45 | $6.10 | $5.57 | 119% |
| RONA (iii)  | 20% | 12.4% | 14.4% | 15.9% | 14.1% | 92% |
| Sustainability/Strategic  | 20% |  |  |  | See page 58 | 150% |
| Total | 100% |  |  |  |  | 138% |

---

Notes:

(i)50% is earned at threshold, 100% at target and 200% at maximum, with a straight-line payout schedule between these points.

(ii)Targets have been adjusted to reflect significant development activity and actual exchange rates.

(iii)For the purposes of the Annual Incentive Plan, the Diluted EPS outcome in the table above aligns with Diluted EPS Pre-Impairment, a non-GAAP metric disclosed in the

2025 Annual Report. The Operating Cash Flow outcome in the table above differs from that disclosed in the 2025 Annual Report as the outcome achieved for 2025 is

calculated by making the following adjustments to Adjusted EBITDA, a non-GAAP metric disclosed in this Proxy Statement and the 2025 Annual Report: deducting

cash outflows on the purchases of property, plant and equipment, and intangibles; adding proceeds from disposal of long-lived assets; and adjusting for movement in

trade working capital and gains/losses on disposal of long-lived assets. RONA is not disclosed elsewhere in this Proxy Statement or the 2025 Annual Report. RONA is

an internal, pre-finance, pre-tax and pre-impairment measure used by management to assess asset efficiency across CRH's segments. RONA is calculated as operating

income (excluding non-cash impairment losses) divided by average net assets, defined as total assets less total liabilities, excluding equity-accounted investments,

interest receivable and payable, deferred and contingent consideration, Net Debt (a non-GAAP metric disclosed in the 2025 Annual Report), and tax-related assets and

liabilities. Average net assets are based on the trailing average of closing balances for the applicable period to reflect seasonality and timing of development activity.

The table below outlines the target bonus opportunity, the maximum bonus payable under the Annual Incentive Plan and the actual bonus paid to

each NEO based on 2025 company and individual performance.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **2025 Annual Incentive Plan – Payout** | **2025 Annual Incentive Plan – Payout** | **2025 Annual Incentive Plan – Payout** | **2025 Annual Incentive Plan – Payout** | **2025 Annual Incentive Plan – Payout** | **2025 Annual Incentive Plan – Payout** | |
| **Name** |  | **Base Salary (i)**<br>**($)** | **Target Bonus**<br>**% of Salary** | **Target Bonus** <br>**Amount**<br>**($)** | **Maximum** <br>**Potential Bonus** <br>**($)** | **Actual Bonus Earned** <br>**Based on 2025** <br>**Performance (ii) ($)** |
| **Name** | **Position** | **Base Salary (i)**<br>**($)** | **Target Bonus**<br>**% of Salary** | **Target Bonus** <br>**Amount**<br>**($)** | **Maximum** <br>**Potential Bonus** <br>**($)** | **Actual Bonus Earned** <br>**Based on 2025** <br>**Performance (ii) ($)** |
| Jim Mintern | Chief Executive Officer | 1750000 | 150.0% | 2625000 | 5250000 | 3622500 |
| Nancy Buese | Chief Financial Officer | 1000000 | 110.0% | 1,100,000 (ii) | 2,200,000 (ii) | 973,184 (ii) |
| Randy Lake | Chief Operating Officer | 1578000 | 125.0% | 1972500 | 3945000 | 2722050 |
| Peter Buckley | President, International Division | 1042455 | 110.0% | 1146701 | 2293401 | 1582447 |
| Nathan Creech | President, Americas Division | 1213000 | 110.0% | 1334300 | 2668600 | 1841334 |
| Alan Connolly | Former Interim Chief Financial Officer | 597720 | 60.0% | 358632 | 717263 | 494913 |

---

**Note**:

(i)The salaries for Mr. Buckley and Mr. Connolly were set and paid in euro in 2025 and have been converted to U.S. Dollar using the average Bloomberg composite rate

for 2025.

(ii)The annual bonus received by Ms. Buese has been pro-rated to reflect the portion of the year for which she served as Chief Financial Officer (appointment was effective

May 12, 2025). The pro-rated Target Bonus Amount and Maximum Potential Bonus were $792,603 and $1,585,205, respectively.

**2025 Long-Term Incentive Plan Awards**

At the 2025 AGM, our shareholders approved the 2025 Equity Incentive Plan, which had previously been approved by the Board. The 2025 Equity

Incentive Plan replaced the 2014 Performance Share Plan and all other Board-approved share plans in operation (other than the Company's Savings-

related Share Option and the Share Participation Schemes in operation in Ireland and the United Kingdom) and no further awards will be granted

under those plans. An aggregate of 15 million of the Company's Ordinary Shares was reserved for issuance under the 2025 Equity Incentive Plan.

The purpose and goal of our 2025 Equity Incentive Plan is to align the interests of the NEOs (and key management across different regions) with

those of shareholders by incentivizing the achievement of long-term performance goals. Awards under the 2025 Equity Incentive Plan are granted in

the form of PSUs (60% of the award), which vest based on performance over a period of three years, and RSUs (40% of the award), which vest

ratably over a period of three years.

2025 Awards

In 2025, the Company granted RSU and PSU awards under the 2025 Equity Incentive Plan to each of the NEOs. The RSU and PSU awards provide

each NEO with the right to receive CRH shares, subject to the fulfillment of certain timing, market, performance and service conditions, as relevant,

over the applicable vesting period.

With respect to the RSUs, the awards vest ratably at 33.3% during the three-year period (May 2026, May 2027 and May 2028). With respect to the

PSUs, the performance conditions are designed to drive long-term shareholder value and consist of Cash Flow performance, RONA performance, and

Relative TSR performance, with the Cash Flow and RONA performance conditions being set by reference to CRH's Strategic Plan. Each performance

condition is measured over a three-year performance period ending on December 31, 2027, with performance determined by the Committee following

completion of the performance period. The PSU awards vest on the third anniversary of the grant date, with the actual vesting percentage ranging

from 0% to 200% based upon actual achievement of the performance conditions as further described below. The performance conditions have been

structured to encourage high levels of performance, with payout dependent on performance relative to CRH's Strategic Plan (in the case of the

cumulative Cash Flow and RONA performance conditions) and performance relative to the Company's Performance Peer Group for 2025 PSUs set

out on page 64 (in the case of Relative TSR). The payout percentage for each performance condition is interpolated for performance between the

minimum threshold and maximum level of performance. The specific targets for the cumulative Cash Flow and RONA metrics have not been disclosed

on the basis that they are competitively sensitive and disclosure would result in competitive harm.

61<br>

CRH PROXY STATEMENT 2026

In addition to their 2025 PSU and RSU awards, Ms. Buese, Mr. Creech and Mr. Connolly each received additional RSU awards, details of which are

outlined in the table below. The additional RSU awards are one-off in nature and are not expected to be recurring under the 2025 Compensation

Framework, which emphasizes pay for performance.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **2025 Awards to NEOs** | **2025 Awards to NEOs** | **2025 Awards to NEOs** | **2025 Awards to NEOs** | **2025 Awards to NEOs** |
|  | **2025 Equity Incentive Plan Annual Awards (i)** | **2025 Equity Incentive Plan Annual Awards (i)** | **2025 Equity Incentive Plan Annual Awards (i)** | **Additional RSU Awards** |
| **Name** | **Target ($)** | **No. of PSUs (60% of Total** <br>**Award)**<br>| **No. of RSUs (40% of Total** <br>**Award)**<br>| **No. of RSUs Granted** |
| Jim Mintern | 10237500 | 67433 | 44955 |  |
| Nancy Buese (ii) | 4000000 | 26347 | 17565 | 21956 |
| Randy Lake | 4300000 | 28324 | 18882 |  |
| Peter Buckley | 2350000 | 15480 | 10317 |  |
| Nathan Creech (iii) | 3500000 | 23054 | 15369 | 32934 |
| Alan Connolly (iv) | 871275 | 5744 | 3821 | 3270 |

---

Notes:

(i)The target award value was converted to PSUs and RSUs on a 60:40 split based on the average close price over the 20-day trading period from April 14, 2025 through

May 9, 2025.

(ii)In connection with her appointment as Chief Financial Officer, Ms. Buese received a one-time RSU award, which will vest 50% in 2026 and 50% in 2027, subject to

continued employment.

(iii)In connection with his support of the leadership transition and his continued efforts to drive performance and growth in the Americas, Mr. Creech received a one-time

RSU award, which will vest 100% in 2028, subject to continued employment

(iv)In connection with his service as Interim Chief Financial Officer from January 1, 2025 through May 11, 2025, Mr. Connolly received a one-time cash bonus of $200,000,

to reflect market pay for the period of time Mr. Connolly held the Interim Chief Financial Officer role, and a one-time RSU grant with a grant date fair value equal to

$300,000, vesting 50% in 2026 and 50% in 2027 to recognize the support for transition of the role to Ms. Buese and is subject to continued employment.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **2025 PSU Awards – Structure** | **2025 PSU Awards – Structure** | **2025 PSU Awards – Structure** | **2025 PSU Awards – Structure** | |  |  |  |  |  |
| **Measures** | **Weighting** | **Threshold Level of Performance** <br>**(50% Payout)** | **Target Level of Performance** <br>**(100% Payout)** | **Maximum Level of Performance** <br>**(200% Payout)** |  |  |  |  |  |
| **Measures** | **Weighting** | **Threshold Level of Performance** <br>**(50% Payout)** | **Target Level of Performance** <br>**(100% Payout)** | **Maximum Level of Performance** <br>**(200% Payout)** | Cash Flow performance (i) | 50% | > 80.0% of Plan | At Plan | > 112.0% of Plan |
| RONA performance (ii) | 25% | Plan - 225bps | At Plan | Plan + 150bps |  |  |  |  |  |
| Relative TSR performance (iii) | 25% | >25th percentile | >55th percentile | >75th percentile |  |  |  |  |  |

---

Notes:

(i)The definition of Cash Flow performance differs from that disclosed in the 2025 Annual Report, and is defined as Adjusted EBITDA, a non-GAAP metric disclosed in this

Proxy Statement and the 2025 Annual Report; less gains/losses on disposal of long-lived assets; plus proceeds from disposal of long lived assets, less cash outflows

on the purchases of property, plant and equipment, and intangibles; less net cash outflows for Interest and Tax.

(ii)Further information on how RONA is calculated for PSU awards is set out on page 60.

(iii)The methodology for calculating TSR assumes all dividends are reinvested on the ex-dividend date at the closing price on that day; the open and close price is based

on the three-month average closing price on the last day before the start of the performance period and the final day of the performance period respectively. The

Performance Peer Group used to assess TSR performance for the 2025 PSU awards is set out on page 64. TSR performance is assessed on a weighted market

capitalization basis.

(iv)Awards, to the extent that they vest, will be adjusted to accrue dividend equivalents based on dividends declared and paid in the period from the date of grant to the

date of vesting.

**Long-Term Incentives Earned in 2025 - 2014 Performance Share Plan Awards**

Prior to the establishment of the 2025 Compensation Framework, CRH maintained a long-term equity incentive compensation program (the '2014

Performance Share Plan'). Awards (in the form of conditional share awards) normally vest based on performance over a period of not less than three

years. The PSP awards granted to Mr. Mintern under the 2014 Performance Share Plan are assessed using the same performance periods as the

other NEOs, but are subject to an additional vesting period ending on the fifth anniversary of the grant date.

2023 PSP Award – Performance Assessed 2025

In 2023, the Company granted PSP awards under the 2014 Performance Share Plan to each of the NEOs (other than Ms. Buese). The PSP awards

provide each NEO with the right to receive CRH shares, subject to the fulfillment of certain market, performance and service conditions over the

applicable vesting period. The performance conditions were designed to drive long-term shareholder value and consisted of Cash Flow performance,

RONA performance, TSR performance and certain sustainability scorecard measures, with the Cash Flow and RONA performance conditions being

set by reference to CRH's Strategic Plan and TSR performance relative to the tailored peer group set out on page 64. Each performance condition

was measured over a three-year performance period ending on December 31, 2025, with performance determined by the Committee following

completion of the performance period, with the actual vesting percentage ranging from 0 to 100% based upon actual achievement of the

performance conditions as further described below.

The PSP awards made in 2023 have been assessed against the applicable targets set by the Committee in 2023. Performance against these targets

has resulted in a 98.75% vesting level (see below for more details). When reviewing performance against the targets, the Committee considered a

number of adjustments consistent with best practice, for example, the impact of significant development activity.

Overall Incentive Outcome

The Committee is satisfied that there is a very strong alignment between the incentive outcomes outlined above for 2025 and the performance of the

Company. The Committee also took into account a number of factors, including, feedback from other Board Committees in relation to matters such

as safety performance and culture, whether any extraneous factors outside the control of management had unduly influenced the outcome and

progress in relation to strategic objectives not captured by the financial measures used for compensation purposes. Based on this review, the

Committee determined that no adjustment to incentive outcomes in respect of any of these matters was necessary.

62<br>

CRH PROXY STATEMENT 2026

---

| | | |
|:---|:---|:---|
| **2023 PSP Award Metrics**  | **2023 PSP Award Metrics**  | |
| ![2023 Performance Metrics-01.jpg](crh-20260326_g82.jpg) | ![2023 Performance Metrics-02.jpg](crh-20260326_g83.jpg) | ![2023 Performance Metrics-03.jpg](crh-20260326_g84.jpg) |

---

Sustainability & Diversity (15% of award)

The Sustainability & Diversity component is comprised of: (i) 5% on driving carbon neutrality, (ii) 5% on progress toward a net zero built environment

and (iii) 5% on creating an inclusive & diverse company. The Compensation Committee approved a combined achievement level on these factors of

13.75%.

Notes:

(i)Cumulative Cash Flow is defined as net increase (decrease) in cash and cash equivalents, as reported under IFRS, adjusted to exclude:

• Dividends paid/received;

• Acquisition/investment expenditure;

• Proceeds from divestitures/disposals;

• Movements in working capital and other related matters;

• Share purchases/issues (scrip dividend, share options/payment expense);

• Financing cash flows (new loans, debt repayments, other); and

• Foreign exchange translation.

The Committee determined that it is appropriate to make these adjustments in order to remove items that it believes do not reflect the quality of management's

operational performance or are largely outside of the Company's control. The Committee also retains the discretion to make further adjustments, for example, as a

result of significant development activity during the performance period or a significant underspend or delay in budgeted capital expenditure, both ordinary and

extraordinary.

(ii)The methodology for calculating TSR assumes all dividends are reinvested on the ex-dividend date at the closing price on that day; the open and close price is based

on the three-month average closing price on the last day before the start of the performance period and the final day of the performance period respectively. For the

2023 awards, TSR performance is assessed on a weighted market capitalization basis. The peer group used to assess TSR performance for the 2023 PSP awards is

set out below.

(iii)RONA is calculated on an IFRS basis in line with targets. Further information on how RONA is calculated for PSP awards is set out on page 60.

(iv)For the purposes of the 2023 awards, the cumulative cash flow for the three years ended December 31, 2025 was $9.7 billion based on financial reporting under IFRS.

TSR performance was in the upper quartile against the tailored peer group. RONA for the year ended December 31, 2025 was 13.1%.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **2023 PSP Awards – Vesting Details** | **2023 PSP Awards – Vesting Details** | **2023 PSP Awards – Vesting Details** | **2023 PSP Awards – Vesting Details** | **2023 PSP Awards – Vesting Details** | **2023 PSP Awards – Vesting Details** | |
| **Name** | **Interests** <br>**Held**<br>| **Vesting Outcome**<br>**(% of Max)**<br>| **Interests** <br>**Due to Vest / Vested**<br>| **Date of** <br>**Vesting**<br>| **Assumed** <br>**Share Price**<br>**($)(i)**<br>| **Estimated Value**<br> **($)**<br>|
| Jim Mintern | 52115 | 98.75% | 51460 | February 23, 2028 | 121.49 | 6251875 |
| Nancy Buese |  |  |  |  |  |  |
| Randy Lake | 74700 | 98.75% | 73767 | February 23, 2026 | 121.49 | 8961953 |
| Peter Buckley | 24493 | 98.75% | 24186 | February 24, 2026 | 121.49 | 2938357 |
| Nathan Creech | 64984 | 98.75% | 64171 | February 23, 2026 | 121.49 | 7796135 |
| Alan Connolly | 18989 | 98.75% | 18752 | February 23, 2026 | 121.49 | 2278180 |

---

Note:

(i)For the purposes of this table, the value of these awards has been estimated using a share price of $121.49 being the closing share price of our Ordinary Shares on

February 23, 2026.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Peer Group for 2014 Performance Share Plan Awards (i) (ii)** | **Peer Group for 2014 Performance Share Plan Awards (i) (ii)** | **Peer Group for 2014 Performance Share Plan Awards (i) (ii)** | **Peer Group for 2014 Performance Share Plan Awards (i) (ii)** | **Peer Group for 2014 Performance Share Plan Awards (i) (ii)** |
| ACS | Heidelberg Materials | Saint Gobain | Vicat | Wienerberger |
| Buzzi | Holcim | Skanska | Vinci |  |
| Cemex | Martin Marietta | Titan Cement | Vulcan Materials |  |

---

Note:

(i) Boral was removed from the peer group for awards under the 2014 Performance Share Plan following its acquisition by Seven Group Holdings in 2024.

(ii) Peer group applicable for 2023 PSP awards. See page 64 for details of the peer group that will apply for PSU awards in 2025.

63<br>

CRH PROXY STATEMENT 2026

**2025 Compensation Decision Process**

**Compensation Committee**

The Committee consists of six non-

management Directors considered by the

Board to be independent under the applicable

NYSE standards. They bring a range of

experience of large organizations and public

companies, including experience in the area of

senior executive compensation, to enable the

Committee to fulfill its role. Their biographical

details are set out on pages 19 to 22.

The Committee operates under an agreed

charter, a copy of which is available on the

CRH website (www.crh.com), and its main

focus is to:

• review and approve the corporate goals and

objectives relevant to the compensation of

the Chief Executive Officer, evaluating his or

her performance in light of those goals and

objectives, and determine and approve the

Chief Executive Officer's compensation

levels and outcomes;

• review and approve the compensation and

incentive compensation and equity-based

plans for executive officers; and

• approve the design of, and determine the

financial and non-financial targets for, any

short-term performance-related pay

schemes operated by the Company and

approve the total annual payments made

under such schemes. The Committee shall

additionally review the design of all long-

term share incentive plans for approval by

the Board and shareholders, as applicable.

In addition, the Committee oversees the

preparation of this CD&A.

In considering compensation levels for NEOs

particularly, the Committee takes into account

compensation trends in the countries in which

the Company operates. The Committee also

takes into consideration feedback which the

Company solicits and receives from

shareholders in relation to executive

compensation and receives advice and

recommendations from other committees in

relation to matters within the remit of these

committees which are relevant to

compensation considerations.

**Compensation Consultants**

In 2025, Semler Brossy Consulting Group LLC

('Semler Brossy') acted as the Committee's

independent compensation consultant and did

not provide any other services to CRH. The

Committee has determined that Semler Brossy

is independent under the factors set forth in

the NYSE rules for compensation committee

advisors and that Semler Brossy does not have

connections with the Company that may impair

its independence. During 2025, Semler Brossy

provided the following compensation services:

• research and advice regarding

compensation trends, compensation design

and best practice and compensation levels

for executive officers and non-management

Directors in companies of similar size and

complexity;

• advice in relation to compensation matters

generally; and

• attendance at Committee meetings, when

required.

**Management** 

Management supports the Committee by

providing information and analysis, and

regularly meets with our independent

compensation consultant to discuss

compensation initiatives and competitive

practices and to coordinate support for the

Committee.

The Chief Executive Officer is responsible for

recommending annual performance goals for

the Chief Financial Officer and the members of

the Global Leadership Team, and for

conducting annual performance evaluations

against such pre-established goals.

Based on performance and an assessment of

competitive pay levels, the Chief Executive

Officer makes recommendations to the

Committee for the compensation of other

senior executives.

**Assessment of Competitive** 

**Pay and Peer Group** 

*Compensation Peer Group*

The Committee reviews an assessment of

competitive pay for our NEOs relative to

market data. Our compensation consultant

develops market data appropriate for a

company of our size using a combination of

peer group data and market surveys. The

market data, in combination with consideration

of each NEO's experience, responsibilities and

performance, assists the Committee in making

informed, market-based decisions regarding

our executive pay programs.

The Committee considered several factors in

selecting our peer group, including industry,

revenue size, geography and market

capitalization. The Committee reviews and

adjusts the peer group periodically on an as-

needed basis.

CRH benchmarks executive compensation

against multiple peer groups, to be used as a

reference point in making compensation

decisions. For the 2025 Compensation

Framework, the peer group consists of U.S.

publicly traded companies primarily within the

Materials and Industrials sector and with

market capitalizations within 3.2x to 0.2x of

CRH. In the aggregate, the compensation peer

group consists of 21 companies. The peer

group includes Martin Marietta and Vulcan

Materials even though they are below the

typical market capitalization size screens, as

both are also included in the Performance Peer

Group as described on page 64. Following a

review during 2025, Amrize and Smurfit

Westrock were added to the go-forward peer

group for 2026 decisions.

64<br>

CRH PROXY STATEMENT 2026

---

| | |
|:---|:---|
| **Company** | **Market Capitalization** <br>**(as of December 31, 2025) ($B) (i)**<br>|
| Caterpillar | 268.1 |
| Linde | 199.1 |
| Deere | 125.9 |
| Honeywell International | 123.9 |
| Eaton | 123.7 |
| General Dynamics | 90.9 |
| Trane Technologies | 86.3 |
| 3M | 85.0 |
| Sherwin-Williams | 80.3 |
| Johnson Controls | 73.2 |
| Cummins | 70.5 |
| PACCAR | 57.5 |
| Carrier Global | 44.5 |
| Vulcan Materials | 37.7 |
| Martin Marietta Materials | 37.6 |
| Nucor | 37.3 |
| Amrize (ii) | 30.7 |
| PPG Industries | 23.0 |
| Smurfit Westrock (ii) | 20.2 |
| Dow | 16.5 |
| LyondellBasell | 13.9 |
| CRH | 83.5 |

---

Note:

(i)Market capitalization figures derived from Bloomberg.

(ii)Amrize and Smurfit Westrock were added to the peer group during 2025 and will be used for go-forward decisions in 2026.

*Performance Peer Group for 2025 PSUs*

Due to the limited number of direct industry competitors that are publicly traded U.S. companies of an appropriate size to include in the

compensation peer group, we use a distinct Performance Peer Group to measure relative TSR for our PSU awards. The group consists of 18

companies, two of which are also compensation peers (Vulcan Materials and Martin Marietta Materials).

---

| | |
|:---|:---|
| **Company** | **Market Capitalization** <br>**(as of December 31, 2025) ($B)(i)**<br>|
| Vinci | 82.0 |
| Holcim | 55.7 |
| Saint Gobain | 50.5 |
| Heidelberg Materials | 46.8 |
| Vulcan Materials | 37.7 |
| Martin Marietta Materials | 37.6 |
| ACS | 27.1 |
| Mastec | 17.2 |
| Cemex | 16.7 |
| Carlisle Companies | 13.4 |
| Masco  | 13.2 |
| Skanska | 11.5 |
| Advanced Drainage Systems | 11.3 |
| Owens Corning | 9.2 |
| Eagle Materials | 6.6 |
| Construction Partners | 6.1 |
| Fortune Brands Innovations | 6.0 |
| Knife River  | 4.0 |

---

Note:

(i)Market capitalization figures derived from Bloomberg.

65<br>

CRH PROXY STATEMENT 2026

**Governance Features of our** 

**Executive Compensation Programs**

**Share Ownership Guidelines** 

To reinforce the alignment between CRH

Directors and executives and shareholders and

foster a long-term, ownership mindset, the

Company introduced share ownership

guidelines in line with U.S. market practice for

its NEOs and non-management Directors

effective January 1, 2025. Pursuant to this

policy, each covered individual is expected to

hold shares having a minimum value

denominated as a multiple of base salary or

retainer:

• Chief Executive Officer: six times annual

base salary

• Other NEOs: three times annual base salary

• Non-management Directors: five times

annual cash retainer

Owned shares, PSPs for which the

performance period has concluded but remain

subject to an additional vesting period, RSUs

and deferred shares are counted towards

meeting ownership guidelines. PSUs subject to

performance and unexercised options are

excluded. Each covered individual is expected

to meet the share ownership guidelines within

five years of their appointment to their covered

role, or within five years from the date of the

implementation of the updated policy (i.e. by

December 31, 2029). Until the guidelines are

met, executives are subject to a 75% net share

retention requirement on the vesting of any

PSUs or RSUs.

The Committee is comfortable that each of the

NEOs is in compliance with, or on track to

comply with, the shareholding guidelines.

**Compensation Policies and Practices** 

**as They Relate to Risk Management**

The Committee has reviewed CRH's executive

and employee compensation programs and

does not believe that the compensation

policies and practices encourage undue or

inappropriate risk taking or create risks that are

reasonably likely to have a material adverse

effect on the Company. The reasons for the

Committee's determination include the

following:

• CRH structures its compensation program

to consist of both fixed and variable

components;

• CRH compensation programs are balanced

between a variety of measures, and both

short-term and long-term incentives are

designed to reward the execution of short-

term and long-term corporate strategies;

• CRH allocates compensation among base

salary, annual cash incentives, and long-

term incentives;

• CRH maintains internal controls over

financial reporting, which are designed to

prevent this information from being

manipulated by any employee, including our

executive officers;

• A significant portion of the compensation

paid to NEOs is in the form of equity awards

to align their interests with the interests of

shareholders; and

• As part of CRH's Anti-Hedging and

Pledging Policy, hedging transactions

involving the Company's equity securities

are prohibited so that CRH's NEOs and

other employees cannot insulate

themselves from the effects of poor share

price performance.

**Anti-Hedging and Pledging Policy**

The Company prohibits Directors and

executive officers from directly or indirectly

engaging in hedging, short sales or any other

derivative transaction involving the use of

market investments to offset, manage the risk

of, hedge or leverage movement in the market

value of CRH's Ordinary Shares.

In addition, Directors and executive officers

may not, at any time, directly or indirectly

pledge or otherwise encumber CRH's Ordinary

Shares as collateral for indebtedness, including

by holding such shares in a margin account.

**Tax Deductibility** 

Section 162(m) of the Internal Revenue Code

limits the amount that the Company may

deduct from our federal income taxes for

compensation paid to certain executive

officers, including NEOs, to $1 million per

executive officer per year. While the Committee

is mindful of the benefit to the Company of the

full tax deductibility of compensation, the

Committee believes that it should retain

flexibility in compensating our NEOs in a

manner that can best promote corporate

objectives and the interest of shareholders.

Therefore, the Committee may approve

compensation that may not be fully deductible

because of the limits of Section 162(m).

**Timing of Equity Grants**

The Company's equity compensation practices

include consistent policies and procedures

with respect to the timing, structure, and

process for the grant of equity-based awards,

including for purposes of annual equity grants

to our NEOs. The grant date of annual equity

awards to our NEOs is generally shortly after

the release of CRH's results for the prior year.

Equity awards are not spring-loaded or

otherwise timed to take advantage of material

non-public information.

**Clawback Policy** 

In compliance with the requirements of the

Exchange Act, the rules promulgated

thereunder by the SEC and the NYSE listing

standards, the Company has adopted a

Clawback Policy that allows the Company to

recoup certain incentive-based compensation

from current and former executive officers

under certain circumstances. A copy of the

Policy is available as Exhibit 97.1 to the 2025

Annual Report (referred to therein as the Policy

Relating to Recovery of Erroneously Awarded

Compensation).

**Other Elements of Our Executive** 

**Compensation Programs** 

**Other Employee Share Schemes** 

Irish-based NEOs are eligible to participate in

both an Irish Revenue Commissioners'

approved (i) Savings-related Share Option

Scheme (the 'SAYE Scheme') and (ii) Share

Participation Scheme (the 'Participation

Scheme') on terms consistent with all other

eligible employees in Ireland.

The SAYE Scheme is open to all eligible

employees in Ireland (with a parallel scheme

operating for eligible CRH employees in the UK

established on similar terms complying with the

UK Revenue requirements). Participants enter

into a savings contract to save up to €500

(£500 in the UK) per month from their net

salaries for a fixed term of three or five years

and at the end of the savings period they may

use the savings to exercise an option (granted

on commencement of the savings period) and

buy CRH shares at a discount of up to 15% of

the market price on the date of invitation to

participate in the scheme. Where the savings

contract entered for the purposes of the SAYE

Scheme is with a financial institution approved

in Ireland for that purpose, gains arising on the

exercise of the option are exempt from income

tax. The last grant under the SAYE Scheme

was in 2022 and no NEO has an outstanding

option.

Each Participation Scheme is open to all

employees of the relevant sponsoring

employing subsidiary in Ireland. Under a

Participation Scheme as operated by CRH

subsidiaries in Ireland, each eligible participant

may opt in to receive an allocation of up to

10% of their base salary (subject to a

maximum of €12,700) in CRH shares annually

(funded via a discretionary bonus payment,

which may be supplemented through

employee salary foregone), with the value of

such shares being free from income tax if

subsequently held in trust for a retention period

of at least three years. The shares are

purchased on the open market at market value

by a trustee, which then holds the acquired

shares for the duration of the retention period.

The Irish-based NEOs participated in the

Participation Scheme in 2025.

**Benefits and Perquisites** 

The Compensation Committee's policy is to set

benefit provisions at an appropriate market

competitive level taking into account market

practice, the level of benefits provided for other

employees in the Company, the NEO's home

jurisdiction and the jurisdiction in which the

NEO is based.

For each of our NEOs, employment-related

benefits include the provision of security,

where deemed appropriate, the use of

company cars (or a car allowance), medical

insurance for the NEO and his/her family,

disability insurance and life insurance.

66<br>

CRH PROXY STATEMENT 2026

Benefits may also be provided in relation to

legal fees incurred in respect of agreeing

service contracts, or similar agreements (for

which the Company may settle any tax

incurred by the NEO) and a gift on retirement.

**Retirement Benefits**

Mr. Mintern received a taxable non-

pensionable cash payment of 10% of salary in

lieu of a pension contribution.

Ms. Buese, Mr. Lake and Mr. Creech

participate in the CRH Americas 401(k) Plan, a

tax-qualified defined contribution plan in which

all U.S.-based employees, including the U.S.-

based NEOs, are eligible to participate on the

same terms. CRH Americas, Inc. ('CRH

Americas') provides matching contributions

equal to 100% of each employee's contribution

up to 5% of the employee's annual base salary

up to the applicable Code limit. Employee

contributions are 100% vested, while CRH

Americas contributions vest at a rate of 20%

per year, becoming fully vested after five years.

The CRH Americas 401(k) Plan also provides

for a discretionary profit-sharing component

where a percentage of base salary may be

contributed by the Company to the 401(k)

Plan. The 401(k) Plan is integral to the

Company's broader compensation and

benefits programs, aiming to attract, retain,

and motivate employees by offering

competitive retirement savings options. Ms.

Buese, Mr. Lake and Mr. Creech also

participate in a Supplemental Executive

Retirement Plan, the details of which are

provided on page 73.

Details in relation to the pension arrangements

of Mr. Mintern, Mr. Buckley and Mr. Connolly

are provided on page 72.

**Employment Agreements**

Each of our NEOs has entered into a written

employment agreement with the Company. For

a more complete description of the Company's

obligations under the NEOs' employment

agreements in the event of a termination of

employment or change in control, see the

section below titled "Payments Upon

Termination or in Connection with a Change in

Control" on pages 74 to 76.

**Employment Agreement** 

**with Mr. Mintern**

Mr. Mintern's employment agreement became

effective on August 6, 2025 (as amended from

time to time, the 'Mintern Employment

Agreement'). It provides for compensation

generally in the form of (1) annual base salary,

including a taxable pension cash adjustment

equal to 10% of annual base salary, (2) an

annual target bonus opportunity of 150% of

base salary, with a maximum bonus of 300%

of base salary, (3) an annual equity incentive

with a total target grant date fair value of 585%

of his base salary, granted 60% in the form of

PSUs and 40% in the form of RSUs, and (4)

participation in CRH benefit plans and

programs.

The Mintern Employment Agreement contained

restrictive covenants which provided that Mr.

Mintern would not compete with CRH, nor

solicit its customers or employees for a period

of 12 months (or nine months in the case of

the non-compete) after the termination of

employment, less the number of weeks Mr.

Mintern was placed on garden leave pursuant

to the Mintern Employment Agreement.

**Employment Agreement** 

**with Ms. Buese**

In connection with Ms. Buese's appointment

as Chief Financial Officer, Ms. Buese entered

into an employment agreement, dated April 11,

2025 and effective May 12, 2025, with the

Company (the 'Buese Employment

Agreement').

It provides for compensation generally in the

form of (1) annual base salary, (2) an annual

target bonus opportunity of 110% of base

salary, with a maximum bonus of 220% of

base salary, and (3) participation in CRH

benefit plans.

Ms. Buese also entered into a protective

covenants agreement which provides that,

subject to applicable state law, Ms. Buese will

not engage in relevant competitive activity for a

period of nine months, nor solicit relevant

customers or employees for a period of 12

months after the termination of employment,

less the number of weeks Ms. Buese was

placed on garden leave pursuant to the Buese

Employment Agreement.

**Employment Agreement** 

**with Mr. Lake**

Mr. Lake's employment agreement became

effective on January 1, 2021 (the 'Lake

Employment Agreement'). It provides for

compensation generally in the form of (1)

annual base salary, (2) an annual target bonus

opportunity of 100% of base salary, with a

maximum bonus of 200% of base salary, and a

requirement that 25% of any bonus earned

while serving on the Global Leadership Team

will be delivered in restricted shares (which

have been in the form of deferred shares under

the 2014 Deferred Share Bonus Plan ('2014

DSBP')) and (3) participation in CRH benefit

plans and a car allowance.

The Lake Employment Agreement contains

several restrictive covenants which provide that

Mr. Lake will not engage in relevant

competitive activity, nor solicit relevant

customers, vendors or employees.

**Employment Agreement** 

**with Mr. Creech**

Mr. Creech's employment agreement became

effective on January 1, 2021 (the 'Creech

Employment Agreement'). It provides for

compensation generally in the form of (1)

annual base salary, (2) an annual target bonus

opportunity of 87.5% of base salary, with a

maximum bonus of 175% of base salary, and a

requirement that 25% of any bonus earned

while serving on the Global Leadership Team

will be delivered in restricted shares (which

have been in the form of deferred shares under

the 2014 DSBP) and (3) participation in CRH

benefit plans and a car allowance.

The Creech Employment Agreement contains

several restrictive covenants which provide that Mr.

Creech will not engage in relevant competitive

activity, nor solicit relevant customers, vendors,

suppliers, or employees for a period of 12 months

after the termination of employment, less the

number of weeks Mr. Creech was placed on

garden leave pursuant to the Creech Employment

Agreement.

**Employment Agreement** 

**with Mr. Buckley**

Mr. Buckley entered into an employment

agreement on February 20, 2024 (the 'Buckley

Employment Agreement'). It provides for

compensation generally in the form of (1)

annual base salary, including an 8% holiday

allowance, (2) an annual target bonus

opportunity of 87.5% of his base salary, with a

maximum bonus of 175% of base salary, with

a requirement that 25% of the discretionary

variable bonus will be delivered in deferred

shares, (3) a reasonable housing and mobility

allowance and (4) participation in CRH benefit

plans and use of a Company car or other

similar benefit in accordance with CRH's car

policy, as well as a car allowance.

The Buckley Employment Agreement contains

several restrictive covenants which provide that

Mr. Buckley will not compete with CRH, nor

solicit its customers or employees for a period

of 12 months (or nine months in the case of

the non-compete) after the termination of

employment, less the number of weeks Mr.

Buckley was placed on garden leave pursuant

to the Buckley Employment Agreement.

**Employment Agreement** 

**with Mr. Connolly**

Mr. Connolly entered into an employment

agreement on September 1, 2025 (the

'Connolly Employment Agreement'). It provides

for compensation generally in the form of (1)

annual base salary, (2) an annual target bonus

opportunity of 60% of base salary, with a

maximum bonus of 120% of base salary and

(3) participation in CRH benefit plans and a

company car.

The Connolly Employment Agreement contains

several restrictive covenants which provide that

Mr. Connolly will not compete with CRH, nor

solicit its customers or employees for a period

of nine months (or six months in the case of

the non-compete) after the termination of

employment, less the number of weeks Mr.

Connolly was placed on garden leave pursuant

to the Connolly Employment Agreement.

67<br>

CRH PROXY STATEMENT 2026

**Executive Compensation** 

**Executive Officer Compensation**

The following tables show annual and long-term compensation, for services in all capacities to CRH, earned by the NEOs. These tables and the

accompanying narratives should be read in conjunction with the CD&A, which provides a detailed overview of the methods used by CRH to

compensate the NEOs.

**Summary Compensation Table** 

The table below summarizes the total compensation paid to or earned by each of the NEOs in 2025 and, in the case of Mr. Mintern, includes

compensation earned for the 2023 and 2024 fiscal years, and, in the case of Messrs. Lake, Buckley and Creech, includes compensation earned for

the 2024 fiscal year.

---

| | | | | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Summary Compensation**  | **Summary Compensation**  | **Summary Compensation**  | **Summary Compensation**  | **Summary Compensation**  | **Summary Compensation**  | **Summary Compensation**  | **Summary Compensation**  | **Summary Compensation**  | |  |  |  |  |  |  |  |  |
| **(a)** | **(b)** | **(c)** | **(d)** | **(e)** | **(f)** | **(g)** | **(h)** | **(i)** | **(j)** |  |  |  |  |  |  |  |  |
| **Name & Principal Position** | **Year** | **Base** <br>**Salary**<br>**($)**<br>| **Bonus**<br>**($)**<br>| **Stock Awards**<br>**($)**<br>| **Option** <br>**Awards**<br>**($)**<br>| **Non-Equity** <br>**Incentive Plan** <br>**Compensation**<br>**($)**<br>| **Change in Pension Value** <br>**and Non-Qualified** <br>**Compensation Earnings**<br>**($)**<br>| **All Other** <br>**Compensation**<br>**($)**<br>| **Total**<br>**($)**<br>|  |  |  |  |  |  |  |  |
| Jim Mintern<br>Chief Executive Officer | 2025 | 1750000 | – | 12041637 | – | 3622500 | 170762 | 256909 | 17841808 |  |  |  |  |  |  |  |  |
| Jim Mintern<br>Chief Executive Officer | 2024 | 1000219 | – | 3144924 | – | 1315488 | – | 230174 | 5690805 |  |  |  |  |  |  |  |  |
| Jim Mintern<br>Chief Executive Officer | 2023 | 963518 | – | 3045382 | – | 1156221 | 712490 | 158946 | 6036557 |  |  |  |  |  |  |  |  |
| Nancy Buese<br>Chief Financial Officer | 2025 | 640385 | 1000000 | 6595625 | – | 973184 | – | 136151 | 9345345 |  |  |  |  |  |  |  |  |
| Nancy Buese<br>Chief Financial Officer | 2025 | 640385 | 1000000 | 6595625 | – | 973184 | – | 136151 | 9345345 | Randy Lake<br>Chief Operating Officer | 2025 | 1578000 | 5556252 | 2722050 | 75840 | 340019 | 10272161 |
| 2024 | 1521520 | – | 4186800 | – | 2251241 | 77344 | 327699 | 8364604 | Randy Lake<br>Chief Operating Officer |  |  |  |  |  |  |  |  |
| Peter Buckley<br>President, International Division | 2025 | 1042455 | – | 2997735 | – | 1582447 | – | 270428 | 5893065 |  |  |  |  |  |  |  |  |
| Peter Buckley<br>President, International Division | 2024 | 876244 | – | 1768223 | – | 1134429 | 35122 | 250538 | 4064556 |  |  |  |  |  |  |  |  |
| Nathan Creech<br>President, Americas Division | 2025 | 1213000 | – | 7644780 | – | 1841334 | 30168 | 263297 | 10992579 |  |  |  |  |  |  |  |  |
| Nathan Creech<br>President, Americas Division | 2024 | 1170000 | – | 3466780 | – | 1514741 | 28611 | 256474 | 6436606 |  |  |  |  |  |  |  |  |
| Alan Connolly<br>Former Interim Chief <br>Financial Officer | 2025 | 597720 | 200000 | 1262300 | – | 494913 | – | 235254 | 2790187 |  |  |  |  |  |  |  |  |
| Alan Connolly<br>Former Interim Chief <br>Financial Officer | 2025 | 597720 | 200000 | 1262300 | – | 494913 | – | 235254 | 2790187 |  |  |  |  |  |  |  |  |

---

Notes:

1. As an FPI in fiscal year 2023, the Company was required to provide executive compensation disclosure on an individual basis only for Mr. Mintern in accordance with

the requirements of Form 20-F. The Company determined that it no longer qualified as an FPI effective January 1, 2025, and Mr. Buckley, Mr. Creech and Mr. Lake

became NEOs for fiscal year 2024.

2. The amounts in column (c) reflect the base salary payments made to the NEOs during the fiscal year. The salaries for Mr. Buckley and Mr. Connolly were set and paid in

euro in each of the years listed above and have been converted to U.S. Dollars using the average Bloomberg composite rate for the applicable year, where relevant. The

salary for Mr. Mintern was also set and paid in euro in 2023 and 2024 and converted to U.S. Dollars using the average Bloomberg composite rate for the applicable

year. The currency conversion results in apparent fluctuations in base salary from one year to the next.

3. In addition to the amounts earned under the 2025 Annual Incentive Plan, details of which are described on pages 59 to 60, the amounts in column (d) include the one-

time cash bonus payments to Ms. Buese ($1,000,000) in connection with her appointment as Chief Financial Officer in May 2025 and to Mr. Connolly ($200,000) to

reflect his service as Interim Chief Financial and to recognize the support for transition of the role to Ms. Buese and is subject to continued employment

4. The amounts in column (e) reflect the aggregate grant date fair value of awards made in the year reported, determined in accordance with FASB ASC Topic 718

(without any assumption for early forfeiture), of PSU and RSU awards, which are described in more detail on pages 60 to 61. The amounts also include one-time RSU

grants with grant date fair values equal to (i) $2,000,000 to Ms. Buese in connection with her appointment as Chief Financial Officer, (ii) $3,000,000 to Mr. Creech,

further details of which are included on page 61 and (iii) $300,000 to Mr. Connolly following his service as Interim Chief Financial Officer. The amount in column (e)

includes PSU awards based on an estimate of the expected value multiplied by the target number of shares comprising an award. Valuing the maximum number of PSU

awards granted in 2025, the payout of which will be determined in February 2028 based on the Company's performance in 2025-2027, the amounts reported above for

2025 are as follows:

Jim Mintern:$13,904,010

Nancy Buese:$5,432,488

Randy Lake:$5,840,126

Peter Buckley:$3,191,821

Nathan Creech:$4,753,504

Alan Connolly:$1,184,355

Assumptions used in the calculation of these amounts are included in note 16 to the audited financial statements for the fiscal year ended December 31, 2025, included

in CRH's 2025 Annual Report filed with the SEC on February 18, 2026.

5. The amounts in column (g) for 2025 reflect the cash earned by the NEOs in 2025 and to be paid in 2026 under the annual bonus arrangements discussed in further

detail on pages 59 to 60.

6. The amounts in column (h) do not represent increased benefit accruals, but reflect changes in the actuarial valuations of legacy benefits accrued by the NEOs as

participants in a contributory defined benefit plan. This disclosure aligns with SEC reporting requirements and reflects updates to assumptions and variations in the

interest rates used to calculate the present values of these legacy benefits. As a result of past changes in Irish pension legislation, Mr. Mintern ceased accruing benefits

under this plan in 2013, opting instead to receive a supplementary taxable non-pensionable cash supplement in lieu of pension benefits. Mr. Mintern's cash supplement

is limited to 10% of salary. These cash supplements are captured in column (i) above. Nil has been reported in column (h) where results equaled a negative value.

7. The amounts shown in column (i) for fiscal year 2025 reflect allowances, benefits and perquisites paid by the Company as follows:

68<br>

CRH PROXY STATEMENT 2026

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Jim Mintern**<br>**($)**<br>| **Nancy Buese**<br>**($)**<br>| **Randy Lake**<br>**($)**<br>| **Peter Buckley**<br>**($)**<br>| **Nathan Creech**<br>**($)**<br>| **Alan Connolly**<br>**($)**<br>|
| Car Expenses/Car Allowances |  |  | 12000 | 22545 | 14400 | 12854 |
| Health Allowances/Health Checks | 3607 |  |  | 12960 |  | 5467 |
| Death & Disability Insurance Premiums | 4099 | 8074 | 11395 | 8871 | 6297 | 3548 |
| 2025 Pension Allowance | 175000 |  |  |  |  | 211888 |
| 401(k) Matching/Pension Contributions |  |  | 17500 |  | 17500 |  |
| Supplemental Executive Retirement <br>Plan Contributions<br>|  | 128077 | 298100 |  | 225100 |  |
| Security Costs\* | 74203 |  | 1024 | 6058 |  |  |
| Mobility/Overseas Working Allowance <br>(including Housing, Utilities, Resettlement and <br>Other Allowances)<br>|  |  |  | 199799 |  |  |
| Tax Support/Tax Gross-Ups |  |  |  | 20193 |  | 780 |
| Other Allowances (including Professional <br>Subscriptions)<br>|  |  |  |  |  | 717 |

---

Notes:

\* The security costs reported reflect the third-party costs paid by CRH in connection with the provision of security at private residences. CRH considers these Company-

incurred costs as reasonable and necessary business expenditures as a result of the individual's employment by CRH, but is reporting these amounts as compensation in

accordance with applicable SEC rules.

69<br>

CRH PROXY STATEMENT 2026

**Grants of Plan-Based Awards**

The following table details the grants of plan-based awards in 2025 to our NEOs:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Grants of plan-based awards in 2025** | **Grants of plan-based awards in 2025** | **Grants of plan-based awards in 2025** | **Grants of plan-based awards in 2025** | **Grants of plan-based awards in 2025** | **Grants of plan-based awards in 2025** | **Grants of plan-based awards in 2025** | **Grants of plan-based awards in 2025** | **Grants of plan-based awards in 2025** | |
| **(a)** | **(b)** | **(c)** | **(d)** | **(e)** | **(f)** | **(g)** | **(h)** | **(i)** | **(j)** |
|  |  | **Estimated Future Pay-outs Under Non-**<br>**Equity Incentive Plan Award** | **Estimated Future Pay-outs Under Non-**<br>**Equity Incentive Plan Award** | **Estimated Future Pay-outs Under Non-**<br>**Equity Incentive Plan Award** | **Estimated Future Pay-outs** <br>**Under Equity Incentive Plan** <br>**Awards** | **Estimated Future Pay-outs** <br>**Under Equity Incentive Plan** <br>**Awards** | **Estimated Future Pay-outs** <br>**Under Equity Incentive Plan** <br>**Awards** | **All other Share** <br>**Awards:** <br>**Number of** <br>**Shares or** <br>**Share Units**<br>**(#)** | **Grant Date** <br>**Fair value of** <br>**Share and** <br>**Option** <br>**Awards**<br>**($)** |
| **Name** | **Grant Date** | **Threshold**<br>**($)**<br>| **Target**<br>**($)**<br>| **Maximum**<br>**($)**<br>| **Threshold**<br>**(#)**<br>| **Target**<br>**(#)**<br>| **Maximum**<br>**(#)**<br>| **All other Share** <br>**Awards:** <br>**Number of** <br>**Shares or** <br>**Share Units**<br>**(#)** | **Grant Date** <br>**Fair value of** <br>**Share and** <br>**Option** <br>**Awards**<br>**($)** |
| Jim Mintern |  |  |  |  |  |  |  |  |  |
| Annual Bonus - Cash | 02/10/2025 |  | 2625000 | 5250000 |  |  |  |  |  |
| Annual Bonus - Deferred Shares | 03/03/2025 |  |  |  |  |  |  | 6771 | 676849 |
| 2025 Equity Incentive Plan - RSUs | 05/13/2025 |  |  |  |  |  |  | 44955 | 4412783 |
| 2025 Equity Incentive Plan - PSUs | 05/13/2025 |  |  |  | 33717 | 67433 | 134866 |  | 6952005 |
| Nancy Buese |  |  |  |  |  |  |  |  |  |
| Annual Bonus - Cash | 05/12/2025 |  | 704423 | 1408846 |  |  |  |  |  |
| 2025 Equity Incentive Plan - RSUs <br>(Annual)<br>| 05/13/2025 |  |  |  |  |  |  | 17565 | 1724180 |
| 2025 Equity Incentive Plan - RSUs <br>(Appointment)<br>| 05/13/2025 |  |  |  |  |  |  | 21956 | 2155201 |
| 2025 Equity Incentive Plan - PSUs | 05/13/2025 |  |  |  | 13174 | 26347 | 52694 |  | 2716244 |
| Randy Lake |  |  |  |  |  |  |  |  |  |
| Annual Bonus - Cash | 02/10/2025 |  | 1972500 | 3945000 |  |  |  |  |  |
| Annual Bonus - Deferred Shares | 03/03/2025 |  |  |  |  |  |  | 7830 | 782732 |
| 2025 Equity Incentive Plan - RSUs | 05/13/2025 |  |  |  |  |  |  | 18882 | 1853457 |
| 2025 Equity Incentive Plan - PSUs | 05/13/2025 |  |  |  | 14162 | 28324 | 56648 |  | 2920063 |
| Peter Buckley |  |  |  |  |  |  |  |  |  |
| Annual Bonus - Cash | 02/10/2025 |  | 1146701 | 2293401 |  |  |  |  |  |
| Annual Bonus - Deferred Shares | 03/03/2025 |  |  |  |  |  |  | 3892 | 389108 |
| 2025 Equity Incentive Plan - RSUs | 05/13/2025 |  |  |  |  |  |  | 10317 | 1012717 |
| 2025 Equity Incentive Plan - PSUs | 05/13/2025 |  |  |  | 7740 | 15480 | 30960 |  | 1595911 |
| Nathan Creech |  |  |  |  |  |  |  |  |  |
| Annual Bonus - Cash | 02/10/2025 |  | 1334300 | 2668600 |  |  |  |  |  |
| Annual Bonus - Deferred Shares | 03/03/2025 |  |  |  |  |  |  | 5268 | 526605 |
| 2025 Equity Incentive Plan - RSUs <br>(Annual)<br>| 05/13/2025 |  |  |  |  |  |  | 15369 | 1508621 |
| 2025 Equity Incentive Plan - RSUs <br>(Retention)<br>| 05/13/2025 |  |  |  |  |  |  | 32934 | 3232801 |
| 2025 Equity Incentive Plan - PSUs | 05/13/2025 |  |  |  | 11527 | 23054 | 46108 |  | 2376752 |
| Alan Connolly |  |  |  |  |  |  |  |  |  |
| Annual Bonus - Cash | 02/10/2025 |  | 358632 | 717263 |  |  |  |  |  |
| 2025 Equity Incentive Plan - RSUs <br>(Annual)<br>| 05/13/2025 |  |  |  |  |  |  | 3831 | 376051 |
| 2025 Equity Incentive Plan - RSUs <br>(Transition)<br>| 06/23/2025 |  |  |  |  |  |  | 3270 | 294071 |
| 2025 Equity Incentive Plan - PSUs | 05/13/2025 |  |  |  | 2872 | 5744 | 11488 |  | 592178 |

---

Notes:

1. For each NEO, the amounts shown in columns (c), (d) and (e) reflect the portion of the annual bonus that would have been paid in cash if, respectively, threshold, target

and maximum performance was achieved for the year.

2. The amounts shown in columns (f), (g) and (h) also reflect the threshold, target and maximum, respectively, levels of PSU awards payable if the performance

measurements are satisfied in the period 2025-2027. These awards are discussed under the heading "2025 Awards" on pages 60 to 61.

3. The amounts in column (i) reflect, where relevant, the portion of the 2024 annual bonus that was deferred into shares for each of Mr. Mintern, Mr. Lake, Mr. Buckley and

Mr. Creech under the 2014 DSBP. The amounts also include: (i) each NEO's annual RSU award, details of which are described on pages 60 to 61; (ii) in the case of Ms.

Buese, a one-time RSU award received in connection with her appointment as Chief Financial Officer, which will vest 50% in 2026 and 50% in 2027; (iii) in the case of

Mr. Creech, a one-time RSU award relating to his support with the leadership transition and his efforts to drive continued performance and growth in the Americas,

which will vest 100% in 2028; and (iv) in the case of Mr. Connolly, a one-time RSU award, which will vest 50% in 2026 and 50% in 2027 to recognize the support for

transition of the role to Ms. Buese, in each case, subject to continued employment; and

4. The amounts shown in column (j) reflect the grant date fair value of each equity award computed in accordance with FASB ASC Topic 718. For performance awards,

the grant date fair value is based on price per share on the date of grant of $103.10.

70<br>

CRH PROXY STATEMENT 2026

**Outstanding Equity Awards at 2025 Fiscal Year-End** 

The following table shows, for each of our NEOs, information with respect to the unexercised share options (columns (d), (e), (f) and (g)), share unit

awards (columns (h) and (i)) that have not vested, and equity incentive plan awards (columns (j) and (k)) outstanding on December 31, 2025.

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Outstanding Equity Awards at 2025 Fiscal Year-End**  | **Outstanding Equity Awards at 2025 Fiscal Year-End**  | **Outstanding Equity Awards at 2025 Fiscal Year-End**  | **Outstanding Equity Awards at 2025 Fiscal Year-End**  | **Outstanding Equity Awards at 2025 Fiscal Year-End**  | **Outstanding Equity Awards at 2025 Fiscal Year-End**  | **Outstanding Equity Awards at 2025 Fiscal Year-End**  | **Outstanding Equity Awards at 2025 Fiscal Year-End**  | **Outstanding Equity Awards at 2025 Fiscal Year-End**  | **Outstanding Equity Awards at 2025 Fiscal Year-End**  | |
| **(a)** | **(b)** | **(c)** | **(d)** | **(e)** | **(f)** | **(g)** | **(h)** | **(i)** | **(j)** | **(k)** |
|  |  |  | **Option Awards** | **Option Awards** | **Option Awards** | **Option Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** |
| **Name** | **Grant Date** | **Vesting** <br>**Year** <br>**(1)**<br>| **Number of** <br>**Securities** <br>**Underlying** <br>**Unexercised** <br>**Options**<br>**(Exercisable)**<br>| **Number of** <br>**Securities** <br>**Underlying** <br>**Unexercised** <br>**Options** <br>**(Unexercisable)** <br>| **Option** <br>**Price**<br>| **Option** <br>**Exp. Date**<br>| **Number of** <br>**Shares or** <br>**Units that** <br>**have not** <br>**Vested (2)**<br>| **Market Value** <br>**of Shares or** <br>**Units that** <br>**have not** <br>**Vested**<br>| **Equity Incentive** <br>**Plan Awards:** <br>**Number of** <br>**Unearned Shares,** <br>**Units or Other** <br>**Rights that have** <br>**not Vested (3)**<br>| **Equity Incentive** <br>**Plan Awards:** <br>**Market Value of** <br>**Unearned Shares,** <br>**Units or Other** <br>**Rights that have** <br>**not Vested (4)**<br>|
| Jim Mintern |  |  |  |  |  |  |  |  |  |  |
| 2022 PSP | 05/03/2022 | 2027 |  |  |  |  |  |  | 61785 | 7710745 |
| 2023 DSBP | 03/07/2023 | 2026 |  |  |  |  | 14372 | 1793626 |  |  |
| 2023 PSP | 03/07/2023 | 2028 |  |  |  |  |  |  | 51460 | 6422266 |
| 2024 DSBP | 03/05/2024 | 2027 |  |  |  |  | 9816 | 1225011 |  |  |
| 2024 PSP | 03/05/2024 | 2029 |  |  |  |  |  |  | 30676 | 3828305 |
| 2025 DSBP | 03/03/2025 | 2028 |  |  |  |  | 6813 | 850286 |  |  |
| 2025 RSU | 05/13/2025 | 2026 |  |  |  |  |  |  | 68141 | 8504018 |
| 2025 RSU | 05/13/2025 | 2027 |  |  |  |  | 15142 | 1889768 |  |  |
| 2025 RSU | 05/13/2025 | 2028 |  |  |  |  | 15142 | 1889768 |  |  |
| 2025 PSU | 05/13/2025 | 2028 |  |  |  |  | 15142 | 1889768 |  |  |
| Nancy Buese |  |  |  |  |  |  |  |  |  |  |
| 2025 PSU | 05/13/2025 | 2028 |  |  |  |  |  |  | 26624 | 3322637 |
| 2025 RSU | 05/13/2025 | 2026 |  |  |  |  | 5916 | 738378 |  |  |
| 2025 RSU | 05/13/2025 | 2027 |  |  |  |  | 5916 | 738378 |  |  |
| 2025 RSU | 05/13/2025 | 2028 |  |  |  |  | 5916 | 738378 |  |  |
| 2025 RSU | 05/13/2025 | 2026 |  |  |  |  | 11093 | 1384443 |  |  |
| 2025 RSU | 05/13/2025 | 2027 |  |  |  |  | 11093 | 1384442 |  |  |
| Randy Lake |  |  |  |  |  |  |  |  |  |  |
| 2022 RSS | 04/07/2022 | 2027 |  |  |  |  | 65758 | 8206598 |  |  |
| 2023 DSBP | 03/07/2023 | 2026 |  |  |  |  | 17064 | 2129525 |  |  |
| 2023 PSP | 03/07/2023 | 2026 |  |  |  |  |  |  | 73767 | 9206077 |
| 2024 DSBP | 03/05/2024 | 2027 |  |  |  |  | 11240 | 1402739 |  |  |
| 2024 PSP | 03/05/2024 | 2027 |  |  |  |  |  |  | 42713 | 5330535 |
| 2025 DSBP | 03/03/2025 | 2028 |  |  |  |  | 7879 | 983301 |  |  |
| 2025 PSU | 05/13/2025 | 2028 |  |  |  |  |  |  | 28621 | 3571957 |
| 2025 RSU | 05/13/2025 | 2026 |  |  |  |  | 6360 | 793740 |  |  |
| 2025 RSU | 05/13/2025 | 2027 |  |  |  |  | 6360 | 793740 |  |  |
| 2025 RSU | 05/13/2025 | 2028 |  |  |  |  | 6360 | 793740 |  |  |
| Peter Buckley |  |  |  |  |  |  |  |  |  |  |
| 2023 PSP | 03/07/2023 | 2026 |  |  |  |  |  |  | 24187 | 3018494 |
| 2024 PSP | 03/05/2024 | 2027 |  |  |  |  |  |  | 22912 | 2859385 |
| 2025 DSBP | 03/03/2025 | 2028 |  |  |  |  | 3917 | 488814 |  |  |
| 2025 PSU | 05/13/2025 | 2028 |  |  |  |  |  |  | 15643 | 1952193 |
| 2025 RSU | 05/13/2025 | 2026 |  |  |  |  | 3475 | 433694 |  |  |
| 2025 RSU | 05/13/2025 | 2027 |  |  |  |  | 3475 | 433694 |  |  |
| 2025 RSU | 05/13/2025 | 2028 |  |  |  |  | 3475 | 433694 |  |  |

---

71<br>

CRH PROXY STATEMENT 2026

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| Nathan Creech |  |  |  |  |  |  |
| 2023 DSBP | 03/07/2023 | 2026 | 9863 | 1230901 |  |  |
| 2023 PSP | 03/07/2023 | 2026 |  |  | 64172 | 8008644 |
| 2024 DSBP | 03/05/2024 | 2027 | 7564 | 943951 |  |  |
| 2024 PSP | 03/05/2024 | 2027 |  |  | 37158 | 4637296 |
| 2025 DSBP | 03/03/2025 | 2028 | 5301 | 661544 |  |  |
| 2025 PSU | 05/13/2025 | 2028 |  |  | 23296 | 2907354 |
| 2025 RSU | 05/13/2025 | 2026 | 5177 | 646065 |  |  |
| 2025 RSU | 05/13/2025 | 2027 | 5177 | 646065 |  |  |
| 2025 RSU | 05/13/2025 | 2028 | 5177 | 646065 |  |  |
| 2025 RSU | 05/13/2025 | 2028 | 33280 | 4153328 |  |  |
| Alan Connolly |  |  |  |  |  |  |
| 2023 PSP | 03/07/2023 | 2026 |  |  | 18752 | 2340243 |
| 2024 PSP | 03/05/2024 | 2027 |  |  | 10990 | 1371495 |
| 2025 PSU | 05/13/2025 | 2028 |  |  | 5804 | 724379 |
| 2025 RSU | 05/13/2025 | 2026 | 1290 | 161043 |  |  |
| 2025 RSU | 05/13/2025 | 2027 | 1290 | 161043 |  |  |
| 2025 RSU | 05/13/2025 | 2028 | 1290 | 161043 |  |  |
| 2025 RSU | 06/23/2025 | 2026 | 1645 | 205334 |  |  |
| 2025 RSU | 06/23/2025 | 2027 | 1645 | 205334 |  |  |

---

Notes:

1. The vesting date for PSP and PSUs generally occurs in March of the relevant year and is subject to confirmation by the Committee. RSUs typically vest on the

anniversary of the date of grant.

2. The amounts shown in columns (h) reflect (i) the number of outstanding awards under the Company's 2014 DSBP, including adjustments for dividends accrued in the

period since the date of grant; and (ii) the number of outstanding RSU awards, including adjustments for dividends accrued in the period since the date of grant,

granted to each NEO.

3. The amounts shown in column (j) reflect the number of outstanding PSP and PSU awards (assuming maximum vesting), including adjustments for dividends accrued

since the date of grant.

4. The market value of these has been estimated using a share price of $124.80, the closing share price of the Company's Ordinary Shares on the NYSE on December 31,

2025. **Option Exercises and Shares Vested**

The table below shows on an aggregated basis for each of the NEO information on (i) the exercise of options for the purchase of CRH shares; and (ii)

the vesting of shares, including deferred shares and PSP awards, during the last completed fiscal year.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Option Exercises and Shares Vested** | **Option Exercises and Shares Vested** | **Option Exercises and Shares Vested** | **Option Exercises and Shares Vested** | |
| **(a)** | **(b)** | **(c)** | **(d)** | **(e)** |
|  | **Option Awards** | **Option Awards** | **Share Awards** | **Share Awards** |
|  | **Number of Shares** <br>**Acquired on Exercise**<br>| **Value Realized on** <br>**Exercise ($)**<br>| **Number of Shares** <br>**Acquired on Vesting**<br>| **Value Realized on** <br>**Vesting ($)**<br>|
| Jim Mintern, Chief Executive Officer |  |  | 8554 | 855143 |
| Nancy Buese, Chief Financial Officer |  |  |  |  |
| Randy Lake, Chief Operating Officer |  |  | 134937 | 13696796 |
| Peter Buckley, President, International Division |  |  | 27278 | 2791358 |
| Nathan Creech, President, Americas Division |  |  | 60563 | 6179934 |
| Alan Connolly, Former Interim Chief Financial Officer |  |  | 22298 | 2281754 |

---

Notes:

1. The amounts shown in column (d) represents the number of shares vested under CRH's 2014 DSBP and 2014 Performance Share Plan.

2. The amounts shown in column (e) have been calculated by multiplying the number of units vested by the closing price of CRH shares on the date of vesting.

72<br>

CRH PROXY STATEMENT 2026

**Pension Benefits**

The following table provides information regarding pension benefits for our NEOs for fiscal year 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Pension Benefits** | **Pension Benefits** | **Pension Benefits** | **Pension Benefits** | |
| **(a)** | **(b)** | **(c)** | **(d)** | **(e)** |
| **Name** | **Plan Name** | **Number of years** <br>**credited service**<br>| **Present value of** <br>**accumulated benefit ($)**<br>| **Payments during** <br>**last fiscal year ($)**<br>|
| Jim Mintern, Chief Executive Officer (1) | Roadstone Group Pension Scheme | 19.98 | 2835454 |  |
| Jim Mintern, Chief Executive Officer (1) | SE Pension Scheme | 1.70 | 1304900 |  |
| Peter Buckley, President, International Division (2) | Roadstone Group Pension Scheme | 7.25 | 113860 |  |
| Peter Buckley, President, International Division (2) | Pension Plan 1 | 7.00 | 178229 |  |
| Alan Connolly, Former Interim Chief Financial Officer | Roadstone Group Pension Scheme | 19.15 | 1756592 |  |
| Alan Connolly, Former Interim Chief Financial Officer | SE Pension Scheme | 2.78 | 919548 |  |

---

Notes:

1. The Irish Finance Act 2006 established a cap on pension provisions by introducing penalty tax charges on pension entitlements above a certain level. The cap in the

Finance Act 2006 was subsequently reduced in the Finance Act 2011 and again in the Finance (No. 2) Act 2013. At the time, Mr. Mintern was accruing benefits as a

participant in a contributory defined benefit plan, based on an accrual rate of 1/60th of Pensionable Salary (defined as basic salary less 0.75 times the Contributory

State Pension) for each year of pensionable service and designed to provide two-thirds of career average salary at retirement for full service. As a result of the legislative

changes, Mr. Mintern opted for an arrangement whereby his pension is capped in line with the provisions of the Finance Act (No. 2) Act 2013, with no further accrual of

member pension being made after this date.

2. The pension plan of Stichting CRH Pensioenfonds is structured as a Collective Defined Contribution (CDC) scheme, which combines elements of both defined benefit

(average pay) and defined contribution pensions. Mr. Buckley is the only NEO who participates in this plan. As a CDC scheme, the pension plan operates with a fixed

employer and employee contribution, while pension accrual is ambition-based. The accrual rate in 2025 is 1.875% of salary above €18,475 (2025), but it may annually

be adjusted depending on the expected yield on the premium. Participants do not bear individual investment risk. Instead, investment and longevity risks are shared

collectively within the fund. If the fund's financial position allows, pensions may be increased through indexation. In cases of financial shortfall, pension accruals may be

reduced, and, in extreme cases, even existing pensions could be adjusted downward. In addition, the pension plan consists of the following components:

• Retirement pension: Accrued based on a percentage of the pensionable salary.

• Partner pension: 70% of the accrued retirement pension.

• Orphan's pension: 14% of the accrued retirement pension.

• Premium waiver in case of disability: Pension accrual continues based on the degree of disability.

The pension is set to commence on the first day of the month in which the participant reaches the age of 68, unless taken earlier (subject to reduction) or deferred (up

to a maximum of 70 years). The plan allows for early retirement from the age of 60, with an actuarial reduction applied, and provides the option to convert retirement

pension into additional partner pension and vice versa. The maximum applicable salary amounts to €137,800. All assets and liabilities of Stichting CRH Pensioenfonds

are maintained by Het Nederlandse Pensioenfonds (HNPF) in an account separate from other assets and liabilities of HNPF.

3. The amount shown in column (d) reflects the total value of the relevant NEOs pension arrangements as of December 31, 2025 and, as the pension benefit arrangements

for each of the NEOs listed are set in euro, have been converted into U.S. Dollars using the average Bloomberg composite exchange rate for 2025. The amount in

column (d) reflects the valuation method and use the assumptions that are included in note 20 to the Company's audited financial statements for the fiscal year ended

December 31, 2025, included in the 2025 Annual Report.

73<br>

CRH PROXY STATEMENT 2026

**2025 Nonqualified Deferred Compensation**

Ms. Buese, Mr. Lake and Mr. Creech participate in the CRH Americas, Inc. Supplemental Executive Retirement Plan (the 'SERP') on the same terms

as other participants in the SERP. The SERP, which is an unfunded, nonqualified deferred compensation plan, provides supplemental savings benefits

to selected officers and key employees of CRH Americas which are not otherwise payable or cannot otherwise be provided under formulas provided

by CRH Americas' tax-qualified plans due to limitations imposed by the Code. The SERP supplements the savings and retirement contributions that

CRH Americas makes under CRH's U.S. tax-qualified 401(k) Plan to provide a combined benefit totaling up to 20% of a participant's base salary.

For participants employed on the last day of the calendar year, CRH Americas credits the participant's account with an amount that, together with

any matching or profit-sharing contribution under the 401(k) Plan, does not exceed 20% of the participant's base salary. Annually, participant's

accounts are credited with interest using a notional interest rate as outlined in the plan document.

Participants are vested in their account balances after completing five years of service. Participants may elect a lump sum distribution or annual

installment payments of up to five years, provided that a participant who separates from service before reaching retirement age (which, for purposes

of the SERP is 55) will receive a lump sum distribution. The following table provides information regarding the nonqualified deferred compensation

plan benefits for Ms. Buese, Mr. Lake and Mr. Creech for fiscal year 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **2025 Nonqualified Deferred Compensation** | **2025 Nonqualified Deferred Compensation** | **2025 Nonqualified Deferred Compensation** | **2025 Nonqualified Deferred Compensation** | | |
| **(a)** | **(b)** | **(c)** | **(d)** | **(e)** | **(f)** |
| **Name** | **Executive Contributions in** <br>**Last FY** <br>**($)**<br>| **Company Contributions** <br>**in Last FY** <br>**($)**<br>| **Aggregate Earnings in the** <br>**Last FY** <br>**($)**<br>| **Aggregate Withdrawals/**<br>**Distributions in the Last FY**<br> **($)**<br>| **Aggregate Balance** <br>**at Last FY End**<br> **($)**<br>|
| Nancy Buese, <br>Chief Financial Officer<br>|  | 128077 |  |  | 128077 |
| Randy Lake, <br>Chief Operating Officer<br>|  | 298100 | 232527 |  | 4107967 |
| Nathan Creech, <br>President, Americas <br>Division<br>|  | 225100 | 92496 |  | 1740619 |

---

Notes:

1. The amounts shown in column (c) reflect the amount contributed by the Company in 2025. These amounts are also included in the "All Other Compensation" column in

the "Summary Compensation Table" on page 67.

2. The amounts shown in column (d) reflect the amount accrued in 2025 from interests or other earnings. The above market interest rate earnings are also included in the

"Change in Pension Value and Non-qualified Compensation Earnings" column in the "Summary Compensation Table" on page 67 as follows: Nancy Buese: $nil; Randy

Lake: $75,840; Nathan Creech: $30,168.

74<br>

CRH PROXY STATEMENT 2026

**Payments Upon Termination or in Connection with a Change in Control** 

This section describes and estimates payments that could be made to the NEOs under different termination events. The estimated payments would

be made under the terms of the relevant employment contracts, incentive compensation and benefits programs. The amounts in the table below are

calculated as if the events occurred as of December 31, 2025 and assumes that the price of CRH's shares is the closing price as of December 31,

2025 ($124.80).

**Severance Benefits Under Employment Agreements**

The following section describes the severance benefits under each of our NEOs' employment agreements. Messrs. Connolly and Buckley do not have

contractual severance protections under their respective employment agreements.

Mr. Mintern

Pursuant to the Mintern Employment Agreement, Mr. Mintern is entitled to resign within 24 months of a "Change in Control" (as defined therein) if the

Change in Control has resulted, or will result, in (i) a material diminution of his position, authority, duties or responsibilities in relation to the Company,

in each case, from those in effect immediately before the Change in Control, (ii) a reduction in his then prevailing base salary, target annual bonus or

annual target long-term incentive opportunity, in each case, from those in effect immediately before the Change in Control or (iii) a requirement to

relocate his primary workplace more than 50 miles from his principal place of employment immediately prior to the Change in Control; provided that

no such entitlement will arise unless Mr. Mintern notifies the Company in writing within 60 days of the initial occurrence of such event and the

Company fails to cure such event within 30 days of such notification. Upon such resignation, he is entitled to (x) three times his base salary, (y) three

times his target bonus and (z) pro-rated bonus for the year of termination, subject to his execution and non-revocation of a release of all claims.

Ms. Buese

Pursuant to the Buese Employment Agreement, upon a termination of employment without "cause" or resignation for "good reason" (each as defined

in the Buese Employment Agreement) outside the two-year period following a Change in Control (as defined in the 2025 Equity Incentive Plan) (such

two-year period, the 'Change in Control Period'), Ms. Buese is entitled to the following severance payments and benefits subject to her execution and

non-revocation of a release of claims against the Company and continued compliance with restrictive covenants:

• one times the sum of the effective base salary and target bonus;

• a pro-rated bonus for the year of termination based on the number of weeks of employment during that year; and

• the cost of Ms. Buese's COBRA premiums for 12 months, grossed-up for taxes.

Upon a termination of employment without "cause" or resignation for "good reason" during the Change in Control Period, Ms. Buese is entitled to the

following severance payments and benefits subject to her execution and non-revocation of a release of claims and continued compliance with

restrictive covenants:

• two times the sum of the effective base salary and target bonus;

• a pro-rated bonus for the year of termination based on the number of weeks of employment during that year; and

• the cost of Ms. Buese's COBRA premiums for 18 months, grossed-up for taxes.

Messrs. Lake and Creech

Pursuant to the Lake Employment Agreement and the Creech Employment Agreement, in connection with a termination without "cause," each of

Messrs. Lake and Creech is entitled to the following severance payments and benefits subject to the execution and non-revocation of a release of

claims against the Company and continued compliance with restrictive covenants:

• 52 weeks of the effective base salary, less the number of weeks Mr. Lake or Mr. Creech was placed on garden leave (if any);

• a pro-rated target bonus based on the number of weeks of severance paid;

• a pro-rated target bonus for the year of termination based on the number of weeks of employment during that year; and

• the cost of COBRA premiums for the same number of weeks as cash severance provided, grossed-up for taxes.

All of the cash payments described above for a termination without "cause" and quantified in the table below will also be paid to Messrs. Lake and

Creech upon resignation, subject to the execution and non-revocation of a release of claims and continued compliance with restrictive covenants.

In addition, Messrs. Mintern, Lake, Creech and Connolly and Ms. Buese's employment agreements provide for notice periods ranging from six to 12 months,

of which the Company may at its sole discretion choose to provide payment in lieu.

**Death and Disability Benefits Under Insurance Policies and Employment Agreements**

Messrs. Mintern and Connolly are both entitled to death and disability payments pursuant to the terms of their employment agreements. In the event

of death, each of Messrs. Mintern and Connolly is entitled to payment of three times his then current base salary (for a termination on December 31,

2025, these payments would total $5,250,000 and $1,793,159, respectively). In the event of disability, each of Messrs. Mintern and Connolly is

entitled to receive 2/3 of his then current base salary less the state disability pension, in each case, subject to the terms of the applicable insurance

policy (for a termination on December 31, 2025, these payments would total $1,166,667 and $398,480, respectively).

Ms. Buese and Messrs. Lake and Creech are entitled to death and disability payments under the Company's applicable insurance policies. In the

event of death, each of Ms. Buese and Messrs. Lake and Creech is eligible for a target coverage of $5,000,000, provided through a combination of

the Company's group term life insurance plans and individual policies paid by the Company. In the event of a termination due to disability, under the

applicable executive disability insurance programs, Ms. Buese is entitled to monthly disability payments until age 65 (for a termination on December

31, 2025, these payments would total $3,573,500) and each of Messrs. Lake and Creech is entitled to monthly disability payments until age 65 plus

additional monthly disability payments for the lesser of 60 months or until age 67 (for a termination on December 31, 2025, these payments would

total $4,639,350 and $8,637,400, respectively).

Mr. Buckley is entitled to death and disability payments under the Company's insurance policy maintained for Dutch employees. In the event of a termination

due to death or disability, Mr. Buckley is entitled to payments equal to two times his then current base salary (for a termination on December 31, 2025, this

payment would be $2,084,910).

75<br>

CRH PROXY STATEMENT 2026

**Treatment of Equity Awards Under Equity Plans**

The treatment of outstanding equity awards is covered by the relevant equity plan and the applicable award agreements as described below.

2025 Equity Incentive Plan

The following description sets forth the treatment of equity awards granted under the 2025 Equity Incentive Plan in the event of a termination of the

NEO's employment. As of December 31, 2025, all the NEOs have RSUs and PSUs outstanding under the 2025 Equity Incentive Plan.

*RSUs:* 

• Upon a termination of employment by the Company without "cause" or by the NEO for "good reason" (each as defined in the 2025 Equity Incentive

Plan), other than during the Change in Control Period, a pro-rata portion of the RSU that would have vested on the next vesting date will remain

outstanding and eligible to vest as if the NEO had remained continuously employed through such vesting date.

• Upon a Change in Control, if the RSUs are not assumed, continued or substituted in connection with such Change in Control, they will become

immediately vested prior to the Change in Control.

• Upon a Change in Control, if the RSUs are assumed, continued or substituted in connection with such Change in Control in accordance with the

2025 Equity Incentive Plan, they will remain outstanding and will accelerate and vest in full upon a termination Company without "cause" or by the

NEO for "good reason" during the Change in Control Period.

• Upon a termination of employment due to death or disability, all unvested RSUs will accelerate and vest in full.

• Upon a termination of employment due to retirement (a voluntary termination by the NEO after the NEO (x) has reached age 60 and (y) has

provided five years of service to the Company), the RSUs will remain outstanding and continue to vest as if the NEO had remained continuously

employed through each vesting date.

*PSUs:*

• Upon a termination of employment by the Company without "cause" or by the NEO for "good reason," other than during the Change in Control

Period, a pro-rata portion of the PSUs will remain outstanding and eligible to vest based on the actual performance level.

• Upon a Change in Control, if the PSUs are not assumed, continued or substituted in connection with such Change in Control, the PSUs will vest

immediately prior to such Change in Control at the greater of the target and the actual level of performance as of the date of such Change in

Control.

• Upon a Change in Control, if the PSUs are assumed, continued or substituted in connection with such Change in Control in accordance with the

2025 Equity Incentive Plan, they will remain outstanding and will accelerate and vest in full at the greater of the target and the actual level of

performance upon a termination of employment by the Company without "cause" or by the NEO for "good reason" during the Change in Control

Period.

• Upon a termination of employment due to death or disability, the PSUs accelerate and vest in full at the target level of performance (or such

greater level as determined by the Committee in its sole discretion).

• Upon a termination of employment due to retirement, a pro-rata portion of the PSUs will remain eligible to vest based on the actual performance

level, as if the NEO had remained continuously employed through the vesting date.

2014 Performance Share Plan

The 2014 Performance Share Plan provides for termination protections in certain circumstances as described below. As of December 31, 2025, all of

the NEOs except Ms. Buese held awards of performance shares under the 2014 Performance Share Plan.

• Upon a termination of employment due to (i) ill health, injury or disability or (ii) the employing company ceasing to be a member of the Company

group, awards under the 2014 Performance Share Plan will vest pro rata based on actual performance.

2013 Restricted Share Plan

The 2013 Restricted Share Plan provides for termination protections in certain circumstances as described below. As of December 31, 2025, only Mr.

Lake held awards under the 2013 Restricted Share Plan.

• Upon a termination of employment due to (i) ill health, injury or disability or (ii) the employing company ceasing to be a member of the Company

group, Mr. Lake's RSU awards granted under the 2013 Restricted Share Plan will vest pro-rata.

76<br>

CRH PROXY STATEMENT 2026

**Payments Upon Termination or in Connection with a Change of Control** 

The following table shows the potential incremental value of payments to each NEO upon certain termination situations, including in the event of a change in

control of CRH, assuming a December 31, 2025 termination date and, where applicable, using the closing price on December 31, 2025 ($124.80).

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Maximum Value of Payments**  | **Maximum Value of Payments**  | **Maximum Value of Payments**  | **Maximum Value of Payments**  | | | | |
|  | **(a)** | **(b)** | **(c)** | **(d)** | **(e)** | **(f)** | **(g)** |
|  | **Name** | **Benefit or Payment**  | **Resignation With Good** <br>**Reason or Involuntary** <br>**Termination Without** <br>**Cause Absent a Change** <br>**in Control**<br>**($)**<br>| **Resignation With Good** <br>**Reason or Involuntary** <br>**Termination Without** <br>**Cause in Connection** <br>**with a Change In** <br>**Control ($)**<br>| **Disability**<br>**($)**<br>| **Death**<br>**($)**<br>| **Retirement**<br>**($)**<br>|
| (1) | Jim Mintern | Cash Payments |  | 16747500 |  |  |  |
| (2) |  | Unvested PSUs | 2834673 | 16630826 | 16630826 | 8504018 | 2834673 |
| (3) |  | Unvested RSUs | 1206345 | 5669303 | 5669303 | 5669303 | 5669303 |
| (4) |  | Health & Welfare Benefits |  |  |  |  |  |
| (1) | Nancy Buese | Cash Payments | 2317992 | 3662800 |  |  |  |
| (2) |  | Unvested PSUs | 1107546 | 3322637 | 3322637 | 3322637 | 1107546 |
| (3) |  | Unvested RSUs | 1355116 | 4984018 | 4984018 | 4984018 | 4984018 |
| (4) |  | Health & Welfare Benefits | 49450 | 74175 |  |  |  |
| (1) | Randy Lake | Cash Payments | 5523000 | 5523000 |  |  |  |
| (2) |  | Unvested PSUs | 1190652 | 15350658 | 15350658 | 3571957 | 1190652 |
| (3) |  | Unvested RSUs | 506689 | 8519307 | 8519307 | 2381221 | 2381221 |
| (4) |  | Health & Welfare Benefits | 50322 | 50322 |  |  |  |
| (1) | Peter Buckley | Cash Payments |  |  |  |  |  |
| (2) |  | Unvested PSUs | 650731 | 6462890 | 6462890 | 1952193 | 650731 |
| (3) |  | Unvested RSUs | 276852 | 1301083 | 1301083 | 1301083 | 1301083 |
| (4) |  | Health & Welfare Benefits |  |  |  |  |  |
| (1) | Nathan Creech | Cash Payments | 3881600 | 3881600 |  |  |  |
| (2) |  | Unvested PSUs | 969118 | 13154061 | 13154061 | 2907354 | 969118 |
| (3) |  | Unvested RSUs | 1296187 | 6091522 | 6091522 | 6091522 | 6091522 |
| (4) |  | Health & Welfare Benefits | 45915 | 45915 |  |  |  |
| (1) | Alan Connolly | Cash Payments |  |  |  |  |  |
| (2) |  | Unvested PSUs | 241460 | 3728193 | 3728193 | 724379 | 241460 |
| (3) |  | Unvested RSUs | 210814 | 893798 | 893798 | 893798 | 893798 |
| (4) |  | Health & Welfare Benefits |  |  |  |  |  |

---

Notes:

1. For Mr. Mintern, the amounts in column (d) reflect a termination of employment in the event he resigns within 24 months of a Change in Control if such Change in

Control has resulted or will result in certain diminution of position, authority, duties or responsibilities, reduction in certain compensation elements or a requirement to

relocate more than 50 miles from his principal place of employment, in each case, as further described above.

2. As of December 31, 2025, Mr. Buckley is retirement eligible under the 2025 Equity Incentive Plan.

3. The amounts in row (4) reflect payments of COBRA premiums for medical, dental, and vision coverage.

**Non-management Director Compensation**

Details of the compensation paid to non-management Directors in 2025 are set out on page 23.

**Compensation Committee Interlocks and Insider Participation**

The members of the Committee during fiscal year 2025 were Lamar McKay, Richie Boucher, Caroline Dowling, Richard Fearon, Johan Karlström, Shaun

Kelly, Gillian L. Platt, Mary K. Rhinehart and Siobhan Talbot, all of whom were determined by the Board to be independent. No member of the Compensation

Committee has been an executive officer or employee of the Company, and, other than described on page 83 with respect to Ms. Talbot and her immediate

family member's employment with a wholly owned subsidiary, no member of the Compensation Committee had any relationships during fiscal year 2025

requiring disclosure by the Company under applicable SEC rules requiring disclosure of certain relationships and related party transactions. No member of the

Compensation Committee or the Board served during fiscal year 2025 as an executive officer of another entity at which one of the Company's executive

officers served as a director or member of such entity's compensation committee (or other committee serving an equivalent function).

77<br>

CRH PROXY STATEMENT 2026

CEO Pay Ratio

For fiscal year 2025, the ratio of our Chief Executive Officer's Annual Total Compensation to the median employee's Annual Total Compensation was

303:1.

To identify our median employee, we used the following methodology, material assumptions, adjustments and estimates:

• SEC rules permit us to use the same median employee for up to three years unless there has been a change in our employee population or

employee compensation arrangements that we reasonably believe would result in a significant change in our pay ratio disclosure. In the event of

such a change, SEC rules permit us to use another employee whose compensation is substantially similar to the original median employee based

on the compensation measure used to select the original median employee. For purposes of calculating annual total compensation under SEC

rules, the Company identified a median employee as of October 1, 2024 (the 'Determination Date').

• As of the Determination Date, we employed approximately 79,791 employees worldwide, including those employed on a full-time, part-time,

seasonal or temporary basis, which includes 45,665 associates in the United States, 4,082 associates in Canada and 30,044 associates who

reside outside of the United States and Canada in 35 countries. In calculating the pay ratio, we excluded, under the de minimis exception to the

pay ratio rule, employees in 21 countries as follows: Ukraine (903), Hungary (838), Spain (500), Mexico (377), Sweden (315), Serbia (292), Malaysia

(88), Estonia (49), Croatia (49), China (48), Other Corporate Entities (39), India (27), Isle of Man (273), Austria (20), Singapore (20), Luxembourg

(15), Italy (14), United Arab Emirates (7), Czech Republic (7), Norway (6), New Zealand (4), representing 4.6% of our total global workforce as of the

Determination Date.

• The median employee identified as of the Determination Date had a variation in their circumstances. Accordingly, the Company revisited the data

from the Determination Date and selected a substitute median employee as of Determination Date whose compensation was next closest to the

original median employee's compensation value and calculated total compensation for such employee using the same methodology. We identified

our median employee as of the Determination Date by comparing a consistently applied compensation measure consisting of salary, wages and

incentive fees, as reflected in our payroll records and as reported to the local tax authorities (the 'Estimated Compensation') for all employees,

excluding our Chief Executive Officer, who were employed by us on the Determination Date. No cost-of-living adjustments were made. No eligible

employees were removed due to tenure. To ensure accuracy and stability, we expanded the range by selecting 13 employees above and 13

employees below the initially calculated median employee. From this population, we identified the employee closest to the median who has not

had a job change (promotion/demotion) within the full fiscal year and has not experienced a significant year-over-year compensation variability due

to variable compensation elements. For this determination, the actual median employee was identified to fit these criteria.

• For non-U.S. employees, we converted their Estimated Compensation to U.S. Dollars from the applicable local currency using the October 1, 2024

exchange rate.

• After identifying the median employee based on Estimated Compensation, we calculated Annual Total Compensation (as defined below) for that

employee using the same methodology we used for our NEOs as set forth in the 2025 Summary Compensation Table on page 67.

• The Annual Total Compensation of our Chief Executive Officer was $17,841,808 and the Annual Total Compensation of our median employee,

other than our Chief Executive Officer, was $58,919.

The SEC's rules for identifying the median compensated associate and calculating the pay ratio based on that associate's Annual Total Compensation

allow companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect

their associate populations and compensation practices. As a result, the pay ratio reported by other companies may not be comparable to the pay

ratio reported above, as other companies have different associate populations and compensation practices and may utilize different methodologies,

exclusions, estimates and assumptions in calculating their own pay ratios.

The above information about the ratio of the annual total compensation, calculated in accordance with the requirements of Item 402(c)(2)(x) of

Regulation S-K ('Annual Total Compensation') of our median associate and the Annual Total Compensation of our Chief Executive Officer has been

provided as required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(u) of Regulation S-K.

78<br>

CRH PROXY STATEMENT 2026

Pay Versus Performance

The following table sets forth certain information with respect to the Company's financial performance and the compensation paid to our NEOs for the

fiscal years ended on December 31, 2025, December 31, 2024 and December 31, 2023.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **(a)** | **(b)** | **(c)** | **(d)** | **(e)** | **(f)** | **(g)** | **(h)** | **(i)** |
|  |  |  |  |  | **Value of Initial Fixed $100**<br>**Investment**<sup>(7)</sup> **Based On:** | **Value of Initial Fixed $100**<br>**Investment**<sup>(7)</sup> **Based On:** |  |  |
| **Fiscal** <br>**Year**<br>| **Summary**<br>**Compensation**<br>**Table Total for**<br>**PEO ($)**<sup>(1)</sup><br>| **Compensation**<br>**Actually Paid**<br>**to PEO ($)**<sup>(2)(3)</sup><br>| **Average** <br>**Summary**<br>**Compensation**<br>**Table Total for**<br>**Non-PEO NEOs** <br>**($)**<sup>(4)</sup><br>| **Average**<br>**Compensation**<br>**Actually Paid**<br>**to Non-PEO**<br>**NEOs ($)**<sup>(2)(4)(5)</sup><br>| **CRH**<br>**Total**<br>**Shareholder**<br>**Return ($)**<br>| **Peer Group**<br>**Total**<br>**Shareholder**<br>**Return ($)**<sup>(6)</sup><br>| **Net Income**<br>**($ in millions)**<br>| **Adjusted** <br>**EBITDA\***<br>**($ in millions)**<sup>(7)</sup><br>|
| 2025 | 17841808 | 29683003 | 7858667 | 13043472 | 262.13 | 109.10 | 3780 | 7681 |
| 2024 | 13582146 | 39593471 | 6157742 | 12319603 | 191.52 | 98.70 | 3521 | 6930 |
| 2023 | 13760706 | 46251328 | 6036557 | 10816925 | 140.89 | 98.74 | 3072 | 6176 |
| 2022 | 11475917 | (3236277) | 4419756 | 2084718 | 77.57 | 87.73 | 3889 | 5388 |

---

Notes:

\*Represents a non-GAAP financial measure. See the discussion within 'Reconciliation of Non-GAAP Figures' in Annex A for a definition and reconciliation to the most

directly comparable GAAP measure.

(1)The principal executive officer ('PEO') for fiscal year 2025 was Mr. Mintern. The PEO for fiscal years 2022 to 2024 was Mr. Manifold. Mr. Manifold retired from his role as

the PEO with effect from December 31, 2024. As an FPI in fiscal year 2023, the Company was required to provide executive compensation disclosure on an individual

basis only for Mr. Manifold and Mr. Mintern in accordance with the requirements of Form 20-F. In fiscal year 2024, the Company determined that it no longer qualified

as an FPI effective January 1, 2025, and Mr. Buckley, Mr. Creech and Mr. Lake became NEOs in fiscal year 2024. Accordingly, for fiscal year 2023, only the

compensation details of Mr. Mintern are included in the Non-PEO NEO details above.

(2)In calculating the compensation actually paid amounts reflected in these columns, the fair value or change in fair value, as applicable, of the equity award adjustments

included in such calculations was computed in accordance with FASB ASC Topic 718. This valuation assumption used to calculate such fair values did not materially

differ from those disclosed at the time of grant

(3)To calculate the Compensation Actually Paid (CAP) for the PEO, the following adjustments were made to the Summary Compensation Table (SCT) total compensation,

calculated in accordance with the SEC methodology for determining CAP for each year shown:

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  |  |
| **Fiscal** <br>**Year**<br>| **SCT Total**<br>**for PEO ($)**<br>| **Less:** <br>**Grant Date Fair** <br>**Value**<br>**of Awards** <br>**Reported in FY** <br>**SCT ($)**<br>| **Less/Plus:** <br>**Change in** <br>**Pension** <br>**Value ($)**<br>| **Plus:** <br>**Pension** <br>**Service** <br>**Cost and** <br>**Associated** <br>**Prior** <br>**Service** <br>**Cost ($)**<br>| **Plus:** <br>**Year-End** <br>**Fair Value of**<br>**Awards** <br>**granted in FY** <br>**that are**<br>**outstanding** <br>**and unvested** <br>**as of**<br>**end of FY ($)**<br>| **Plus:** <br>**Vesting**<br>**Date Fair** <br>**Value**<br>**of Awards** <br>**that are** <br>**granted**<br>**and vested in**<br>**the same FY** <br>**($)**<br>| **Plus:** <br>**Change in** <br>**Fair Value of** <br>**Prior Year** <br>**Awards** <br>**outstanding**<br>**and unvested**<br>**as of end of** <br>**FY ($)**<br>| **Plus/Less:** <br>**Change in** <br>**Fair Value**<br>**of Prior Year**<br>**Awards that**<br>**vested in FY** <br>**($)**<br>| **Less:** <br>**Prior Year**<br>**Awards that** <br>**fail to meet** <br>**vesting**<br>**conditions**<br>**during FY ($)**<br>| **Plus:** <br>**Dividends**<br>**or other**<br>**earnings paid**<br>**on all awards** <br>**in FY prior to**<br>**vesting date** <br>**($)**<br>| **CAP for**<br>**PEO ($)**<br>|
| 2025 | 17841808 | (12041637) | (170762) | 62000 | 18585927 |  | 4599854 | 58386 |  | 747427 | 29683003 |
| 2024 | 13582146 | (8307724) | (50929) |  | 8060676 |  | 19527637 | 2699758 |  | 4081907 | 39593471 |
| 2023 | 13760706 | (8086438) | (857367) |  | 9553746 |  | 26063718 | 2328964 |  | 3487998 | 46251328 |
| 2022 | 11475917 | (6658789) |  | 86153 | 3553806 |  | (9963460) | (2050846) |  | 320943 | (3236277) |

---

Notes:

(4)The non-PEO NEOs represent the following individuals for each of the years shown:

• 2025: Nancy Buese (Current Chief Financial Officer), Randy Lake (Chief Operating Officer), Peter Buckley (President, International Division), Nathan Creech

(President, Americas Division), and Alan Connolly (Former Interim Chief Financial Officer).

• 2024: Jim Mintern (Current Chief Executive Officer and Former Chief Financial Officer), Randy Lake (Chief Operating Officer), Peter Buckley (President, International

Division) and Nathan Creech (President, Americas Division).

• 2022 and 2023: Jim Mintern (Current Chief Executive Officer and Former Chief Financial Officer).

(5)To calculate the CAP for the non-PEO NEOs, the following adjustments were made to SCT total compensation, calculated in accordance with the SEC methodology for

determining CAP for each year shown:

79<br>

CRH PROXY STATEMENT 2026

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  | **Adjustments to SCT**  |  |
| **Fiscal** <br>**Year**<br>| **SCT Total for**<br>**Non-PEO**<br>**NEOs ($)**<br>| **Less:**<br>**Grant Date**<br>**Fair Value of**<br>**Awards**<br>**Reported in**<br>**FY SCT ($)**<br>| **Less/Plus:** <br>**Change in** <br>**Pension** <br>**Value ($)**<br>| **Plus:** <br>**Pension** <br>**Service Cost** <br>**and** <br>**Associated** <br>**Prior Service** <br>**Cost ($)**<br>| **Plus:** <br>**Year-End**<br>**Fair Value of**<br>**Awards** <br>**granted**<br>**in FY that are**<br>**outstanding**<br>**and unvested**<br>**as of end of** <br>**FY ($)**<br>| **Plus:** <br>**Vesting**<br>**Date Fair**<br>**Value of**<br>**Awards that**<br>**are granted**<br>**and vested**<br>**in the same** <br>**FY ($)**<br>| **Plus/Less:** <br>**Change in** <br>**Fair Value of** <br>**Prior Year** <br>**Awards**<br>**outstanding** <br>**and**<br>**unvested as** <br>**of end of FY** <br>**($)**<br>| **Plus/Less:** <br>**Change in**<br>**Fair Value of**<br>**Prior Year**<br>**Awards that**<br>**vested in FY** <br>**($)**<br>| **Less:** <br>**Prior**<br>**Year Awards**<br>**that fail to**<br>**meet vesting**<br>**conditions**<br>**during FY ($)**<br>| **Plus:** <br>**Dividends**<br>**or other**<br>**earnings** <br>**paid**<br>**on all awards**<br>**in FY prior to**<br>**vesting date** <br>**($)**<br>| **CAP for** <br>**Non-PEO** <br>**NEOs ($)**<br>|
| 2025 | 7858667 | (4811338) |  | 11876 | 7082193 |  | 2169468 | 435976 |  | 296630 | 13043472 |
| 2024 | 6157742 | (3141682) | (8781) | 21776 | 3034406 |  | 4780449 | 792058 |  | 683635 | 12319603 |
| 2023 | 6036557 | (3045382) | (712490) | 47571 | 3623851 |  | 4000348 | 391772 |  | 474698 | 10816925 |
| 2022 | 4419756 | (2352655) |  | 60937 | 1243102 |  | (974832) | (446574) |  | 134984 | 2084718 |

---

Notes:

(6)The selected peer group is the S&P 500 Materials Section. The comparison of TSRs assumes that $100 was invested on December 31, 2021 in Ordinary Shares and

the S&P 500 Index and that dividends were reinvested when and as paid.

(7)Our company-selected measure, which is the measure we believe represents the most important financial performance not otherwise presented in the table above that

we use to link CAP to our NEOs for fiscal year 2025 to our Company's performance, is Adjusted EBITDA\*. Adjusted EBITDA\* is a key driver of CRH's financial

performance and is widely used by investors, shareholders and other stakeholders in their assessment of CRH's performance. It also drives all long-term financial

metrics (Cash Flow and RONA) and all short-term financial metrics (Cash Flow, EPS and RONA).

\*Represents a non-GAAP financial measure. See the discussion within 'Reconciliation of Non-GAAP Figures' in Annex A for a definition and reconciliation to the most

directly comparable GAAP measure.

The items listed below represents an unranked list of the performance measures we consider most important in linking compensation actually paid to

our NEOs to Company performance for the fiscal year ended December 31, 2025:

---

| |
|:---|
| **Most Important Performance Measures for PEO and Non-PEO NEOs**<sup>(8)</sup> |
| Adjusted EBITDA\* |
| Cash Flow |
| RONA |

---

Note:

(8)The most important performance measures include our company selected measure and the two financial metrics used for long-term incentive awards with performance-

based vesting, as described in our CD&A.

The following chart illustrates the relationship between CAP for our PEO and the average CAP for our Non-PEO NEOs against the Company's TSR, as

well as the relationship between our TSR and the TSR of our peer group:

![FY2025 _PVP_1.jpg](crh-20260326_g85.jpg)

80<br>

CRH PROXY STATEMENT 2026

The following chart illustrates the relationship between CAP for our PEO and the average CAP for our Non-PEO NEOs against the Company's Net

Income:

![FY2025 _PVP_2.jpg](crh-20260326_g86.jpg)

The following chart illustrates the relationship between CAP for our PEO and the average CAP for our Non-PEO NEOs against the Company's

Adjusted EBITDA:

![FY2025 _PVP_3.jpg](crh-20260326_g87.jpg)

81<br>

CRH PROXY STATEMENT 2026

Share Ownership Information

**Shareholdings of Certain Owners and Management**

The table below shows the total number of our Ordinary Shares beneficially owned by (i) each of our Directors and NEOs, (ii) all those known by us to

beneficially own more than 5% of our Ordinary Shares and (iii) all of our Directors and executive officers as a group, as of March 27, 2026. Unless

otherwise indicated, (i) each beneficial owner listed below has sole voting and dispositive power over the securities held and (ii) the address of each

beneficial owner listed in the following table is c/o CRH, Stonemason's Way, Rathfarnham, Dublin 16, D16 KH51, Ireland.

Beneficial ownership is determined in accordance with the rules and regulations of the SEC. These rules generally provide that a person is the

beneficial owner of securities if such person has or shares the power to vote or direct the voting thereof, or to dispose or direct the disposition thereof

or has the right to acquire such powers within 60 days.

---

| | | |
|:---|:---|:---|
| **Security Ownership (i)** | | |
| **Name and Address of Beneficial Owner** | **Number of Ordinary Shares Beneficially Held (v)** | **Percent of Outstanding Shares** |
| Non-management Directors |  |  |
| Richie Boucher | 26593 | \* |
| Lamar McKay | 5976 | \* |
| Caroline Dowling | 2976 | \* |
| Richard Fearon | 145776 | \* |
| Johan Karlström | 3976 | \* |
| Shaun Kelly | 5976 | \* |
| Badar Khan | 4476 | \* |
| Gillian L. Platt | 3133 | \* |
| Mary K. Rhinehart | 3272 | \* |
| Siobhán Talbot | 9526 | \* |
| Christina Verchere | 2976 | \* |
| Executive Officers |  |  |
| Jim Mintern | 57612 | \* |
| Nancy Buese | 16833 | \* |
| Randy Lake | 106892 | \* |
| Peter Buckley | 171367 | \* |
| Nathan Creech | 149919 | \* |
| Kristin Lane | 19581 | \* |
| Pádraig Ó Ríordáin | 3980 | \* |
| Juan Pablo San Agustín | 51807 | \* |
| Philip Wheatley | 53156 | \* |
| Total Directors and Executive Officers as a Group (20 persons) | 845803 | \* |
| Greater Than 5% Beneficial Owners |  |  |
| Vanguard (ii) | 79117624 | 11.8% |
| BlackRock Inc. (iii) | 45908063 | 6.9% |
| Fidelity (iv) | 36156016 | 5.4% |

---

Notes:

\*Indicates person has beneficial ownership of less than 1%.

(i)For purposes of this table "beneficial ownership" is determined in accordance with Rule 13d-3 under the Exchange Act, pursuant to which a person or group of persons

is deemed to have "beneficial ownership" of any Ordinary Shares that such person has the right to acquire within 60 days of the date of determination.

(ii)Based solely on the Schedule 13G/A filed by The Vanguard Group and its affiliates ('Vanguard') with the SEC on January 7, 2026. Vanguard's clients, including

investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt

of dividends from, or the proceeds from the sale of, such Ordinary Shares. The address for Vanguard is 100 Vanguard Blvd., Malvern, Pennsylvania 19355.

(iii)Based solely on the Schedule 13G filed by BlackRock, Inc. and its affiliates ('BlackRock') with the SEC on January 21, 2026. The address for BlackRock is 50 Hudson

Yards, New York, New York 10001.

(iv)Based solely on the Schedule 13G filed by FMR LLC and its affiliates ('Fidelity') and Abigail P. Johnson with the SEC on November 12, 2024. The address of each of

these individuals and entities is c/o FMR LLC, 245 Summer Street, Boston, Massachusetts 02210. The following entities beneficially own shares of Ordinary Shares:

FIAM LLC, Fidelity Diversifying Solutions LLC, Fidelity Institutional Asset Management Trust Company, Fidelity Management & Research Company LLC, Fidelity

Management Trust Company, and Strategic Advisers LLC.

(v)Includes the number of Ordinary Shares underlying RSUs that vest within 60 days of March 27, 2026, as applicable, excluding dividend equivalent units that will vest in

that period.

**Section 16(a) Reports**

Section 16(a) of the Exchange Act and SEC rules require our Directors, executive officers, and beneficial owners of more than 10% of our Ordinary Shares to file reports

of their ownership and changes in ownership of our Ordinary Shares with the SEC. Based solely on our review of the reports filed during 2025 and questionnaires from

our Directors and executive officers, we determined that no Director, executive officer, or beneficial owner of more than 10% of our Ordinary Shares failed to file an

ownership report on a timely basis during 2025.

82<br>

CRH PROXY STATEMENT 2026

Securities Authorized for Issuance Under Equity Compensation Plans

The following table summarizes information, as of December 31, 2025, relating to our equity compensation plans pursuant to which grants of options,

restricted share awards, performance share awards, deferred share awards or other rights to acquire our Ordinary Shares may be granted from time

to time.

---

| | | | |
|:---|:---|:---|:---|
| **Plan Category** | **(A)**<br>**Number of Securities to be Issued** <br>**Upon Exercise of Outstanding Options,** <br>**Warrants and Rights**<br>| **(B)**<br>**Weighted - Average** <br>**Exercise Price of**<br>**Outstanding Options,** <br>**Warrants and Rights ($) (3)**<br>| **(C)**<br>**Number of Securities Remaining** <br>**Available for Future Issuance Under** <br>**Equity Compensation Plans (Excluding** <br>**Securities Reflected in Column (A)) (4)**<br>|
| Equity compensation plans <br>approved by security holders (1)<br>| 7270122 | 35.07 | 14632632 |
| Equity compensation plans not <br>approved by security holders (2)<br>| 271883 |  |  |
| **Total**  | 7542005 | 35.07 | 14632632 |

---

Notes:

(1)Includes the 2025 Equity Incentive Plan, the 2014 Performance Share Plan, the Company's Savings-related Share Option Schemes and the Irish Share Participation

Schemes, each of which has been approved by the shareholders. No further awards may be granted under the 2014 Performance Share Plan. For a description of

these plans, please see pages 60 to 62 and 65.

(2)Includes the 2014 DSBP and the 2013 Restricted Share Plan. No further awards will be granted under the 2014 DBSP or the 2013 Restricted Share Plan.

(3)The weighted average exercise price of outstanding options, warrant and rights excludes awards under the 2025 Equity Incentive Plan, the 2014 Performance Share

Plan, the 2013 Restricted Share Plan and the 2014 DSBP because awards under such plans do not have an exercise price.

(4)The Company has an aggregate of 14.6 million Ordinary Shares available for issuance under equity compensation plans, comprised of 13.3 million Ordinary Shares

available for issuance pursuant to the 2025 Equity Incentive Plan and 1.3 million shares available for issuance pursuant to the Savings-related Share Option that may be

offered by CRH's Irish and UK employing entities.

Related Party Transactions

We have a written policy and procedures with respect to the review, approval and monitoring of any proposed transactions with related persons.

Under this policy, all related person transactions are prohibited unless approved by the Nomination & Corporate Governance Committee, which will

approve a transaction only if it determines that the transaction is not inconsistent with the interests of the Company and its shareholders. In addition,

the CoBC, which sets forth standards applicable to all employees, officers and directors of the Company, requires that all employees, officers and

directors must disclose all potential conflicts of interest and promptly take actions to eliminate a conflict when the Company so requests.

If it is inappropriate for the Nomination & Corporate Governance Committee to review and consider the approval of a proposed related party

transaction for reasons of conflict of interests or otherwise, then the proposed transaction will be approved by another independent body of the

Board. In addition, if a proposed related party transaction involves a related party who is a member of the Nomination & Corporate Governance

Committee (or such alternate independent body considering such transaction) or an immediate family member thereof, such Director may not

participate in any discussion or vote regarding approval or rejection of such transaction, although such director may be counted in determining the

presence of a quorum at a meeting to review such transaction.

The Nomination & Corporate Governance Committee has delegated authority to the Chair of the Committee to approve certain transactions subject to

the policy. A summary of any new transactions approved by the Chair is provided to the Nomination & Corporate Governance Committee for its

review at its next scheduled meeting.

**Transactions with Related Persons** 

BlackRock

Based on a Schedule 13G filed with the SEC, BlackRock held more than 5% of CRH's outstanding ordinary shares during 2025. During 2025, CRH

had an approximate daily balance of $429,000,000 in a money market fund managed by BlackRock, for which BlackRock received fees of

approximately $316,000 based on the amounts invested. Additionally, one of the Company's wholly-owned subsidiary's pension scheme investments

are managed through BlackRock which resulted in approximately $16,000 of fees. These transactions with BlackRock have been conducted in the

ordinary course of business and on customary terms negotiated on an arm's-length basis, and they have been approved in line with the Company's

policy on transactions with related persons.

Fidelity

Based on a Schedule 13G filed with the SEC, Fidelity held more than 5% of CRH's outstanding ordinary shares during 2025. During 2025, certain

recordkeeping and other administrative services for the 401(k) employee contribution and employer match programs in the United States were

managed by Fidelity which resulted in approximately $1,202,000 of fees. In addition, in connection with the migration of the administration of its

equity incentive plans to Fidelity, CRH received a transition assistance payment of $350,000. These transactions with Fidelity have been conducted in

the ordinary course of business and on customary terms negotiated on an arm's-length basis, and they have been approved in line with the

Company's policy on transactions with related persons.

Extech Building Materials

During fiscal year 2025, Extech Building Materials ('Extech') purchased building materials totaling approximately $6,988,000 from certain of our

wholly-owned subsidiaries. Extech is majority owned by the family of Bob Feury, CRH's former Chief Culture & People Officer, who owns a minority

equity stake in Extech. Mr. Feury's father, Robert Feury Sr., is a director and part owner of Extech, his brother, Tim Feury, is Extech's chief executive

and part owner and his brother, Brian Feury, is Extech's chief operating officer and part owner. These transactions with Extech were conducted on an

arm's-length basis in the ordinary course of business and they have been approved in line with the Company's policy on transactions with related

persons.

83<br>

CRH PROXY STATEMENT 2026

Familial Employment Relationships

An immediate family member (as defined by Item 404 of Regulation S-K) of Siobhán Talbot, one of our non-management Directors, is employed by an

indirect wholly owned subsidiary of the Company in an operational role. In 2025, the immediate family member received total compensation in the

amount of approximately $130,000, inclusive of salary, overtime, annual bonus and certain benefits in the ordinary course. Decisions as to the

immediate family member's compensation are based on merit and made pursuant to the Company's compensation policies and practices applicable

to other similarly situated employees. The immediate family member's employment and related compensation has been approved in line with the

Company's policy on transactions with related persons.

Keaton Clay, the son-in-law of Randy Lake, our Chief Operating Officer, is employed by Oldcastle Infrastructure, an indirect wholly owned subsidiary

of the Company, in a sales representative role. In 2025, Mr. Clay received total compensation in the amount of approximately $138,500, inclusive of

salary, annual bonus and certain benefits in the ordinary course. Decisions as to Mr. Clay's individual compensation are based on merit and made

pursuant to the Company's compensation policies and practices applicable to other similarly situated employees. Mr. Clay's employment and related

compensation has been approved in line with the Company's policy on transactions with related persons.

Insider Trading Arrangements and Policies

We are committed to promoting high standards of ethical business conduct and compliance with applicable laws, rules and regulations. As part of

this commitment, we have adopted an Insider Trading Policy governing transactions in our securities by our Directors and employees, as well as by

CRH itself, that we believe is reasonably designed to promote compliance with insider trading laws, rules and regulations and listing standards. A

copy of our Insider Trading Policy was filed as Exhibit 19.1 to our 2025 Annual Report.

IMAGE PLACEHOLDER

84<br>

CRH PROXY STATEMENT 2026

General Information

This Proxy Statement relates to the solicitation

of votes or proxies by CRH, on behalf of the

Board, for use at the Company's 2026 AGM

and at any adjournment or postponement of

such meeting. The Company bears the cost of

solicitation of proxies by the Company. In

addition to this mailing, our Directors,

executive officers, and employees in the

ordinary course of their employment, without

special compensation other than

reimbursement of expenses, may solicit

proxies personally, electronically, by telephone,

or with additional mailings. We are paying D.F.

King a fee of approximately $40,750 for

assistance with soliciting proxies. We may also

reimburse intermediaries, fiduciaries,

custodians, and brokerage houses, for their

expenses incurred in forwarding these

materials to the beneficial owners of shares

held in their names.

The Company's website address is

*www.crh.com*. We include website addresses

throughout this Proxy Statement for reference

only. The information contained in, or available

through, these websites is not part of, or

incorporated by reference into, this Proxy

Statement. Addresses, including electronic

addresses provided in this Proxy Statement,

are provided solely for the purposes so

specified. You may not use any electronic

address provided in this Proxy Statement or

other proxy materials to communicate with the

Company for any purpose other than those

expressly stated herein or therein.

**What is the date, time and location** 

**of the 2026 AGM?**

The 2026 AGM of CRH will be held at the

Royal Marine Hotel, Marine Road, Dun

Laoghaire, Co. Dublin, Ireland at 11:00 a.m.

(Dublin) on Thursday, May 7, 2026.

**Where can I locate information** 

**regarding the 2026 AGM?**

Information regarding the 2026 AGM, including

a copy of this Proxy Statement, our 2025

Annual Report, proxy card (together, the 'Proxy

Materials'), the Irish Statutory Accounts and

copies of any other documentation relating to

the 2026 AGM is available on the CRH

website, *www.crh.com*. To access these

documents, please select AGM under

"Shareholder Center" in the Investors section

of the website.

**What is the "Notice-and-Access"** 

**model and why did the Company** 

**elect to use it?**

We are making this Proxy Statement and 2025

Annual Report available to Ordinary

Shareholders on the Internet under the SEC's

Notice-and-Access model. On or about March

27, 2026, we will mail to all shareholders (as of

the close of business on the Record Date) a

Notice of Internet Availability in lieu of mailing a

full printed set of the Proxy Materials.

Accordingly, on or about March 27, 2026, our

Proxy Materials are first being made available

to our shareholders on

*www.envisionreports.com/CRH*. The Notice of

Internet Availability includes instructions for

accessing an electronic copy of the Proxy

Materials on the internet and for how to vote.

The Notice of Internet Availability also includes

instructions on how to request a full set of

printed Proxy Materials.

We believe the electronic method of delivery

under the Notice of Internet Availability model

will decrease postage and printing expenses,

expedite delivery of Proxy Materials to you, and

reduce our environmental impact, and we

encourage you to take advantage of the

availability of the Proxy Materials on the

Internet. If you received the Notice of Internet

Availability but would like to receive a full

printed set of the Proxy Materials in the mail,

you may follow the instructions in the Notice of

Internet Availability for requesting such

materials.

**Why did I receive a Notice in the** 

**mail regarding the Notice of Internet** 

**Availability of Proxy Materials instead** 

**of a full set of printed Proxy Materials?**

Under rules adopted by the SEC, we are

making the Proxy Materials available to our

shareholders primarily through the Internet

("Notice-and-Access"). On or about March 27,

2026, we will mail the Notice of Internet

Availability to holders of our Ordinary Shares at

the Record Date (7:00 p.m. (Dublin)/3:00 p.m.

(New York) on Wednesday, March 11, 2026,

other than to those shareholders who

previously requested electronic or paper

delivery of communications from us. The

Notice of Internet Availability contains

instructions on how to access an electronic

copy of our Proxy Materials, including this

Proxy Statement and our 2025 Annual Report

to shareholders. The Notice of Internet

Availability also contains instructions on how to

request a paper copy of the Proxy Materials.

We believe that this process will allow us to

provide you with the information you need in a

timely manner, while conserving natural

resources and lowering the costs of printing

and distributing our Proxy Materials.

**Can I access proxy materials** 

**on the Internet?**

The Notice of Internet Availability will provide

you with instructions for viewing our proxy

materials for the 2026 AGM at

*www.envisionreports.com/CRH*. You may elect

to receive an e-mail, which will provide a link to

these documents on the internet instead of

waiting to receive the Notice of Internet

Availability to access the Proxy Materials.

**Can I vote my shares by filling out** 

**and returning the Notice of Internet** 

**Availability?**

No. The Notice of Internet Availability only

identifies the items to be voted on at the 2026

AGM. You cannot vote by marking the Notice

of Internet Availability and returning it. The

Notice of Internet Availability provides

instructions on how to cast your vote. For

additional information, see "How do I vote my

shares and what are the voting deadlines?"

**Why didn't I receive a Notice of** 

**Internet Availability in the mail** 

**regarding the internet availability** 

**of the Proxy Materials?**

We are providing some of our shareholders,

including shareholders who have previously

requested to receive paper copies of the Proxy

Materials, with paper copies of the Proxy

Materials instead of a Notice of Internet

Availability. In addition, we are providing the

Proxy Materials by e-mail to those

shareholders who have previously elected

delivery of the proxy materials electronically.

Those shareholders should have received an e-

mail containing a link to the website where

those materials are available and a link to the

proxy voting website.

**Why are there two sets of Financial** 

**Statements covering the same fiscal** 

**period?**

CRH's 2025 Annual Report contains financial

statements for 2025 prepared in accordance

with U.S. GAAP and filed with the SEC on

Form 10-K on February 18, 2026.

CRH is required under the Irish Companies Act

2014 to prepare financial statements in

accordance with IFRS as adopted by the

European Union (the 'Irish Statutory

Accounts'). A copy of the Irish Statutory

Accounts for 2025, including the reports of our

Directors and auditors thereon, is available on

the Company's website, *www.crh.com*, under

the heading "Shareholder Center", and will be

laid before the 2026 AGM.

85<br>

CRH PROXY STATEMENT 2026

**What is the Record Date for** 

**the 2026 AGM?**

The Record Date for the 2026 AGM is 7:00

p.m. (Dublin)/3:00 p.m. (New York) on

Wednesday, March 11, 2026 for Ordinary

Shareholders and, 7:00 p.m. (Dublin)/2:00p.m.

(New York) on Sunday, May 3, 2026 for 7%

Preference Shareholders, and references to

Record Date in this Proxy Statement shall be

construed accordingly.

A shareholder must hold their interest in CRH

Ordinary Shares or 7% Preference Shares (see

"How do I know what category of shareholder I

am?") on the applicable Record Date in order

to exercise their right to participate and vote at

the 2026 AGM, and any change after the

applicable Record Date shall be disregarded in

determining the right of that person to attend

and vote at the meeting.

The Record Date is earlier than the date of the

2026 AGM. Accordingly, if a shareholder

acquires Ordinary Shares or 7% Preference

Shares after the applicable Record Date, they

may vote those shares only if they are

appointed as a proxy to do so from the person

who held the shares on the applicable Record

Date.

If the meeting is adjourned, any change to the

Record Date (and/or voting deadlines) will be

communicated to shareholders by the

Company.

**Who can vote at the 2026 AGM?**

You can vote at the 2026 AGM if you were a

Ordinary Shareholder in the Company at 7:00

p.m. (Dublin)/3:00 p.m. (New York) on

Wednesday, March 11, 2026, or for the

purposes of Proposal 9 only, a 7% Preference

Shareholder at 7.00 p.m. (Dublin)/2:00p.m.

(New York) on Sunday, May 3, 2026.

The 7% Preference Shareholders are entitled

to vote in respect of a capital reduction of the

Company and will therefore be entitled to vote

on Proposal 9 at the 2026 AGM with the

Ordinary Shareholders, voting as a single

class, but the 7% Preference Shareholders are

unable to vote on any other Proposals at the

2026 AGM.

The 5% Preference Shareholders are not

entitled to vote on any Proposals at the 2026

AGM. The 5% Preference Shareholders are

entitled to vote at the 5% Preference Share

Scheme Meeting, and the 7% Preference

Shareholders are entitled to vote at the 7%

Preference Share Scheme Meeting. Separate

notices and related materials have been sent to

the Preference Shareholders in respect of the

Scheme Meetings.

As of March 11, 2026, there were 669,399,849

Ordinary Shares outstanding (excluding

Treasury Shares), each of which entitles the

holder to one vote for each matter to be voted

on at the 2026 AGM.

**How do I know what category** 

**of shareholder I am?**

'Registered shareholders' refers to persons

listed on the register of members (i.e. those

shareholders whose shareholding is evidenced

by their Statement of Holding and who do not

hold their interests in shares as street name

holders or DI holders).

'Street name holders' refers to persons who

hold their interests in CRH shares in a

brokerage account or via a broker, bank or

other nominee that is a participant in DTC.

'DI holders' refers to holders of CRH UK

Depository Interests entered in the register of

DI Holders of the Company.

References to 'shareholder' in this "General

Information" section refers to registered

shareholders, street name holders and DI

holders.

**How do I vote?**

The process for appointing a proxy and/or

voting in connection with the Proposals to be

voted on at the 2026 AGM depends on how

you hold your shares (see "How do I know

what category of shareholder I am?").

The information in this section in respect of

voting procedures for street name holders and

DI holders (see further below) is for guidance

only and such persons should consult their

stockbroker or the intermediary through which

they acquired their shares at the earliest

opportunity for further information on the

processes and timelines for submitting proxies

and voting instructions for the 2026 AGM.

**1. Registered shareholders:** 

Registered shareholders at the Record Date

may vote by proxy or in person*.*

Voting by proxy

Registered shareholders may vote by proxy in

advance of the deadline for voting of 11:00

a.m. (Dublin)/6:00 a.m. (New York) on May 5,

2026 by using any one of the following

methods:

(i)online by visiting *www.envisionreports.com/*

*CRH* or scanning the QR code and following

the instructions on their proxy card; or

(ii)by mail, if a registered shareholder received

printed Proxy Materials, by following the

instructions on their proxy card and

returning their completed proxy card in the

postage-paid envelope accompanying their

proxy materials.

A registered shareholder may also appoint a

proxy by delivering their proxy card (or a proxy

in the form set out in Section 184 of the

Companies Act 2014) to the Company

Secretary, CRH, 42 Fitzwilliam Square, Dublin

2, D02 R279, Ireland, to be received no later

than 11:00 a.m. (Dublin)/6:00 a.m. (New York)

on May 5, 2026. A proxy is not required to be

a shareholder of the Company.

Registered shareholders eligible to attend and

vote at the 2026 AGM may exercise their right

to vote at the 2026 AGM by appointing one or

more proxies, who need not be a shareholder,

to attend, speak and vote instead of the

registered shareholder. Registered

shareholders may appoint the Chair of the

2026 AGM or another individual, who need not

be a shareholder of the Company, as their

proxy. Appointment of a proxy does not

preclude shareholders from attending and

voting at the 2026 AGM should they

subsequently wish to do so.

In the case of joint holders, the vote of the

senior holder who tenders a vote, whether in

person or by proxy, will be accepted to the

exclusion

of the votes of the other registered

shareholder(s) and, for this purpose, seniority

will be determined by the order in which the

names stand in the register of members.

Voting in person

Registered shareholders may alternatively

attend the 2026 AGM in person to vote in

person.

**2. Street name holders:** 

Only those street name holders holding Ordinary

Shares on the Record Date are entitled to vote on

the Proposals in respect of such shares.

Voting by proxy

Street name holders may direct their broker,

bank or other nominee on how to vote their

shares by following the instructions for voting

on the voting instruction form provided by their

broker, bank or other nominee. If a street name

holder does not direct their broker, bank or

other nominee on how to vote their shares on

their voting instruction form, their shares will

not be voted at the 2026 AGM on certain

matters (see "What are broker non-votes and

what effect do they have?"). Please note that

the deadline for voting by street name holders

is 4:59 a.m. (Dublin) on May 5, 2026/11:59

p.m. (New York) on May 4, 2026. We

encourage street name holders to

communicate their voting decisions to their

broker, bank or other nominee by the time

prescribed by their broker, bank or other

nominee well in advance of this deadline to

ensure that their vote will be counted.

Voting in person

If a street name holder wishes to vote in

person at the 2026 AGM, they must obtain a

legal proxy from their broker, bank or other

nominee and present it to the Company

Secretary or other Company representative, at

the 2026 AGM.

**3. DI holders:** 

DI holders on the Record Date are entitled to

provide voting instructions to Computershare

U.K. in respect of the number of DIs registered

in their name(s) at that time.

86<br>

CRH PROXY STATEMENT 2026

Voting by proxy

DI holders may direct Computershare U.K. to

vote the shares represented by their DIs in two

ways:

(A)By Internet—CREST. Issue an instruction

through the CREST electronic voting

appointment service using the procedures

described in the CREST manual (available

from *www.euroclear.com*). CREST personal

members or other CREST sponsored

members, and those CREST members who

have appointed a voting service provider,

should refer to their CREST sponsor or

voting services provider, who will be able to

take the appropriate action on their behalf.

For instructions made using the CREST

service to be valid, the appropriate CREST

message (a CREST Voting Instruction) must

be properly authenticated in accordance

with the specifications of Euroclear U.K. &

International Limited ('EUI') and must

contain the information required for such

instructions, as described in the CREST

Manual. The message, regardless of

whether it relates to the voting instruction or

to an amendment to the instruction given to

Computershare U.K., must be transmitted

so as to be received by the Company's

agent (ID 3RA50) by no later than 11:00

a.m. (Dublin)/6:00 a.m. (New York) on May

1, 2026.

The time of receipt will be taken to be the

time (as determined by the timestamp

applied to the CREST Voting Instruction by

the CREST applications host) from which

the Company's agent is able to retrieve the

CREST Voting Instruction by inquiry to

CREST in the manner prescribed by

CREST. EUI does not make available

special procedures in CREST for any

particular messages. Normal system timings

and limitations apply to the transmission of

a CREST Voting Instruction. It is the

responsibility of the CREST member to take

(or to procure that the CREST sponsor or

voting service provider takes) such action

necessary to ensure that a CREST Voting

Instruction is transmitted by any particular

time. CREST members and, where

applicable, their CREST sponsors or voting

service providers, are referred to those

sections of the CREST Manual concerning

practical limitations of the CREST system

and timings.

(B)By Mail. Complete and return a Form of

Instruction to Computershare U.K. by

posting it to Computershare Investor

Services PLC, The Pavilions, Bridgwater

Road, Bristol, BS99 6ZY, United Kingdom.

To be effective, all Forms of Instruction

must be received by Computershare U.K.

by 11:00 a.m. (Dublin)/6:00 a.m. (New York)

on May 1, 2026. Computershare U.K., as

the depositary, will then make arrangements

to vote your underlying shares according to

your instructions.

Voting in person

DI holders who wish to attend and vote at the

2026 AGM in person must obtain a Letter of

Representation from their broker or nominee

and then provide this letter by e-mail to

Computershare U.K. at

ukallditeam2@computershare.co.uk by 11:00

a.m. (Dublin)/6:00 a.m. (New York) on May 1,

2026. Computershare U.K., on behalf of

Computershare Trust Company N.A., will then

provide the DI holder with a separate Letter of

Representation which will confirm the amount

of Ordinary Shares they will represent, allowing

the DI Holder to attend, speak and vote at the

2026 AGM.

DI holders must bring the Letter of

Representation and present it to the Company

Secretary or other Company representative at

the 2026 AGM. Any DI holders that do not

follow the above process will be unable to vote

their Ordinary Shares in person at the 2026

AGM.

**How do I vote if I'm a 7% Preference** 

**Shareholder?** 

Under the Articles, 7% Preference

Shareholders are entitled to vote in respect of

a capital reduction of the Company and will

therefore be entitled to vote on Proposal 9 at

the AGM with the Ordinary Shareholders,

voting as a single class, but the 7% Preference

Shareholders are not entitled to vote on any

other Proposals at the AGM.The process for

appointing a proxy and/or voting in connection

with the Proposals to be proposed at the 2026

AGM depends on how you hold your shares.

Holders of CREST Depository Interests ('CDIs')

through the CREST system and/or participants

of the Euroclear Bank system (the 'EB System')

('EB Participants') should carefully review the

document titled "Proxy Voting - Important

Information", which is available on the CRH

website, *www.crh.com*. The information in this

section in respect of voting procedures for EB

Participants and CDI holders (see further

below) is for guidance only and such persons

should consult their stockbroker or the

intermediary through which they acquired their

7% Preference Shares at the earliest

opportunity for further information on the

processes and timelines for submitting proxies

and voting instructions for the 2026 AGM.

**Registered 7% Preference** 

**Shareholders:** 

Registered 7% Preference Shareholders whose

name appears on the register of members of

CRH (i.e. those who hold their 7% Preference

Shares directly on the register of members and

who therefore do not hold their interests in 7%

Preference Shares through the EB System or

as CDIs through the CREST System) may vote

by proxy or in person.

Voting by proxy

Registered 7% Preference Shareholders may

vote by proxy in advance of the deadline for

voting of 11:00 a.m. (Dublin)/6:00 a.m. (New

York) on May 5, 2026 by using any one of the

following methods:

(i)online by visiting

*www.eproxyappointment.com* 

or scanning the QR code and following the

instructions on their proxy card; or

(ii)by mail, if a registered 7% Preference

Shareholder received printed Proxy

Materials, by following the instructions on

their proxy card and returning their

completed proxy card in the postage-paid

envelope accompanying their proxy

materials.

A registered 7% Preference Shareholder may

also appoint a proxy by delivering their proxy

card (or a proxy in the form set out in Section

184 of the Companies Act 2014) to The

Company Secretary, CRH, 42 Fitzwilliam

Square, Dublin 2, D02 R279, Ireland, to be

received no later than 11:00 a.m. (Dublin)/6:00

a.m. (New York) on May 5, 2026. A proxy is

not required to be a shareholder of the

Company. Registered 7% Preference

Shareholders eligible to attend and vote at the

2026 AGM may exercise their right to vote at

the 2026 AGM by appointing one or more

proxies, who need not be a member, to attend,

speak and vote instead of the registered 7%

Preference Shareholder.

Registered 7% Preference Shareholders may

appoint the Chair of the 2026 AGM or another

individual, who need not be a member(s) of the

Company, as their proxy. Appointment of a

proxy does not preclude members from

attending and voting at the 2026 AGM should

they subsequently wish to do so. In the case of

joint holders, the vote of the senior who

tenders a vote, whether in person or by proxy,

will be accepted to the exclusion of the votes

of the other registered 7% Preference

Shareholder(s) and, for this purpose, seniority

will be determined by the order in which the

names stand in the register of members.

Voting in person

Registered 7% Preference Shareholders may

alternatively attend the 2026 AGM in person to

vote in person.

**Holdings in Uncertificated Form as an** 

**EB Participant:** 

7% Preference Shareholders who hold

interests in the 7% Preference Shares through

a participant account in the EB System can

submit proxy appointments (including voting

instructions) electronically in the manner

described in the document issued by Euroclear

Bank entitled 'Euroclear Bank as issuer CSD

for Irish corporate securities' and available on

the Euroclear website (www.euroclear.com).

87<br>

CRH PROXY STATEMENT 2026

7% Preference Shareholders holding their

interests through the EB System or the CREST

System will need to comply with any additional

voting deadlines imposed by the respective

service offerings. All relevant persons are

recommended to consult with their

stockbroker or other intermediary at the

earliest opportunity.

**Holdings in Uncertificated Form via** 

**CDIs:** 

7% Preference Shareholders who hold

interests in the 7% Preference Shares as CDIs

in the CREST system may vote by (i) sending

electronic voting instructions to Euroclear Bank

via Broadridge Financial Solutions Limited

('Broadridge'); or (ii) appointing a proxy via the

Broadridge Global Proxy Voting service. There

is no facility to offer a letter of representation/

appoint a corporate representative other than

through the submission of third-party proxy

appointment instructions through Broadridge.

**What are broker non-votes and what** 

**effect do they have?**

Broker non-votes occur when nominees, such

as banks and brokers holding shares in "street

name" on behalf of beneficial owners, do not

receive voting instructions from the beneficial

holders. If that happens, the nominees may

vote those shares only on matters deemed

"routine" by NYSE. On "non-routine" matters,

nominees cannot vote unless they receive

voting instructions from beneficial owners. If

your nominee elects to vote your shares on

some but not all matters, it will result in a

"broker non-vote" for the matters on which the

broker does not vote.

The proposals at the 2026 AGM that are

considered "routine" matters are: Proposal 3

— (a) Ratification of Appointment of Deloitte

U.S. as Auditor; and (b) Authority to Set

Auditor Compensation; Proposal 4— Authority

to allot Shares; Proposal 5—Disapplication of

Pre-emption Rights; Proposal 6— Authority to

Purchase Own Shares; and Proposal 7—To

Re-Issue Treasury Shares.

The remaining proposals being considered at

the 2026 AGM are considered "non-routine"

matters. Therefore, if your shares are held in

"street name" and you do not provide

instructions as to how your shares are to be

voted on Proposals 1, 2, 8, 9, 10, 11 and 12,

your broker will not be able to vote your shares

on these non-routine proposals.

**What constitutes a quorum?**

As provided by the Company's Articles, two

shareholders present in person or by proxy

who have the right to attend and vote at the

meeting constitutes a quorum at the AGM.

Abstentions and broker "non-votes" are

counted as present for the purposes of

determining whether a quorum exists.

**Can I revoke my proxy or change** 

**my vote after I have voted?**

Yes. If you are a registered shareholder and

previously voted by Internet, scanning a QR

Code or mail, you may revoke your proxy or

change your vote by:

• voting at a later date by Internet or scanning

the QR code as set forth above before the

closing of proxy deadline;

• mailing a proxy card that is properly signed

and dated with a later date than your

previous vote and that is received no later

than the proxy deadline;

• attending the 2026 AGM in Dublin and

voting during the meeting; or

• sending a written notice of revocation to the

Company Secretary, CRH, 42 Fitzwilliam

Square, Dublin 2, D02 R279, Ireland or by

e-mail to *companysecretarysoffice@crh.com* 

before the commencement of the meeting*.*

If you are a street name holder, you must

contact the holder of record to revoke a

previously authorized proxy.

UK DI Holders should contact Computershare

U.K. for instructions on how to revoke their

proxies or change their vote.

**How are resolutions put** 

**to a vote decided?**

All resolutions at the 2026 AGM will be put to a

poll. Pursuant to Section 190(b) of the

Companies Act 2014, where a poll is taken at

the Annual General Meeting, a shareholder,

present in person or by proxy, holding more

than one share need not cast all his/her votes

in the same way.

**If I attend the 2026 AGM in person,** 

**what do I need to bring?**

Persons attending the 2026 AGM should bring

photographic identification to verify their

identify and present it to the Company

Secretary or other Company representative at

the 2026 AGM.

Persons attending the 2026 AGM (other than

registered holders attending in person) must

also bring the proxy or other document

evidencing their authority to attend and vote at

the 2026 AGM (see also "How do I vote?") and

present it to the Company Secretary or other

Company representative at the 2026 AGM.

During the meeting, persons attending in

person may not use cameras, smart phones or

other audio, video or electronic recording

devices, unless expressly authorized by the

Chair of the meeting.

**How do I submit director nominees** 

**or a shareholder proposal at the** 

**2027 AGM?**

Any eligible shareholder who intends to present a

proposal at the 2027 Annual General Meeting

('2027 AGM') and who wishes to have a proposal

included in CRH's proxy statement for that annual

meeting pursuant to SEC Rule 14a-8 must deliver

the proposal to the Company Secretary on or

before November 27, 2026 and must satisfy the

rules and regulations of the SEC to be eligible for

inclusion in the proxy statement for that meeting.

As the rules of the SEC make clear, simply

submitting a proposal does not guarantee its

inclusion.

To be eligible for consideration at the 2027 AGM,

any Director nomination or proposal of other

business (other than a proposal pursuant to Rule

14a-8) by a shareholder must comply with the

procedures and other requirements specified in

CRH's Articles, as amended from time to time.

Any Director nomination or other proposal that is

a proper subject for consideration would be

required to be received by the Company

Secretary not earlier than January 8, 2027 and

not later than 5:00 p.m. at CRH's principal

executive offices on February 8, 2027.

Notice provided by shareholders under the

SEC's Rule 14a-19 who intend to solicit

proxies in support of nominees (other than the

Company's nominees) submitted pursuant to

our Articles must be received by March 8,

2027 and must comply with the requirements

of our Articles and the additional requirements

of Rule 14a-19(b).

Please note that the advance notice

requirements of Rule 14a-19 do not override or

supersede any longer advance notice

requirements or any other requirements in our

Articles.

All submissions to, or requests of, the

Company Secretary should be made to CRH's

principal executive offices at Stonemason's

Way, Rathfarnham, Dublin 16, D16 KH51,

Ireland, or via e-mail at

*companysecretarysoffice@crh.com*. Please

ensure that receipt of all submissions is

confirmed.

**How do I obtain more information** 

**about CRH?** 

A copy of our 2025 Annual Report to

shareholders accompanies this Proxy

Statement.

***We will furnish without charge to each person***

***whose proxy is being solicited in connection***

***with the Annual Meeting, upon request of any***

***such person, a copy of our Annual Report on***

***Form 10-K for the year ended December 31,***

***2025, as filed with the SEC, including the***

***consolidated financial statements and notes***

***thereto, excluding exhibits. Written requests***

***for copies of such report should be directed***

***to the Company Secretary and should be***

***made to CRH's principal executive offices at***

***Stonemason's Way, Rathfarnham, Dublin 16,***

***D16 KH51, Ireland, or via e-mail at***

***companysecretarysoffice@crh.com. Copies of***

***any exhibit to the Annual Report on Form 10-K***

***will be forwarded upon receipt of a written***

***request to our Investor Relations department at***

***such address, subject to a reasonable charge***

***for copying and mailing.***

88<br>

CRH PROXY STATEMENT 2026

In addition, you may also obtain, free of

charge, a copy of our 2025 Annual Report on

Form 10-K, our Corporate Governance

Guidelines, our Code of Business Conduct and

the charters for our Acquisitions, Divestments

& Finance, Audit, Compensation, Nomination &

Corporate Governance and Safety,

Environment & Social Responsibility

Committees by writing to CRH, c/o Company

Secretary, 42 Fitzwilliam Square, Dublin 2, D02

R279, Ireland, or via e-mail at

*companysecretarysoffice@crh.com.* 

These documents, as well as other information

about CRH, are also available on our website

at *www.crh.com.* 

**Householding**

SEC rules permit a single Notice of Internet

Availability or full set of Proxy Materials to be

sent to shareholders sharing the same last

name and household mailing address, unless

contrary instructions are provided by the

impacted shareholders prior to the mailing

date. Each shareholder continues to receive a

separate proxy card. This procedure is referred

to as householding. While the Company does

not household its mailings to its shareholders

of record, a number of brokerage firms with

account holders who are Company

shareholders have instituted householding. In

these cases, a single Notice of Internet

Availability will be delivered to multiple

shareholders sharing the same last name and

household mailing address unless contrary

instructions have been received from the

affected shareholders. Any shareholder can

receive an emailed copy of this Proxy

Statement and the 2025 Annual Report on the

CRH website, *www.crh.com*.

Once a shareholder has received notice from

his or her broker that the broker will be

householding communications to the

shareholder's address, householding will

continue until the shareholder is notified

otherwise or until the shareholder revokes his

or her consent. If at any time a shareholder no

longer wishes to participate in householding

and would prefer to receive a separate Proxy

Statement and the 2025 Annual Report, he or

she should notify his or her broker.

Shareholders who hold their shares through a

bank, broker or other nominee who currently

receive multiple copies of the Proxy Materials

at their address and would like to request

householding of their communications should

contact their broker.

89<br>

CRH PROXY STATEMENT 2026

Annex A – Reconciliation of

Non-GAAP Financial Measures

**1. Adjusted EBITDA & Adjusted EBITDA Margin**

Adjusted EBITDA is defined as earnings from continuing operations before interest, taxes, depreciation, depletion, amortization, Loss on impairments,

gain/loss on divestitures and investments, Income/loss from equity method investments, substantial acquisition-related costs, and pension expense/

income excluding current service cost component. It is quoted by management in conjunction with other GAAP and non-GAAP financial measures to

aid investors in their analysis of the performance of the Company. Adjusted EBITDA by segment is monitored by management in order to allocate

resources between segments and to assess performance.

Adjusted EBITDA margin is calculated by expressing Adjusted EBITDA as a percentage of Total revenues.

Reconciliation to its most directly comparable GAAP measure is presented below:

---

| | | | |
|:---|:---|:---|:---|
| ***in $ millions*** | **2025** | **2024** | **2023** |
| Net income | 3790 | 3521 | 3072 |
| (Income) loss from equity method investments (i) | (26) | 108 | 17 |
| Income tax expense  | 1041 | 1085 | 925 |
| Gain on divestitures and investments (ii) | (1) | (250) |  |
| Pension income excluding current service cost component (ii) | (21) | (7) | (3) |
| Other interest, net (ii) | (7) | (1) | 5 |
| Interest expense | 810 | 612 | 376 |
| Interest income | (146) | (143) | (206) |
| Depreciation, depletion and amortization | 2156 | 1798 | 1633 |
| Loss on impairments (i) | 40 | 161 | 357 |
| Substantial acquisition-related costs (iii) | 45 | 46 | – |
| Adjusted EBITDA | 7681 | 6930 | 6176 |
| Total revenues | 37447 | 35572 | 34949 |
| Net income margin | 10.1% | 9.9% | 8.8% |
| Adjusted EBITDA margin  | 20.5% | 19.5% | 17.7% |

---

Notes:

(i)For the year ended December 31, 2025, the Loss on impairments totaled $40 million, principally related to International Solutions. For the year ended December 31, 2024, the total impairment

loss comprised $0.35 billion, principally related to the Architectural Products reporting unit within International Solutions and the equity method investment in China. For the year ended

December 31, 2023, the total impairment loss comprised $62 million within Americas Materials Solutions and $295 million within International Solutions.

(ii)Gain on divestitures and investments, pension income excluding current service cost component and other interest, net have been included in Other nonoperating income (expense), net in the

Consolidated Statements of Income.

(iii)Represents expenses associated with non-routine substantial acquisitions, which meet the criteria for being separately reported in Note 3 "Acquisitions" in Item 8. "Financial Statements and

Supplementary Data" in the 2025 Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on February 18, 2026, as well as other acquisition costs of an

extraordinary nature. Expenses in 2025 and 2024 primarily include legal, consulting and other tax expenses related to these acquisitions.

90<br>

CRH PROXY STATEMENT 2026

**Source Data**

---

| | | |
|:---|:---|:---|
| ***In millions, except per share data*** | **€** | **$** |
| 2015 EBITDA (as defined) (i) | 2219 |  |
| Less: EBITDA (as defined) from divested businesses |  |  |
| Europe Distribution (i) | (171) |  |
| Americas Distribution (i) | (140) |  |
| Building Envelope (ii) | (121) |  |
|  | 1787 |  |
| 2015 IFRS based EBITDA (as defined) (iii) (iv) |  | 1983 |
| 2025 Adjusted EBITDA\* per the Annual Report on Form 10-K |  | 7681 |
| 10-Year CAGR |  | 15% |
| 2015 Diluted EPS (i) | 0.89 |  |
| 2015 IFRS Diluted EPS (iii) (iv) |  | 0.98 |
| 2025 U.S. GAAP Diluted EPS per the Annual Report on Form 10-K |  | 5.51 |
| 10-Year CAGR |  | 19% |

---

(i)As reported under IFRS in the Annual Report on Form 20-F for 2015.

(ii)The results for Building Envelope stated are under IFRS and were not previously separately reported in external filings.

(iii)Effective from January 1, 2020, CRH changed its reporting currency from euro to U.S. Dollar. Reported results for 2015 have been translated from euro to U.S. Dollar using the

2015 average exchange rate of $1.1095 to €1.

(iv)The adjustments required to reflect these metrics under U.S. GAAP have not been quantified. No material differences have been identified that would impact trends calculated in

accordance with U.S. GAAP in comparison to IFRS.

91<br>

CRH PROXY STATEMENT 2026

Annex B – Part I – 5% Preference

Share Scheme of Arrangement

**The information contained in Annexes B and C of this Proxy Statement is not required to be included pursuant to the**

**rules and regulations of the U.S. Securities and Exchange Commission, and is included solely to comply with the**

**requirements of the Companies Act 2014 in order to provide the information required under such laws applicable to**

**the Preference Shareholders.**

SCHEME OF ARRANGEMENT

THE HIGH COURT

IN THE MATTER OF

CRH PUBLIC LIMITED COMPANY

AND IN THE MATTER OF THE COMPANIES ACT 2014

SCHEME OF ARRANGEMENT

UNDER CHAPTER 1 OF PART 9 OF THE COMPANIES ACT 2014

BETWEEN CRH PUBLIC LIMITED COMPANY AND THE 5% PREFERENCE SHARE SCHEME SHAREHOLDERS

(AS HEREINAFTER DEFINED)

PRELIMINARY:

(A)CRH is a public limited company incorporated in Ireland under the Act with registration number 12965.

(B)The authorised share capital of CRH at the date of this 5% Preference Share Scheme is €401,297,940 divided into 150,000 5% Cumulative

Preference Shares of €1.27 each, 872,000 7% "A" Cumulative Preference Shares of €1.27 each and 1,250,000,000 Ordinary Shares of €0.32

each. As of the Latest Practicable Date, (i) 705,043,723 Ordinary Shares have been issued and are credited as fully paid and the remainder are

unissued, (ii) 50,000 5% Cumulative Preference Shares have been issued and are credited as fully paid and the remainder are unissued, and (iii)

872,000 7% "A" Cumulative Preference Shares have been issued and are credited as fully paid.

(C)The purpose of the 5% Preference Share Scheme is to provide for the cancellation of all 5% Preference Share Scheme Shares, pursuant to a

scheme of arrangement under Chapter 1 of Part 9 of the Act and Sections 84 and 85 of the Act, in consideration for a cash payment of the 5%

Cancellation Consideration to the 5% Preference Share Scheme Shareholders, and to take certain steps to facilitate the foregoing, including the

cancellation of the listing and admission to trading of the 5% Preference Shares on Euronext Growth Dublin.

(D)All references are to Dublin (Ireland) time unless otherwise stated.

(E)The explanatory statement required to be furnished pursuant to Section 452 of the Act is set out in "Part II - 5% Preference Share Scheme of

Arrangement Explanatory Statement" of Annex B to the Proxy Statement and was also issued to the 5% Preference Shareholders on March 27,

2026 as part of the 5% Preference Share Scheme Circular.

92<br>

CRH PROXY STATEMENT 2026

**The Scheme of Arrangement** 

**1. Definitions**

---

| | |
|:---|:---|
| **In this 5% Preference Share Scheme, unless inconsistent with the subject or context, the following expressions bear the following meanings:** | **In this 5% Preference Share Scheme, unless inconsistent with the subject or context, the following expressions bear the following meanings:** |
| "5% Cancellation Consideration" | has the meaning given to it in Clause 3.1;  |
| "5% Preference Share Cancellation" | the cancellation of all of the 50,000 issued and outstanding 5% Preference Shares to be implemented <br>pursuant to the 5% Preference Share Scheme, and the related Reduction of Capital, in exchange for a <br>cash payment of the 5% Cancellation Consideration; <br>|
| "5% Preference Share Court Hearing" | the hearing by the Irish High Court at which the application is made to sanction the proposed 5% <br>Preference Share Scheme under Section 453(2)(c) of the Act;<br>|
| "5% Preference Share Form of Proxy" | the form of proxy for the 5% Preference Share Scheme Meeting, which has been issued to 5% <br>Preference Shareholders on March 27, 2026 as part of the 5% Preference Share Scheme Circular;<br>|
| "5% Preference Share Scheme Record Time" | 11:59 pm (Dublin) on the last Business Day before the Effective Date (or such other day and/or time as is <br>specified as the record time for determining those 5% Preference Shares that will be subject to the 5% <br>Preference Share Scheme); <br>|
| "5% Preference Share Scheme Circular"  | the document distributed to the 5% Preference Shareholders on March 27, 2026 in respect of the 5% <br>Preference Share Scheme containing (i) this 5% Preference Share Scheme Document, (ii) the notice of <br>the 5% Preference Share Scheme Meeting, (iii) an explanatory statement as required by Section 452 of <br>the Act with respect to the 5% Preference Share Scheme (as also set out in 'Part II - 5% Preference <br>Share Scheme of Arrangement Explanatory Statement' of Annex B to the Proxy Statement), (iv) the 5% <br>Preference Share Form of Proxy, and (v) the accompanying cover letter;<br>|
| "5% Preference Share Scheme Document" | this document, as set out in 'Part I – 5% Preference Share Scheme of Arrangement' of Annex B to the <br>Proxy Statement, and as also distributed to 5% Preference Shareholders as part of the 5% Preference <br>Share Scheme Circular;<br>|
| "5% Preference Share Scheme Meeting" | the meeting of the 5% Preference Shareholders convened pursuant to the authority of the Board under <br>Section 450(1) of the Act (and any adjournment of such meeting), to be held at 10:30 a.m., or if later, <br>immediately after the conclusion or adjournment of the preceding 7% Preference Share Scheme Meeting <br>on May 21, 2026 at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland for <br>the purposes of considering and, if thought fit, approving the 5% Preference Share Scheme (with or <br>without any modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court)), <br>notice of which was sent to the 5% Preference Shareholders on March 27, 2026 and is part of the 5% <br>Preference Share Scheme Circular;<br>|
| "5% Preference Share Scheme Order" | the order or orders of the Irish High Court under Section 453 of the Act sanctioning the 5% Preference <br>Share Scheme and, if applicable, confirming the Reduction of Capital which forms part of it under <br>Sections 84 and 85 of the Act;<br>|
| "5% Preference Share Scheme Shareholders" | Holders of 5% Preference Share Scheme Shares; |
| "5% Preference Share Scheme Shares" | any 5% Preference Shares in issue at the 5% Preference Share Scheme Record Time; |
| "5% Preference Share Scheme" or "5% Preference <br>Share Scheme of Arrangement"<br>| this proposed scheme of arrangement under Chapter 1 of Part 9 of the Act, and the Reduction of Capital, <br>with or subject to any modifications, addition(s) or condition(s) approved or imposed by the Irish High <br>Court and agreed to by CRH in relation to the cancellation of the 5% Preference Share Scheme Shares;<br>|
| "5% Preference Shareholders" | Holders of the 5% Preference Shares; |
| "5% Preference Shares"  | the 50,000 5% Cumulative Preference Shares of €1.27 each in the share capital of CRH (ISIN: <br>IE0001827264), admitted to trading on Euronext Growth Dublin;<br>|
| "7% Cancellation Consideration" | €3.556 for each 7% Preference Share cancelled pursuant to the 7% Preference Share Scheme; |
| "7% Preference Share Scheme" or "7% Preference <br>Share Scheme of Arrangement"<br>| the proposed scheme of arrangement under Chapter 1 of Part 9 of the Act, and the related reduction of <br>capital, with or subject to any modifications, addition(s) or condition(s) approved or imposed by the Irish <br>High Court and agreed to by CRH in relation to the cancellation of the 7% Preference Shares;<br>|
| "7% Preference Share Scheme Circular" | the document distributed to the 7% Preference Shareholders on March 27, 2026 in respect of the 7% <br>Preference Share Scheme containing (i) the 7% Preference Share Scheme Document, (ii) the notice of the <br>7% Preference Share Scheme Meeting, (iii) an explanatory statement as required by Section 452 of the <br>Act with respect to the 7% Preference Share Scheme (as also set out in 'Part II - 7% Preference Share <br>Scheme of Arrangement Explanatory Statement' of Annex C to the Proxy Statement), (iv) the form of <br>proxy, and (v) the accompanying cover letter;<br>|
| "7% Preference Share Scheme Document" | the document as set out in 'Part I – 7% Preference Share Scheme of Arrangement' of Annex C to the <br>Proxy Statement, and as also distributed to 7% Preference Shareholders as part of the 7% Preference <br>Share Scheme Circular;<br>|
| "7% Preference Share Scheme Meeting" | the meeting of the 7% Preference Shareholders convened pursuant to the authority of the Board under <br>Section 450(1) of the Act (and any adjournment of such meeting), to be held at 10:00 a.m. on May 21, <br>2026 at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland for the purposes <br>of considering and, if thought fit, approving the 7% Preference Share Scheme (with or without any <br>modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court), notice of which <br>was sent to the 7% Preference Shareholders on March 27, 2026 and is part of the 7% Preference Share <br>Scheme Circular;<br>|
| "7% Preference Shareholders" | Holders of the 7% Preference Shares; |

---

93<br>

CRH PROXY STATEMENT 2026

---

| | |
|:---|:---|
| "7% Preference Shares" | the 7% "A" Cumulative Preference Shares of €1.27 each in the share capital of CRH (ISIN <br>IE0001827603), currently admitted to trading on the LSE but expected to be delisted from the LSE on <br>April 20, 2026;<br>|
| "Act" | the Companies Act 2014 of Ireland (as amended); |
| "AGM" | the annual general meeting of CRH (and any adjournment thereof) to be held at 11:00 a.m. (Dublin) on <br>Thursday, May 7, 2026 at the Royal Marine Hotel, Marine Road, Dún Laoghaire, Co. Dublin, Ireland;<br>|
| "AGM Voting Record Time" | 7:00 p.m. (Dublin)/3:00 p.m. (New York) on March 11, 2026 for Ordinary Shareholders, and 7:00 p.m. <br>(Dublin)/2:00 p.m. (New York) on May 3, 2026 for 7% Preference Shareholders;<br>|
| "Articles"  | the articles of association of CRH as at the date of the 5% Preference Share Scheme Circular; |
| "Belgian Law Rights" | the fungible co-ownership rights governed by Belgian law over a pool of book-entry interests in securities <br>of the same issue (i.e. as can be identified by an ISIN) which the EB Participants hold;<br>|
| "Board of Directors" or "Board" | the board of directors of CRH from time to time; |
| "Broadridge" | Broadridge Financial Solutions Limited; |
| "Business Day" | any day, other than a Saturday, Sunday, public holiday or a day on which banks in Ireland, London or in <br>New York are authorised or required by law or executive order to be closed;<br>|
| "Cancellation Consideration" | the 5% Cancellation Consideration and the 7% Cancellation Consideration  |
| "CDIs" | an English law security issued by the CREST Depository that represents a CREST member's interest in a <br>5% Preference Share (including the Belgian Law Rights in respect of a 5% Preference Share);<br>|
| "Company" or "CRH" | CRH plc, a public limited company incorporated under the Act with registration number 12965 and <br>having its registered office at 42 Fitzwilliam Square, Dublin 2, D02 R279, Ireland;<br>|
| "CREST Depository" | CREST Depository Limited, a subsidiary of Euroclear UK & International ("EUI") (or any successor or <br>assignee of it in such capacity from time to time);<br>|
| "DWT" | Irish dividend withholding tax; |
| "EB" or "Euroclear Bank"  | Euroclear Bank S.A./N.V., an international central depository system based in Belgium; |
| "EB Nominee" | Euroclear Nominees Limited, a wholly owned subsidiary of Euroclear Bank, established under the laws of <br>England and Wales with registration number 02369969 (or any such successor or assignee of it in such <br>capacity from time to time); <br>|
| "EB Participant" | a participant in the EB System that has entered into an agreement to participate in the EB System subject <br>to the EB Terms and Conditions;<br>|
| "EB System" | the securities settlement system operated by Euroclear Bank and governed by Belgian law (or any <br>successor or assignee of it in such capacity from time to time) or any replacement for such system from <br>time to time;<br>|
| "EB Terms and Conditions" | the document issued by Euroclear Bank entitled "Terms and Conditions governing use of Euroclear" <br>dated June 2025;<br>|
| "Effective Date" | the date on which the 5% Preference Share Scheme becomes effective in accordance with its terms;  |
| "Effective Time" | the time on the Effective Date at which the 5% Preference Share Scheme Order and a copy of the minute <br>required by Section 86 of the Act are registered by the Registrar of Companies; <br>|
| "Euro" or "€"  | euro, the lawful currency of Ireland; |
| "Euronext" | the corporate group consisting of Euronext N.V., a company with limited liability ("naamloze <br>venootschap") organised under the laws of the Netherlands, Euronext Brussels, Euronext Dublin, <br>Euronext Lisbon, Euronext Paris and Oslo Børs and/or any other subsidiary of Euronext N.V., as the <br>context may require;<br>|
| "Euronext Dublin" | the Irish Stock Exchange plc, trading as Euronext Dublin incorporated and registered in Ireland under the <br>Act with registered number 539157 (or any successor or assignee of it in such capacity from time to <br>time);<br>|
| "Euronext Growth Dublin" | a Euronext Growth market operated by Euronext Dublin;  |
| "Euronext Growth" | a multilateral trading facility within the scope of Article 4(1)(22) of MiFID II operated by the respective <br>Euronext Market Undertakings with the commercial name "Euronext Growth";<br>|
| "Holder" | in relation to any Ordinary Share and/or Preference Share, the Member whose name is entered in the <br>Register of Members as the holder of that share and any Joint Holder, including any person(s) entitled by <br>transmission; <br>|
| "Irish High Court" | the High Court of Ireland; |
| "Irish Revenue" | the Revenue Commissioners of Ireland, the Irish Government agency responsible for customs, excise, <br>taxation and related matters;<br>|
| "Joint Holder(s)" | the Members whose names are entered in the Register of Members as the joint holders of a 5% <br>Preference Share and includes any person(s) entitled by transmission;<br>|
| "Latest Practicable Date" | March 11, 2026; |
| "LSE" | the London Stock Exchange Group plc or the market conducted by it, as the context requires, or any <br>successor or assignee of it in such capacity from time to time or any replacement for such system from <br>time to time;<br>|
| "Members" | the members of CRH as entered in the Register of Members at any relevant date and "Member" will be <br>interpreted accordingly;<br>|

---

94<br>

CRH PROXY STATEMENT 2026

---

| | |
|:---|:---|
| "Ordinary Shareholders" | a Holder of Ordinary Shares; |
| "Ordinary Shares" | the ordinary shares of €0.32 each in the share capital of CRH; |
| "Overseas Shareholders" | a 5% Preference Shareholder who is resident in, ordinarily resident in, or a citizen of a jurisdiction outside <br>of Ireland;<br>|
| "Preference Shares" | the 5% Preference Shares and the 7% Preference Shares; |
| "Preference Shareholders" | the 5% Preference Shareholders and the 7% Preference Shareholders; |
| "Preference Share Scheme Circular(s)" | the 5% Preference Share Scheme Circular and/or the 7% Preference Share Scheme Circular, as the <br>context so requires;<br>|
| "Proxy Statement" | the 2026 Notice of Meeting and Proxy Statement issued to Ordinary Shareholders and 7% Preference <br>Shareholders (and made available to 5% Preference Shareholders for information purposes only) on <br>March 27, 2026 and available on CRH's website at *www.crh.com/investors/shareholder-meetings;* <br>|
| "Reduction of Capital" | the reduction of the share capital of CRH by the cancellation of the 5% Preference Share Scheme Shares <br>to be effected as part of the 5% Preference Share Scheme as referred to in Clause 2 of this 5% <br>Preference Share Scheme;<br>|
| "Register of Members" | the register of members of CRH which is maintained pursuant to Section 169 of the Act; |
| "Registrar" | Computershare Investor Services (Ireland) Limited, 3100 Lake Drive, Citywest Business Campus, Dublin <br>24, D24 AK82, Ireland, or such other registrar as may be appointed by the Company from time to time;<br>|
| "Registrar of Companies" | the Registrar of Companies in Dublin, Ireland; |
| "Regulatory Information Service" | a regulatory information service as defined in the Irish Takeover Rules; |
| "Restricted Jurisdiction" | any jurisdiction in respect of which it would be unlawful for the 5% Preference Share Scheme Circular to <br>be released, published or distributed, in whole or in part;<br>|
| "Restricted Overseas Shareholder" | a 5% Preference Shareholder (including an individual, partnership, unincorporated syndicate, limited <br>liability company, unincorporated organisation, trust, trustee, executor, administrator or other legal <br>representative) in, or resident in, or any 5% Preference Shareholder whom CRH believes to be in, or <br>resident in, a Restricted Jurisdiction;<br>|
| "Scheme Document(s)" | the 5% Preference Share Scheme Document and/or the 7% Preference Share Scheme Document, as <br>the context so requires;<br>|
| "Scheme Meeting(s)" | the 5% Preference Share Scheme Meeting and/or the 7% Preference Share Scheme Meeting as the <br>context so requires;<br>|
| "Scheme(s)" or "Scheme(s) of Arrangement"  | the 5% Preference Share Scheme and/or the 7% Preference Share Scheme, as the context so requires; |
| "Tax Treaty Country" | a country which has signed a Double Taxation Agreement with Ireland; |
| "TCA" | Taxes Consolidation Act 1997;  |
| "Voting Record Time" | 7:00 p.m. (Dublin) on May 17, 2026 or, if the 5% Preference Share Scheme Meeting is adjourned, on the <br>day that is four days before the day appointed for the adjourned meeting;<br>|

---

and unless otherwise specified, references to Clauses are Clauses of this 5% Preference Share Scheme.

2. Cancellation of the 5% Preference Share Scheme Shares

Pursuant to Sections 84 to 86 and Chapter 1 of Part 9 of the Act and Article 54 of the Articles, and upon and with effect from the Effective Time,

the issued share capital of CRH shall be reduced by cancelling and extinguishing all of the 5% Preference Share Scheme Shares, and thereby

reducing the amount standing to the credit of the Company's preference share capital account by an amount equal to the nominal value of the

5% Preference Share Scheme Shares at the Effective Time, being a sum of €63,500.

3. Consideration for the Cancellation of the 5% Preference Share Scheme Shares

3.1In consideration for the cancellation of the 5% Preference Share Scheme Shares pursuant to Clause 2, the Company shall pay to (or

procure the payment to) each Holder of 5% Preference Share Scheme Shares (as appearing on the Register of Members at the 5%

Preference Share Scheme Record Time) an amount in cash equal to €2.54 in respect of each 5% Preference Share Scheme Share

cancelled (the "5% Cancellation Consideration") (without interest and less any applicable withholding taxes (if any) as may be required by

law), in accordance with Clause 4 of this 5% Preference Share Scheme. The Company shall procure that the 5% Cancellation

Consideration is distributed to such Holders of the 5% Preference Share Scheme Shares within 14 days of the Effective Date in

accordance with Clause 4 of this Scheme.

3.2The 5% Cancellation Consideration represents a premium of 100% to the nominal value of each 5% Preference Share, with such premium

above nominal value to be paid from the Company's profits available for distribution, and the nominal value to be paid by repayment of

capital. The 5% Cancellation Consideration comprises the entire amount payable in respect of the cancellation of the 5% Preference

Shares and there is no separate entitlement or payment in respect of any dividend entitlement unpaid or otherwise accrued up to and

including the Effective Time.

3.3Neither CRH nor its agents shall be liable to any 5% Preference Share Scheme Shareholder for any cash payment, dividends or

distributions with respect to the 5% Preference Share Scheme Shares delivered to a public official in compliance with any abandoned

property, escheat or law permitting attachment of money or property or similar law.

4. Settlement of the 5% Cancellation Consideration

4.1Not later than 14 days after the Effective Date, the 5% Cancellation Consideration to which any 5% Preference Share Scheme

Shareholder is entitled under the 5% Preference Share Scheme will be distributed in the following manner:

(a)in the case of 5% Preference Share Scheme Shares which at the 5% Preference Share Scheme Record Time are in registered

95<br>

CRH PROXY STATEMENT 2026

form, in accordance with the provisions of Clause 4.3 of this 5% Preference Share Scheme, by means of a SEPA payment to the

5% Preference Shareholder's nominated bank account for CRH distributions in respect of the 5% Preference Shares (unless such

Holder of the 5% Preference Share Scheme Shares notifies the Registrar in writing prior to the 5% Preference Share Scheme

Record Time revoking that mandate and requesting that the 5% Cancellation Consideration be paid by cheque, in the same

manner as those without a bank mandate in place or to an alternate bank account) or, absent a bank mandate being recorded on

the Register of Members by the 5% Preference Share Scheme Record Time, by the despatch of cheques payable in Euro (€) for

the sums payable to them, in accordance with Clause 3.1 of this 5% Preference Share Scheme and Article 137 of the Articles; or

(b)in the case of 5% Preference Share Scheme Shares which at the 5% Preference Share Scheme Record Time are in unregistered

form (i.e. held through the EB System), by electronically transferring the sum to Euroclear Bank and the cash to which the 5%

Preference Share Scheme Shareholder is entitled will be paid in euro (€) by means of the EB System.

4.2As from the 5% Preference Share Scheme Record Time, each holding of 5% Preference Share Scheme Shares credited to any securities

clearance account in the EB System shall be disabled and all 5% Preference Share Scheme Shares will be removed from the EB System

in due course.

4.3Consideration payable to 5% Preference Shareholders with dividend bank mandates shall be paid by means of SEPA. All despatches of

cheques required to be made pursuant to this 5% Preference Share Scheme shall be effected by sending the same through the post in

prepaid envelopes addressed to the Holders entitled thereto at their respective registered addresses as appearing in the Register of

Members at the 5% Preference Share Scheme Record Time (or, in the case of Joint Holders, at the registered address of that one of the

Joint Holders whose name stands first in the said Register of Members in respect of such joint holding at the 5% Preference Share

Scheme Record Time) or in accordance with any special instructions regarding communications, and neither CRH nor its respective

agents shall be responsible for any loss or delay in the transmission of any cheques sent in accordance with this Clause 4.3, which shall

be sent at the risk of persons entitled thereto.

4.4All cheques drawn in accordance with this Clause 4 shall be in Euro (€) and, subject to Clause 4.5, shall be made payable to the 5%

Preference Share Scheme Shareholder or, in the case of Joint Holders, to that one Joint Holder who is the first named Holder of the 5%

Preference Share Scheme Shares concerned, or as otherwise properly directed by the persons entitled thereto, and the despatch of any

such cheque shall be a complete discharge to CRH for the moneys represented thereby.

4.5Each mandate in force on the Effective Date relating to the payment of dividends or other distributions on any 5% Preference Share

Scheme Shares and other instructions given to CRH by Holders of the 5% Preference Shares shall, unless notice of revocation of such

instructions is received by the Registrar prior to the 5% Preference Share Scheme Record Time, be deemed to be an effective mandate or

instruction to CRH to pay and dispatch the 5% Cancellation Consideration payable under Clause 3 in accordance with such mandate.

5. Certificates for 5% Preference Share Scheme Shares

With effect from the Effective Date, (i) except for the payment obligations required to be made under Clause 4, Euroclear Bank shall be instructed

to disable the entitlements to 5% Preference Share Scheme Shares of Holders of 5% Preference Share Scheme Shares in unregistered form and

(ii) any certificates or other statements of ownership representing 5% Preference Share Scheme Shares shall cease to have effect as documents

of title to the shares comprised therein and every holder thereof shall be bound at the request of CRH to deliver up such certificates and/or

statements to CRH as CRH may direct.

6. Conditions of the 5% Preference Share Scheme of Arrangement

The 5% Preference Share Scheme will not be completed unless, among other things, the following conditions are satisfied or, if allowed by law,

waived:

(a)approval of the 5% Preference Share Scheme by the 5% Preference Shareholders who represent at least 75% in value of the

members present and voting either in person or by proxy at the 5% Preference Share Scheme Meeting, and with the quorum of at

least two persons holding or representing in person or by proxy at least one-third in nominal value of the 5% Preference Shares in

issue being satisfied at the 5% Preference Share Scheme Meeting;

(b)each of Proposals 8, 9, 10 and 11 (set out in the Proxy Statement) are duly passed by the requisite majorities of Ordinary

Shareholders (and 7% Preference Shareholders, voting with the Ordinary Shareholders, in respect of Proposal 9 only) at the AGM

(or any adjournment of such meeting);

(c)the sanction by the Irish High Court of the 5% Preference Share Scheme (with or without any modification(s), addition(s) or

condition(s) approved or imposed by the Irish High Court) pursuant to section 453 of the Act, and the confirmation of the

Reduction of Capital involved therein by the Irish High Court;

(d)the delivery of a copy of the 5% Preference Share Scheme Order, together with the minute required by Section 86 of the Act, to

the Registrar of Companies for registration in accordance with Section 454 of the Act, and registration of the 5% Preference Share

Scheme Order and minute confirming the Reduction of Capital by the Registrar of Companies; and

(e)the Board not having resolved to abandon, discontinue and/or withdraw the 5% Preference Share Scheme prior to the 5%

Preference Share Court Hearing.

7. Delisting from Euronext Growth Dublin

In connection with the cancellation of the 5% Preference Shares, the Company has applied to Euronext Growth Dublin for the cancellation of the

listing and admission to trading of the 5% Preference Shares on Euronext Growth Dublin, with such delisting being subject to receipt of the

requisite approvals for the cancellation of the 5% Preference Shares at the AGM and the 5% Preference Share Scheme Meeting. If the 5%

Preference Share Scheme becomes effective, approval by the requisite majority of 5% Preference Shareholders of the 5% Preference Share

Scheme shall be deemed to be their consent to the cancellation of the listing and admission to trading of the 5% Preference Shares from

Euronext Growth Dublin. If the 5% Preference Share Scheme becomes effective, the delisting from Euronext Growth Dublin is expected to take

effect on or around the Effective Time.

8. Overseas Shareholders

8.1The provisions of Clauses 2, 3 and 4 shall be subject to any prohibition or condition imposed by law.

96<br>

CRH PROXY STATEMENT 2026

8.2Notwithstanding the provisions of Clause 8.1, CRH retains the right to permit the release, publication or distribution of the 5% Preference

Share Scheme Circular (or any parts thereof) and/or the Proxy Statement to any Restricted Overseas Shareholder who satisfies CRH (in its

sole discretion) that doing so will not infringe the laws of the relevant Restricted Jurisdiction, or require compliance with any governmental

or other consent or any registration, filing or other formality that CRH is unable to comply with or which CRH regards as unduly onerous to

comply with.

9. The Effective Time

This 5% Preference Share Scheme shall become effective as soon as a copy of the 5% Preference Share Scheme Order and a copy of the minute

required by Section 86 of the Act have been delivered to the Registrar of Companies for registration and registered by the Registrar of

Companies. This is subject to CRH not having agreed prior to the Effective Date, with the consent of the Irish High Court (where required), not to

proceed with the 5% Preference Share Scheme and in such case all undertakings given to the Irish High Court in respect of this 5% Preference

Share Scheme shall be deemed to have lapsed with immediate effect.

10. Modification

CRH may consent on behalf of all persons concerned to any modification of or addition to this 5% Preference Share Scheme or any condition that

the Irish High Court may approve or impose.

11. Costs

The costs of the 5% Preference Share Scheme, including costs of the preparation, approval and implementation of the 5% Preference Share

Scheme, will be paid by CRH.

12. Governing Law

This 5% Preference Share Scheme shall be governed by, and construed in accordance with, the laws of Ireland. CRH and the 5% Preference

Share Scheme Shareholders hereby agree that the Irish High Court shall have exclusive jurisdiction to hear and determine any suit, action or

proceeding or to settle any dispute which may arise in relation thereto and the sanction thereof.

Date: March 27, 2026

97<br>

CRH PROXY STATEMENT 2026

Annex B – Part II – 5% Preference Share

Scheme Of Arrangement Explanatory

Statement

**The information contained in Annexes B and C of this Proxy Statement is not required to be included pursuant to the rules and** 

**regulations of the U.S. Securities and Exchange Commission, and is included solely to comply with the requirements of the** 

**Companies Act 2014 in order to provide the information required under such laws applicable to Preference Shareholders (in** 

**compliance with Section 452 of the Companies Act 2014). This "5% Preference Share Scheme of Arrangement Explanatory** 

**Statement" sets out the explanatory statement in respect of the 5% Preference Share Scheme for the purposes of Section 452** 

**of the Act.**

Capitalised terms used but not defined in this "5% Preference Share Scheme of Arrangement Explanatory Statement" have the meaning ascribed to

such terms in the "5% Preference Share Scheme of Arrangement". To each 5% Preference Share Scheme Shareholder at the 5% Preference Share

Scheme Meeting. Recommended Cancellation of the 5% Preference Shares to be implemented by way of a Scheme of Arrangement under Chapter 1

of Part 9 of the Act, and a capital reduction under Sections 84 and 85 of the Act.

1. Overview

1.1.On March 13, 2026, following a review of its LSE Ordinary Share listing as well as its preference share capital structure, CRH announced

its intention to delist the Ordinary Shares and 7% Preference Shares from the LSE, and subject to approval by Ordinary Shareholders and

Preference Shareholders, to cancel the 5% Preference Shares and 7 Preference Shares. As part of that review, the Board carefully

considered, amongst other factors, the additional cost and regulatory and administrative obligations arising from retaining the 5%

Preference Shares and the 7% Preference Shares. Following completion of the review, the Board concluded that it is in the best interests

of CRH and its Ordinary Shareholders and Preference Shareholders as a whole to seek to simplify the Company's share capital structure,

and reduce certain regulatory and administrative obligations applicable to it, by retiring CRH's two classes of legacy Preference Shares

(and delisting the 5% Preference Shares from Euronext Growth Dublin) in exchange for cash consideration, subject to approval of the

Ordinary Shareholders and the Preference Shareholders.

1.2.The total par value of the issued and outstanding legacy Preference Shares is €1,170,940, and there has been very little reported trading

in the Preference Shares over the past decade, leaving the Preference Shareholders with limited opportunity to sell their shares. The

proposed cancellations of the Preference Shares will provide the Preference Shareholders with the opportunity to convert their illiquid

assets into cash at a significant premium. CRH is required to comply with various administrative and regulatory requirements associated

with the Preference Shares. CRH believes that these compliance and other administrative burdens are disproportionate to the value of the

Preference Shares and the small percentage of the Company's total issued share capital that they represent (approximately .5%) as of the

Latest Practicable Date. The Board believes that the cancellations of the Preference Shares, if implemented, would yield a number of

efficiencies for CRH and its shareholders, through simplifying the Company's capital structure and streamlining applicable regulatory

requirements, while providing an opportunity to Preference Shareholders to monetize their holdings.

1.3.CRH proposes to cancel its two classes of Preference Shares (the "Preference Share Cancellations") pursuant to two separate schemes

of arrangement under Chapter 1 of Part 9 of the Act. A scheme of arrangement is a court-approved arrangement between a company and

its shareholders carried out in accordance with the Act. The Preference Share Cancellations will also involve the associated reduction of

capital under the Act to cancel the Preference Shares. Each of the Schemes of Arrangement and the related reduction of capital require

the approval of the Irish High Court.

1.4.The 5% Preference Shares are currently admitted to trading on Euronext Growth Dublin. The 7% Preference Shares are currently admitted

to trading on the LSE but will be delisted with effect from 8:00 a.m. (UK time) on April 20, 2026. The last day of trading of the 7%

Preference Shares on the LSE will be April 17, 2026.

1.5.The Preference Share Cancellations are subject to certain conditions set forth in the Schemes of Arrangement and will become effective

only after all such conditions have been satisfied or, if allowed by law, waived. Each Preference Share Cancellation will require, among

other things: (i) approval at the AGM of each of Proposals 8, 9, 10 and 11 (as set out in the Proxy Statement), (ii) approval by the

applicable class of Preference Shareholders at the Scheme Meetings, and (iii) the sanction of the applicable Scheme, and the confirmation

of the applicable reduction of capital, by the Irish High Court.

1.6.Subject to the satisfaction or, if allowed by law, waiver of the conditions, at the Effective Time, all Preference Shares will be cancelled

pursuant to Sections 84 to 86 of the Act in accordance with the terms of each Scheme. The conditions to each of the Preference Share

Cancellations are set out in Clause 6 of the applicable Scheme Document.

1.7.Under the terms of the proposed Schemes each class of Preference Shareholders will receive cancellation consideration of an amount

equal to 40 times the annual dividend per Preference Share. This reflects a value determined by reference to the annual dividend per

Preference Share capitalized at a rate of 2.5156% or approximately 100bps below the 30-year Bund rate as of March 12, 2026. Under the

terms of the proposed Schemes: (i) the 5% Preference Shareholders will receive the 5% Cancellation Consideration, representing 200% of

the nominal value per share, and (ii) the 7% Preference Shareholders will receive the 7% Cancellation Consideration, representing 280% of

the nominal value per share. The premium above nominal value will be paid from the Company's profits available for distribution, and the

nominal value will be paid by way of repayment of capital. The Cancellation Consideration comprises the entire amount payable in respect

of the cancellation of the Preference Shares and there is no separate entitlement or payment in respect of any dividend entitlement unpaid

98<br>

CRH PROXY STATEMENT 2026

or otherwise accrued up to and including the Effective Time. The total aggregate payment in consideration for the cancellation of the

Preference Shares will be €3.23 million (approximately $3.75 million). Given historic low levels of trading for the Preference Shares on their

respective exchanges (including predecessor exchanges), it is not possible to identify the market value of the Preference Shares and the

extent to which the Cancellation Consideration amounts to a premium to the market value of the Preference Shares. However, the Board

believes that the Cancellation Consideration represents a significant premium to the value of the Preference Shares.

1.8.The Company has applied to the UK Financial Conduct Authority (the "FCA") and the LSE respectively for the listing of the 7% Preference

Shares on the official list of the FCA to be cancelled and for the admission to trading of the 7% Preference Shares on the Main Market of

the LSE to be cancelled, with such delisting to become effective from 8:00 a.m. (UK time) on April 20, 2026. The Company has also

applied to Euronext Growth Dublin for the cancellation of the listing and admission to trading of the 5% Preference Shares on Euronext

Growth Dublin, with such delisting being subject to receipt of the requisite approvals for the cancellation of the 5% Preference Shares at

the AGM and the 5% Preference Share Scheme Meeting. If the 5% Preference Share Scheme becomes effective, the delisting from

Euronext Growth Dublin is expected to take effect on or around the Effective Time.

1.9.The text of each Scheme of Arrangement is set out in full in Part I of Annex B and Annex C of the Proxy Statement and in the applicable

Preference Share Scheme Circular.

The 5% Preference Share Scheme

1.10.If the requisite approvals are obtained at the AGM and the 5% Preference Share Scheme Meeting, CRH will apply to the Irish High Court

to set a date for the hearing to sanction the 5% Preference Share Scheme under Section 453(2)(c) of the Act and to confirm the

Reduction of Capital. Legal notices advertising the date of the 5% Preference Share Court Hearing will be published following the

application by CRH.

1.11.If the 5% Preference Share Scheme is implemented, at the Effective Time (i) the 5% Preference Shares will be automatically cancelled,

and extinguished in exchange for a cash payment of the 5% Cancellation Consideration to the 5% Preference Share Scheme

Shareholders, (ii) the Company's capital will be reduced pursuant to Sections 84 to 86 of the Act by the cancellation of an amount

standing to the credit of the Company's preference share capital account equal to the nominal value of the 5% Preference Shares as at

the Effective Time (being an amount equal to €63,500), (iii) the Articles will be amended to remove references to the 5% Preference Shares

and to include a new Article to facilitate implementation of the 5% Preference Share Scheme, (iv) the authorised share capital of the

Company will be varied by the removal of the aggregate amount associated with the 5% Preference Shares, being an amount equal to

€190,500, and (v) the listing and the admission to trading of the 5% Preference Shares on Euronext Growth Dublin will be cancelled.

1.12.Provided the conditions to the 5% Preference Share Scheme are satisfied or, if permitted by law, waived, the 5% Preference Share

Scheme is expected to take effect in accordance with its terms as soon as a copy of the 5% Preference Share Scheme Order sanctioning

the 5% Preference Share Scheme together with the minute required by Section 86(1) of the Act have been delivered to the Registrar of

Companies for registration and registered by the Registrar of Companies. As at the Latest Practicable Date, the 5% Preference Share

Scheme is expected to become effective before the end of July 2026. The timing depends on a number of factors including the availability

of the Irish High Court to hear the application to sanction the 5% Preference Share Scheme and, if sanctioned, the date the 5%

Preference Share Scheme Order is delivered to and registered by the Registrar of Companies.

1.13.Upon the 5% Preference Share Scheme becoming effective, it will be binding on all 5% Preference Shareholders, irrespective of whether

or not they attended or voted on the relevant resolutions at the 5% Preference Share Scheme Meeting, or whether they voted in favour of

or against the 5% Preference Share Scheme.

1.14.The effectiveness of the 5% Preference Share Scheme will be notified to Ordinary Shareholders and Preference Shareholders by (i) an

announcement through a Regulatory Information Service, with such announcement being made available on the Company's website, and/

or (ii) in such other manner as the Irish High Court might direct.

1.15.The expected dates set out above are subject to change at the discretion of the Board, and any such change will be announced on the

Company's website and (where required) in the manner set out in (i) and/or (ii) above.

2. Consents and Meetings

2.1.The 5% Preference Share Scheme Meeting is being convened pursuant to the authority of the Board to seek the approval of the 5%

Preference Share Scheme by the 5% Preference Shareholders as of the Voting Record Time. The 5% Preference Share Scheme Meeting

is to be held at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland on May 21, 2026 at 10:30 a.m. (Dublin),

or if later, immediately after the conclusion or adjournment of the preceding 7% Preference Share Scheme Meeting.

2.2.Notice of the 5% Preference Share Scheme Meeting was distributed to the 5% Preference Shareholders on March 27, 2026 and forms

part of the 5% Preference Share Scheme Circular. Entitlement to notice of and/or to vote at the 5% Preference Share Scheme Meeting

will be determined by reference to the Register of Members at the Voting Record Time. The purpose of the 5% Preference Share Scheme

Meeting is to consider and vote on the 5% Preference Share Scheme. The Irish High Court can only sanction the 5% Preference Share

Scheme, and the 5% Preference Share Scheme can only be effective, if it, among other things, is approved by the necessary majority of

5% Preference Shareholders at the 5% Preference Share Scheme Meeting.

2.3.In addition to requiring approval at the 5% Preference Share Scheme Meeting, implementation of the 5% Preference Share Scheme also

requires approval by the Ordinary Shareholders (and the 7% Preference Shareholders, voting with the Ordinary Shareholders as a single

class, for the purposes of Proposal 9 only) of Proposals 8, 9, 10 and 11 at the AGM which are necessary to effect and to implement the

5% Preference Share Scheme, as described below. The AGM is to be held at the Royal Marine Hotel, Marine Road, Dún Laoghaire, Co.

Dublin, Ireland on May 7, 2026 at 11:00 a.m. (Dublin), and the Proxy Statement was made available to Ordinary Shareholders and the 7%

Preference Shareholders and, for information only, to the 5% Preference Shareholders on March 27, 2026, and is available here:

*www.crh.com/investors/shareholder-meetings*. Entitlement to notice of and/or to vote at the AGM will be determined by reference to the

Register of Members at the AGM Voting Record Time.

2.4.The 5% Preference Shares carry limited voting rights, and the Holders of the 5% Preference Shares are not entitled to attend and vote at

general meetings unless their dividends are in arrears, or in other limited circumstances. As such, the 5% Preference Shareholders are not

99<br>

CRH PROXY STATEMENT 2026

entitled to vote on the resolutions proposed at the AGM, but rather will vote on the 5% Preference Share Scheme at the 5% Preference

Share Scheme Meeting.

2.5.As of the Latest Practicable Date, 50,000 5% Preference Shares were issued and outstanding and there were 37 registered members in

respect of the 5% Preference Shares whose names were registered in the Register of Members.

3. The 5% Preference Share Scheme Meeting

3.1.The 5% Preference Share Scheme Meeting has been convened for 10:30 a.m. (Dublin), or if later, immediately after the conclusion or

adjournment of the preceding 7% Preference Share Scheme Meeting, on May 21, 2026 to enable the 5% Preference Share Scheme

Shareholders to consider and, if thought fit, approve the 5% Preference Share Scheme.

3.2.To be passed, the resolution to approve the 5% Preference Share Scheme requires the approval of 5% Preference Shareholders

representing at least 75% in value of the 5% Preference Share Scheme Shares held by such holders at the Voting Record Time voting in

person or by proxy. The quorum for the 5% Preference Share Scheme Meeting (or at any adjournment of such meeting) shall be at least

two persons holding or representing by proxy at least one-third in nominal value of the 5% Preference Shares.

3.3.At the 5% Preference Share Scheme Meeting, voting will be by poll and not by a show of hands, and each holder of 5% Preference Share

Scheme Shares as at the Voting Record Time who is present (in person or by proxy) will be entitled to one vote for each 5% Preference

Share Scheme Share held as of the Voting Record Time.

4. The AGM

4.1.In addition to the 5% Preference Share Scheme Meeting, the AGM will take place for the Ordinary Shareholders (and the 7% Preference

Shareholders, voting with the Ordinary Shareholders as a single class, for the purposes of Proposal 9 only) to consider and, if thought fit,

approve Proposals 8 through 11 at the AGM in connection with the Preference Share Cancellations (which in the case of a special

resolution require a vote in favour of not less than three-fourths (75%) of the votes cast in person or by proxy, and in respect of an

ordinary resolution requires a simple majority (>50%) of the votes cast in person or by proxy).

4.2.The Proposals to be voted upon are set out in full on pages 31 to 38 of the Proxy Statement. In summary, at the AGM, Ordinary

Shareholders (and 7% Preference Shareholders, voting with the Ordinary Shareholders as a single class, for the purposes of Proposal 9

only) will be asked to approve: (i) the Schemes and to authorise the directors of CRH to give effect to the Schemes (as described in

Proposal 8), (ii) the capital reduction relating to the cancellation of any class(es) of Preference Shares cancelled pursuant to the Schemes

(Proposal 9), (iii) a variation in CRH's authorised share capital to remove any cancelled class(es) of Preference Shares (Proposal 10), and

(iv) certain amendments to the Articles to remove references to any class(es) of Preference Shares cancelled pursuant to the Schemes

(Proposal 11), in each case, subject to (A) the applicable Scheme being approved by the requisite majorities at the applicable Scheme

Meeting, (B) the Irish High Court sanctioning the applicable Scheme and confirming the applicable Reduction of Capital, and (C) each of

Proposals 8 to 11 being approved by the requisite majorities at the AGM.

5.5% Preference Share Irish High Court Hearing

5.1.If the requisite approvals are obtained at the AGM and the 5% Preference Share Scheme Meeting, the 5% Preference Share Court

Hearing to sanction the 5% Preference Share Scheme is expected to be held before the end of July 2026, subject to the discretion of the

Irish High Court. All 5% Preference Shareholders of record are entitled to attend the 5% Preference Share Court Hearing in person, or

may be represented by counsel or a solicitor at their own expense to support or oppose the sanctioning of the 5% Preference Share

Scheme.

6. Interests Held by CRH Directors and Executive Officers and the effect of the 5% Preference Share Scheme on their Interests

6.1.No director or executive officer of the Company holds any interests in the 5% Preference Shares, or has any substantial interests, directly

or indirectly, in the matters relating to the Preference Share Cancellations. The effect of the 5% Preference Share Scheme on the interests

of the CRH directors, does not differ from its effect on the like interests of other persons.

7. Amendment or Termination

7.1.The 5% Preference Share Scheme may be amended, modified or supplemented at any time before or after its approval at the 5%

Preference Share Scheme Meeting. However, after approval at the 5% Preference Share Scheme Meeting, no amendment, modification

or supplement may be made or effected to the 5% Preference Share Scheme that legally requires further approval by the 5% Preference

Shareholders without obtaining such approval.

7.2.At the 5% Preference Share Court Hearing, the Irish High Court may impose such conditions as it deems appropriate in relation to the 5%

Preference Share Scheme. The Board of Directors may consent on behalf of all persons concerned to any modification of or addition to

the 5% Preference Share Scheme or any condition that the Irish High Court may approve or impose. The Irish High Court would be

unlikely to approve or impose any modification of, or addition to, or a condition to, the 5% Preference Share Scheme which might be

materially adverse to the interests of the 5% Preference Shareholders, unless such 5% Preference Shareholders were informed of any

such modification, addition or condition. It would be a matter for the Irish High Court to decide in its discretion whether or not a further

meeting or meetings of the 5% Preference Shareholders should be held in these circumstances. Similarly, if a modification, addition or

condition is put forward which, in the opinion of the Board of Directors, is of such a nature or importance that it requires the consent of

5% Preference Shareholders at a further meeting or meetings, the Board of Directors will not take the necessary steps to enable the 5%

Preference Share Scheme to become effective unless and until such consent is obtained.

8. Settlement, Listing and Dealings

8.1.The Company has applied to Euronext Growth Dublin for the cancellation of the listing and admission to trading of the 5% Preference

Shares on Euronext Growth Dublin, with such delisting being subject to receipt of the requisite approvals for the cancellation of the 5%

Preference Shares at the AGM and the 5% Preference Share Scheme Meeting. If the 5% Preference Share Scheme becomes effective,

the last day of dealings in the 5% Preference Shares on Euronext Growth Dublin is currently expected to be on or around the Effective

Date. No transfers of 5% Preference Shares will be registered after this date.

8.2.Where, at the 5% Preference Share Scheme Record Time, a person holds 5% Preference Shares in registered form, payment of the 5%

Cancellation Consideration will be paid in accordance with Clause 3 and Clause 4 of the 5% Preference Share Scheme Document by

100<br>

CRH PROXY STATEMENT 2026

cheque payable in Euro (€) for the sums payable to them dispatched by ordinary prepaid post save that 5% Preference Shareholders that

hold their 5% Preference Shares in registered form and have a valid bank mandate in place with the Registrar for the purposes of

receiving 5% Preference Share distributions into that bank account, will receive cash due under the 5% Preference Share Scheme into

that bank account as described in Clauses 3 and 4 of the 5% Preference Share Scheme Document.

8.3.Where, at the 5% Preference Share Scheme Record Time, a 5% Preference Shareholder holds 5% Preference Shares in unregistered

form (i.e. through the EB System), the 5% Cancellation Consideration to which such 5% Preference Shareholder is entitled will be paid in

Euro (€) by means of the EB System by CRH procuring the electronic transfer of the sum payable to Euroclear Bank as described in

Clauses 3 and 4 of the 5% Preference Share Scheme Document.

9. Tax Information in Respect of the 5% Preference Share Scheme

THE TAX CONSIDERATIONS SUMMARISED BELOW ARE FOR GENERAL INFORMATION ONLY AND ARE IN RESPECT OF TAX

CONSIDERATIONS OF THE SCHEMES ONLY. EACH 5% PREFERENCE SHAREHOLDER SHOULD CONSULT HIS OR HER OWN TAX

ADVISER AS TO THE PARTICULAR TAX CONSEQUENCES THAT MAY APPLY TO SUCH PREFERENCE SHAREHOLDER.

Irish Tax Considerations

Scope of Summary

9.1.The following is a summary of the material Irish tax considerations applicable to the persons who are the ultimate owners of the 5%

Preference Shares for Irish tax purposes and references to "5% Preference Shareholders" in this summary in paragraph 9 should be read

accordingly.

9.2.References to "Non-Irish Holders" in this paragraph 9 are to 5% Preference Shareholders who: are the absolute beneficial owners of their

5% Preference Shares; are neither resident (nor, in the case of individuals, ordinarily resident) in Ireland for Irish tax purposes; and the 5%

Preference Shares have not at any time been (i) used in or for the purposes of a trade carried on by that 5% Preference Shareholder

through an Irish branch or agency; nor (ii) used, held or acquired for use by or for the purposes of such branch or agency.

9.3.This summary is based on existing Irish tax law and the published practice of the Irish Revenue in or around the date of this document.

Changes in law and/or administrative practice may result in a change in the Irish tax considerations described below, possibly with

retrospective effect. Furthermore, we can provide no assurances that the tax consequences contained in this summary will not be

challenged by the Irish Revenue or will be sustained by an Irish court if they were to be challenged. This summary does not constitute

legal or tax advice and is intended only as a general guide. The summary is not exhaustive, and 5% Preference Shareholders should

consult their own tax advisors regarding the Irish tax consequences (and tax consequences under the laws of other relevant jurisdictions)

of the acquisition, ownership and disposal of 5% Preference Shares pursuant to the Schemes. The summary applies only to certain

categories of person and, in particular, may not apply to such persons as dealers in securities, trustees, insurance companies, collective

investment schemes, persons who acquired their 5% Preference Shares or, who are deemed to have acquired their 5% Preference

Shares, by virtue of an office or employment (performed or carried on to any extent in Ireland) or entities associated with the Company

(being entities (i) which are, directly or indirectly, entitled to more than 50% of the ownership rights, voting power or profits of the

Company (or entities in which the Company holds such an entitlement), (ii) which have definite influence in the Company (or entities in

which the company has such influence); or (iii) where a third entity has such entitlements or influence in respect of another entity and the

Company).

9.4.The law or practice of Irish Revenue may change, prospectively or retroactively, which could increase, reduce or mitigate possible tax

consequences for 5% Preference Shareholders. Also, the assumed practices may not be issued by the Irish Revenue. The position under

current Irish law is uncertain and CRH makes no assurances on the tax position for Preference Shareholders.

9.5.PREFERENCE SHAREHOLDERS WHO ARE IN ANY DOUBT ABOUT THEIR TAX POSITION AND / OR MAY BE SUBJECT TO TAXATION

IN ANY JURISDICTION OTHER THAN IRELAND ARE STRONGLY RECOMMENDED TO CONSULT AN APPROPRIATELY QUALIFIED

INDEPENDENT PROFESSIONAL ADVISER IMMEDIATELY.

Irish Capital Gains Tax

Non-Irish resident shareholders

9.6In general, a non-Irish 5% Preference Shareholder should not be within the charge to Irish capital gains tax, referred to as "Irish CGT", or

corporation tax on chargeable gains (as applicable) on the disposal of their 5% Preference Shares pursuant to the 5% Preference Share

Scheme.

9.7A 5% Preference Shareholder who is an individual and who is temporarily non-resident in Ireland may, under Irish anti-avoidance

legislation, be liable to Irish CGT on any chargeable gain realised on the disposal of their 5% Preference Shares during the period in which

the individual is a non-resident.

Irish resident shareholders

9.85% Preference Shareholders that are resident or ordinarily resident in Ireland for Irish tax purposes or that have used their 5% Preference

Shares in or for the purposes of a trade carried on by the 5% Preference Shareholder in Ireland through a branch or agency, or whose 5%

Preference Shares were used or held or acquired for use by or for the purposes of such a branch or agency (each an "Irish Holder") will,

subject to the availability of any exemptions and reliefs, generally be within the charge to Irish CGT on the disposal of their 5% Preference

Shares pursuant to the Schemes.

9.9For the purpose of Irish CGT, an Irish Holder should be treated as having made a disposal of their 5% Preference Shares for consideration

of an amount equal to the cash received for the cancellation of the 5% Preference Shares pursuant to the Scheme. This may, subject to

the Irish Holder's individual circumstances and any available exemption or relief, give rise to a chargeable gain (or allowable loss) for the

purposes of Irish CGT. Irish CGT applies a rate of 33% on any chargeable gain (subject to any available exemption or relief).

Irish Dividend Withholding Tax

9.10Payments made by CRH to 5% Preference Shareholders under the Schemes for the redemption, repayment or purchase of its 5%

Preference Shares will not be subject to DWT in Ireland where the arrangement does not form part of a scheme the main purpose of

which is to enable the owner of the shares to participate in the profits of the company without receiving a dividend. Unless exempted, any

101<br>

CRH PROXY STATEMENT 2026

dividends or other relevant distributions paid by CRH to 5% Preference Shareholders under the Schemes will be subject to withholding at

the standard rate of income tax (currently 25%). The withholding tax requirement will not apply to distributions paid to certain categories

of Irish resident 5% Preference Shareholders or to distributions paid to certain categories of non-Irish resident 5% Preference

Shareholders.

9.11The following Irish resident 5% Preference Shareholders, inter alia, are exempt from withholding if, on a timely basis in advance of the

payment of any relevant dividend they make an appropriate declaration of entitlement to exemption to CRH:

(a) Irish resident companies;

(i)pension schemes approved by the Irish Revenue;

(ii) qualifying fund managers or qualifying savings managers in relation to approved retirement funds or approved

minimum retirement funds;

(iii) PRSA administrators who receive the relevant distribution as income arising in respect of PRSA assets;

(iv) qualifying employee share ownership trusts;

(v) collective investment undertakings;

(vi) tax-exempt charities;

(vii) designated brokers receiving the distribution for special portfolio investment accounts;

(viii)any person who is entitled to exemption from income tax under Schedule F on dividends in respect of an investment in

whole or in part of payments received in respect of a civil action or from the Personal Injuries Assessment Board for

damages in respect of mental or physical infirmity;

(ix)certain qualifying trusts established for the benefit of an incapacitated individual and/or persons in receipt of income from

such a qualifying trust;

(x)any person entitled to exemption to income tax under Schedule F by virtue of section 192(2) of the TCA;

(xi)unit trusts to which section 731(5)(a) of the TCA applies; and

(xii)certain Irish Revenue-approved amateur and athletic sport bodies.

9.12The following non-resident 5% Preference Shareholders are exempt from withholding if they make to CRH, in advance of payment of any

dividend, an appropriate declaration of entitlement to exemption:

(a)persons (other than a company) who (i) are neither resident nor ordinarily resident in Ireland and (ii) are resident for tax

purposes in (a) a Tax Treaty Country or (b) an EU member state other than Ireland;

(bcompanies not resident in Ireland which are resident in an EU member state or a Tax Treaty Country and are not controlled,

directly or indirectly, by an Irish resident or Irish residents;

(c)companies not resident in Ireland which are directly or indirectly controlled by a person or persons who are, by virtue of the

law of a Tax Treaty Country or an EU member state, resident for tax purposes in a Tax Treaty Country or an EU member

state other than Ireland and which are not controlled directly or indirectly by persons who are not resident for tax purposes

in a Tax Treaty Country or EU member state;

(d)companies not resident in Ireland, the principal class of shares of which is substantially and regularly traded on a recognised

stock exchange in a Tax Treaty Country or an EU member state including Ireland or on an approved stock exchange; or

(e)companies not resident in Ireland that are 75% subsidiaries of a single company, or are wholly-owned by two (2) or more

companies, in either case the principal classes of shares of which is or are substantially and regularly traded on a

recognised stock exchange in a Tax Treaty Country or an EU member state including Ireland or on an approved stock

exchange.

9.13In the case of an individual non-Irish resident 5% Preference Shareholder resident in an EU member state or Tax Treaty Country, the

declaration must be accompanied by a current certificate of tax residence from the tax authorities in the 5% Preference Shareholder's

country of residence. In the case of both an individual and corporate non-Irish resident 5% Preference Shareholder resident in an EU

member state or Tax Treaty Country, the declaration must also contain an undertaking that he, she or it will advise the Company

accordingly if he, she or it ceases to meet the conditions to be entitled to the DWT exemption. No declaration is required if the 5%

Preference Shareholder is a 5% parent company in another EU member state in accordance with section 831 of the TCA.

9.14Investors who hold their shares through a qualifying intermediary should make the appropriate declaration of entitlement to exemption on

a timely basis to that intermediary.

Irish Stamp Duty

9.155% Preference Shareholders will not be chargeable to Irish stamp duty on the disposal of their 5% Preference Shares under the 5%

Preference Share Scheme.

10. Overseas Shareholder

10.1.As regards Overseas Shareholders, the 5% Preference Share Scheme may be affected by the laws of the relevant jurisdictions. Such

Overseas Shareholders should inform themselves about and observe any applicable legal requirements. It is the responsibility of Overseas

Shareholders to satisfy themselves as to the full observance of the laws of the relevant jurisdiction in connection therewith, including the

obtaining of any governmental, exchange control or other consents which may be required, or the compliance with other necessary

formalities which are required to be observed and the payment of any issue, transfer or other taxes due in such jurisdiction.

10.2.This explanatory statement has been prepared for the purposes of complying solely with the laws of Ireland, in particular with Section 452

of the Act, and the information disclosed may be different from that which would have been disclosed if this document had been prepared

in accordance with the laws of jurisdictions outside Ireland. Overseas Shareholders are encouraged to consult their local tax advisor.

102<br>

CRH PROXY STATEMENT 2026

11.5% Preference Share Forms of Proxy

11.1.5% Preference Shareholders who hold their 5% Preference Shares in their own name as of the date of this document have been sent a

5% Preference Share Form of Proxy for the 5% Preference Share Scheme Meeting. 5% Preference Shareholders are strongly encouraged

to complete and return their 5% Preference Share Forms of Proxy as soon as possible.

12. Action to be Taken

12.1.You will find enclosed with the 5% Preference Share Scheme Circular (i) the full terms of the 5% Preference Share Scheme of

Arrangement, (ii) the formal notice of the 5% Preference Share Scheme Meeting, and (iii) the 5% Preference Share Form of Proxy for use

at the 5% Preference Share Scheme Meeting. Your attention is drawn to the "Notes" section at the end of the notice of the 5% Preference

Share Scheme Meeting.

12.2.It is important that as many votes as possible are cast at the 5% Preference Share Scheme Meeting so that the Irish High Court may be

satisfied that there is a fair and reasonable representation of the opinion of 5% Preference Shareholders as of the Voting Record Time

when it is considering whether to sanction the 5% Preference Share Scheme. In addition, the quorum required for the 5% Preference

Share Scheme Meeting (or at any adjournment of such meeting) shall be at least two persons holding or representing in person or by

proxy at least one-third in nominal value of the 5% Preference Shares. You are therefore strongly encouraged to complete and return your

5% Preference Share Form of Proxy in accordance with the deadlines set out below.

Registered Shareholders

12.3For 5% Preference Shareholders whose name appears on the Register of Members (i.e. those who hold their 5% Preference Shares

directly on the Register of Members and who therefore do not hold their interests in 5% Preference Shares as Belgian Law Rights through

the EB System or as CDIs through the CREST securities settlement system ("CREST"), you may appoint a proxy by completing the

enclosed 5% Preference Share Form of Proxy. To be valid, the 5% Preference Share Form of Proxy must be delivered in writing, together

with any power of attorney or other authority under which it is signed or a certified copy thereof to the Registrar by post to Computershare

Investor Services (Ireland) Limited, 3100 Lake Drive, Citywest Business Campus, Dublin 24, D24 AK82, Ireland in the enclosed reply paid

envelope or by hand during normal business hours by no later than 10.30 a.m, (Dublin) on May 19, 2026 (being 48 hours prior to the 5%

Preference Share Scheme Meeting).

12.45% Preference Shareholders who wish to submit proxies by electronic means may do so up to the same deadline (i.e. not later than 48

hours prior to the meeting) by visiting www.exproxyappointment.com or scanning the QR code and following the instructions on the 5%

Preference Share Form of Proxy. 5% Preference Shareholders who have any queries in relation to the proxy appointment process, do not

receive a 5% Preference Share Form of Proxy by post, or who wish to be sent paper copies of documents relating to the 5% Preference

Share Scheme Meeting, should contact the Registrar (Computershare Investor Services (Ireland) Limited, 3100 Lake Drive, Citywest

Business Campus, Dublin 24, D24 AK82, Ireland or telephone (+353 (1) 6968467)). The completion of a 5% Preference Share Form of

Proxy will not preclude you from attending the 5% Preference Share Scheme Meeting and voting in person, if you wish to do so.

Holdings in Uncertificated Form as an EB Participant

12.55% Preference Shareholders who hold interests in the 5% Preference Shares through a participant account in the EB System can submit

electronic voting instructions in the manner described in the document issued by Euroclear Bank entitled 'Euroclear Bank as issuer CSD

for Irish corporate securities' and available on the Euroclear Bank website (www.euroclear.com).

12.6EB Participants can either send: electronic voting instructions to instruct EB Nominees to, either itself, or by appointing the Chair of the

5% Preference Share Scheme Meeting as a proxy to:

• vote in favour of the 5% Preference Share Scheme;

• vote against the 5% Preference Share Scheme;

• abstain in respect of the 5% Preference Share Scheme; and/or

• give a discretionary vote to the Chair of the 5% Preference Share Scheme Meeting in respect of the 5% Preference Share Scheme;

or

• give a proxy voting instruction to appoint a third party (other than EB Nominee or the Chair of the 5% Preference Share Scheme),

who may be a corporate representative or the EB Participant themselves, to attend the meeting and vote the number of 5%

Preference Shares specified in the proxy voting instruction by providing Euroclear Bank with the proxy details as requested in its

notification (e.g. proxy first name, proxy last name, proxy address). There is no facility to offer a letter of representation or to appoint

a corporate representative other than through submission of third party proxy appointment instructions.

Further detail in relation to the procedures for voting in respect of shares held through an EB Participant is set out in the "Notes" section in

the Notice of the 5% Preference Share Scheme Meeting. While the voting deadline will be confirmed by Euroclear Bank and notified by it

to EB Participants, Euroclear Bank will, wherever practical, aim to have a voting instruction deadline of one hour prior to the Company's

proxy appointment deadline (being 48 hours before the time appointed for the 5% Preference Share Scheme Meeting or any adjournment

thereof).

Holdings through CDIs in CREST

12.7As of the Latest Practicable Date, no 5% Preference Shareholders hold their interests in 5% Preference Shares through CDIs, but the

information below has been included in the event this changes before the Voting Record Time.

12.8Voting instructions for 5% Preference Shareholders who hold interests in the 5% Preference Shares as CDIs in the CREST system are to

be received via Broadridge. Further details on this service are set out on the 'All you need to know about SRD II in Euroclear UK & Ireland'

webpage of the Euroclear Bank website (www.euroclear.com) which is accessible to CREST participants (see section CREST International

Service – Proxy voting).

103<br>

CRH PROXY STATEMENT 2026

12.9CDI holders will be required to use the EUI proxy voting service facilitated by the Broadridge Global Proxy Voting service in order to

receive meeting announcements and send back voting instructions, as required. To facilitate client set up, CDI holders who wish to

participate in the proxy voting service, will need to complete a Meetings and Voting Client Set-up Form (CRT408), a copy of which is

available on the Euroclear Bank website (www.euroclear.com) which is accessible to CREST participants. Completed application forms

should be returned to EUI by an authorised signatory with another relevant authorised signatory copied in for verification purposes using

the following email address: uk-membership@euroclear.com. Fully completed and returned application forms will be shared with

Broadridge by EUI. This will enable Broadridge to contact a shareholder and share further detailed information on the service offering and

initiate the process for granting their access to the Broadridge platform.

12.10Further detail in relation to the procedures for voting in respect of shares held through CDIs is set out in the "Notes" section in the Notice

of the 5% Preference Share Scheme Meeting. While the voting deadline will be confirmed by, or on behalf of Euroclear UK (by Broadridge)

and notified by them to CDI holders, the voting deadline for holders of CDIs in respect of the 5% Preference Share Scheme Meeting is

expected to be two Business Days prior to Euroclear Bank's voting instruction deadline.

12.115% Preference Shareholders should consult with their stockbroker or other intermediary at the earliest opportunity for further information

on the processes and timelines for submitting proxies and voting instructions for the 5% Preference Share Scheme Meeting through the

respective systems.

12.12If you have any queries in relation to action to be taken, please contact the Registrar, Computershare Investor Services (Ireland) Limited,

3100 Lake Drive, Citywest Business Campus, Dublin 24, D24 AK82, Ireland, on (+353 (1) 6968467) between 9.00 a.m. and 5.00 p.m.

Monday to Friday (other than bank holidays in Ireland). For legal reasons, the Registrar will not be able to provide advice on the merits of

the cancellation itself or give financial, legal or tax advice.

13. Further Information

13.1.The terms of the 5% Preference Share Scheme are set out in full in "Part I – The 5% Preference Share Scheme of Arrangement" of Annex

B to the Proxy Statement and the 5% Preference Share Scheme Circular.

13.2.Further information regarding the Preference Share Cancellations is set out in the FAQs Regarding the LSE Delisting and Preference Share

Cancellations at Annex E of the Proxy Statement, which are available on the Company's website, www.crh.com under the heading

"Shareholder Center".

14. Board Recommendation

14.1.The Board considers the Preference Share Cancellations to be in the best interests of CRH and its Ordinary Shareholders and Preference

Shareholders as a whole. Your vote is very important. Whether or not you plan to attend the 5% Preference Share Scheme Meeting,

please take appropriate action to make sure your 5% Preference Shares are represented and voted at the 5% Preference Share Scheme

Meeting.

14.2.Accordingly, the Board unanimously recommends that you vote "FOR" the approval of the 5% Preference Share Scheme at the 5%

Preference Share Scheme Meeting.

104<br>

CRH PROXY STATEMENT 2026

Annex C – Part I – 7% Preference

Share Scheme of Arrangement

**The information contained in Annexes B and C of this Proxy Statement is not required to be included pursuant to the rules and** 

**regulations of the U.S. Securities and Exchange Commission, and is included solely to comply with the requirements of the** 

**Companies Act 2014 in order to provide the information required under such laws applicable to the Preference Shareholders.**

SCHEME OF ARRANGEMENT

THE HIGH COURT

IN THE MATTER OF

CRH PUBLIC LIMITED COMPANY

AND IN THE MATTER OF THE COMPANIES ACT 2014

SCHEME OF ARRANGEMENT

UNDER CHAPTER 1 OF PART 9 OF THE COMPANIES ACT 2014

BETWEEN CRH PUBLIC LIMITED COMPANY AND THE 7% PREFERENCE SHARE SCHEME SHAREHOLDERS

(AS HEREINAFTER DEFINED)

PRELIMINARY:

(A)CRH is a public limited company incorporated in Ireland under the Act with registration number 12965.

(B)The authorised share capital of CRH at the date of this 7% Preference Share Scheme is €401,297,940 divided into 150,000 5% Cumulative

Preference Shares of €1.27 each, 872,000 7% "A" Cumulative Preference Shares of €1.27 each and 1,250,000,000 Ordinary Shares of €0.32

each. As of the Latest Practicable Date, (i) 705,043,723 Ordinary Shares have been issued and are credited as fully paid and the remainder are

unissued, (ii) 50,000 5% Cumulative Preference Shares have been issued and are credited as fully paid and the remainder are unissued, and (iii)

872,000 7% "A" Cumulative Preference Shares have been issued and are credited as fully paid.

(C)The purpose of the 7% Preference Share Scheme is to provide for the cancellation of all 7% Preference Share Scheme Shares pursuant to a

scheme of arrangement under Chapter 1 of Part 9 of the Act and Sections 84 and 85 of the Act, in consideration for a cash payment of the 7%

Cancellation Consideration to the 7% Preference Share Scheme Shareholders, and to take certain steps to facilitate the foregoing.

(D)All references are to Dublin (Ireland) time unless otherwise stated.

(E)The explanatory statement required to be furnished pursuant to Section 452 of the Act is set out in "Part II - 7% Preference Share Scheme of

Arrangement Explanatory Statement" of Annex C to the Proxy Statement, and was also issued to the 7% Preference Shareholders on March 27,

2026 as part of the 7% Preference Share Scheme Circular.

105<br>

CRH PROXY STATEMENT 2026

**1. The Scheme of Arrangement** 

**1.1 Definitions**

---

| | |
|:---|:---|
| **In this 7% Preference Share Scheme, unless inconsistent with the subject or context, the following expressions bear the following meanings:** | **In this 7% Preference Share Scheme, unless inconsistent with the subject or context, the following expressions bear the following meanings:** |
| "5% Cancellation Consideration" | €2.54 for each 5% Preference Share cancelled pursuant to the 5% Preference Share Scheme; |
| "5% Preference Share Scheme" or "5% Preference <br>Share Scheme of Arrangement"<br>| the proposed scheme of arrangement under Chapter 1 of Part 9 of the Act, and the related reduction of <br>capital, with or subject to any modifications, addition(s) or condition(s) approved or imposed by the Irish <br>High Court and agreed to by CRH in relation to the cancellation of the 5% Preference Shares;<br>|
| "5% Preference Share Scheme Circular" | the document distributed to the 5% Preference Shareholders on March 27, 2026 in respect of the 5% <br>Preference Share Scheme containing (i) the 5% Preference Share Scheme Document, (ii) the notice of the <br>5% Preference Share Scheme Meeting, (iii) an explanatory statement as required by Section 452 of the <br>Act with respect to the 5% Preference Share Scheme (as also set out in 'Part II - 5% Preference Share <br>Scheme of Arrangement Explanatory Statement' of Annex B to the Proxy Statement), (iv) the form of <br>proxy, and (v) the accompanying cover letter;<br>|
| "5% Preference Share Scheme Document" | the document as set out in 'Part I – 5% Preference Share Scheme of Arrangement' of Annex B to the <br>Proxy Statement, and as also distributed to 5% Preference Shareholders as part of the 5% Preference <br>Share Scheme Circular;<br>|
| "5% Preference Shareholders" | Holders of the 5% Preference Shares;  |
| "5% Preference Shares" | the 50,000 5% Cumulative Preference Shares of €1.27 each in the share capital of CRH (ISIN: <br>IE0001827264), admitted to trading on Euronext Growth Dublin; <br>|
| "7% Cancellation Consideration" | has the meaning given to it in Clause 3.1; |
| "7% Preference Share Cancellation" | the cancellation of all of the 872,000 issued and outstanding 7% Preference Shares to be implemented <br>pursuant to the 7% Preference Share Scheme, and the related Reduction of Capital in exchange for a <br>cash payment of the 7% Cancellation Consideration;<br>|
| "7% Preference Share Court Hearing" | the hearing by the Irish High Court at which the application is made to sanction the proposed 7% <br>Preference Share Scheme under Section 453(2)(c) of the Act;<br>|
| "7% Preference Share Forms of Proxy" | the form of proxy for the 7% Preference Share Scheme Meeting and the form of proxy for the AGM, and <br>"7% Preference Share Forms of Proxy" shall mean any of them, which have been issued to 7% <br>Preference Shareholders on March 27, 2026 as part of the 7% Preference Share Scheme Circular; <br>|
| "7% Preference Share Scheme Circular" | the document distributed to the 7% Preference Shareholders on March 27, 2026 in respect of the 7% <br>Preference Share Scheme containing (i) this 7% Preference Share Scheme Document, (ii) the notice of <br>the 7% Preference Share Scheme Meeting, (iii) an explanatory statement as required by Section 452 of <br>the Act with respect to the 7% Preference Share Scheme (as also set out in 'Part II - 7% Preference <br>Share Scheme of Arrangement Explanatory Statement' of Annex C to the Proxy Statement), (iv) the 7% <br>Preference Share Forms of Proxy, and (v) the accompanying cover letter;<br>|
| "7% Preference Share Scheme Document" | this document, as set out in 'Part I – 7% Preference Share Scheme of Arrangement' of Annex C to the <br>Proxy Statement, and as also distributed to 7% Preference Shareholders as part of the 7% Preference <br>Share Scheme Circular;<br>|
| "7% Preference Share Scheme Meeting" | the meeting of the 7% Preference Shareholders convened pursuant to the authority of the Board under <br>Section 450(1) of the Act (and any adjournment of such meeting), to be held at 10:00 a.m. on May 21, <br>2026 at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland for the purposes <br>of considering and, if thought fit, approving the 7% Preference Share Scheme (with or without any <br>modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court)), notice of which <br>was sent to the 7% Preference Shareholders on March 27, 2026 and is part of the 7% Preference Share <br>Scheme Circular; <br>|
| "7% Preference Share Scheme Order" | the order or orders of the Irish High Court under Section 453 of the Act sanctioning the 7% Preference <br>Share Scheme and, if applicable, confirming the Reduction of Capital which forms part of it under <br>Sections 84 and 85 of the Act;<br>|
| "7% Preference Share Scheme Record Time" | 11:59 pm (Dublin) on the last Business Day before the Effective Date (or such other day and/or time as is <br>specified as the record time for determining those 7% Preference Shares that will be subject to the 7% <br>Preference Share Scheme);<br>|
| "7% Preference Share Scheme Shares" | any 7% Preference Shares in issue at the 7% Preference Share Scheme Record Time; |
| "7% Preference Share Scheme Shareholders" | Holders of the 7% Preference Share Scheme Shares; |
| "7% Preference Share Scheme" or "7% Preference <br>Share Scheme of Arrangement"<br>| this proposed scheme of arrangement under Chapter 1 of Part 9 of the Act, and the Reduction of Capital, <br>with or subject to any modifications, addition(s) or condition(s) approved or imposed by the Irish High <br>Court and agreed to by CRH in relation to the cancellation of the 7% Preference Share Scheme Shares;<br>|
| "7% Preference Shareholders"  | Holders of the 7% Preference Shares; |
| "7% Preference Shares" | the 7% "A" Cumulative Preference Shares of €1.27 each in the share capital of CRH (ISIN <br>IE0001827603), currently admitted to trading on the LSE but expected to be delisted from the LSE on <br>April 20, 2026;<br>|
| "Act" | the Companies Act 2014 of Ireland (as amended); |
| "AGM" | the annual general meeting of CRH (and any adjournment thereof) to be held at 11:00 a.m. (Dublin) on <br>Thursday, May 7, 2026 at the Royal Marine Hotel, Marine Road, Dún Laoghaire, Co. Dublin, Ireland;<br>|

---

106<br>

CRH PROXY STATEMENT 2026

---

| | |
|:---|:---|
| "AGM Voting Record Time" | 7:00 p.m. (Dublin)/3:00 p.m. (New York) on March 11, 2026 for Ordinary Shareholders, and 7:00 p.m. <br>(Dublin)/2:00 p.m. (New York) on May 3, 2026 for 7% Preference Shareholders;<br>|
| "Articles"  | the articles of association of CRH as at the date of the 7% Preference Share Scheme Circular; |
| "Belgian Law Rights" | the fungible co-ownership rights governed by Belgian law over a pool of book-entry interests in securities <br>of the same issue (i.e. as can be identified by an ISIN) which the EB Participants hold;<br>|
| "Board of Directors" or "Board"  | the board of directors of CRH from time to time; |
| "Broadridge" | Broadridge Financial Solutions Limited; |
| "Business Day" | any day, other than a Saturday, Sunday, public holiday or a day on which banks in Ireland, London or in <br>New York are authorised or required by law or executive order to be closed;<br>|
| "Cancellation Consideration" | the 5% Cancellation Consideration and the 7% Cancellation Consideration; |
| "CDIs" | an English law security issued by the CREST Depository that represents a CREST member's interest in a <br>7% Preference Share (including the Belgian Law Rights in respect of a 7% Preference Share);<br>|
| "Company" or "CRH" | CRH plc, a public limited company incorporated under the Act with registration number 12965 and <br>having its registered office at 42 Fitzwilliam Square, Dublin 2, D02 R279, Ireland; <br>|
| "CREST Depository" | CREST Depository Limited, a subsidiary of Euroclear UK & International Limited ("EUI") (or any successor <br>or assignee of it in such capacity from time to time);<br>|
| "DWT" | Irish dividend withholding tax; |
| "EB" or "Euroclear Bank"  | Euroclear Bank S.A./N.V., an international central depository system based in Belgium;  |
| "EB Nominee" | Euroclear Nominees Limited, a wholly owned subsidiary of Euroclear Bank, established under the laws of <br>England and Wales with registration number 02369969 (or any such successor or assignee of it in such <br>capacity from time to time); <br>|
| "EB Participant" | a participant in the EB System that has entered into an agreement to participate in the EB System subject <br>to the EB Terms and Conditions;<br>|
| "EB System" | the securities settlement system operated by Euroclear Bank and governed by Belgian law (or any <br>successor or assignee of it in such capacity from time to time) or any replacement for such system from <br>time to time;<br>|
| "EB Terms and Conditions" | the document issued by Euroclear Bank entitled "Terms and Conditions governing use of Euroclear" <br>dated June 2025;<br>|
| "Effective Date" | the date on which the 7% Preference Share Scheme becomes effective in accordance with its terms;  |
| "Effective Time" | the time on the Effective Date at which the 7% Preference Share Scheme Order and a copy of the minute <br>required by Section 86 of the Act are registered by the Registrar of Companies; <br>|
| "Euro" or "€" | euro, the lawful currency of Ireland; |
| "Euronext" | the corporate group consisting of Euronext N.V., a company with limited liability ("naamloze <br>venootschap") organised under the laws of the Netherlands, Euronext Brussels, Euronext Dublin, <br>Euronext Lisbon, Euronext Paris and Oslo Børs and/or any other subsidiary of Euronext N.V., as the <br>context may require;<br>|
| "Euronext Dublin" | the Irish Stock Exchange plc, trading as Euronext Dublin incorporated and registered in Ireland under the <br>Act with registered number 539157 (or any successor or assignee of it in such capacity from time to <br>time);<br>|
| "Euronext Growth Dublin" | a Euronext Growth market operated by Euronext Dublin;  |
| "Euronext Growth" | a multilateral trading facility within the scope of Article 4(1)(22) of MiFID II operated by the respective <br>Euronext Market Undertakings with the commercial name "Euronext Growth";<br>|
| "Holder" | in relation to any Ordinary Share and/or Preference Share, the Member whose name is entered in the <br>Register of Members as the holder of that share and any Joint Holder, including any person(s) entitled by <br>transmission; <br>|
| "Irish High Court" | the High Court of Ireland;  |
| "Irish Revenue"  | the Revenue Commissioners of Ireland, the Irish Government agency responsible for customs, excise, <br>taxation and related matters;<br>|
| "Joint Holder(s)" | the Members whose names are entered in the Register of Members as the joint holders of a 7% <br>Preference Share and includes any person(s) entitled by transmission; <br>|
| "Latest Practicable Date" | March 11, 2026; |
| "LSE" | the London Stock Exchange Group plc or the market conducted by it, as the context requires, or any <br>successor or assignee of it in such capacity from time to time or any replacement for such system from <br>time to time;<br>|
| "Members" | the members of CRH as entered in the Register of Members at any relevant date and "Member" will be <br>interpreted accordingly;<br>|
| "Ordinary Shareholders" | a Holder of Ordinary Shares;  |
| "Ordinary Shares" | the ordinary shares of €0.32 each in the share capital of CRH;  |
| "Overseas Shareholders" | a 7% Preference Shareholder who is resident in, ordinarily resident in, or a citizen of a jurisdiction outside <br>of Ireland;<br>|
| "Preference Shares"  | the 5% Preference Shares and the 7% Preference Shares; |

---

107<br>

CRH PROXY STATEMENT 2026

---

| | |
|:---|:---|
| "Preference Shareholders" | the 5% Preference Shareholders and the 7% Preference Shareholders;  |
| "Preference Share Scheme Circular(s)" | the 5% Preference Share Scheme Circular and/or the 7% Preference Share Scheme Circular, as the <br>context so requires;<br>|
| "Proxy Statement" | the 2026 Notice of Meeting and Proxy Statement issued to Ordinary Shareholders and 7% Preference <br>Shareholders (and made available to 5% Preference Shareholders for information purposes only) on <br>March 27, 2026 and available on CRH's website at www.crh.com/investors/shareholder-meetings;<br>|
| "Reduction of Capital" | the reduction of the share capital of CRH by the cancellation of the 7% Preference Share Scheme Shares <br>to be effected as part of the 7% Preference Share Scheme as referred to in Clause 2 of this 7% <br>Preference Share Scheme;<br>|
| "Register of Members" | the register of members of CRH which is maintained pursuant to Section 169 of the Act; |
| "Registrar" | Computershare Investor Services (Ireland) Limited, 3100 Lake Drive, Citywest Business Campus, Dublin <br>24, D24 AK82, Ireland, or such other registrar as may be appointed by the Company from time to time; <br>|
| "Registrar of Companies" | the Registrar of Companies in Dublin, Ireland;  |
| "Regulatory Information Service" | a regulatory information service as defined in the Irish Takeover Rules; |
| "Restricted Jurisdiction" | any jurisdiction in respect of which it would be unlawful for the 7% Preference Share Scheme Circular to <br>be released, published or distributed, in whole or in part;<br>|
| "Restricted Overseas Shareholder"  | a 7% Preference Shareholder (including an individual, partnership, unincorporated syndicate, limited <br>liability company, unincorporated organisation, trust, trustee, executor, administrator or other legal <br>representative) in, or resident in, or any 7% Preference Shareholder whom CRH believes to be in, or <br>resident in, a Restricted Jurisdiction; <br>|
| "Scheme Document(s)" | the 5% Preference Share Scheme Document and/or the 7% Preference Share Scheme Document, as <br>the context so requires;<br>|
| "Scheme Meeting(s)" | the 5% Preference Share Scheme Meeting and/or the 7% Preference Share Scheme Meeting as the <br>context so requires;<br>|
| "Scheme(s)" or "Schemes of Arrangement"  | the 5% Preference Share Scheme and/or the 7% Preference Share Scheme, as the context so requires; |
| "Tax Treaty Country" | a country which has signed a Double Taxation Agreement with Ireland; |
| "TCA" | Taxes Consolidation Act 1997; |
| "Voting Record Time" | 7:00 p.m. (Dublin) on May 17, 2026 or, if the 7% Preference Share Scheme Meeting is adjourned, on the <br>day that is four days before the day appointed for the adjourned meeting;<br>|

---

and unless otherwise specified, references to Clauses are Clauses of this 7% Preference Share Scheme.

2. Cancellation of the 7% Preference Share Scheme Shares

Pursuant to Sections 84 to 86 and Chapter 1 of Part 9 of the Act and Article 54 of the Articles, and upon and with effect from the Effective Time,

the issued share capital of CRH shall be reduced by cancelling and extinguishing all of the 7% Preference Share Scheme Shares, and thereby

reducing the amount standing to the credit of the Company's preference share capital account by an amount equal to the nominal value of the

7% Preference Share Scheme Shares at the Effective Time, being a sum of €1,107,440.

3. Consideration for the Cancellation of the 7% Preference Share Scheme Shares

3.1In consideration for the cancellation of the 7% Preference Share Scheme Shares pursuant to Clause 2, the Company shall pay to (or

procure the payment to) each Holder of 7% Preference Share Scheme Shares (as appearing on the Register of Members at the 7%

Preference Share Scheme Record Time) an amount in cash equal to €3.556 in respect of each 7% Preference Share Scheme Share

cancelled (the "7% Cancellation Consideration") (without interest and less any applicable withholding taxes (if any) as may be required by

law), in accordance with Clause 4 of this 7% Preference Share Scheme. The Company shall procure that the 7% Cancellation

Consideration is distributed to such Holders of the 7% Preference Share Scheme Shares within 14 days of the Effective Date in

accordance with Clause 4 of this Scheme.

3.2The 7% Cancellation Consideration represents a premium of 180% to the nominal value of each 7% Preference Share, with such premium

above nominal value to be paid from the Company's profits available for distribution, and the nominal value to be paid by repayment of

capital. The 7% Cancellation Consideration comprises the entire amount payable in respect of the cancellation of the 7% Preference

Shares and there is no separate entitlement or payment in respect of any dividend entitlement unpaid or otherwise accrued up to and

including the Effective Time.

3.3Neither CRH nor its agents shall be liable to any 7% Preference Share Scheme Shareholder for any cash payment, dividends or

distributions with respect to the 7% Preference Share Scheme Shares delivered to a public official in compliance with any abandoned

property, escheat or law permitting attachment of money or property or similar law.

4. Settlement of the 7% Cancellation Consideration

4.1Not later than 14 days after the Effective Date, the 7% Cancellation Consideration to which any 7% Preference Share Scheme

Shareholder is entitled under the 7% Preference Share Scheme will be distributed in the following manner:

(a)in the case of 7% Preference Share Scheme Shares which at the 7% Preference Share Scheme Record Time are in registered

form, in accordance with the provisions of Clause 4.3 of this 7% Preference Share Scheme, by means of a SEPA payment to the

7% Preference Shareholder's nominated bank account for CRH distributions in respect of the 7% Preference Shares (unless such

Holder of the 7% Preference Share Scheme Shares notifies the Registrar in writing prior to the 7% Preference Share Scheme

Record Time revoking that mandate and requesting that the 7% Cancellation Consideration be paid by cheque in the same

manner as those without a bank mandate in place,or to an alternate bank account) or, absent a bank mandate being recorded on

the Register of Members by the 7% Preference Share Scheme Record Time, by the despatch of cheques payable in Euro (€) for

the sums payable to them, in accordance with Clause 3.1 of this 7% Preference Share Scheme and Article 137 of the Articles; or

108<br>

CRH PROXY STATEMENT 2026

(b)in the case of 7% Preference Share Scheme Shares which at the 7% Preference Share Scheme Record Time are in unregistered

form (i.e. held through the EB System), by electronically transferring the sum to Euroclear Bank and the cash to which the 7%

Preference Share Scheme Shareholder is entitled will be paid in euro (€) by means of the EB System.

4.2As from the 7% Preference Share Scheme Record Time, each holding of 7% Preference Share Scheme Shares credited to any securities

clearance account in the EB System shall be disabled and all 7% Preference Share Scheme Shares will be removed from the EB System

in due course.

4.3Consideration payable to 7% Preference Shareholders with dividend bank mandates shall be paid by means of SEPA. All despatches of

cheques required to be made pursuant to this 7% Preference Share Scheme shall be effected by sending the same through the post in

prepaid envelopes addressed to the Holders entitled thereto at their respective registered addresses as appearing in the Register of

Members at the 7% Preference Share Scheme Record Time (or, in the case of Joint Holders, at the registered address of that one of the

Joint Holders whose name stands first in the said Register of Members in respect of such joint holding at the 7% Preference Share

Scheme Record Time) or in accordance with any special instructions regarding communications, and neither CRH nor its respective

agents shall be responsible for any loss or delay in the transmission of any cheques sent in accordance with this Clause 4.3, which shall

be sent at the risk of persons entitled thereto.

4.4All cheques drawn in accordance with this Clause 4 shall be in Euro (€) and, subject to Clause 4.5, shall be made payable to the 7%

Preference Share Scheme Shareholder or, in the case of Joint Holders to that one Joint Holder who is the first named Holder of the 7%

Preference Share Scheme Shares concerned, or as otherwise properly directed by the persons entitled thereto, and the despatch of any

such cheque shall be a complete discharge to CRH for the moneys represented thereby.

4.5Each mandate in force on the Effective Date relating to the payment of dividends or other distributions on any 7% Preference Share

Scheme Shares and other instructions given to CRH by Holders of the 7% Preference Share shall, unless notice of revocation of such

instructions is received by the Registrar prior to the 7% Preference Share Scheme Record Time, be deemed to be an effective mandate or

instruction to CRH to pay and dispatch the 7% Cancellation Consideration payable under Clause 3 in accordance with such mandate.

5. Certificates for 7% Preference Share Scheme Shares

5.1With effect from the Effective Date, (i) except for the payment obligations required to be made under Clause 4, Euroclear Bank shall be

instructed to disable the entitlements to 7% Preference Share Scheme Shares of Holders of 7% Preference Share Scheme Shares in

unregistered form, and (ii) any certificates or other statements of ownership representing 7% Preference Share Scheme Shares shall cease

to have effect as documents of title to the shares comprised therein and every holder thereof shall be bound at the request of CRH to

deliver up such certificates and/or statements to CRH as CRH may direct.

6. Conditions of the 7% Preference Share Scheme of Arrangement

6.1The 7% Preference Share Scheme will not be completed unless, among other things, the following conditions are satisfied or, if allowed

by law, waived:

(a)approval of the 7% Preference Share Scheme by the 7% Preference Shareholders who represent at least 75% in value of the

members present and voting either in person or by proxy at the 7% Preference Share Scheme Meeting, and with the quorum of at

least two persons holding or representing in person or by proxy at least one-third in nominal value of the 7% Preference Shares in

issue being satisfied at the 7% Preference Share Scheme Meeting;

(b)each of Proposals 8, 9, 10 and 11 (set out in the Proxy Statement) are duly passed by the requisite majorities of Ordinary

Shareholders (and 7% Preference Shareholders, voting with the Ordinary Shareholders, in respect of Proposal 9 only) at the AGM

(or any adjournment of such meeting);

(c)the sanction by the Irish High Court of the 7% Preference Share Scheme (with or without any modification(s), addition(s) or

condition(s) approved or imposed by the Irish High Court) pursuant to section 453 of the Act, and the confirmation of the

Reduction of Capital involved therein by the Irish High Court;

(d)the delivery of a copy of the 7% Preference Share Scheme Order, together with the minute required by Section 86 of the Act, to

the Registrar of Companies for registration in accordance with Section 454 of the Act, and registration of the 7% Preference Share

Scheme Order and minute confirming the Reduction of Capital by the Registrar of Companies; and

(e)the Board not having resolved to abandon, discontinue and/or withdraw the 7% Preference Share Scheme prior to the 7%

Preference Share Court Hearing.

7. Overseas Shareholders

7.1The provisions of Clauses 2, 3 and 4 shall be subject to any prohibition or condition imposed by law.

7.2Notwithstanding the provisions of Clause 7.1, CRH retains the right to permit the release, publication or distribution of the 7% Preference

Share Scheme Circular (or any parts thereof) and/or the Proxy Statement to any Restricted Overseas Shareholder who satisfies CRH (in its

sole discretion) that doing so will not infringe the laws of the relevant Restricted Jurisdiction, or require compliance with any governmental

or other consent or any registration, filing or other formality that CRH is unable to comply with or which CRH regards as unduly onerous to

comply with.

8. The Effective Time

This 7% Preference Share Scheme shall become effective as soon as a copy of the 7% Preference Share Scheme Order and a copy of the minute

required by Section 86 of the Act have been delivered to the Registrar of Companies for registration and registered by the Registrar of

Companies. This is subject to CRH not having agreed prior to the Effective Date, with the consent of the Irish High Court (where required), not to

proceed with the 7% Preference Share Scheme and in such case all undertakings given to the Irish High Court in respect of this 7% Preference

Share Scheme shall be deemed to have lapsed with immediate effect.

9. Modification

CRH may consent on behalf of all persons concerned to any modification of or addition to this 7% Preference Share Scheme or any condition that

the Irish High Court may approve or impose.

109<br>

CRH PROXY STATEMENT 2026

10. Costs

The costs of the 7% Preference Share Scheme, including costs of the preparation, approval and implementation of the 7% Preference Share

Scheme, will be paid by CRH.

11. Governing Law

This 7% Preference Share Scheme shall be governed by, and construed in accordance with, the laws of Ireland. CRH and the 7% Preference

Share Scheme Shareholders hereby agree that the Irish High Court shall have exclusive jurisdiction to hear and determine any suit, action or

proceeding or to settle any dispute which may arise in relation thereto and the sanction thereof.

Date: March 27, 2026

110<br>

CRH PROXY STATEMENT 2026

Annex C – Part II – 7% Preference Share

Scheme Of Arrangement Explanatory

Statement

**The information contained in Annexes B and C of this Proxy Statement is not required to be included pursuant to the rules and** 

**regulations of the U.S. Securities and Exchange Commission, and is included solely to comply with the requirements of the** 

**Companies Act 2014 in order to provide the information required under such laws applicable to Preference Shareholders (in** 

**compliance with Section 452 of the Companies Act 2014).**

This "7% Preference Share Scheme of Arrangement Explanatory Statement" sets out the explanatory statement in respect of the 7% Preference

Share Scheme for the purposes of Section 452 of the Act. Capitalised terms used but not defined in this "7% Preference Share Scheme of

Arrangement Explanatory Statement" have the meaning ascribed to such terms in the "7% Preference Share Scheme of Arrangement". To each 7%

Preference Share Scheme Shareholder at the 7% Preference Share Scheme Meeting. Recommended Cancellation of the 7% Preference Shares to be

implemented by way of a Scheme of Arrangement under Chapter 1 of Part 9 of the Act, and a capital reduction under Sections 84 and 85 of the Act.

**1. Overview**

1.1On March 13, 2026, following a review of its LSE Ordinary Share listing as well as its preference share capital structure, CRH announced

its intention to delist the Ordinary Shares and 7% Preference Shares from the LSE, and subject to approval by Ordinary Shareholders and

Preference Shareholders, to cancel the 5% Preference Shares and the 7% Preference Shares. As part of the review, the Board carefully

considered, amongst other factors, the additional cost and regulatory and administrative obligations arising from retaining the 5%

Preference Shares and the 7% Preference Shares. Following completion of the review, the Board concluded that it is in the best interests

of CRH and its Ordinary Shareholders and Preference Shareholders as a whole to seek to simplify the Company's share capital structure,

and reduce certain regulatory and administrative obligations applicable to it, by retiring CRH's two classes of legacy Preference Shares

(and delisting the 5% Preference Shares from Euronext Growth Dublin), in exchange for cash consideration, subject to approval of the

Ordinary Shareholders and the Preference Shareholders.

1.2The total par value of the issued and outstanding legacy Preference Shares is €1,170,940, and there has been very little reported trading

in the Preference Shares over the past decade, leaving the Preference Shareholders with limited opportunity to sell their shares. The

proposed cancellations of the Preference Shares will provide the Preference Shareholders with the opportunity to convert their illiquid

assets into cash at a significant premium. CRH is required to comply with various administrative and regulatory requirements associated

with the Preference Shares. CRH believes that these compliance and other administrative burdens are disproportionate to the value of the

Preference Shares and the small percentage of the Company's total issued share capital that they represent (approximately .5%) as of the

Latest Practicable Date. The Board believes that the cancellations of the Preference Shares, if implemented, would yield a number of

efficiencies for CRH and its shareholders, through simplifying the Company's capital structure and streamlining applicable regulatory

requirements, while providing an opportunity to Preference Shareholders to monetize their holdings.

1.3CRH proposes to cancel its two classes of Preference Shares (the "Preference Share Cancellations") pursuant to two separate schemes

of arrangement under Chapter 1 of Part 9 of the Act. A scheme of arrangement is a court-approved arrangement between a company and

its shareholders carried out in accordance with the Act. The Preference Share Cancellations will also involve the associated reduction of

capital under the Act to cancel the Preference Shares. Each of the Schemes of Arrangement and the related reduction of capital require

the approval of the Irish High Court.

1.4The 5% Preference Shares are currently admitted to trading on Euronext Growth Dublin. The 7% Preference Shares are currently admitted

to trading on the LSE but will be delisted with effect from 8:00 a.m. (UK time) on April 20, 2026. The last day of trading of the 7%

Preference Shares on the LSE will be April 17, 2026.

1.5The Preference Share Cancellations are subject to certain conditions set forth in the Schemes of Arrangement and will become effective

only after all such conditions have been satisfied or, if allowed by law, waived. Each Preference Share Cancellation will require, among

other things, (i) approval at the AGM of each of Proposals 8, 9, 10 and 11 (as set out in the Proxy Statement), (ii) approval by the

applicable class of Preference Shareholders at the Scheme Meetings, and (iii) the sanction of the applicable Scheme, and the confirmation

of the applicable reduction of capital, by the Irish High Court.

1.6Subject to the satisfaction or, if allowed by law, waiver of the conditions, at the Effective Time, all Preference Shares will be cancelled

pursuant to Sections 84 to 86 of the Act in accordance with the terms of each Scheme. The conditions to each of the Preference Share

Cancellations are set out in Clause 6 of the applicable Scheme Document.

1.7Under the terms of the proposed Schemes each class of Preference Shareholders will receive cancellation consideration of an amount

equal to 40 times the annual dividend per Preference Share. This reflects a value determined by reference to the annual dividend per

Preference Share capitalized at a rate of 2.5156% or approximately 100bps below the 30-year Bund rate as of March 12, 2026. Under the

terms of the proposed Schemes: (i) the 5% Preference Shareholders will receive the 5% Cancellation Consideration, representing 200% of

the nominal value per share, and (ii) the 7% Preference Shareholders will receive the 7% Cancellation Consideration, representing 280% of

the nominal value per share. The premium above nominal value will be paid from the Company's profits available for distribution, and the

nominal value will be paid by way of repayment of capital. The Cancellation Consideration comprises the entire amount payable in respect

of the cancellation of the Preference Shares and there is no separate entitlement or payment in respect of any dividend entitlement unpaid

or otherwise accrued up to and including the Effective Time. The total aggregate payment in consideration for the cancellation of the

111<br>

CRH PROXY STATEMENT 2026

Preference Shares will be €3.23 million (approximately $3.75 million). Given historic low levels of trading for the Preference Shares on their

respective exchanges (including predecessor exchanges), it is not possible to identify the market value of the Preference Shares and the

extent to which the Cancellation Consideration amounts to a premium to the market value of the Preference Shares. However, the Board

believes that the Cancellation Consideration represents a significant premium to the value of the Preference Shares.

1.8The Company has applied to the UK Financial Conduct Authority (the "FCA") and the LSE respectively for the listing of the 7% Preference

Shares on the official list of the FCA to be cancelled and for the admission to trading of the 7% Preference Shares on the Main Market of

the LSE to be cancelled, with such delisting to become effective from 8:00 a.m. (UK time) on April 20, 2026. The Company has also

applied to Euronext Growth Dublin for the cancellation of the listing and admission to trading of the 5% Preference Shares on Euronext

Growth Dublin, with such delisting being subject to receipt of the requisite approvals for the cancellation of the 5% Preference Shares at

the AGM and the 5% Preference Share Scheme Meeting. If the 5% Preference Share Scheme becomes effective, the delisting from

Euronext Growth Dublin is expected to take effect on or around the Effective Time.

1.9The text of each Scheme of Arrangement is set out in full in Part I of Annex B and Annex C of the Proxy Statement and in the applicable

Preference Share Scheme Circular.

The 7% Preference Share Scheme

1.10If the requisite approvals are obtained at the AGM and the 7% Preference Share Scheme Meeting, CRH will apply to the Irish High Court

to set a date for the hearing to sanction the 7% Preference Share Scheme under Section 453(2)(c) of the Act and to confirm the

Reduction of Capital. Legal notices advertising the date of the 7% Preference Share Court Hearing will be published following the

application by CRH.

1.11If the 7% Preference Share Scheme is implemented, at the Effective Time (i) the 7% Preference Shares will be automatically cancelled and

extinguished in exchange for a cash payment of the 7% Cancellation Consideration to the 7% Preference Share Scheme Shareholders, (ii)

the Company's capital will be reduced pursuant to Sections 84 to 86 of the Act by the cancellation of an amount standing to the credit of

the Company's preference share capital account equal to the nominal value of the 7% Preference Shares as at the Effective Time (being

an amount equal to €1,107,440, (iii) the Articles will be amended to remove references to the 7% Preference Shares and to include a new

Article to facilitate implementation of the 7% Preference Share Scheme, and (iv) the authorised share capital of the Company will be varied

by the removal of the aggregate amount associated with the 7% Preference Shares, being an amount equal to €1,107,440.

1.12Provided the conditions to the 7% Preference Share Scheme are satisfied or, if permitted by law, waived, the 7% Preference Share

Scheme is expected to take effect in accordance with its terms as soon as a copy of the 7% Preference Share Scheme Order sanctioning

the 7% Preference Share Scheme together with the minute required by Section 86(1) of the Act have been delivered to the Registrar of

Companies for registration and registered by the Registrar of Companies. As at the Latest Practicable Date, the 7% Preference Share

Scheme is expected to become effective before the end of July 2026. The timing depends on a number of factors including the availability

of the Irish High Court to hear the application to sanction the 7% Preference Share Scheme and, if sanctioned, the date the 7%

Preference Share Scheme Order is delivered to and registered by the Registrar of Companies.

1.13Upon the 7% Preference Share Scheme becoming effective, it will be binding on all 7% Preference Shareholders, irrespective of whether

or not they attended or voted on the relevant resolutions at the 7% Preference Share Scheme Meeting, or whether they voted in favour of

or against the 7% Preference Share Scheme.

1.14The effectiveness of the 7% Preference Share Scheme will be notified to Ordinary Shareholders and Preference Shareholders by (i) an

announcement through a Regulatory Information Service, with such announcement being made available on the Company's website, and/

or (ii) in such other manner as the Irish High Court might direct.

1.15The expected dates set out above are subject to change at the discretion of the Board, and any such change will be announced on the

Company's website and (where required) in the manner set out in (i) and/or (ii) above.

2. Consents and Meetings

2.1The 7% Preference Share Scheme Meeting is being convened pursuant to the authority of the Board to seek the approval of the 7%

Preference Share Scheme by the 7% Preference Shareholders as of the Voting Record Time. The 7% Preference Share Scheme Meeting

is to be held at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland on May 21, 2026 at 10:00 a.m. (Dublin).

2.2Notice of the 7% Preference Share Scheme Meeting was distributed to the 7% Preference Shareholders on March 27, 2026, and forms

part of the 7% Preference Share Scheme Circular. Entitlement to notice of and/or to vote at the 7% Preference Share Scheme Meeting

will be determined by reference to the Register of Members at the Voting Record Time. The purpose of the 7% Preference Share Scheme

Meeting is to consider and vote on the 7% Preference Share Scheme. The Irish High Court can only sanction the 7% Preference Share

Scheme and the 7% Preference Share Scheme can only be effective if it, among other things, is approved by the necessary majority of

7% Preference Shareholders at the 7% Preference Share Scheme Meeting.

2.3In addition to requiring approval at the 7% Preference Share Scheme Meeting, implementation of the 7% Preference Share Scheme also

requires approval by the Ordinary Shareholders (and the 7% Preference Shareholders voting with the Ordinary Shareholders as a single

class, for the purposes of Proposal 9 only) of Proposals 8, 9, 10 and 11 at the AGM which are necessary to effect and to implement the

7% Preference Share Scheme, as described below. The AGM is to be held at the Royal Marine Hotel, Marine Road, Dún Laoghaire, Co.

Dublin, Ireland on May 7, 2026 at 11:00 a.m. (Dublin), and the Proxy Statement was made available to Ordinary Shareholders and the 7%

Preference Shareholders and for information only to the 5% Preference Shareholders on March 27, 2026, and is available here:

*www.crh.com/investors/shareholder-meetings.* Entitlement to notice of and/or to vote at the AGM will be determined by reference to the

Register of Members at the AGM Voting Record Time. Under the Articles, 7% Preference Shareholders are entitled to vote in respect of a

capital reduction of the Company and will therefore be entitled to vote on Proposal 9 at the AGM with the Ordinary Shareholders, voting

as a single class. The 7% Preference Shareholders are not entitled to vote on any other Proposals at the AGM.

2.4As of the Latest Practicable Date, 872,000 7% Preference Shares were issued and outstanding and there were 292 registered members

in respect of the 7% Preference Shares whose names were registered in the Register of Members.

112<br>

CRH PROXY STATEMENT 2026

3. The 7% Preference Share Scheme Meeting

3.1The 7% Preference Share Scheme Meeting has been convened for 10:00 a.m. (Dublin) on May 21, 2026 to enable the 7% Preference

Share Scheme Shareholders to consider and, if thought fit, approve the 7% Preference Share Scheme.

3.2To be passed, the resolution to approve the 7% Preference Share Scheme requires the approval of 7% Preference Shareholders

representing at least 75% in value of the 7% Preference Share Scheme Shares held by such holders at the Voting Record Time voting in

person or by proxy. The quorum for the 7% Preference Share Scheme Meeting (or at any adjournment of such meeting), shall be at least

two persons holding or representing by proxy at least one-third in nominal value of the 7% Preference Shares.

3.3At the 7% Preference Share Scheme Meeting, voting will be by poll and not by a show of hands, and each holder of 7% Preference Share

Scheme Shares as at the Voting Record Time who is present (in person or by proxy) will be entitled to one vote for each 7% Preference

Share Scheme Share held as of the Voting Record Time.

4. The AGM

4.1In addition to the 7% Preference Share Scheme Meeting, the AGM will take place for the Ordinary Shareholders (and the 7% Preference

Shareholders, voting with the Ordinary Shareholders as a single class, for the purpose of Proposal 9 only) to consider and, if thought fit,

approve Proposals 8 through 11 at the AGM in connection with the Preference Share Cancellations (which in the case of a special

resolution require a vote in favour of not less than three-fourths (75%) of the votes cast in person or by proxy, and in respect of an

ordinary resolution requires a simple majority (>50%) of the votes cast in person or by proxy).

4.2The Proposals to be voted upon are set out in full on pages 31 to 38 of the Proxy Statement. In summary, at the AGM, Ordinary

Shareholders (and 7% Preference Shareholders, voting with the Ordinary Shareholders as a single class, for the purposes of Proposal 9

only) will be asked to approve: (i) the Schemes and to authorise the directors of CRH to give effect to the Schemes (as described in

Proposal 8), (ii) the capital reduction relating to the cancellation of any class(es) of Preference Shares cancelled pursuant to the Schemes

(Proposal 9), (iii) a variation in CRH's authorised share capital to remove any cancelled class(es) of Preference Shares (Proposal 10), and

(iv) certain amendments to the Articles to remove references to any class(es) of Preference Shares cancelled pursuant to the Schemes

(Proposal 11), in each case, subject to (A) the applicable Scheme being approved by the requisite majorities at the applicable Scheme

Meeting, (B) the Irish High Court sanctioning the applicable Scheme and confirming the applicable Reduction of Capital, and (C) each of

Proposals 8 to 11 being approved by the requisite majorities at the AGM.

5.7% Preference Share Irish High Court Hearing

5.1If the requisite approvals are obtained at the AGM and the 7% Preference Share Scheme Meeting, the 7% Preference Share Court

Hearing to sanction the 7% Preference Share Scheme is expected to be held before the end of July 2026, subject to the discretion of the

Irish High Court. All 7% Preference Shareholders of record are entitled to attend the 7% Preference Share Court Hearing in person, or

may be represented by counsel or a solicitor at their own expense to support or oppose the sanctioning of the 7% Preference Share

Scheme.

6. Interests Held by CRH Directors and Executive Officers and the effect of the 7% Preference Share Scheme on their Interests

6.1No director or executive officer of the Company holds any interests in the 7% Preference Shares, or has any substantial interests, directly

or indirectly, in the matters relating to the Preference Share Cancellations. The effect of the 7% Preference Share Scheme on the interests

of the CRH directors, does not differ from its effect on the like interests of other persons.

7. Amendment or Termination

7.1The 7% Preference Share Scheme may be amended, modified or supplemented at any time before or after its approval at the 7%

Preference Share Scheme Meeting. However, after approval at the 7% Preference Share Scheme Meeting, no amendment, modification

or supplement may be made or effected to the 7% Preference Share Scheme that legally requires further approval by the 7% Preference

Shareholders without obtaining such approval.

7.2At the 7% Preference Share Court Hearing, the Irish High Court may impose such conditions as it deems appropriate in relation to the 7%

Preference Share Scheme. The Board of Directors may consent on behalf of all persons concerned to any modification of or addition to

the 7% Preference Share Scheme or any condition that the Irish High Court may approve or impose. The Irish High Court would be

unlikely to approve or impose any modification of, or addition to, or a condition to, the 7% Preference Share Scheme which might be

materially adverse to the interests of the 7% Preference Shareholders, unless such 7% Preference Shareholders were informed of any

such modification, addition or condition. It would be a matter for the Irish High Court to decide in its discretion whether or not a further

meeting or meetings of the 7% Preference Shareholders should be held in these circumstances. Similarly, if a modification, addition or

condition is put forward which, in the opinion of the Board of Directors, is of such a nature or importance that it requires the consent of

7% Preference Shareholders at a further meeting or meetings, the Board of Directors will not take the necessary steps to enable the 7%

Preference Share Scheme to become effective unless and until such consent is obtained.

8. Settlement, Listing and Dealings

8.1The Company has applied to the FCA and the LSE for the listing of the 7% Preference Shares on the official list of the FCA to be cancelled

and for the 7% Preference Shares to cease to be admitted to trading on the Main Market of the LSE. It is expected that the delisting from

the LSE will become effective from 8:00 a.m. (UK time) on April 20, 2026, such that the last day of dealings in the 7% Preference Shares

on the LSE will be April 17, 2026.

8.2Where, at the 7% Preference Share Scheme Record Time, a person holds 7% Preference Shares in registered form, payment of the 7%

Cancellation Consideration will be paid in accordance with Clause 3 and Clause 4 of the 7% Preference Share Scheme Document by

cheque payable in Euro (€) for the sums payable to them dispatched by ordinary prepaid post save that 7% Preference Shareholders that

hold their 7% Preference Shares in registered form and have a valid bank mandate in place with the Registrar for the purposes of

receiving 7% Preference Share distributions into that bank account, will receive cash due under the 7% Preference Share Scheme into

that bank account as described in Clause 3 and 4 of the 7% Preference Share Scheme Document.

8.3Where, at the 7% Preference Share Scheme Record Time, a 7% Preference Shareholder holds 7% Preference Shares in unregistered

form (i.e. through the EB System), the 7% Cancellation Consideration to which such 7% Preference Shareholder is entitled will be paid in

113<br>

CRH PROXY STATEMENT 2026

Euro (€) by means of the EB System by CRH procuring the electronic transfer of the sum payable to Euroclear Bank as described in

Clauses 3 and 4 of the 7% Preference Share Scheme Document.

9. Tax Information in Respect of the 7% Preference Share Scheme

THE TAX CONSIDERATIONS SUMMARISED BELOW ARE FOR GENERAL INFORMATION ONLY AND ARE IN RESPECT OF TAX

CONSIDERATIONS OF THE SCHEMES ONLY. EACH 7% PREFERENCE SHAREHOLDER SHOULD CONSULT HIS OR HER OWN TAX ADVISER

AS TO THE PARTICULAR TAX CONSEQUENCES THAT MAY APPLY TO SUCH PREFERENCE SHAREHOLDER.

Irish Tax Considerations

Scope of Summary

9.1The following is a summary of the material Irish tax considerations applicable to the persons who are the ultimate owners of the 7%

Preference Shares for Irish tax purposes and references to "7% Preference Shareholders" in this summary in paragraph 9 should be read

accordingly.

9.2References to "Non-Irish Holders" in this paragraph 9 are to 7% Preference Shareholders who: are the absolute beneficial owners of their

7% Preference Shares; are neither resident (nor, in the case of individuals, ordinarily resident) in Ireland for Irish tax purposes; and the 7%

Preference Shares have not at any time been (i) used in or for the purposes of a trade carried on by that 7% Preference Shareholder

through an Irish branch or agency; nor (ii) used, held or acquired for use by or for the purposes of such branch or agency.

9.3This summary is based on existing Irish tax law and the published practice of the Irish Revenue in or around the date of this document.

Changes in law and/or administrative practice may result in a change in the Irish tax considerations described below, possibly with

retrospective effect. Furthermore, we can provide no assurances that the tax consequences contained in this summary will not be

challenged by the Irish Revenue or will be sustained by an Irish court if they were to be challenged. This summary does not constitute

legal or tax advice and is intended only as a general guide. The summary is not exhaustive, and 7% Preference Shareholders should

consult their own tax advisors regarding the Irish tax consequences (and tax consequences under the laws of other relevant jurisdictions)

of the acquisition, ownership and disposal of 7% Preference Shares pursuant to the Schemes. The summary applies only to certain

categories of person and, in particular, may not apply to such persons as dealers in securities, trustees, insurance companies, collective

investment schemes, persons who acquired their 7% Preference Shares or, who are deemed to have acquired their 7% Preference

Shares, by virtue of an office or employment (performed or carried on to any extent in Ireland) or entities associated with the Company

(being entities (i) which are, directly or indirectly, entitled to more than 50% of the ownership rights, voting power or profits of the

Company (or entities in which the Company holds such an entitlement), (ii) which have definite influence in the Company (or entities in

which the Company has such influence); or (iii) where a third entity has such entitlements or influence in respect of another entity and the

Company).

9.4The law or practice of Irish Revenue may change, prospectively or retroactively, which could increase, reduce or mitigate possible tax

consequences for 7% Preference Shareholders. Also, the assumed practices may not be issued by the Irish Revenue. The position under

current Irish law is uncertain and CRH makes no assurances on the tax position for Preference Shareholders.

9.5PREFERENCE SHAREHOLDERS WHO ARE IN ANY DOUBT ABOUT THEIR TAX POSITION AND / OR MAY BE SUBJECT TO TAXATION

IN ANY JURISDICTION OTHER THAN IRELAND ARE STRONGLY RECOMMENDED TO CONSULT AN APPROPRIATELY QUALIFIED

INDEPENDENT PROFESSIONAL ADVISER IMMEDIATELY.

Irish Capital Gains Tax

Non-Irish resident shareholders

9.6In general, a non-Irish 7% Preference Shareholder should not be within the charge to Irish capital gains tax, referred to as "Irish CGT", or

corporation tax on chargeable gains (as applicable) on the disposal of their 7% Preference Shares pursuant to the 7% Preference Share

Scheme.

9.7A 7% Preference Shareholder who is an individual and who is temporarily non-resident in Ireland may, under Irish anti-avoidance legislation,

be liable to Irish CGT on any chargeable gain realised on the disposal of their 7% Preference Shares during the period in which the individual

is a non-resident.

Irish resident shareholders

9.87% Preference Shareholders that are resident or ordinarily resident in Ireland for Irish tax purposes or that have used their 7% Preference

Shares in or for the purposes of a trade carried on by the 7% Preference Shareholder in Ireland through a branch or agency, or whose 7%

Preference Shares were used or held or acquired for use by or for the purposes of such a branch or agency (each an "Irish Holder") will,

subject to the availability of any exemptions and reliefs, generally be within the charge to Irish CGT on the disposal of their 7% Preference

Shares pursuant to the Schemes.

9.9For the purpose of Irish CGT, an Irish Holder should be treated as having made a disposal of their 7% Preference Shares for consideration

of an amount equal to the cash received for the cancellation of the 7% Preference Shares pursuant to the Scheme. This may, subject to the

Irish Holder's individual circumstances and any available exemption or relief, give rise to a chargeable gain (or allowable loss) for the

purposes of Irish CGT. Irish CGT applies a rate of 33% on any chargeable gain (subject to any available exemption or relief).

Irish Dividend Withholding Tax

9.10Payments made by CRH to 7% Preference Shareholders under the Schemes for the redemption, repayment or purchase of its 7%

Preference Shares will not be subject to DWT in Ireland where the arrangement does not form part of a scheme the main purpose of which

is to enable the owner of the shares to participate in the profits of the company without receiving a dividend. Unless exempted, any

dividends or other relevant distributions paid by CRH to 7% Preference Shareholders under the Schemes will be subject to withholding at

the standard rate of income tax (currently 25%).

9.11The withholding tax requirement will not apply to distributions paid to certain categories of Irish resident 7% Preference Shareholders or to

distributions paid to certain categories of non-Irish resident 7% Preference Shareholders.

114<br>

CRH PROXY STATEMENT 2026

The following Irish resident 7% Preference Shareholders, inter alia, are exempt from withholding if, on a timely basis in advance of the

payment of any relevant dividend they make an appropriate declaration of entitlement to exemption to CRH:

(a)Irish resident companies;

(i)pension schemes approved by the Irish Revenue;

(ii)qualifying fund managers or qualifying savings managers in relation to approved retirement funds or approved minimum

retirement funds;

(iii)PRSA administrators who receive the relevant distribution as income arising in respect of PRSA assets;

(iv)qualifying employee share ownership trusts;

(v)collective investment undertakings;

(vi)tax-exempt charities;

(vii)designated brokers receiving the distribution for special portfolio investment accounts;

(viii)any person who is entitled to exemption from income tax under Schedule F on dividends in respect of an investment in

whole or in part of payments received in respect of a civil action or from the Personal Injuries Assessment Board for

damages in respect of mental or physical infirmity;

(ix)certain qualifying trusts established for the benefit of an incapacitated individual and/or persons in receipt of income from

such a qualifying trust;

(x)any person entitled to exemption to income tax under Schedule F by virtue of section 192(2) of the TCA;

(xi)unit trusts to which section 731(5)(a) of the TCA applies; and

(xii)certain Irish Revenue-approved amateur and athletic sport bodies.

9.12The following non-resident 7% Preference Shareholders are exempt from withholding if they make to CRH, in advance of payment of any

dividend, an appropriate declaration of entitlement to exemption:

(a)persons (other than a company) who (i) are neither resident nor ordinarily resident in Ireland and (ii) are resident for tax purposes

in (a) a Tax Treaty Country or (b) an EU member state other than Ireland;

(b)companies not resident in Ireland which are resident in an EU member state or a Tax Treaty Country and are not controlled,

directly or indirectly, by an Irish resident or Irish residents;

(c)companies not resident in Ireland which are directly or indirectly controlled by a person or persons who are, by virtue of the law of

a Tax Treaty Country or an EU member state, resident for tax purposes in a Tax Treaty Country or an EU member state other than

Ireland and which are not controlled directly or indirectly by persons who are not resident for tax purposes in a Tax Treaty Country

or EU member state;

(d)companies not resident in Ireland, the principal class of shares of which is substantially and regularly traded on a recognised stock

exchange in a Tax Treaty Country or an EU member state including Ireland or on an approved stock exchange; or

(e)companies not resident in Ireland that are 75% subsidiaries of a single company, or are wholly-owned by two (2) or more

companies, in either case the principal classes of shares of which is or are substantially and regularly traded on a recognised

stock exchange in a Tax Treaty Country or an EU member state including Ireland or on an approved stock exchange.

9.13In the case of an individual non-Irish resident 7% Preference Shareholder resident in an EU member state or Tax Treaty Country, the

declaration must be accompanied by a current certificate of tax residence from the tax authorities in the 7% Preference Shareholder's

country of residence. In the case of both an individual and corporate non-Irish resident 7% Preference Shareholder resident in an EU

member state or Tax Treaty Country, the declaration must also contain an undertaking that he, she or it will advise the Company

accordingly if he, she or it ceases to meet the conditions to be entitled to the DWT exemption. No declaration is required if the 7%

Preference Shareholder is a 5% parent company in another EU member state in accordance with section 831 of the TCA.

9.14Investors who hold their shares through a qualifying intermediary should make the appropriate declaration of entitlement to exemption on

a timely basis to that intermediary.

Irish Stamp Duty

9.157% Preference Shareholders will not be chargeable to Irish stamp duty on the disposal of their 7% Preference Shares under the 7%

Preference Share Scheme.

10. Overseas Shareholders

10.1As regards Overseas Shareholders, the 7% Preference Share Scheme may be affected by the laws of the relevant jurisdictions. Such

Overseas Shareholders should inform themselves about and observe any applicable legal requirements. It is the responsibility of

Overseas Shareholders to satisfy themselves as to the full observance of the laws of the relevant jurisdiction in connection therewith,

including the obtaining of any governmental, exchange control or other consents which may be required, or the compliance with other

necessary formalities which are required to be observed and the payment of any issue, transfer or other taxes due in such jurisdiction.

10.2This explanatory statement has been prepared for the purposes of complying solely with the laws of Ireland, in particular with Section 452

of the Act, and the information disclosed may be different from that which would have been disclosed if this document had been prepared

in accordance with the laws of jurisdictions outside Ireland. Overseas Shareholders are encouraged to consult their local tax advisor.

11.7% Preference Share Forms of Proxy

11.17% Preference Shareholders who hold their 7% Preference Shares in their own name as of the date of this document have been sent 7%

Preference Share Forms of Proxy for the 7% Preference Share Scheme Meeting and the AGM. 7% Preference Shareholders are strongly

encouraged to complete and return their 7% Preference Share Forms of Proxy as soon as possible.

115<br>

CRH PROXY STATEMENT 2026

12. Action to be Taken

12.1You will find enclosed with the 7% Preference Share Scheme Circular, (i) the full terms of the 7% Preference Share Scheme of

Arrangement, (ii) the formal notice of the 7% Preference Share Scheme Meeting, and (iii) the 7% Preference Share Form of Proxy for use

at the 7% Preference Share Scheme Meeting. Your attention is drawn to the "Notes" section at the end of the notice of the 7% Preference

Share Scheme Meeting.

12.2It is important that as many votes as possible are cast at the 7% Preference Share Scheme Meeting so that the Irish High Court may be

satisfied that there is a fair and reasonable representation of the opinion of 7% Preference Shareholders as of the Voting Record Time

when it is considering whether to sanction the 7% Preference Share Scheme. In addition, the quorum required for the 7% Preference

Share Scheme Meeting (or at any adjournment of such meeting) shall be at least two persons holding or representing in person or by

proxy at least one-third in nominal value of the 7% Preference Shares. You are therefore strongly encouraged to complete and return your

7% Preference Share Form of Proxy in accordance with the deadlines set out below.

12.3Further information regarding voting at the AGM in respect of Proposal 9 can be found in the Proxy Statement. Your attention is drawn to

the General Information section of the Proxy Statement on pages 84 to 88.

Registered Shareholders

12.4For 7% Preference Shareholders whose name appears on the Register of Members (i.e. those who hold their 7% Preference Shares

directly on the Register of Members and who therefore do not hold their interests in 7% Preference Shares as Belgian Law Rights through

the EB System or as CDIs through the CREST securities settlement system ("CREST"), you may appoint a proxy by completing the

enclosed 7% Preference Share Form of Proxy for the 7% Preference Share Scheme Meeting. To be valid, the 7% Preference Share Form

of Proxy must be delivered in writing, together with any power of attorney or other authority under which it is signed or a certified copy

thereof to the Registrar by post to Computershare Investor Services (Ireland) Limited, 3100 Lake Drive, Citywest Business Campus, Dublin

24, D24 AK82, Ireland in the enclosed reply paid envelope or by hand during normal business hours by no later than 10:00 a.m. (Dublin)

on May 19, 2026 (being 48 hours prior to the 7% Preference Share Scheme Meeting).

12.57% Preference Shareholders who wish to submit proxies by electronic means may do so up to the same deadline (i.e. not later than 48

hours prior to the meeting) by visiting www.exproxyappointment.com or scanning the QR code and following the instructions on the 7%

Preference Share Form of Proxy for the 7% Preferernce Share Scheme Meeting. 7% Preference Shareholders who have any queries in

relation to the proxy appointment process, do not receive a 7% Preference Share Form of Proxy by post, or who wish to be sent paper

copies of documents relating to the 7% Preference Share Scheme Meeting, should contact the Registrar, (Computershare Investor

Services (Ireland) Limited, 3100 Lake Drive, Citywest Business Campus, Dublin 24, D24 AK82, Ireland or telephone (+353 (1) 6968467)).

The completion of a 7% Preference Share Form of Proxy will not preclude you from attending the 7% Preference Share Scheme Meeting

and voting in person, if you wish to do so.

Holdings in Uncertificated Form as an EB Participant

12.67% Preference Shareholders who hold interests in the 7% Preference Shares through a participant account in the EB System can submit

electronic voting instructions in the manner described in the document issued by Euroclear Bank entitled 'Euroclear Bank as issuer CSD

for Irish corporate securities' and available on the Euroclear Bank website (www.euroclear.com).

12.7EB Participants can either send: electronic voting instructions to instruct EB Nominees to either itself, or by appointing the Chair of the 7%

Preference Share Scheme Meeting as a proxy to:

• vote in favour of the 7% Preference Share Scheme;

• vote against the 7% Preference Share Scheme;

• abstain in respect of the 7% Preference Share Scheme; and/or

• give a discretionary vote to the Chair of the 7% Preference Share Scheme Meeting in respect of the 7% Preference Share Scheme;

or

• give a proxy voting instruction to appoint a third party (other than EB Nominee or the Chair of the 7% Preference Share Scheme),

who may be a corporate representative or the EB Participant themselves, to attend the meeting and vote the number of 7%

Preference Shares specified in the proxy voting instruction by providing Euroclear Bank with the proxy details as requested in its

notification (e.g. proxy first name, proxy last name, proxy address). There is no facility to offer a letter of representation or to appoint

a corporate representative other than through submission of third party proxy appointment instructions.

12.8Further detail in relation to the procedures for voting in respect of shares held through an EB Participant is set out in the "Notes" section in

the Notice of the 7% Preference Share Scheme Meeting. While the voting deadline will be confirmed by Euroclear Bank and notified by it

to EB Participants, Euroclear Bank will, wherever practical, aim to have a voting instruction deadline of one hour prior to the Company's

proxy appointment deadline (being 48 hours before the time appointed for the 7% Preference Share Scheme Meeting or any adjournment

thereof.)

Holdings through CDIs in CREST

12.9Voting instructions for 7% Preference Shareholders who hold interests in the 7% Preference Shares as CDIs in the CREST system are to

be received via Broadridge. Further details on this service are set out on the 'All you need to know about SRD II in Euroclear UK & Ireland'

webpage of the Euroclear Bank website (www.euroclear.com) which is accessible to CREST participants (see section CREST International

Service – Proxy voting).

12.10CDI holders will be required to use the EUI proxy voting service facilitated by the Broadridge Global Proxy Voting service in order to

receive meeting announcements and send back voting instructions, as required. To facilitate client set up, CDI holders who wish to

participate in the proxy voting service, will need to complete a Meetings and Voting Client Set-up Form (CRT408), a copy of which is

available on the Euroclear Bank website (www.euroclear.com) which is accessible to CREST participants. Completed application forms

should be returned to EUI by an authorised signatory with another relevant authorised signatory copied in for verification purposes using

the following email address: uk-membership@euroclear.com. Fully completed and returned application forms will be shared with

116<br>

CRH PROXY STATEMENT 2026

Broadridge by EUI. This will enable Broadridge to contact a shareholder and share further detailed information on the service offering and

initiate the process for granting their access to the Broadridge platform.

12.11Further detail in relation to the procedures for voting in respect of shares held through CDIs is set out in the "Notes" section in the Notice

of the 7% Preference Share Scheme Meeting. While the voting deadline will be confirmed by, or on behalf of Euroclear UK (by Broadridge)

and notified by them to CDI holders, the voting deadline for holders of CDIs in respect of the 7% Preference Share Scheme Meeting is

expected to be two Business Days prior to Euroclear Bank's voting instruction deadline.

12.127% Preference Shareholders should consult with their stockbroker or other intermediary at the earliest opportunity for further information

on the processes and timelines for submitting proxies and voting instructions for the 7% Preference Share Scheme Meeting through the

respective systems.

12.13If you have any queries in relation to action to be taken, please contact the Registrar, Computershare Investor Services (Ireland) Limited,

3100 Lake Drive, Citywest Business Campus, Dublin 24, D24 AK82, Ireland, on (+353 (1) 6968467) between 9.00 a.m. and 5.00 p.m.

Monday to Friday (other than bank holidays in Ireland). For legal reasons, the Registrar will not be able to provide advice on the merits of

the cancellation itself or give financial, legal or tax advice.

13. Further Information

13.1The terms of the 7% Preference Share Scheme are set out in full in "Part I – The 7% Preference Share Scheme of Arrangement" of Annex

C to the Proxy Statement and the 7% Preference Share Scheme Circular.

13.2Further information regarding the Preference Share Cancellations is set out in the FAQs Regarding the LSE Delisting and Preference Share

Cancellations at Annex E of the Proxy Statement, which are available on the Company's website, www.crh.com under the heading

"Shareholder Centre".

14. Board Recommendation

14.1The Board considers the Preference Share Cancellations to be in the best interests of CRH and its Ordinary Shareholders and Preference

Shareholders as a whole. Your vote is very important. Whether or not you plan to attend the 7% Preference Share Scheme Meeting,

please take appropriate action to make sure your 7% Preference Shares are represented and voted at the 7% Preference Share Scheme

Meeting.

14.2Accordingly, the Board unanimously recommends that you vote "FOR" the approval of the 7% Preference Share Scheme at the 7%

Preference Share Scheme Meeting.

117<br>

CRH PROXY STATEMENT 2026

Annex D – Proposal 11 – Approval of

Certain Amendments to the Articles to

Remove References therein to any

Class(es) of Proposed Preference Shares

Cancelled in connection with the

Proposed Preference Share Cancellations

**The proposed amendments to the Company's Articles are to (i) remove references to any classes of Preference Shares** 

**cancelled pursuant to any of the Schemes, (ii) delete redundant provisions that relate to the Preference Shares, (iii) insert a** 

**new Article 16 to facilitate implementation of the Schemes, and (iv) reflect consequential renumbering of and updates to cross** 

**references in the Articles to reflect such amendments. Certain explanatory footnotes are included in the proposed** 

**amendments to the Articles described in Annex D to denote the amendments which will apply in circumstances where (i) both** 

**Schemes, and/or (ii) only one of the Schemes, are implemented.**

An indication of the amendments made is set out as follows:

![Annex D - Rider - 9 March 2026-1.jpg](crh-20260326_g88.jpg)

118<br>

CRH PROXY STATEMENT 2026

![Annex D - Rider - 9 March 2026-2.jpg](crh-20260326_g89.jpg)

119<br>

CRH PROXY STATEMENT 2026

![Annex D - Rider - 9 March 2026-3.jpg](crh-20260326_g90.jpg)

120<br>

CRH PROXY STATEMENT 2026

![Annex D - Rider - 9 March 2026-4.jpg](crh-20260326_g91.jpg)

121<br>

CRH PROXY STATEMENT 2026

![Annex D - Rider - 9 March 2026-5.jpg](crh-20260326_g92.jpg)

122<br>

CRH PROXY STATEMENT 2026

![Annex D - Rider - 9 March 2026-6.jpg](crh-20260326_g93.jpg)

123<br>

CRH PROXY STATEMENT 2026

![Annex D - Rider - 9 March 2026-7.jpg](crh-20260326_g94.jpg)

124<br>

CRH PROXY STATEMENT 2026

![Annex D - Rider - 9 March 2026-8.jpg](crh-20260326_g95.jpg)

125<br>

CRH PROXY STATEMENT 2026

Annex E – FAQs for shareholders holding

5% Preference Shares and/or 7%

Preference Shares in connection with the

LSE Delisting and Preference Shares

Cancellations

**SECTION 1: GENERAL**

Capitalised terms used in this FAQ document shall have the meaning ascribed to such terms in the Notice of AGM and Proxy Statement

2026 (the "Proxy Statement"), available on the Company's website (Shareholder Center - CRH).

1. How do I know if my holding in CRH plc is in the form of Preference Shares

'Preference Shareholders' refers to persons who hold CRH's 5% Preference Shares and/or 7% Preference Shares. This is distinct and separate

from a holding of CRH's Ordinary Shares.

You can hold Preference Shares in two ways:

(i)directly as a registered shareholder, with your name being listed on CRH's Register of Members, and with your holding being evidenced

in documentary form, (for example, by a dividend voucher issued to you by Computershare, or by a Statement of Holding issued to you

by Computershare on request), and your dividends being paid to you by Computershare. Documentation received by you from

Computershare will indicate which class of Preference Share you own; or

(ii)indirectly through a broker, custodian or nominee, holding as a Euroclear Bank participant (i.e. a participant in the Euroclear Bank

clearing system used for the preference shares), and with your dividends being paid to you by your broker, custodian or nominee.

You should contact your broker, custodian, nominee, or your financial adviser, if you are unsure if you own Preference Shares.

2. What changes are happening to the Preference Shares?

Following a review of CRH's London Stock Exchange ('LSE') listings and preference share capital structure, the Board has determined that it is in

the best interests of the Company and shareholders:

(i)to delist the 7% Preference Shares from the LSE and to seek shareholder approval for the 7% Preferences Shares to be

cancelled; and

(ii)to seek shareholder approval for the 5% Preference Shares to be cancelled and for the 5% Preference Shares to be delisted from

Euronext Growth Dublin ('EGD') in connection with such cancellation.

The cancellation of the Preference Shares, if approved by shareholders, will be carried out by way of court-approved schemes of arrangement.

See Section 3 below for further information. The delisting of the 7% Preference Shares from the LSE does not require shareholder approval. The

delisting of the 5% Preference Shares from EGD will occur if shareholder and court approval for the cancellation of the 5% Preference Shares is

obtained.

**SECTION 2: THE 7% PREFERENCE SHARE DELISTING** 

1. What is the LSE Delisting?

CRH has announced that it has applied for the cancellation of the listing of its 7% Preference Shares on the Official List of the FCA, and the

cancellation of the admission to trading of those shares on the main market for listed securities of the LSE. This will take effect at the same time

as the equivalent delisting of CRH's Ordinary Shares from the LSE (collectively with the delisting of the 7% Preference Shares, the 'LSE Delisting').

In practice, this means that, following the LSE Delisting, it will no longer be possible to trade 7% Preference Shares on the LSE, or on any other

stock exchange. As discussed further below in Section 3, there will be an opportunity for holders of the 7% Preference Shares to convert their

preference shares into cash at a premium price pursuant to the proposed cancellation of the 7% Preference Shares.

The delisting of the 7% Preference Shares is independent of the proposal to cancel the 7% Preference Shares, and will occur whether or not the

cancellation of the 7% Preference Shares becomes effective.

This FAQ document has been prepared for shareholders holding Preference Shares in connection with the LSE Delisting, and the cancellation of

the Preference Shares. A separate FAQ document for shareholders holding Ordinary Shares in connection with the LSE Delisting is available at

*https://www.crh.com/investors/ordinary-shareholders/*.

2. When will the LSE Delisting take effect?

It is expected that the LSE Delisting will become effective from 8:00 a.m. (UK time) on April 20, 2026, such that the last day of trading of 7%

Preference Shares on the LSE will be April 17, 2026.

126<br>

CRH PROXY STATEMENT 2026

3. Why is CRH implementing the LSE Delisting?

As part of the review of its listing structure, CRH carefully considered, amongst other things, the level of trading activity for its ordinary shares on

the LSE as well as the additional cost, and regulatory and administrative obligations arising from retaining the LSE listing and concluded that it is

in the best interests of the Company and its shareholders to proceed with the LSE Delisting.

4. If the cancellation of the 7% Preference Shares is not approved after the delisting of the 7% Preference Shares becomes effective, will

the 7% Preference Shares be listed on another exchange?

If the proposed cancellation of the 7% Preference Shares does not become effective, the Board does not intend to apply for a listing of the 7%

Preference Shares on another stock exchange. Consequently, it will only be possible to sell or transfer 7% Preference Shares in an off-market

transaction following the LSE Delisting. You should contact your financial adviser for further information in relation to off-market transactions.

5. Why is CRH delisting the 7% Preference Shares from the LSE, irrespective of the outcome of the proposal to cancel the 7% Preference

Shares, whereas the 5% Preference Shares will only be delisted if the cancellation of the 5% Preference Shares becomes effective?

The 7% Preference Shares are being delisted from the LSE as CRH has determined to cancel all of its listings on the LSE, regardless of whether

the cancellation of the 7% Preference Shares becomes effective. No shareholder approval is required in connection with the LSE Delisting.

The delisting of the 5% Preference Shares from EGD will only occur if the cancellation of the 5% Preference Shares becomes effective, as

shareholder approval is required for the delisting. The shareholder approval for the delisting from EGD is being sought as part of the approval of

the scheme to cancel the 5% Preference Shares.

6. Can I vote on the LSE Delisting at the 2026 AGM?

No shareholder approval is required for the LSE Delisting under the UK Listing Rules. Following a period of consultation, the Board has

determined that the LSE Delisting is in the best interests of the Company and shareholders. Please refer to Questions 2 and 3 for more

information.

7. Will the LSE Delisting impact how I receive my dividends?

No, the LSE Delisting will not impact how you receive your dividends. You will receive your dividends in the same way you normally do. However,

please refer to Question 10 in Section 3 in relation to how the cancellation of the 7% Preference Shares will impact dividend payments.

8. Can I continue to hold my 7% Preference Shares indirectly through a broker, custodian, nominee or other intermediary in the EB

System following the delisting of the 7% Preference Shares from the LSE?

Whether you may continue to hold your 7% Preference Shares through a broker, custodian, nominee or other intermediary in the same manner as

you currently hold your 7% Preference Shares will be dependent on whether the intermediaries (brokers, custodians and nominees) will continue

to support holdings through the securities settlement system operated by Euroclear Bank following the LSE Delisting. You should contact the

intermediary through which you hold your 7% Preference Shares for further information. Please refer to Section 3 for further information on this.

**SECTION 3: THE PREFERENCE SHARE CANCELLATIONS AND DELISTING OF THE 5% PREFERENCE SHARES**

1. What are the Preference Share Cancellations?

In addition to the delisting of the 7% Preference Shares from the LSE, CRH is also proposing to cancel the 5% Preference Shares and the 7%

Preference Shares in exchange for a premium cash consideration payment. Further details regarding the terms of the cancellations of the

Preference Shares are set out on pages 31 to 38 of the Proxy Statement.

2. What will happen as a result of the Preference Share Cancellations?

If any of the proposed cancellations of the Preference Shares become effective, the applicable class of Preference Shares will be cancelled and

extinguished and will cease to exist, and the holders of such Preference Shares will receive cash consideration in exchange for such cancellation

(as detailed further in Question 5 below).

3. Why are the Preference Shares being cancelled?

The Board believes that the proposed cancellations, if implemented, would result in a number of benefits for CRH and its shareholders, including

reducing certain administrative obligations and streamlining applicable regulatory requirements, while providing an opportunity to the preference

shareholders to monetize their holdings.

4. When are the cancellations of the Preference Shares expected to become effective?

The cancellations of the Preference Shares are expected to be completed in mid-2026, subject to obtaining the required shareholder and court

approvals. No assurance can be provided as to when or if the cancellations will be completed.

5. If the cancellations of the Preference Shares are approved, when will I receive the consideration for the cancellation of my Preference

Shares?

Preference Shareholders will receive a premium cash consideration payment within 14 days of the cancellation of a class of Preference Shares

becoming effective. The payment will be made in the same manner as dividend payments are typically made, unless Preference Shareholders

provide written instructions to the Company's Registrar, Computershare, by the applicable scheme record time (being 11:59 p.m. (Dublin) on the

last business day before the applicable scheme becomes effective), revoking any existing mandates in place and providing updated mandate

instructions.

6. How has the consideration payment for the cancellation of the preference shares been calculated?

The proposed cancellations would be in exchange for a cash payment of an amount equal to 40 times the annual dividend per preference share.

This amount has been calculated by capitalizing the annual dividend payable at a rate of 2.5156%, approximately 100bps below the yield on a 30-

year German bond (the "Bund") as at March 12, 2026. This is calculated by dividing the annual dividend per share by a rate of 2.5156%. The

payments would be €2.54 per share in respect of the 5% Preference Shares, representing 200% of nominal value, and €3.556 per share in

respect of the 7% Preference Shares, representing 280% of nominal value, with both classes having a nominal value of €1.27.

127<br>

CRH PROXY STATEMENT 2026

7. When and where will the AGM and scheme meetings be held?

Please refer to pages 32 and 84 of the Proxy Statement for further details of the time, date and location of the AGM and Preference Share

scheme meetings. Please also refer to Questions 9 and 13 in relation to who can vote at the meetings.

8. Why are Preference Shareholders being asked to vote at a Scheme Meeting?

It is proposed that the cancellation of the Preference Shares will be carried out by way of two separate schemes of arrangement under Irish law.

Irish law requires that three separate shareholders meetings are held in connection with the cancellations, the two Scheme Meetings and the

AGM, to approve resolutions in connection with the cancellation of the Preference Shares.

The Board have convened (i) a scheme meeting of the 5% Preference Shareholders to obtain their approval of the scheme of arrangement

regarding the cancellation of the 5% Preference Shares (including the delisting from EGD), and (ii) a scheme meeting of the 7% Preference

Shareholders to obtain their approval of the scheme of arrangement regarding the cancellation of the 7% Preference Shares.

It will not be possible to complete the cancellation of any class of Preference Shares unless the requisite shareholder approvals have been

obtained at the applicable Scheme Meetings, and at the AGM. Approval of the Irish High Court is also required in respect of the cancellation of

each class of Preference Shares.

If you are a Preference Shareholder, you will receive a notice of scheme meeting, an explanatory statement in relation to the resolutions proposed,

the terms of the Scheme, and a proxy card allowing you to cast your vote in respect of the resolution proposed at the Scheme Meeting. At the

respective Scheme Meetings, the Preference Shareholders will be asked to vote on, and if they see fit approve, the cancellation of the applicable

class of Preference Shares.

If the relevant shareholder approvals are obtained in relation to the cancellation of the Preference Shares, CRH will apply to the Irish High Court to

sanction one or both of the schemes of arrangements (as applicable).

9. Can Preference Shareholders vote at the AGM?

7% Preference Shareholders are entitled to vote in respect of a capital reduction of the Company and will therefore be entitled to vote on

Proposal 9 at the AGM, with the ordinary shareholders, which relates to the reduction to the Company's capital in connection with the

cancellation of any class of Preference Shares. 7% Preference Shareholders will not have the right to vote on any other resolutions at the AGM.

5% Preference Shareholders do not have the right to vote on any of the resolutions proposed at the AGM.

10. What will happen to any dividends at the time the Preference Shares Cancellations take effect?

Nothing will happen in respect of any dividend rights or entitlements at the time the cancellations of the Preference Shares take place. There is no

separate entitlement or payment in respect of any dividend unpaid or otherwise accrued up to and including the time at which the applicable

cancellation becomes effective. The cash consideration payment that is being paid to Preference Shareholders in connection with the cancellation

of the Preference Shares comprises the entire amount payable in respect of the cancellation of the Preference Shares.

11. What are the tax implications for me if my Preference Shares are cancelled pursuant to the proposed cancellations?

In general, Preference Shareholders who are resident in Ireland (or those who are ordinarily resident in Ireland or have used their shares in

connection with a trade carried on in Ireland through a branch or agency) should generally be subject to Irish capital gains tax ("Irish CGT") or Irish

corporation tax at a rate of 33% on any chargeable gain arising on the disposal of their Preference Shares pursuant to the cancellations. This is

subject to any available exemptions and reliefs.

Preference Shareholders who are not resident in Ireland should not generally be subject to Irish CGT or Irish corporation tax on chargeable gains

on the disposal of their Preference Shares pursuant to the cancellations.

The cash payment that is being paid to Preference Shareholders in connection with the cancellations should not be subject to Irish dividend

withholding tax. Further, Preference Shareholders should not be chargeable to Irish stamp duty on the disposal of their Preference Shares

pursuant to the cancellations of the Preference Shares.

You should consult your own tax advisor regarding the tax consequences of the Cancellation in your particular circumstances. Please refer to

pages 31 to 34 of the Proxy Statement for further information.

12. What will happen if the proposed Preference Share cancellations do not complete?

If the proposed cancellations of the Preference Shares are not approved at the AGM, and/or by the applicable Preference Shareholders at the

Scheme Meetings, the Company will not be able to implement the proposed cancellations, no payment of consideration for the cancellation will

be made to Preference Shareholders and the Preference Shareholders will continue to hold the Preference Shares in the same manner as they

currently do today, save that the 7% Preference Shares will no longer be listed on the LSE as a result of the LSE Delisting.

13. Who can attend and vote at the Scheme Meetings?

The record date for the Scheme Meetings is 7.00 p.m. (Irish time) on Sunday, May 17, 2026.

Registered Preference Shareholders

If you hold your Preference Shares directly on the CRH register of members and you are listed on CRH's register of members at the record date,

you are entitled to receive notice of, attend, speak, and vote at the applicable Scheme Meeting and any adjournments thereof.

Such registered holders may appoint a proxy by completing the Form of Proxy in accordance with the instructions printed thereon in connection

with the cancellation of the applicable class of Preference Shares. To be valid, the Forms of Proxy must be delivered to the Registrar by post no

later than 48 hours prior to the meeting (i.e. 10.00 a.m. (Irish Time) on May 19, 2026, for the Scheme Meeting in respect of the 7% Preference

Shares, and 10.30 a.m. (Irish Time) on May 19, 2026, for the Scheme Meeting in respect of the 5% Preference Shares).

Preference Shareholders who hold in registered form and who wish to submit proxies by electronic means may do so up to the same deadline

(i.e. not later than 48 hours prior to the meeting) by visiting (www.eproxyappointment.com) or scanning the QR code and following the instructions

on the Form of Proxy. Preference Shareholders who have any queries in relation to the proxy appointment process should contact the Registrar

(Computershare Investor Services (Ireland) Limited, 3100 Lake Drive, Citywest Business Campus, Dublin 24, D24 AK82, Ireland or telephone

(+353 (1) 6968467)).

128<br>

CRH PROXY STATEMENT 2026

Interests held through a participant account in the Euroclear Bank System

Preference Shareholders who hold interests in the Preference Shares through a participant account in the Euroclear Bank System (i.e. the

Euroclear Bank clearing system used for the preference shares), can submit electronic voting instructions in the manner described in the

document issued by Euroclear Bank entitled 'Euroclear Bank as issuer CSD for Irish corporate securities' and available on the Euroclear Bank

website (www.euroclear.com).

EB participants can send electronic voting instructions to instruct Euroclear Nominees to appoint either itself (or another named person) or the

Chair of the applicable Scheme Meeting as a proxy to vote in relation to the cancellation of the Preference Shares.

Euroclear Bank's voting instruction deadline is expected to be 9.00 a.m. (Irish Time) on May 19, 2026 for the Scheme Meeting in respect of the

7% Preference Shares, and 9.30 a.m. (Irish Time) on May 19, 2026, for the Scheme Meeting in respect of the 5% Preference Shares).

Interests held via CREST Depository Interests ("CDIs") through the CREST clearing system

Voting instructions for Preference Shareholders who hold interests in the Preference Shares as CDIs in the CREST system are to be received via

Broadridge. Further details on this service are set out on the 'All you need to know about SRD II in Euroclear UK & Ireland' webpage of the

Euroclear Bank website (www.euroclear.com) which is accessible to CREST participants (see section CREST International Service – Proxy voting).

Holders of CDIs will be required to use the CREST operator's proxy voting service facilitated by the Broadridge Global Proxy Voting service in

order to receive meeting announcements and send back voting instructions, as required. To facilitate client set up, holders of CDIs who wish to

participate in the proxy voting service, will need to complete a Meetings and Voting Client Set-up Form (CRT408), a copy of which is available on

the Euroclear Bank website (www.euroclear.com) which is accessible to CREST participants. Completed application forms should be returned to

EUI by an authorised signatory with another relevant authorised signatory copied in for verification purposes using the following email address:

uk-membership@euroclear.com. Fully completed and returned application forms will be shared with Broadridge by EUI. This will enable

Broadridge to contact a shareholder and share further detailed information on the service offering and initiate the process for granting their access

to the Broadridge platform.

The voting deadline for holders of CDIs in respect of the Scheme Meetings is expected to be two business days prior to Euroclear Bank's voting

instructions deadline.

Preference Shareholders should consult with their stockbroker or other intermediary at the earliest opportunity for further information on the

processes and timelines for submitting proxies and voting instructions for the Scheme Meetings through the respective systems.

Preference Shareholders who hold their interests through CDIs and/or an EB participant in the Euroclear Bank System wishing to attend, speak,

ask questions and vote at a Scheme Meeting must arrange to have themselves appointed as their own proxy as explained in the notes to the

notice convening the Scheme Meetings which will be issued to each Preference Shareholder.

If you have any queries in relation to action to be taken, please contact the Registrar, Computershare Investor Services (Ireland) Limited. For legal

reasons, the Registrar will not be able to provide advice on the merits of the cancellation itself or give financial, legal or tax advice.

If you are unsure of any of the information provided, please contact your financial advisor or broker for further information.

For further information, please refer to pages 97 to 103 of Annex B and pages 110 to 116 of Annex C of the Proxy Statement.

14. If the cancellation of the 5% Preference Shares is not approved, will the listing of the 5% Preference Shares on EGD be cancelled?

The cancellation of the listing of the 5% Preference Shares on EGD will only occur if the cancellation of the 5% Preference Shares becomes

effective.

15. If the 5% Preference Share Cancellation is approved, when will the delisting of the 5% Preference Shares from EGD take place?

If the cancellation of the 5% Preference Shares is approved and becomes effective, it is proposed that the delisting of the 5% Preference Shares

from EGD will take effect from 7:00 a.m. (Irish time) on the date after the date on which the cancellation of the 5% Preference Shares becomes

effective (expected to be in mid-2026). An announcement with further information regarding the scheme effective date will be released by the

Company at a later date.

**SECTION 4: PREFERENCE SHAREHOLDER SUPPORTS**

Helplines are available as set out below. Please contact the service appropriate to your query. Please also note that shareholder helpline

operators cannot give financial, tax, investment or legal advice.

A.General Queries on the Delisting of the 7% Preference Shares and the Preference Share Cancellations

If you have a query which is not addressed by the answers to the questions in sections 1 to 3 above, you can contact a toll-free CRH helpline as

follows:

Telephone:Ireland (+353) 1800 948 270

United Kingdom (+44) 0800 029 4526

Updates to the operation of this helpline will be advised on the following page on the CRH website, www.crh.com/investors/preference-shareholders*.*

Please note that the operators of the CRH helpline will not be in a position to provide technical assistance in relation to the delisting of the 7%

Preference Shares and/or the Preference Share Cancellations. They will also not be able to deal with queries from Registered Holders in relation

to the day to day management of their shareholding – see B below for the correct contact details.

\*\*Lines are open 9.00 a.m. to 5:30 p.m. (Irish time), Monday to Friday (excluding public holidays in England and Wales).

B.Preference Shareholders who hold their shares in directly on the CRH Register of Members (and not through a broker, custodian,

nominee or other intermediary)\* with queries in relation to the day-to-day management of their Preference Share holdings (such as

account balances, dividend payments, address changes, etc.) should contact Computershare Investor Services (Ireland) Limited as

follows:

129<br>

CRH PROXY STATEMENT 2026

Address:Computershare Investor Services (Ireland) Limited

3100 Lake Drive,

Citywest Business Campus,

Dublin 24

D24 AK82

Ireland.

Telephone:(+353 (1) 6968467), (calls to this helpline from outside Ireland are charged at the applicable international rates)\*\*

Email:webcorres@computershare.co.uk

Website:*www.investorcentre.com/ie*

\*Preference shareholders who hold preference shares through a broker, custodian, nominee or other intermediary should contact the relevant

intermediary with queries on the day to day management of their holdings.

\*\*Lines are open 8:30 a.m. to 5:30 p.m. (Irish time), Monday to Friday (excluding public holidays).

130<br>

CRH PROXY STATEMENT 2026

Annex F – Proposal 12 – Proposed

Amendments to Articles of Association

**The proposed amendment to the Company's Articles includes the deletion of Article 87 in its entirety and consequential** 

**renumbering of and updates to cross references in the Articles.**

The full text of Article 87 is set out as follows:

87. The qualification of a Director shall be the holding alone and not jointly with any other person of 1,000 Ordinary Shares in the capital of the

Company and Ordinary Shares shall also be deemed to be held by a Director for the purposes of this Article, where the Director holds an

interest in such Ordinary Shares through a central securities depository. A Director may act before acquiring his qualification but must

acquire the same within two months (with such time period to be extended if trading in the Company's shares is prohibited at the relevant

time) after his appointment or election.

An indication of the deletion of Article 87 and update to the cross reference in Article 102 is set out as follows:

![Annex F (11 March 2026)-1.jpg](crh-20260326_g96.jpg)

131<br>

CRH PROXY STATEMENT 2026

![Annex F (11 March 2026)-2.jpg](crh-20260326_g97.jpg)

![CRH-Logo-FullColour-RGB.jpg](crh-20260326_g1.jpg)<br>

**CRH**

1350 Avenue of the Americas

New York

NY 10019

USA

E-mail: mail@crh.com

Telephone: +353 1 404 1000

Website: *www.crh.com*

Registered Office

42 Fitzwilliam Square

Dublin 2

D02 R279

Ireland

E-mail: crh42@crh.com

Telephone: +353 1 634 4340

CRH<sup>®</sup> is a registered trademark of CRH

![0486DF_CRH_Broker_3-5-26.jpg](crh-20260326_g98.jpg)

![0486DF_CRH_Broker_3-5-262.jpg](crh-20260326_g99.jpg)

![9002 CRH 7pc Proxy-1.jpg](crh-20260326_g100.jpg)

![9002 CRH 7pc Proxy-2.jpg](crh-20260326_g101.jpg)